Walter E. Washington Convention Center WASHINGTON, DC ... · Discussants: Robert J. Applegate, Kirk...

TCTCONFERENCE.COM

Walter E. Washington Convention CenterWASHINGTON, DC

October 29-November 2, 2016

INNOVATE. EDUCATE. COLLABORATE.

AGENDA

TCT - Agenda

Last updated November 2, 2016 at 4:05 pm

The agenda listed below may not be as up to date as our website. Please refer to our conference website for the latest agenda details.

Saturday, October 29, 2016

CardioVascular Professionals (CVP) Course: 25th Annual Cardiovascular Nurse and Technologist Symposium, Part I: RegisteredCardiovascular Invasive Specialists (RCIS) Review Course

Saturday, October 29 12:00 PM - 6:15 PM Walter E. Washington Convention Center Room 204, Level 2Accreditation: CME/CNE/ASRT

Session I. Fundamental Knowledge12:00 PM - 1:45 PM

Moderator: Thomas H. Maloney Discussants: Robert Kutys, Tim J. Lapp, Maria E. Romero, George W. Vetrovec

12:00 PM Introduction and Session Objectives Thomas H. Maloney

12:05 PM In-depth Coronary Angiography, and Coronary Complication Review Matched With InteractiveCadaver Heart Dissection and PCI Robert Kutys, Maria E. Romero, George W. Vetrovec

12:45 PM In-depth Cardiac Structure, Conduction System, and Hemodynamic Review of the NormalHeart Matched With Interactive Cadaver Heart Dissection by the Pathologist Robert Kutys, Tim J. Lapp, Maria E. Romero

1:30 PM Keynote Lecture: Enter the Bioresorbable Scaffold Era: Similarities and Differences FromMetallic DES Azeem Latib

Session II. The Aortic Valve: A Deep Dive1:45 PM - 3:05 PM

Moderator: Thomas H. Maloney Discussants: Sarah Clarke, Jeff Davis, Paul D. Mahoney

1:45 PM Fundamental Knowledge: Aortic Valve Anatomy, Function, and Relational Pathology Sarah Clarke

2:05 PM Hemodynamics of Aortic Stenosis: You CAN Do This Jeff Davis

2:25 PM How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making andProcedural Guidance Paul D. Mahoney

2:50 PM Live Demo: Transcatheter Aortic Valve Replacement Paul D. Mahoney

Visit Nurse Tech Exhibits/ Break3:05 PM - 3:20 PM

3:05 PM Nurse Tech Exhibits/ Break

Session III. The Mitral Valve: A Deep Dive3:20 PM - 4:30 PM

Moderator: Jeff Davis Discussants: Zachary M. Gertz, James B. Hermiller Jr, Tim R. Martin

3:20 PM Fundamental Knowledge: Mitral Valve Anatomy, Function, and Relational Pathology Tim R. Martin

3:40 PM Hemodynamics of Mitral Regurgitation, Making it Simple and Understandable Zachary M. Gertz

4:00 PM How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair ClinicalDecision-Making and Procedural Guidance James B. Hermiller Jr

4:15 PM Live Demo: Transcatheter Mitral Valve Repair Zachary M. Gertz, James B. Hermiller Jr

Session IV. The Right Heart: A Deep Dive4:30 PM - 5:15 PM

Moderator: Jeff Davis Discussants: Kenneth A. Gorski, Tim J. Lapp, David A. Wood

4:30 PM Fundamental Knowledge: Pulmonic Valve Anatomy, Function, and Relational Pathology Kenneth A. Gorski

4:45 PM Fundamental Knowledge: Tricuspid Valve Anatomy, Function, and Relational Pathology David A. Wood

5:00 PM Hemodynamics of the Right Heart: The Essentials Tim J. Lapp

Session V. Hands on Hearts Bioskills Session - Cadaver Hearts (Courtesy of CVPath)5:15 PM - 6:15 PM

Moderators: Marsha Holton, Robert Kutys, Thomas H. Maloney, Maria E. Romero, Torie Samuda Discussant: Jeff Davis

5:15 PM Session V. Hands on Hearts Bioskills Session - Cadaver Hearts (Courtesy of CVPath)

CardioVascular Professionals (CVP) Course: 25th Annual Cardiovascular Nurse and Technologist Symposium - Evening Reception

Saturday, October 29 6:15 PM - 7:15 PM Walter E. Washington Convention Center 204 Foyer, Level 2Accreditation: none

ABCs of Interventional Cardiology 2016: An Introductory Course

Saturday, October 29 2:00 PM - 6:00 PM Walter E. Washington Convention Center Room 147, Level 1Accreditation: CME/ASRT/CNE

Session I. Basics of Cardiac Anatomy and Angiography2:00 PM - 3:15 PM

Moderators: George D. Dangas, Vijay Kunadian Discussants: Hemal Gada, Philippe Généreux, Alexandra J. Lansky, Gennaro Sardella

2:00 PM Overview of Cardiac and Coronary Anatomy Vijay Kunadian

2:12 PM Discussion With Audience Q&A

2:15 PM Right and Left Heart Catheterization: Technique and Hemodynamics Robert T. Pyo


2:30 PM Coronary Angiography: Set-up, Views, Artifacts, and Pitfalls Philippe Généreux


2:45 PM Intravascular Imaging: Core Concepts Gennaro Sardella


3:00 PM Vascular Access Routes and Complications Robert T. Pyo


Session II. Overview of Cardiovascular Pathophysiology and Treatment3:15 PM - 4:30 PM

Moderators: Peter Barlis, Greg L. Kaluza Discussants: Ziad A. Ali, Nicola Corvaja, David A. Cox, Hitinder S. Gurm, Allen Jeremias, Michael C. Kim

3:15 PM Coronary Artery Disease: Pathology and Pathogenesis Greg L. Kaluza


3:30 PM Coronary Pathophysiology and FFR Allen Jeremias


3:45 PM Acute Coronary Syndromes: NSTE-ACS Ziad A. Ali


4:00 PM Acute Coronary Syndromes: STEMI Michael C. Kim


4:15 PM Valvular Heart Disease: Diagnosis and Treatment Options Nicola Corvaja


Break4:30 PM - 4:45 PM

Session III. Introduction to Coronary Angioplasty and Stenting4:45 PM - 6:00 PM

Moderators: Bonnie H. Weiner, Jose M. WileyDiscussants: Piera Capranzano, Joseph P. Carrozza Jr, Robert J. Gil, John M. Lasala, Robert T. Pyo, GennaroSardella, Hadley Wilson

4:45 PM Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons) Bonnie H. Weiner


5:00 PM Interventional Pharmacology Overview for PCI and ACS Piera Capranzano


5:15 PM Atherotomy, Atherectomy, and Embolic Protection Robert T. Pyo


5:40 PM DES Systems and Outcomes Gennaro Sardella


SCAI Cath Lab Leadership Bootcamp @ TCT 2016

Saturday, October 29 2:00 PM - 6:00 PM Cardiovascular Research Foundation Room 103A, Level 1Accreditation: CME/ASRT/CNE

Bootcamp I: Leadership and Administration2:00 PM - 3:00 PM

Moderators: Robert J. Applegate, Charles E. Chambers Discussants: Megan Berlinger, Kirk N. Garratt, Ehtisham Mahmud, Bernadette S. Speiser

2:00 PM Welcome and Introduction Charles E. Chambers

2:05 PM Effective Strategies for Success of the Medical Director Ehtisham Mahmud

2:15 PM The Role and Responsibilities of the Cath Lab Manager Bernadette S. Speiser

2:25 PM Physician and Management Partnerships: Benefits and Challenges Megan Berlinger

2:35 PM How to Defuse Interpersonal Conflicts in the Cath Lab Kirk N. Garratt

2:45 PM Roundtable Discussion With Audience Q&A

Bootcamp II: Economics and Payments3:00 PM - 4:00 PM

Moderators: Megan Berlinger, Peter L Duffy Discussants: Robert J. Applegate, Kirk N. Garratt, Duane S. Pinto

3:00 PM A Primer of Cath Lab Economics 2016 Robert J. Applegate

3:10 PM Cath Lab as a Value Proposition Kirk N. Garratt

3:20 PM MACRA and Payment Changes: Are you Ready? Peter L Duffy

3:30 PM Bundle Payment for PCI: Are You Prepared? Duane S. Pinto


Bootcamp III: Quality4:00 PM - 5:00 PM

Moderators: Charles E. Chambers, Michael A. Kutcher Discussants: Ori Ben-Yehuda, Arnold Seto

4:00 PM The 10 Most Important Quality Metrics for Your Cath Lab Michael A. Kutcher

4:10 PM SCAI AUC and PCI Risk Apps: How to Make Them Work in Your Lab Charles E. Chambers

4:20 PM Can Risk-Adjusted Outcomes Differentiate Individual Operator Performance? Arnold Seto

4:30 PM Vendor and Industry Relations: The Good, Bad, and Ugly Ori Ben-Yehuda


Bootcamp IV: New Technology5:00 PM - 6:00 PM

Moderators: Ehtisham Mahmud, Kenneth Rosenfield Discussants: Emmanouil S. Brilakis, Jason Fontana, Daniel M. Kolansky

5:00 PM High Cost Technologies: How Do You Afford Them? Kenneth Rosenfield

5:10 PM Integration of Novel Technologies in the Cath Lab: An Industry Perspective Jason Fontana

5:20 PM Training Standards for New Technology: Professional Societies, Industry or FDA Daniel M. Kolansky

5:30 PM Occupational Hazards and Technologies to Address Them Emmanouil S. Brilakis


Special Session: Saturday Night Fights at TCT

Saturday, October 29 6:15 PM - 7:35 PM Walter E. Washington Convention Center Hall BAccreditation: none

Round 1: Bioresorbable Scaffolds – Beauty or the Beast6:15 PM - 6:35 PM

Moderator: Mark Reisman

6:15 PM Niche Technology Paul S. Teirstein

6:20 PM Expanded Use Gregg W. Stone

6:25 PM Rebuttal (Niche Technology) Paul S. Teirstein

6:27 PM Rebuttal (Expanded Use) Gregg W. Stone

6:29 PM Discussion

Round 2: TAVR – Opening the Floodgates6:35 PM - 6:55 PM


6:35 PM Ready for Low-Risk Patients Martin B. Leon

6:40 PM Not so Fast Michael J. Mack

6:45 PM Rebuttal (Ready for Low-Risk Patients ) Martin B. Leon

6:47 PM Rebuttal (Not so Fast) Michael J. Mack

6:49 PM Discussion

Round 3: Revascularization for Stable CAD – Feast or Famine?6:55 PM - 7:15 PM


6:55 PM CHIP (Complex High-Risk Angioplasty) Is the Future Ajay J. Kirtane

7:00 PM The Mainstay Are Watchful Waiting and Medical Therapy David J. Maron

7:05 PM Rebuttal (CHIP) Ajay J. Kirtane

7:07 PM Rebuttal (Medical Therapy) David J. Maron

7:09 PM Discussion

Round 4: DAPT Duration – On Again, Off Again7:15 PM - 7:35 PM


7:15 PM The Longer the Better Laura Mauri

7:20 PM The Shorter the Better George D. Dangas

7:25 PM Rebuttal (Longer the Better) Laura Mauri

7:27 PM Rebuttal (Shorter the Better) George D. Dangas

7:29 PM Discussion

Satellite Special Session: The Translational Pathways for Cardiovascular Devices; Current and Future Direction (Sponsored by ISCTR)

Saturday, October 29 7:00 AM - 5:00 PM Walter E. Washington Convention Center Room 146A, Level 1Accreditation: none

Session I - Basic Process for Device Development7:00 AM - 9:00 AM

Moderators: Jack C. Lewin, Bram D. Zuckerman

7:00 AM Welcome Statement ISCTR Lecturers: Nabil Dib, Spencer B. King III

7:05 AM ISCTR Mission And Statement of Meeting Purpose ISCTR Lecturer: Nabil Dib

7:20 AM Requirement for New Technology to be Included in the Guidelines, “The Ultimate Goal” ISCTR Lecturer: Alice K. Jacobs

7:35 AM CMS Criteria For Reimbursement of Cardiovascular Innovation ISCTR Lecturer: Joseph Chin

7:50 AM Regulatory Requirement for Marketing Approval ISCTR Lecturer: Deborah Castillo, PhD

8:05 AM Pre-Clinical and Clinical Trial Design and Endpoints of Fast Track to Device Approval ISCTR Lecturer: Roseann White

8:20 AM A Unified Approach for Clinical Trial Design That Meets The Requirement of RegulatoryApproval, Reimbursement And The Clinical Practice Guideline ISCTR Lecturer: Mitchell W. Krucoff

8:35 AM Panel Discussion Discussants: Deborah Castillo, PhD, Anthony N. DeMaria, Nabil Dib, Alice K. Jacobs, Spencer B.King III, Mitchell W. Krucoff, Jack C. Lewin, Robert Roberts, Stanton J. Rowe, Chuck Simonton,Roseann White, Bram D. Zuckerman

9:00 AM Break

Break9:00 AM - 9:15 AM

Session II – Pre-Clinical, Early Feasibility, and Safety Study for Device Development9:15 AM - 11:00 AM

Moderators: Andrew Farb, David Reuter, MD

9:15 AM Current Challenges and Future Direction for Feasibility and Early Human Study for DeviceEvaluation; FDA Point of View ISCTR Lecturer: Andrew Farb

9:30 AM Current Challenges and Future Direction for Feasibility and Early Human Study for DeviceEvaluation; Industry Point of View ISCTR Lecturer: David Reuter, MD

9:45 AM Requirements for Medical Device Manufacturing And Iteration; Industry Point of View ISCTR Lecturer: Richard J. Rapoza

10:00 AM Requirements for Medical Device Manufacturing And Iteration; FDA Point of View ISCTR Lecturer: Brad Quinn

10:15 AM Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation; Investigator Point OfView ISCTR Lecturer: Renu Virmani

10:30 AM Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation; FDA Point Of View ISCTR Lecturer: Judith Davis, DVM

10:45 AM Panel Discussion Discussants: Judith Davis, DVM, Andrew Farb, Robert Kohler, Michael Minogue, James E. Muller,Laura Perkins, DVM, Brad Quinn, Richard J. Rapoza, Patricia Todd, Renu Virmani, Roseann White

Lunch11:00 AM - 11:20 AM

Presentation of the Glen and Marilyn Nelson Award11:20 AM - 12:00 PM

11:20 AM Presentation of the Glen and Marilyn Nelson Award for Innovation and Translation inCardiovascular Medicine to Robert Califf Award Presenters: Anthony N. DeMaria, Marilyn Nelson ISCTR Lecturer: Nabil Dib

11:30 AM Keynote Speaker Dr. Robert Califf: The Translational Pathway to Expedite Scientific Discoveryto Patients ISCTR Lecturer: Robert M. Califf

Session III – Aortic Valve Development12:00 PM - 1:00 PM

Moderators: Spencer B. King III, Stanton J. Rowe

12:00 PM The Clinical Need for Innovative Treatment for Aortic Valve Disease ISCTR Lecturer: Martin B. Leon

12:15 PM Current Challenges and Future Direction for Aortic Valve Development and Iteration; IndustryPoint of View ISCTR Lecturer: Stanton J. Rowe

12:30 PM Current Challenges and Future Direction for Aortic Valve Development and Iteration; FDAPoint Of View ISCTR Lecturer: Nicole Ibrahim

12:45 PM Panel Discussion Discussants: Nicole Ibrahim, Spencer B. King III, Michael J. Mack, Stanton J. Rowe, PatriciaTodd, Renu Virmani, Bram D. Zuckerman

Session IV – Mitral/Tricuspid Valve Development1:00 PM - 2:00 PM

Moderators: Dorothy Abel, MD, Gregg W. Stone

1:00 PM The Clinical Need for Innovative Treatment for Mitral/Tricuspid Valve Disease ISCTR Lecturer: Michael J. Mack

1:15 PM Current Challenges and Future Direction for Mitral/Tricuspid Valve Development And Iteration;Industry Point of View ISCTR Lecturer: Patricia Todd

1:30 PM Current Challenges and Future Direction for Mitral/Tricuspid Valve Development and Iteration;FDA Point of View ISCTR Lecturer: John C Laschinger

1:45 PM Panel Discussion Discussants: Dorothy Abel, John C Laschinger, Michael J. Mack, Gregg W. Stone, Patricia Todd,Renu Virmani

Session V - Coronary Stent Development2:00 PM - 3:00 PM

Moderators: Neal Fearnot, Spencer B. King III

2:00 PM The Clinical Need for Innovative Coronary Stent ISCTR Lecturer: Gregg W. Stone

2:15 PM Current Challenges and Future Direction for Coronary Stent Development and Iteration; FDAPoint of View ISCTR Lecturer: Michael C. John

2:30 PM Current Challenges and Future Direction for Coronary Stent Development and Iteration;Industry Point of View ISCTR Lecturer: Chuck Simonton

2:45 PM Panel Discussion Discussants: Neal Fearnot, Michael C. John, Spencer B. King III, Chuck Simonton, Gregg W.Stone, Craig A. Thompson, Mark Toland

Break3:00 PM - 3:10 PM

Session VI – Catheter Ablation Development3:10 PM - 4:15 PM

Moderators: Mark Fellman, MD, Douglas Packer, MD

3:10 PM The Clinical Need for the Treatment of Arrhythmia, Innovative Catheter Ablation ISCTR Lecturer: Douglas Packer, MD

3:25 PM Current Challenges and Future Direction for Catheter Ablation Development and Iteration;Industry Point of View ISCTR Lecturer: Uri Yaron, PhD

3:40 PM Current Challenges and Future Direction for Catheter Ablation Development and Iteration;FDA Point of View ISCTR Lecturer: Mark Fellman, MD

3:55 PM Panel Discussion Discussants: Mark Carlson, Anthony N. DeMaria, Jun Dong, MD, PhD, Mark Fellman, MD,Timothy Laske, PhD, Douglas Packer, MD, Win-Kuang Shen, MD, Uri Yaron, PhD

Session VII – Consensus Document4:15 PM - 5:00 PM

4:15 PM Writing Consensus Document ISCTR Lecturer: Anthony N. DeMaria

4:30 PM Panel Discussion Discussants: Anthony N. DeMaria, Nabil Dib, Andrew Farb, Spencer B. King III, Jack C. Lewin,Rick McGuire, James E. Muller, Robert Roberts, Stanton J. Rowe, Chuck Simonton, RoseannWhite, Bram D. Zuckerman

Satellite Special Session: Durable Polymers: Re-evaluating Their Role in Cardiovascular Devices (Sponsored by CVPath Institute, Inc. andUC Berkeley, Supported by Abbott)

Saturday, October 29 3:00 PM - 5:30 PM Walter E. Washington Convention Center Room 145A, Level 1Accreditation: CME

Durable Polymers: Re-evaluating Their Role in Cardiovascular Devices3:00 PM - 5:30 PM

Chairs: Aloke V. Finn, Kevin Healy, MD, Renu Virmani Facultys: Sripal Bangalore, David Grainger, PhD, Hyo-Soo Kim, Gaku Nakazawa, MD, Tullio Palmerini, BuddyRatner, PhD, Kazuyuki Yahagi, MD

3:00 PM Inauguration Kevin Healy, PhD, Renu Virmani

3:05 PM History of Polymers in Cardiology Renu Virmani

3:20 PM Fundamentals of Blood-Material Interaction and DES Polymers in Review David Grainger, PhD

3:35 PM Specifics of Blood-Material Interaction for Fluoropolymer vs Metal Buddy Ratner, PhD

3:50 PM Latest Preclinical Findings From Second Generation DES Aloke V. Finn

4:05 PM Break

4:15 PM Relevant Clinical Data Summary - BMS vs Polymeric DES Tullio Palmerini

4:30 PM Relevant Clinical Data Summary - Different Polymeric DES Head-to-Head Data Gaku Nakazawa, MD

4:45 PM Moderated Panel and Audience Q&A Moderator: Aloke V. Finn

Poster Abstracts and Challenging Cases

Saturday, October 29 6:00 PM - 8:00 PM Walter E. Washington Convention Center Hall B, Lower LevelAccreditation: none

Sunday, October 30, 2016

Breakfast Meeting: A New Era in Fusion Imaging for Structural Heart Procedures (Sponsored by Siemens)

Sunday, October 30 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 143A, Level 1Accreditation: none

Check In and Breakfast6:30 AM - 7:00 AM

A New Era in Fusion Imaging for Structural Heart Procedures7:00 AM - 8:00 AM

Facultys: Brian Bethea, MD, Brij Maini

7:00 AM A New Era in Image Guidance for Structural Heart Procedures: Leveraging a Team-basedApproach for Improved Outcomes Brian Bethea, MD, Brij Maini

7:03 AM Mitraclip case and discussion on how to troubleshoot when encountering difficulty in gainingaccess Brian Bethea, MD, Brij Maini

7:15 AM Two TAVR cases including a valve-in-valve patient and a case performed using ICE Brian Bethea, MD, Brij Maini

7:35 AM Watchman procedure that will showcase the use of CT, Angio with contrast, 3D TEE, and ICE Brian Bethea, MD, Brij Maini

7:45 AM Q&A Discussion Moderators: Brian Bethea, MD, Brij Maini

Breakfast Meeting: Cathworks “Wire-less” Angiography FFR: Clinical and Cath Lab Integration Pathways (Sponsored by CathWorks Ltd)



Cathworks “Wire-less” Angiography FFR: Clinical and Cath Lab Integration Pathways7:00 AM - 8:00 AM

Chairs: Bernard De Bruyne, Ran Kornowski Facultys: John D. Carroll, Pablo Codner, MD, William F. Fearon, Peter J. Fitzgerald, Martin B. Leon

7:00 AM Introduction Martin B. Leon

7:05 AM Clinical Value and Limitations of Current FFR Systems William F. Fearon

7:15 AM 3D Coronary Reconstruction From 2D Coronary 3D From 2D Coronary Angiograms John D. Carroll

7:20 AM Cathworks Technology and Updates from the Clinical Validation Studies Bernard De Bruyne

7:30 AM Interesting Cathworks Clinical Cases from Investigator Sites Pablo Codner, MD

7:40 AM “Live” Case-in-a-Box: Newest Cathworks On-site System Ran Kornowski

7:50 AM Roundtable Discussion Moderators: John D. Carroll, Ran Kornowski

Breakfast Meeting: Chocolate: Second Generation Balloon DCB Platform (Sponsored by TriReme Medical, LLC)

Sunday, October 30 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144B, Level 1Accreditation: none


Chocolate: Second Generation Balloon DCB Platform7:00 AM - 8:00 AM

Chairs: Martin B. Leon, Jasvindar Singh Facultys: Tim A. Fischell, Manish A. Parikh, Mehdi H. Shishehbor

7:00 AM Chocolate's Unique Mechanism of Action - Clear and Visible Difference Tim A. Fischell

7:10 AM Clinical Perspective Martin B. Leon

7:15 AM Coronary Chocolate and OVP - The Importance and Need for Optimal Vessel Prep Jasvindar Singh

7:33 AM Coronary Chocolate Acute, Image-Guided Mechanistic Registry, Chocolate Heart FIM andDCB Future Manish A. Parikh

7:51 AM First Head-to-Head Peripheral DCB Study - Chocolate Touch Mehdi H. Shishehbor

Breakfast Meeting: Contrast-Induced Acute Kidney Injury: Focus on Hydration and Dye Saving (Sponsored by CRF, Supported by OspreyMedical and Renal Guard Solutions Inc.)

Sunday, October 30 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: none


Contrast-Induced Acute Kidney Injury: Focus on Hydration and Dye Saving7:00 AM - 8:00 AM

Facultys: Prakash Balan, Somjot S. Brar, Carlo Briguori, Alaide Chieffo, Steffen Desch, Giora Weisz

7:00 AM Welcome and Introductions Somjot S. Brar

7:05 AM Importance of Hydration: How to Do it Best? RenalGuard Therapy Somjot S. Brar

7:15 AM Dye Saving Tips: The DyeVert Plus System Steffen Desch

7:25 AM Case Presentation: A Difficult Patient at High Risk for AKI - How to Choose Optimal DyeSavings and Hydration Methods Case Presenter: Alaide Chieffo

7:40 AM Practical Application: Incorporating a Hydration and Dye Savings Protocol for Patients atHigh Risk of AKI Prakash Balan

7:50 AM Discussion: The Future of AKI Regarding Contrast and Hydration Status

Breakfast Meeting: Endovascular Carotid Barostimulation: A Novel Interventional Approach to Hypertension Treatment (Sponsored byVascular Dynamics, Inc.)

Sunday, October 30 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 149, Level 1Accreditation: none


Endovascular Carotid Barostimulation: A Novel Interventional Approach to Hypertension Treatment7:00 AM - 8:00 AM

Chair: Gregg W. Stone Facultys: Mark C. Bates, Farrell O. Mendelsohn, Wilko Spiering, Bryan Williams

7:00 AM Introduction Gregg W. Stone

7:05 AM Endovascular Carotid Barostimulation via Transcatheter-Delivered Implant: DeviceTechnology and Mechanism of Action Moderator: Gregg W. Stone Discussant: Mark C. Bates

7:15 AM Procedure Description and Case Report Farrell O. Mendelsohn

7:25 AM Evidence of Safety and Preliminary Efficacy: European Results From First-in-Man Study Wilko Spiering

7:40 AM Introduction to a Randomized, Blinded, Sham Controlled Pivotal Trial Moderator: Gregg W. Stone Discussant: Bryan Williams

7:50 AM Discusssion Moderator: Gregg W. Stone

Breakfast Meeting: Intra-aortic Balloon Counterpulsation for Percutaneous Aortic Valve or Complex PCI Procedures: Award-Winning CasePresentations (Sponsored by CRF, Supported by Getinge Group)



Intra-aortic Balloon Counterpulsation for Percutaneous Aortic Valve or Complex PCI Procedures7:00 AM - 8:00 AM

Chairs: Tayo A. Addo, George D. Dangas, Vijay Kunadian Facultys: Etelberto Hernández, Kevin O'Gallagher, Vimalkumar Veerappan Kandasamy

7:00 AM Electrical Storm in the Setting of Right Coronary Artery ST Elevation Myocardial Infarctionand the Role of Intra-aortic Balloon Pump Case Presenter: Vimalkumar Veerappan Kandasamy

7:15 AM Q&A

7:20 AM Complicated Acute Coronary Syndrome in an Elderly Patient: Usefulness of Intra-aorticBalloon Pump in Urgent High-risk Percutaneous Coronary Intervention Case Presenter: Etelberto Hernández

7:35 AM Q&A

7:40 AM IABP Support for Emergency Transfer Following Iatrogenic Coronary Dissection Case Presenter: Kevin O'Gallagher

7:55 AM Q&A

Breakfast Meeting: Moving Forward in Anticoagulation Care With the Availability of a Reversal Agent (Sponsored by Boehringer-Ingelheim)

Sunday, October 30 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 145B, Level 1Accreditation: none


Moving Forward in Anticoagulation Care With the Availability of a Reversal Agent7:00 AM - 8:00 AM

7:00 AM Moving Forward in Anticoagulation Care With the Availability of a Reversal Agent James A. Reiffel

Breakfast Meeting: The Transcatheter Revolution – Are You and the Heart Team Ready? (Sponsored by CRF, Supported by Medtronic,Inc.)

Sunday, October 30 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: CME


The Transcatheter Revolution – Are You and the Heart Team Ready?7:00 AM - 8:00 AM

Co-Chairs: A. Pieter Kappetein, Paul Sorajja Facultys: Ted Feldman, Christopher U. Meduri, Michael J. Reardon, Mathew Williams

7:00 AM Going Beyond the High-risk Patient: The New Boundaries for Transcatheter Therapy Michael J. Reardon

7:12 AM The Halo Effect and Bottom-Line Results From Therapy Expansion Christopher U. Meduri

7:24 AM How to Meet the Logistical Challenges of a Rapidly Growing Program Mathew Williams

7:36 AM Leveraging the TAVR Experience Into TMVR: Similarities and Differences for the Heart Team Ted Feldman

7:48 AM Panel Q&A

Main Arena I, Sunday, Oct. 30

Sunday, October 30 8:00 AM - 1:00 PM Walter E. Washington Convention Center Ballroom, Level 3Accreditation: CME/ASRT/CNE

Plenary Session I. Live Cases8:00 AM - 9:00 AM

Live Case Moderator: Martin B. Leon Live Case Co-Moderator: Antonio Colombo Live Case Discussants: Alexandre Abizaid, Jorge A. Belardi, Paul Hsien-Li Kao, Dimitrios Karmpaliotis, AkikoMaehara, Seung-Jung Park, Ashok Seth, Craig R. Smith, Hendrik Treede, Stephan Windecker, Alan C. Yeung Digital Moderator: Nirat Beohar Digital Panelists: Adriano Caixeta, Simon R. Dixon, Michael S. Lee Factoid Facultys: Jaya Chandrasekhar, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong Hwa Yamamoto

8:00 AM Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of MedicalSciences, Beijing, China Live Case Operators: Jie Qian, MD, Shubin Qiao, MD, Yongjian Wu, MD, Yuejin Yang, MD

8:30 AM Zhongshan Hospital, Shanghai, China Live Case Operators: Junbo Ge, Lei Ge, MD

Plenary Session II. Late-Breaking Clinical Trials 1: Cosponsored by The Lancet9:00 AM - 10:00 AM

Moderator: Gregg W. Stone Digital Moderator: Wayne B. Batchelor Digital Panelists: Andrea Abizaid, Vinay K. Bahl, Francesco Prati Discussants: Giuseppe Biondi-Zoccai, Stephane Cook, Marco A. Costa, Stephen G. Ellis, John McB. Hodgson,Angela Hoye, Ik-Kyung Jang, Peter Juni, Sigmund Silber Co-Moderator: Stuart Spencer

9:00 AM ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guidedvs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease Ziad A. Ali

9:12 AM Moderated Roundtable Discussion Discussant: Ziad A. Ali

9:20 AM BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing TwoDifferent Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-BasedDrug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease Clemens von Birgelen

9:32 AM Moderated Roundtable Discussion Discussant: Clemens von Birgelen

9:40 AM BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs aZotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary ArteryDisease David E. Kandzari

9:52 AM Moderated Roundtable Discussion Discussant: David E. Kandzari

Plenary Session III. Live Cases10:00 AM - 11:00 AM

Live Case Moderator: Gregg W. Stone Live Case Co-Moderator: Patrick W. Serruys Live Case Discussants: Anita Asgar, Christian W. Hamm, Spencer B. King III, Ran Kornowski, Raj Makkar, Gary S.Mintz, Barry D. Rutherford, Manel Sabate, Joachim Schofer, Joanna J. Wykrzykowska, Ralph Stephan vonBardeleben Digital Moderator: Fernando Alfonso Digital Panelists: Ian C. Gilchrist, Detlef G. Mathey, Richard Smalling Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Darshan Doshi, Serdar Farhan, Jonathan Soverow, MyongHwa Yamamoto

10:00 AM McGill University Health Center, Montreal, Canada Live Case Operators: Fahd Mahkdom, MD, Giuseppe Martucci, MD, Nicolo Piazza

10:30 AM Antwerp Cardiovascular Centre, ZNA Middelheim, Antwerp, Belgium Live Case Operators: Benjamin Scott, MD, Stefan Verheye, Paul Vermeersch, MD

Plenary Session IV. Career Achievement Award11:00 AM - 11:15 AM

Award Presenters: Martin B. Leon, Gregg W. Stone Award Recipient: Runlin Gao

Plenary Session V. TCT Focus Session#1: The Innovators Roundtable11:15 AM - 12:15 PM

Moderator: Juan F. Granada Digital Moderator: Louis A. Cannon Digital Panelists: Neal L. Eigler, Tim A. Fischell, Robert J. Lederman Discussants: Shmuel Banai, Todd J. Brinton, Daniel Burkhoff, Elazer R. Edelman, Andrew Farb, Peter J. Fitzgerald,Barry T. Katzen, Frank Litvack, John B. Simpson, Paul G. Yock Co-Moderator: Martin B. Leon

11:15 AM Featured Lecture: Interventional Innovation is Alive and Well – Reflections and Predictions Elazer R. Edelman

11:35 AM Featured Lecture: The Digital Health Revolution Will Transform Cardiovascular DiseaseManagement in the Future Peter J. Fitzgerald

11:55 AM Animated Discussion

Plenary Session VI. First Report Investigations 112:15 PM - 1:00 PM

Moderator: David W.M. Muller Digital Moderator: Jonathan M. Hill Digital Panelists: Stephen P. Hoole, Hyo-Soo Kim, Jacek Legutko Discussants: Dariusz Dudek, Michael Joner, Henning Kelbæk, Takeshi Kimura, Masato Nakamura, YoshinobuOnuma, Serban Puricel, David G. Rizik, Giulio G. Stefanini

12:15 PM ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of anEverolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent inPatients With Coronary Artery Disease Runlin Gao

12:25 PM Moderated Roundtable Discussion Discussant: Runlin Gao

12:30 PM ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of anEverolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent inPatients With Coronary Artery Disease Patrick W. Serruys

12:40 PM Moderated Roundtable Discussion Discussant: Patrick W. Serruys

12:45 PM LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, RandomizedTrial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With CoronaryArtery Disease at High Bleeding Risk Philip M. Urban

12:55 PM Moderated Roundtable Discussion Discussant: Philip M. Urban

Coronary Theater I, Sunday, Oct. 30

Sunday, October 30 8:00 AM - 12:00 PM Walter E. Washington Convention Center Coronary Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: LM/Bifurcation8:00 AM - 10:00 AM

Live Case Moderator: George D. Dangas Live Case Co-Moderator: Issam D. Moussa Live Case Discussants: Yasushi Asakura, Donald Cutlip, Jorge Gaspar, Dietmar H. Glogar, Michalis Hamilos, NielsR. Holm, Irene M. Lang, Manish A. Parikh, Jamil Abdalla Saad Digital Moderator: Kevin J. Beatt Digital Panelists: Somjot S. Brar, Jose de Ribamar Costa Jr, R. Stefan Kiesz Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

8:00 AM Antwerp Cardiovascular Centre, ZNA Middelheim Antwerp, Belgium Live Case Operators: Alessia Azzano, MD, Benjamin Scott, MD, Stefan Verheye, PaulVermeersch, MD, PhD

9:00 AM Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of MedicalSciences, Beijing, China Live Case Operators: Jie Qian, MD, Shubin Qiao, MD, Yongjian Wu, MD, Yuejin Yang, MD

Session II. Live Cases: CTOs/CHIP10:00 AM - 12:00 PM

Live Case Moderator: J. Aaron Grantham Live Case Co-Moderator: Christoph K. Naber Live Case Discussants: Carlo Briguori, Pawel E. Buszman, Andrejs Erglis, Gary Gershony, Robert J. Gil, Hyeon-Cheol Gwon, Thomas A. Ischinger, Henning Kelbæk, Bernhard Witzenbichler Digital Moderator: Alan C. Yeung Digital Panelists: Michael A. Kutcher, Gennaro Sardella, Hadley Wilson Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

10:00 AM Zhongshan Hospital, Fudan University, Shanghai, China Live Case Operators: Junbo Ge, Lei Ge, MD

11:00 AM McGill University Health Center, Montreal, Canada Live Case Operators: Sonny Dandona, MD, Rustem Dautov, MD, Stéphane Rinfret, Luiz FernandoYbarra, MD

Didactic Session: Clinical Trial Design, Statistics, and Interpretation

Sunday, October 30 2:00 PM - 6:07 PM Walter E. Washington Convention Center Room 206, Level 2Accreditation: CME/ASRT/CNE

Session I. Hot Topics in Clinical Trial Design2:00 PM - 3:01 PM

Moderators: Roxana Mehran, Pascal Vranckx Discussants: Scott Berry, Sanjay Kaul, Thomas McAndrew, Stuart J. Pocock, John A. Spertus, Tracy Y. Wang

2:00 PM Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit inSuperiority and Non-inferiority Trials Robert A. Harrington

2:08 PM Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, andInterpretability? Adaptive Design in a Frequentist Framework! Stuart J. Pocock

2:16 PM Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, andInterpretability? Adaptive Design in A Bayesian Framework! Scott Berry


2:31 PM Issues With Non-inferiority Trials: Choosing the Margin and Comparator; Creep, Noise, andMore Sanjay Kaul

2:39 PM Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in RandomizedTrials: Why the Resistance? John A. Spertus

2:47 PM The Extraordinary Frustration of Converting Meaningful Clinical Trial Results (and Guidelines)Into Changes in Clinical Practice Pascal Vranckx


Session II. Clinical Trial Interpretation – Common Pitfalls3:01 PM - 3:45 PM

Moderators: Peter Juni, E. Magnus Ohman Discussants: Ori Ben-Yehuda, John A. Bittl, Ioanna Kosmidou, Stuart J. Pocock, Gregg W. Stone, Jan Tijssen

3:01 PM Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the PrimaryEndpoint? Gregg W. Stone

3:11 PM Levels of Evidence: Single-center vs Multicenter Trials Roxana Mehran

3:19 PM Clinical Trial Interpretation: Relative vs Absolute Differences John A. Bittl

3:27 PM Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study Ori Ben-Yehuda


Session III. Limitations of Observational Studies and Randomized Trials3:45 PM - 4:29 PM

Moderators: Eugene H. Blackstone, Robert W. Yeh Discussants: Scott Berry, Donald Cutlip, Kirk N. Garratt, Robert A. Harrington, Stuart J. Pocock, Tracy Y. Wang

3:45 PM Importance of Unmeasured Confounders in Observational Registries: ASCERT and OtherExamples Kirk N. Garratt

3:53 PM Comparison of Propensity Score Methods and Covariate Adjustment in ObservationalStudies: Similarities and Differences Stuart J. Pocock

4:01 PM Can Propensity and Instrumental Variable Methods Overcome the Limitations ofObservational Databases: Lessons From TRANSLATE-ACS Tracy Y. Wang

4:09 PM When Are Randomized Trials Not Enough, and Can Observational Data Reliably InformComparative Effectiveness Decisions? Robert A. Harrington


Session IV. If You Want to Publish, Do a Meta-analysis! BUT…4:29 PM - 5:05 PM

Moderators: Ori Ben-Yehuda, Tullio Palmerini

4:29 PM Strengths and Limitations of Meta-analysis: Standard, Network and Bayesian Techniques, andthe Value of Individual Patient-level Data Pooling Giuseppe Biondi-Zoccai

4:39 PM What Journal Editors Think of Meta-analysis: A Roundtable Discussion Discussants: Anthony N. DeMaria, Joseph A. Hill, Spencer B. King III, Stuart Spencer, David O.Williams

4:47 PM What Clinicians and Trialists Think of Meta-analysis: A Roundtable Discussion Discussants: David A. Cox, Donald Cutlip, Bernard J. Gersh, Laura Mauri, E. Magnus Ohman,Harvey D. White

4:55 PM What Statisticians Think of Meta-analysis: A Roundtable Discussion Discussants: Scott Berry, Eugene H. Blackstone, Peter Juni, Stuart J. Pocock, Jan Tijssen,Roseann White

5:03 PM Take-home Messages: Strengths, Limitations, and the Future of Meta-analysis Moderators: Ori Ben-Yehuda, Tullio Palmerini

Session V. Advanced Concepts You Should Understand5:05 PM - 6:07 PM

Moderators: Scott Berry, Stuart J. Pocock Discussants: Eugene H. Blackstone, Peter Juni, Bjorn Redfors, Jan Tijssen, William S. Weintraub

5:05 PM Limitations of Composite Endpoints and Strategies for Hierarchical Testing Jan Tijssen

5:13 PM Analyzing Repeat Events Eugene H. Blackstone

5:21 PM Accounting for the Risk of Competing Events Peter Juni

5:29 PM Surrogate Endpoints: Construction, Validation, and “Trustiness” William S. Weintraub

5:37 PM Mediation Analysis: A Method to Assign Attributable Risk Bjorn Redfors

5:45 PM Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies:Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others) Ajay J. Kirtane


Didactic Session: Interventional Therapies for Hypertension (Renal Denervation and Beyond)


Session I. Hypertension Treatment 2016: Updated Review of the Essentials2:00 PM - 2:47 PM

Moderators: Felix Mahfoud, Michael A. Weber Discussants: Chaim S. Lotan, Marie-Claude Morice, Vasilios Papademetriou, Wilko Spiering, Terje K. Steigen, RenuVirmani

2:00 PM Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice(SPRINT, PATHWAYS, Others) Michael A. Weber

2:10 PM Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management? Ehtisham Mahmud


2:24 PM The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy andPathophysiology) Michael Joner

2:32 PM Hypertension Treatment Targets Beyond the Kidneys Atul Pathak


Session II. Critical Appraisal of Ongoing and Planned Studies in Renal Denervation2:47 PM - 4:26 PM

Moderators: Farrell O. Mendelsohn, Stephen G. Worthley Discussants: Bagrat Alekyan, Steven L. Almany, Darrel P. Francis, Melvin D. Lobo, James R. Margolis, KinturSanghvi, Michael A. Weber

2:47 PM Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year Felix Mahfoud

2:57 PM Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices Horst Sievert

3:04 PM Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and FutureHypertension Device Trials Bryan Williams

3:11 PM Device Overview and Ongoing Study Design: Boston Scientific REINFORCE Ajay J. Kirtane

3:18 PM Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTNTrial Program David E. Kandzari

3:25 PM Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program William B. White

3:32 PM Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study Laura Mauri

3:39 PM Device Overview and Ongoing Study Design: Kona WAVE IV Trial Roland E Schmieder

3:46 PM Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlledTARGET BP I Trial David E. Kandzari

3:53 PM Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results AccuratelyReflect RDN Effectiveness? Justin E. Davies

4:01 PM Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Martin B. Leon


Session III. Novel Hypertension Approaches Beyond Renal Denervation4:26 PM - 5:31 PM

Moderators: Ajay J. Kirtane, Bryan Williams Discussants: Mark C. Bates, Sameer Gafoor, Vasilios Papademetriou, C. Venkata S. Ram, Robert S. Schwartz,Horst Sievert, Wojtek Wojakowski

4:26 PM Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx DeviceResults Atul Pathak

4:36 PM Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and theCALM Studies Wilko Spiering

4:46 PM Shunt-based Technologies for Hypertension Control: The Rox Medical Program Paul A. Sobotka

4:56 PM Pacing-based Treatments of Hypertension: BackBeat Medical Karl-Heinz Kuck

5:06 PM Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies William B. White


Session IV. Autonomic Modulation: New Targets, New Opportunities5:31 PM - 6:00 PM

Moderators: Elazer R. Edelman, Krishna J. Rocha-Singh Discussants: Justin E. Davies, Richard R. Heuser, Michael Joner, William B. White, Adam Witkowski

5:31 PM Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure Farrell O. Mendelsohn

5:39 PM Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias Vivek Y. Reddy

5:47 PM Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions Adam Witkowski


Didactic Session: Left Atrial Appendage Closure, Part 1: Indications and Outcomes


Session I. Atrial Fibrillation Background and Management: Core Concepts2:00 PM - 3:09 PM

Moderators: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt Discussants: Michael D. Ezekowitz, Christopher B. Granger, Michelle O'Donoghue, Vivek Y. Reddy

2:00 PM Atrial Fibrillation: Scope of the Problem Michael D. Ezekowitz

2:07 PM Role of LAA in Atrial Arrhythmias: Origin and Maintenance Karl-Heinz Kuck

2:14 PM Impact of LAA Exclusion on Neurohormonal Modulation DJ Lakkireddy

2:21 PM Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance Michelle O'Donoghue

2:33 PM What are Valid Absolute and Relative Contraindications to Warfarin and NOACs? Freek W.A. Verheugt

2:40 PM Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Vivek Y. Reddy

2:47 PM Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trialsand the Real World Christopher B. Granger


Session II. Clinical Outcomes After LAA Closure3:09 PM - 5:15 PM

Moderators: Vivek Y. Reddy, Steven J. Yakubov Discussants: Krzysztof Bartus, Peter C. Block, Eulogio J. Garcia, Philippe Garot, Clifford J. Kavinsky, GiuseppeTarantini

3:09 PM Surgical Approaches to LAA Closure: Techniques, Devices, and Results Marc Gillinov

3:19 PM Epicardial Closure of the LAA With the Lariat: What Do we Know About It’s Safety andEfficacy? Matthew J. Price

3:31 PM Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin andNOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Vivek Y. Reddy

3:46 PM Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy BeenProven? David R. Holmes Jr.

3:56 PM Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry Martin W Bergmann


4:14 PM Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients:Certainties, Data Gaps, and Future Studies Apostolos Tzikas

4:29 PM Early and Late Results With the Occlutech LAA Occluder (and Future studies) Horst Sievert

4:36 PM Early and Late Results With the Wavecrest LAA Occluder (and Future Studies) Gregg W. Stone

4:43 PM Early and Late Results With the LAmbre LAA Occluder (and Future Studies) Yat-Yin Lam

4:50 PM Early Clinical Results With the Cardia LAA Occluder (and Future Studies) Josep Rodés-Cabau

4:57 PM Rationale for and Outcomes of LAA Closure Plus Pulmonary Vein Isolation Jamil Abdalla Saad


Session III. Two Great LAA Closure Debates5:15 PM - 6:07 PM

Moderators: David R. Holmes Jr., Josep Rodés-Cabau Discussants: Steven R. Bailey, Patrick A. Calvert, Reda Ibrahim, Ioanna Kosmidou, Jan Kovac, Randall J. Lee

5:15 PM Pre-debate #1 Vote: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAAClosure? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

5:17 PM Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure?No – Chronic Anticoagulation Should be Offered First Stefan C. Bertog

5:24 PM Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure?Yes – As Long As Full Consent Is Provided, Let the Patient Decide! David Hildick-Smith


5:39 PM Post-debate #1 Vote (Who Won?): Should Low Bleeding Risk Patients With Atrial FibrillationBe Offered LAA Closure? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

5:41 PM Pre-debate #2 Vote: How Should Patients With Atrial Fibrillation and Recent Stents or ACS BeManaged? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

5:43 PM Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents orACS? No – A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First! Freek W.A. Verheugt

5:50 PM Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents orACS? Yes – Minimize Bleeding Risk and Improve Long-term Outcomes! Brian K. Whisenant


6:05 PM Post-debate #2 Vote (Who Won?): How Should Patients With Atrial Fibrillation and RecentStents or ACS Be Managed? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

Didactic Session: Metallic Drug-Eluting Stents: New Data, New Directions


Session I. Worldwide Clinical Trial Summaries and Updates With the Major DES2:00 PM - 3:38 PM

Moderators: Dean J. Kereiakes, Pieter C. Smits Discussants: Sripal Bangalore, Giuseppe De Luca, David G. Rizik, Erick Schampaert, Dinesh Shah, Christian M.Spaulding

2:00 PM Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents Tullio Palmerini

2:10 PM Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-ElutingStents - Evolution From the Fluoropolymer-Based Promus Element to the BioabsorbablePolymer-Based Synergy Dean J. Kereiakes

2:20 PM Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents Roxana Mehran

2:30 PM Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents Stephan Windecker

2:38 PM Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-ElutingStents Shigeru Saito

2:46 PM Stent Design and Comprehensive Data Review: Orsiro Cobalt Chromium Sirolimus-ElutingStents Thomas Pilgrim

2:54 PM Comparative DES Outcomes: What Have We Learned From 7 SORT-OUT Trials? Lisette Okkels Jensen

3:02 PM Comparative DES Outcomes: What Have We Learned From the SCAAR Registry? Update onRecent New Generation DES Stefan K. James

3:09 PM Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BESTto SYNTAX II and Beyond Patrick W. Serruys

3:16 PM The Last Word on DES in Diabetics: Two-Year TUXEDO Outcomes Upendra Kaul


Session II. Debate and Audience Survey3:38 PM - 4:20 PM

Moderators: Manel Sabate, Robert-Jan van Geuns Discussants: Ehrin J. Armstrong, Dariusz Dudek, Giampaolo Niccoli, Ron Waksman, Simon J. Walsh, HadleyWilson

3:38 PM Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or OutcomesBetween the Most Widely Used Contemporary Metallic DES? No – for All Practical Purposesthe Outcomes Are Similar! Julinda Mehilli

3:45 PM Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or OutcomesBetween the Most Widely Used Contemporary Metallic DES? Yes – There Are ImportantDistinctions Relevant to Our Patients! Manel Sabate

3:52 PM Rebuttal Questions to the Debaters

3:56 PM Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role! Eric R. Bates

4:03 PM Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History! Sunil V. Rao

4:10 PM Rebuttal Questions to the Debaters

4:14 PM What Proportion of PCI Patients Will You Treat With BMS Today? Poll Moderators: Manel Sabate, Robert-Jan van Geuns


Session III: Metal Stent Failures: Deep Dive Into Stent Thrombosis and Restenosis4:20 PM - 6:23 PM

Moderators: Fernando Alfonso, Stephan Windecker Discussants: Fausto Feres, Ioannis Iakovou, Takeshi Kimura, Masato Nakamura, Pieter R. Stella, Thomas D.Stuckey

4:20 PM Very Late Failures After Metallic DES: Frequency and Clinical Predictors Mahesh V Madhavan

4:27 PM Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis andRestenosis: Are We Making Progress as Stents Evolve? Aloke V. Finn

4:34 PM Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer? Juan F. Granada

4:41 PM Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes WithDES? Elazer R. Edelman

4:48 PM Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality ImagingStudies Yasunori Ueda

4:55 PM New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DESEvaluated By IVUS and OCT (With Case Examples) Akiko Maehara

5:02 PM Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?Gary S. Mintz

5:09 PM OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications Stephen WL Lee

5:15 PM Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety? Giulio Guagliumi

5:21 PM Are All Stent Thromboses Prognostically Created Equal? Impact of Original ClinicalPresentation, Stent Location and Thrombosis Timing Robert-Jan van Geuns

5:28 PM How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspectsand Beyond Giulio G. Stefanini

5:38 PM Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Case Presenter: Ehrin J. Armstrong

5:45 PM Prognosis and Treatment Options for DES Restenosis and Re-restenosis Fernando Alfonso

5:55 PM Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Ron Waksman

6:01 PM Case Presentation: Evaluation and Management of Recurrent DES Restenosis Case Presenter: Adnan K. Chhatriwalla


Didactic Session: PCI Pharmacotherapy: Procedural Antithrombins and Acute/Chronic DAPT

Sunday, October 30 2:00 PM - 6:03 PM Walter E. Washington Convention Center Room 201, Level 2Accreditation: CME/CNE/ASRT

Session I: Bivalirudin vs Heparin ± GP IIb/IIIa Inhibitors 2016: Dissecting the Merits2:00 PM - 3:05 PM

Moderators: A. Michael Lincoff, Franz-Josef Neumann Discussants: Somjot S. Brar, Piera Capranzano, Mark B. Effron, Bill J. French, Yaling Han, Carey D. Kimmelstiel,Arnold Seto

2:00 PM Start With a Three-way Debate: Heparin Monotherapy Is the Optimal ProceduralAnticoagulant in STEMI Patients Undergoing Primary PCI! A. Michael Lincoff

2:08 PM Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is theOptimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Jorge F. Saucedo

2:16 PM Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMIPatients Undergoing Primary PCI! Harvey D. White

2:24 PM Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Gregg W. Stone

2:31 PM Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From RandomizedTrials John A. Bittl


2:54 PM Session Question #1: In STEMI Patients Undergoing Primary PCI With HeparinAnticoagulation, How Frequently Should GP IIb/IIIa Inhibitors Be Used? Poll Moderators: A. Michael Lincoff, Franz-Josef Neumann

2:56 PM Session Question #2: In STEMI Patients Undergoing Primary PCI With Femoral Access, WhatProportion Should Be Treated With Bivalirudin ? Poll Moderators: A. Michael Lincoff, Franz-Josef Neumann

2:58 PM Session Question #3: In STEMI Patients Undergoing Primary PCI With Radial Access, WhatProportion Should Be Treated With Bivalirudin? Poll Moderators: A. Michael Lincoff, Franz-Josef Neumann

3:00 PM Closing Comments From the Moderators: What Have We Learned? Moderators: A. Michael Lincoff, Franz-Josef Neumann

Session II: The Role of Cangrelor Across the Spectrum of PCI3:05 PM - 4:07 PM

Moderators: Deepak L. Bhatt, Christian W. Hamm Discussants: Dimitrios Alexopoulos, Dominick J. Angiolillo, David Erlinge, Eli I. Lev, Duane S. Pinto, Gary L. Schaer

3:05 PM Cangrelor Deep Dive: What Have We Learned From the CHAMPION Trials? Deepak L. Bhatt

3:17 PM Transitioning Between Cangrelor and Oral P2Y12 Inhibitors: All the Permutations Paul A. Gurbel

3:25 PM Debate: Making the Case for Cangrelor Use in All PCI Patients! Franz-Josef Neumann

3:33 PM Debate: Making the Case for Very Limited Use of Cangrelor! Sorin J. Brener


3:56 PM Session Question #1: What Percentage of Patients With STEMI Undergoing Primary PCIShould Be Treated With Cangrelor ? Poll Moderators: Deepak L. Bhatt, Christian W. Hamm

3:58 PM Session Question #2: In Patients With NSTE-ACS, What Is the Optimal P2Y12 InhibitorApproach? Poll Moderators: Deepak L. Bhatt, Christian W. Hamm

4:00 PM Session Question #3: In Patients With Stable CAD Undergoing PCI Who Were Not PreloadedWith An Oral P2Y12 Inhibitor, What Percentage Should Be Treated With Cangrelor ? Poll Moderators: Deepak L. Bhatt, Christian W. Hamm

4:02 PM Closing Comments From the Moderators: What Have We Learned? Moderators: Deepak L. Bhatt, Christian W. Hamm

Session III: DAPT Duration4:07 PM - 6:03 PM

Moderators: John A. Bittl, Daniel I. Simon Discussants: Sorin J. Brener, Hyeon-Cheol Gwon, Sanjay Kaul, Glenn N. Levine, Jean-François Tanguay, Philip M.Urban

4:07 PM Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most! Laura Mauri

4:15 PM Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most! Salvatore Cassese

4:23 PM Summary and Rationale For the ESC Guidelines on DAPT Duration After PCI Freek W.A. Verheugt

4:31 PM Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI Glenn N. Levine

4:39 PM Strengths and Limitations of Risk Scores to Identify Patients for Long vs Short DAPT Roxana Mehran

4:47 PM Individualizing Care: Which Patients Might Benefit From Prolonged DAPT? Who Might BeHarmed? Robert W. Yeh

4:55 PM Optimal DAPT Duration After Complex or Complicated PCI: A Pooled Analysis Gennaro Giustino

5:03 PM If Prolonged (>1 year) DAPT Is Chosen: Choosing Between Clopidogrel, Prasugrel andTicagrelor C. Michael Gibson

5:11 PM Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal SinusRhythm Patrick W. Serruys

5:19 PM Do All Patients With ACS Need 1 Year (Or Longer) DAPT After PCI? Tullio Palmerini

5:27 PM From ARCTIC to ANTARCTICA: Is the Concept of Tailored Antiplatelet Therapy Finished Eric Van Belle


5:50 PM Session Question #1: What Is the Optimal DAPT Duration For Most Patients With Stable CADTreated With Contemporary DES Who Are at Low Bleeding Risk ? Poll Moderators: John A. Bittl, Daniel I. Simon

5:52 PM Session Question #2: What Is the Optimal DAPT Duration For Most Patients With Stable CADTreated With Contemporary DES Who Are at Moderate/High Bleeding Risk? Poll Moderators: John A. Bittl, Daniel I. Simon

5:54 PM Session Question #3: What Is the Optimal DAPT Duration For Most Patients With Troponin+ACS Treated With Contemporary DES Who Are at Low Bleeding Risk? Poll Moderators: John A. Bittl, Daniel I. Simon

5:56 PM Session Question #4: What Is the Optimal DAPT Duration For Most Patients WithContemporary DES Who Are at Moderate/High Bleeding Risk ? Poll Moderators: John A. Bittl, Daniel I. Simon

5:58 PM Closing Comments From the Moderators: What Have We Learned? Moderators: John A. Bittl, Daniel I. Simon

Didactic Session: Peripheral Vascular Intervention, Part 1: Aortoiliac, Renal, Mesenteric, and Venous

Sunday, October 30 2:00 PM - 6:00 PM

Walter E. Washington Convention Center Room 146A, Level 1Accreditation: CME/CNE/ASRT

Session I. Aortoiliac Intervention2:00 PM - 3:25 PM

Moderators: D. Christopher Metzger, Constantino S. Pena Discussants: Ehrin J. Armstrong, Lawrence A. Garcia, Zvonimir Krajcer, Kenneth Ouriel, Mehdi H. Shishehbor,David P. Slovut

2:00 PM Introduction to the TCT 2016 Peripheral Vascular Intervention Sessions Michael R. Jaff

2:05 PM Management of Iliac Artery Occlusions: Essential Literature Review Mehdi H. Shishehbor

2:15 PM Technical Components of Iliac Artery Occlusion Endovascular Treatment: The Tips and Tricks David P. Slovut

2:25 PM Optimal Stent Selection for Aortoiliac Intervention: Understanding the Differences Ehrin J. Armstrong

2:35 PM Management of Complications From Aortoiliac Intervention Constantino S. Pena


3:00 PM LIVE-IN-A-BOX CASE DEMONSTRATION: Aortoiliac Intervention Case Presenter: D. Christopher Metzger

Session II. Renal and Mesenteric Ischemia3:25 PM - 5:35 PM

Moderators: Gary M. Ansel, Michael R. Jaff Discussants: Herbert D. Aronow, Sahil A. Parikh, John H. Rundback, Ido Weinberg

3:25 PM Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications? Sahil A. Parikh

3:35 PM Renal Artery Fibromuscular Dysplasia: Natural History and Treatment Michael R. Jaff

3:45 PM Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes Mehdi H. Shishehbor


4:05 PM LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)Case Presenter: D. Christopher Metzger

4:30 PM Pre-debate Vote: Is Chronic Mesenteric Ischemia Best Managed by Surgery or Catheter-based Intervention? Poll Moderators: Gary M. Ansel, Michael R. Jaff

4:32 PM Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-basedIntervention! Herbert D. Aronow

4:40 PM Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Surgery

4:48 PM Rebuttal Questions From the Moderators and Audience

4:58 PM Post-debate Vote (Who Won?): Is Chronic Mesenteric Ischemia Best Managed by Surgery orCatheter-based Intervention? Poll Moderators: Gary M. Ansel, Michael R. Jaff

5:00 PM Management of Visceral Artery Aneurysms: When to Intervene and How to Do It Constantino S. Pena

5:10 PM LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (FibromuscularDysplasia) Case Presenter: D. Christopher Metzger

Session III. Complex Venous Intervention5:35 PM - 6:00 PM

Moderators: Mahmood K. Razavi, Robert M. Schainfeld Discussants: Gary M. Ansel, Frank F. Ing, Lindsay S. Machan, Jose M. Wiley

5:35 PM Recannalizing Occluded Systemic Veins Case Presentation (With Discussion) Case Presenter: Frank F. Ing

Didactic Session: Radial Access and Intervention


Walter E. Washington Convention Center Room 150, Level 1Accreditation: CME/CNE/ASRT

Session I: Radial Access and Intervention – The Evidence2:00 PM - 3:00 PM

Moderators: Francesco Burzotta, Sunil V. Rao Discussants: Olivier F. Bertrand, Davide Capodanno, Sanjit S. Jolly, Michael A. Kutcher, Samir B. Pancholy, MladenI. Vidovich

2:00 PM Introduction Poll Moderators: Francesco Burzotta, Sunil V. Rao

2:01 PM Audience Survey: Question 1: How Often Do you Use Radial Access in ACS Patients? Poll Moderators: Francesco Burzotta, Sunil V. Rao

2:03 PM Audience Survey: Question 2: If I Am Unable to Complete the Procedure From the Radial Site,My Standard Approach Is to Switch to? Poll Moderators: Francesco Burzotta, Sunil V. Rao

2:05 PM Radial Access in ACS: Case Closed? Davide Capodanno

2:15 PM Update on Radial Artery Occlusion: Incidence, Presentation, Prevention, and Treatment Samir B. Pancholy

2:25 PM Radial to Femoral Crossovers: Frequency, Predictors and Techniques to Minimize Olivier F. Bertrand

2:35 PM Anatomical Variants and Their Impact on Radial Success Francesco Burzotta


Session II: Radial Approach Controversies – Rapid Fire Debates3:00 PM - 4:12 PM

Moderators: Ian C. Gilchrist, James Nolan Discussants: Morton J. Kern, Mamas Mamas, Ramon Quesada, Jennifer A. Tremmel

3:00 PM Predebate Poll: Are Femoral Outcomes Worse at High Volume Radial Centers? Poll Moderators: Ian C. Gilchrist, James Nolan

3:02 PM Debate - Are Femoral Outcomes Worse at High Volume Radial Centers? The Evidence IsClear, Femoral Outcomes Are Worse at High Volume Radial Centers! Michel R. Le May

3:07 PM Debate - Are Femoral Outcomes Worse at High Volume Radial Centers? Nonsense, RadialOperators Are Great at Femoral Access, Too! James Nolan


3:16 PM Postdebate Poll: Are Femoral Outcomes Worse at High Volume Radial Centers? Poll Moderators: Ian C. Gilchrist, James Nolan

3:18 PM Predebate Poll: Is Complex PCI With Radial Access as Good as With Femoral Access? Poll Moderators: Ian C. Gilchrist, James Nolan

3:20 PM Debate - Is Complex PCI Just As Good With Radial Access? Even Complex PCI Can Be Donevia Radial Access! Ramon Quesada

3:25 PM Debate - Is Complex PCI Just As Good With Radial Access? Femoral Access Is Still the Wayto Go for Complex Cases! John C. Messenger


3:34 PM Postdebate Poll: Is Complex PCI With Radial Access as Good as With Femoral Access? Poll Moderators: Ian C. Gilchrist, James Nolan

3:36 PM Predebate Poll: Is the Radial Approach Preferred for Patients With Prior CABG? Poll Moderators: Ian C. Gilchrist, James Nolan

3:38 PM Debate - Is the Radial Approach Preferred for Patients With Prior CABG? Femoral Access IsPreferred in Patients With Prior CABG! Daniel H. Steinberg

3:43 PM Debate - Is the Radial Approach Preferred for Patients With Prior CABG? It’s Just a Matter ofProficiency! Stefano Rigattieri


3:52 PM Postdebate Poll: Is the Radial Approach Preferred for Patients With Prior CABG? Poll Moderators: Ian C. Gilchrist, James Nolan

3:54 PM Predebate Poll: Should Patients With Advanced Renal Disease Undergo PCI via RadialAccess? Poll Moderators: Ian C. Gilchrist, James Nolan

3:56 PM Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? NoWay, Preserve Future Dialysis Access at All Costs! Michael S. Lee

4:01 PM Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? OfCourse! Renal Patients Are at the Highest Risk! Binita Shah


4:10 PM Post Debate Poll: Should Patients With Advanced Renal Disease Undergo PCI via RadialAccess? Poll Moderators: Ian C. Gilchrist, James Nolan

Session III: Perfecting the Transradial Technique4:12 PM - 5:10 PM

Moderators: Ian C. Gilchrist, Rajiv Gulati Discussants: Khaldoon Alaswad, Ivo Bernat, Ronald Caputo, Sasko Kedev, Tejas Patel, Adhir Shroff

4:12 PM Dealing With Arterial Tortuosity In the Arm, Chest, and Heart Tejas Patel

4:22 PM Increasing Guide Support: Large Bore Guides and Guide Extensions Rajiv Gulati

4:32 PM Transulnar PCI: How and When To Do It Sasko Kedev

4:42 PM Transradial CTOs: Strategies for Success Khaldoon Alaswad

4:52 PM PRACTICAL: A Randomized Trial of Radial Artery Clamp Time Shahar Lavi


Session IV: Radical Radial Cases and Teachable Moments5:10 PM - 6:00 PM

Moderators: Francesco Burzotta, Shigeru Saito Discussants: Robert J. Applegate, Warren J. Cantor, Tak W. Kwan, Jose L. Leiva-Pons, Christopher Pyne

5:10 PM Unprotected Left Main and Multivessel Transradial PCI Case Presenter: Vladimir Dzavik

5:20 PM Addressing a CTO With Slender Technique Case Presenter: Shigeru Saito

5:30 PM My Best Radial Case of Last Year Case Presenter: Yujie Zhou

5:40 PM A Predictable Complication (In retrospect) and A Great Save: When Transradial Goes Wrong Case Presenter: Mauricio G. Cohen

5:50 PM A Complex Transradial Peripheral Case Case Presenter: Zoltan Ruzsa

Didactic Session: The Left Main and Bifurcation Summit, Part 1: Technique and Cases



Session I. Anatomical and Physiologic Considerations in Bifurcation Lesions2:00 PM - 2:54 PM

Moderators: Antonio Colombo, Thierry Lefevre Discussants: Nicolas Foin, Ioannis Iakovou, Allen Jeremias, Jens Flensted Lassen, Marco V. Wainstein, Joanna J.Wykrzykowska

2:00 PM Bifurcation Lesion Anatomy: The Basics Jens Flensted Lassen

2:08 PM How Intravascular Ultrasound Imaging Can Guide and Improve Left Main and Non-Left MainBifurcation Lesion PCI: Studies and Practical Case examples Akiko Maehara

2:18 PM How Should I Use FFR in Left Main and Non-Left Main Bifurcation Lesions? Studies andPractical Case Examples Bon-Kwon Koo

2:28 PM Technical Uncertainties 1: When to Predilate the Side Branch? Studies and Practical CaseExamples Hyeon-Cheol Gwon

2:36 PM Technical Uncertainties 2: Kiss, POT, and RePOT - When and How? Ioannis Iakovou


Session II. Left Main and Non-Left Main Bifurcation Lesion PCI: How to Do It2:54 PM - 4:10 PM

Moderators: Philippe Généreux, David Hildick-Smith Discussants: Theodore A. Bass, Francesco Burzotta, Bernard R. Chevalier, Robert J. Gil, Azeem Latib, ThierryLefevre

2:54 PM Lessons Learned From Bench Testing: What Should Be the Ideal Stenting Technique forBifurcations? Nicolas Foin

3:02 PM Provisional Side Branch Stenting: Lesion Selection, Technique, and Decision-making Thierry Lefevre

3:10 PM Double Stenting With Culotte: Step-by-step Bernard R. Chevalier

3:18 PM Double Stenting With DK-Crush: Step-by-step Shao-Liang Chen

3:26 PM Double Stenting With TAP: Step-by-step Francesco Burzotta

3:34 PM Technical Aspects Specific for the Left Main Distal Bifurcation I: Lessons From Experience Nicholas J. Lembo

3:42 PM Technical Aspects Specific for the Left Main Distal Bifurcation II: Insights From the MITORegistry Sunao Nakamura


Session III. Novel Bifurcation Technologies and Approaches4:10 PM - 4:53 PM

Moderators: Francesco Burzotta, Dean J. Kereiakes Discussants: Nirat Beohar, Antonio Colombo, Carlo Di Mario, Vladimir Dzavik, Manuel Pan, Goran Stankovic

4:10 PM Dedicated Bifurcation Stents (Tryton, Axxess, and Others): When, Why, and How? Antonio L. Bartorelli

4:20 PM BVS in Bifurcation Lesions: What to Do and What Not to Do Manuel Pan

4:28 PM Bail-out Side Branch Stenting After BVS Azeem Latib

4:36 PM Drug-eluting Balloons for Bifurcations in Daily Practice Goran Stankovic


Session IV. Left Main PCI in Daily Practice: Cases Series4:53 PM - 6:00 PM

Moderators: David E. Kandzari, Jens Flensted Lassen Discussants: Yaron Almagor, Dietmar H. Glogar, Thierry Lefevre, Alexander Grigorievich Osiev, Manuel Pan, Seung-Jung Park

4:53 PM Distal LM Cases With Difficult Side Branches Access Case Presenter: Thierry Lefevre

5:01 PM Complex Left Main Cases With Planned One-stent Approach Case Presenter: Yves R. Louvard

5:09 PM Complex Left Main Cases With Planned Two-stent Approach Case Presenter: David G. Rizik

5:17 PM Management of the Left Circumflex: Case Presentations Case Presenter: Carlo Di Mario

5:25 PM Strategies for Calcified Left Main Bifurcation Lesions Case Presenter: Mathew K. Samuel

5:33 PM A Case Series of Left Main Trifurcations Afzalur Rahman

5:41 PM Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab Philippe Généreux


Didactic Session: Transcatheter Aortic Valve Therapies Part 1: Evolving Clinical Indications for TAVR - Now and in the Future

Sunday, October 30 2:00 PM - 6:00 PM Walter E. Washington Convention Center Room 146B/C, Level 1Accreditation: CME/CNE/ASRT

Session I. TAVR 2016: Clinical Indications I2:00 PM - 3:45 PM

Moderators: Patrick T. O'Gara, Alec S. Vahanian Discussants: Samir R. Kapadia, A. Pieter Kappetein, Martin B. Leon, Michael J. Mack, Josep Rodés-Cabau, WilsonY. Szeto, E. Murat Tuzcu

2:00 PM Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate UseCriteria for TAVR Samir R. Kapadia

2:08 PM An Interesting Alternative: The New WikiRecs for TAVR Use in Lower Risk Patients Catherine M. Otto

2:16 PM Flash Debate: Point – Guidelines Should Remain the Standard for Clinical Practice! Patrick T. O'Gara

2:21 PM Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving TranscatheterValve Therapies! John G. Webb


2:35 PM Real-world Requirements and Expectations for TAVR in Lower Risk Patients Martin B. Leon

2:43 PM Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Susheel Kodali

2:51 PM Intermediate-Risk Studies II: Updates From SURTAVI Jeffrey J. Popma


3:01 PM Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study Neil E. Moat

3:06 PM Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial Michael J. Mack

3:11 PM Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Jeffrey J. Popma


3:20 PM Flash Debate: Point – Surgical Risk Stratification for TAVR Should Be Replaced by Anatomicand Clinical Profiling! Stephan Windecker

3:25 PM Flash Debate: Counterpoint – Stay the Course: We Need the Next Round of Low-RiskRandomized TAVR Studies AND Long-Term Follow-up to Justify Changes! Lars G. Svensson

3:30 PM Flash Debate: Counterpoint – The Emergence of TAVR Risk Scores Are a Better Solution toPatient Selection! David J. Cohen


Session II. TAVR 2016: Clinical Indications II3:45 PM - 6:00 PM

Moderators: A. Pieter Kappetein, Allan Schwartz Discussants: Anita Asgar, Vinayak Bapat, Linda D. Gillam, Ran Kornowski, Jonathon A. Leipsic, Catherine M. Otto,Philippe Pibarot, Vinod H. Thourani

3:45 PM Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and SpecialConsiderations for TAVR Lars Sondergaard

3:53 PM TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples) Mathew Williams


4:05 PM Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registryand Other Studies Danny Dvir

4:13 PM Transcatheter Valve-in-Valve Therapy: Clinical and Technical Pearls Vinayak Bapat


4:25 PM Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis Philippe Pibarot

4:33 PM Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR Howard C. Herrmann


4:45 PM Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial Martin B. Leon

4:55 PM Severe Asymptomatic Aortic Stenosis: Introduction to EARLY-TAVR Philippe Généreux

5:05 PM Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative? Hendrik Treede


5:20 PM Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation -Outcomes and Management Strategies (Including MitraClip) Marco Barbanti

5:30 PM Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic CoronarySyndromes - When and How Much to Treat James B. Hermiller Jr

5:40 PM Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation -Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure) Samir R. Kapadia


Didactic Session: Transcatheter Mitral Valve Therapies Part 1: Current Standard of Care


Session I. Mitral Regurgitation: The Big Picture2:00 PM - 2:52 PM

Moderators: Ted Feldman, Allan Schwartz Discussants: Wayne B. Batchelor, Blase A. Carabello, JoAnn Lindenfeld, Francesco Maisano, Randolph P. Martin,Mark Reisman

2:00 PM A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists Mark Reisman

2:10 PM Epidemiology and Treatment of Primary and Secondary Mitral Regurgitation: GlobalPerspectives Ralph Stephan von Bardeleben

2:20 PM Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: DespiteClass I Guidelines, Are the Benefits Substantial? JoAnn Lindenfeld

2:30 PM What’s New and What's Controversial in the US and EU Guidelines? Catherine M. Otto


Session II. Mitral Regurgitation Core Concepts: Imaging2:52 PM - 3:39 PM

Moderators: Paul A. Grayburn, Patrizio Lancellotti Discussants: Jeroen J. Bax, Linda D. Gillam, Jonathon A. Leipsic, Stamatios Lerakis, Maurice E. Sarano, Neil J.Weissman

2:52 PM Echo Quantification of MR Severity: Classification and Common Pitfalls Paul A. Grayburn

2:59 PM Prognostic and Treatment Decision Implications of Exercise Induced Mitral Regurgitation Patrizio Lancellotti

3:06 PM Strengths and Weaknesses of CMR for Quantification of MR Stamatios Lerakis

3:13 PM Emerging Role of CT for Assessment of Mitral Valve Anatomy and Dysfunction Hasan Jilaihawi

3:20 PM Procedural Guidance: Beyond TEE - ICE, Navigator, and More Brij Maini


Session III. Mitral Regurgitation: Evolution of Surgical Therapy3:39 PM - 4:26 PM

Moderators: Michael J. Mack, Francesco Maisano Discussants: Michael Argenziano, James S. Gammie, Marc Gillinov, Patrick M. McCarthy, Neil E. Moat, Robert LSmith

3:39 PM Surgical Outcomes in Primary MR: Results From Expert Surgeons vs “Real Life” Surgeons Patrick M. McCarthy

3:46 PM Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes? Robert L Smith

3:53 PM Applying Lessons From the CTSN to Clinical Practice Michael J. Mack

4:00 PM How Good Can Surgical Outcomes Be in Secondary MR? Michael Argenziano

4:07 PM Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation Marco Moscarelli


Session IV. Mitral Regurgitation: New MitraClip Evidence and Knowledge4:26 PM - 6:07 PM

Moderators: Alec S. Vahanian, Ralph Stephan von Bardeleben Discussants: Gorav Ailawadi, Stephan Baldus, Olaf Franzen, David W.M. Muller, Michael J. Rinaldi

4:26 PM MitraClip: 40,000 Cases Worldwide: What We Know and What We Don’t Ted Feldman

4:33 PM Updated MitraClip Outcomes From the STS TVT Registry Gorav Ailawadi

4:40 PM Updated MitraClip Outcomes From European Registries Ralph Stephan von Bardeleben

4:47 PM Predictors of MitraClip Outcomes: TRAMI and GRASP-IT Davide Capodanno

4:54 PM How and When to Use Multiple MitraClips Stephan Baldus

5:01 PM Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits? Hüseyin Ince

5:08 PM Techniques to Achieve >1+ MR After MitraClip: How Often Is This Obtainable? Saibal Kar

5:15 PM Complications After MitraClip: Frequency, Avoidance, and Treatment Scott Lim

5:22 PM Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients Gregg W. Stone

5:29 PM Pre-debate Vote: What Is the best treatment for End-stage Heart Failure Patient With SevereFMR? MitraClip or LVAD/Transplant? Poll Moderators: Alec S. Vahanian, Ralph Stephan von Bardeleben

5:31 PM What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR?MitraClip Should Always Be Considered First! Saibal Kar

5:38 PM What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? StopWasting Valuable Time – Go Straight to LVAD/Transplant! Nir Uriel

5:45 PM Post-debate Vote (Who Won?): What Is the Best Treatment for End-stage Heart Failure PatientWith Severe FMR? MitraClip or LVAD/Transplant? Poll Moderators: Alec S. Vahanian, Ralph Stephan von Bardeleben


Learn the Technique (Case Reviews): Below the Knee Access and Intervention


Walter E. Washington Convention Center Room 103B, Level 1Accreditation: CME/CNE/ASRT

Below the Knee Access and Intervention12:00 PM - 1:00 PM

Moderators: Koen Deloose, Jihad A. Mustapha Discussants: Lawrence A. Garcia, Ethan C. Korngold, Jose M. Wiley

12:00 PM How Do I Perform the "Ideal BTK Angioplasty?" Case-Based Experiences Case Presenter: Koen Deloose

12:10 PM Long CTO: How Do I Get Across Antegrade? Case Presenter: Ethan C. Korngold

12:20 PM When Do I Switch to Pedal Retrograde Access and How Do I Do it? Case Presenter: Jihad A. Mustapha

12:30 PM This Vessel Is a Rock! How and When to Debulk? Case Presenter: William A. Gray

12:40 PM Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More Case Presenter: Jihad A. Mustapha

12:50 PM A Case Series of Ischemic and Nonischemic Leg Ulcers Case Presenter: Ethan C. Korngold

Learn the Technique (Case Reviews): Complex Bifurcations (Organized by the European Bifurcation Club)

Sunday, October 30 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 145B, Level 1Accreditation: CME/CNE/ASRT

Complex Bifurcations12:00 PM - 1:00 PM

Moderator: Goran Stankovic Discussants: Jens Flensted Lassen, Thierry Lefevre, Yves R. Louvard

12:00 PM How and When to Perform Provisional T Stenting According to EBC Standards (With CaseExamples) Case Presenter: Thierry Lefevre


12:15 PM How and When to Perform Inverted Provisional T Stenting (Step-by-step With Case Examples)Case Presenter: Yves R. Louvard


12:30 PM How and When to Perform Culotte Stenting (Step-by-step With Case Examples) Case Presenter: Jens Flensted Lassen


12:45 PM How and When to Perform DK Crush Stenting (Step-by-step With Case Examples) Case Presenter: Goran Stankovic


Learn the Technique (Case Reviews): CTO Antegrade Reentry Techniques

Sunday, October 30 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 144B, Level 1Accreditation: CME/ASRT/CNE

CTO Antegrade Reentry Techniques12:00 PM - 1:00 PM

Moderators: Colm Hanratty, Simon J. Walsh Discussants: J. Aaron Grantham, James C. Spratt, R. Michael Wyman

12:00 PM Case #1: Antegrade Dissection and Reentry: Stingray Is Not STAR Case Presenter: James C. Spratt


12:15 PM Cases #2 and #3: Antegrade Dissection and Reentry: Bridgepoint Step-by-step (2 Cases) Case Presenter: Colm Hanratty


12:30 PM Cases #4 and #5: Antegrade Dissection and Reentry: Salvaging Success From ImminentFailure Case Presenter: R. Michael Wyman


12:45 PM Case #6: A Case That Could Only Be Done With Antegrade Dissection and Reentry Case Presenter: Simon J. Walsh


Learn the Technique (Case Reviews): Interventional “Rich Emotional Experiences” (aka Complications)


Interventional “Rich Emotional Experiences” (aka Complications)12:00 PM - 1:00 PM

Moderator: Dimitrios Karmpaliotis Discussants: Khaldoon Alaswad, Emmanouil S. Brilakis, Francesco Pelliccia, Ashish Pershad, Minh Vo

12:00 PM Guide Catheter Complications Case Presenter: Francesco Pelliccia


12:12 PM My Worst Perforation of the Year Case Presenter: Khaldoon Alaswad


12:24 PM My Most Unforgettable Atherectomy Complication of the Year Case Presenter: Minh Vo


12:36 PM Stent Embolizations Case Presenter: Emmanouil S. Brilakis


12:48 PM A Guide Extension Misadventure Case Presenter: Ashish Pershad


Learn the Technique (Case Reviews): Management of Calcified Coronary Lesions

Sunday, October 30 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 145A, Level 1Accreditation: CME/ASRT/CNE

Management of Calcified Coronary Lesions12:00 PM - 1:00 PM

Moderators: Mohamed Abdel-Wahab, Philippe Généreux Discussants: Maurice Buchbinder, Jeffrey Chambers, Ajay J. Kirtane, Jeffrey W. Moses, Mark Reisman

12:00 PM Case Presentations: Choosing Between Rotational and Orbital Atherectomy Case Presenter: Jeffrey W. Moses


12:15 PM Case Presentations: Knowing When Balloon-Only Lesion Preparation of Calcified Lesions IsSufficient Case Presenter: Mohamed Abdel-Wahab


12:30 PM Case Presentations: Intravascular Imaging and Physiologic Assessment Should BeMandatory When Treating Calcified Lesions Case Presenter: Ziad A. Ali


12:45 PM Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use ofBioresorbable Scaffolds Case Presenter: Manuel Pan


Learn the Technique (Case Reviews): Nuts and Bolts of FFR, iFR, and CFR


Nuts and Bolts of FFR, iFR, and CFR12:00 PM - 1:00 PM

Moderators: Javier Escaned, Habib Samady Discussants: Justin E. Davies, Allen Jeremias, David F. Kong, Giampaolo Niccoli

12:00 PM In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making Case Presenter: Keith G. Oldroyd


12:15 PM In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment Case Presenter: Hitoshi Matsuo


12:30 PM In This Case: Contrast Was an Alternative to Adenosine for Stenosis Interrogation Case Presenter: William F. Fearon


12:45 PM In This Case: Microcirculation Assessment With CFR and IMR Was Key for Decision-making Case Presenter: Bon-Kwon Koo


Learn the Technique (Case Reviews): Nuts and Bolts of OCT Imaging


Nuts and Bolts of OCT Imaging12:00 PM - 1:00 PM

Moderators: Akiko Maehara, Francesco Prati Discussants: Hiram G Bezerra, Giulio Guagliumi, Yukio Ozaki, Enrico Romagnoli

12:00 PM Case Presentations: OCT-Guided Stent Implantation: How to Do It Case Presenter: Takashi Akasaka


12:15 PM Case Presentations: How to Deploy a Bioresorbable Scaffold With OCT. Preintervention andPostintervention Information Case Presenter: Corrado Tamburino


12:30 PM Case Presentations: Just Don’t Do it! Lessons From Baseline and Postintervention OCT Case Presenter: Francesco Prati


12:45 PM Case Presentations: When OCT Changes Your Strategy in ACS Case Presenter: Fernando Alfonso


Learn the Technique (Case Reviews): Paravalvular Leak Closure

Sunday, October 30 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME/ASRT/CNE

Paravalvular Leak Closure12:00 PM - 1:00 PM

Moderators: Eulogio J. Garcia, E. Murat Tuzcu Discussants: Reda Ibrahim, Amar Krishnaswamy, Carlos E. Ruiz

12:00 PM Introduction to Paravalvular Leak Closure E. Murat Tuzcu

12:05 PM Case #1. Post-SAVR Paravalvulular Leak Case Presenter: Eulogio J. Garcia

12:13 PM Case #2. Post-TAVR Paravalvulular Leak Case Presenter: Reda Ibrahim


12:30 PM Case #3. Mitral Leak, Transfemoral Closure Case Presenter: Amar Krishnaswamy

12:38 PM Case #4 Mitral Leak, Transapical Closure Case Presenter: Carlos E. Ruiz


12:55 PM Take-home Message E. Murat Tuzcu

Learn the Technique (Case Reviews): Procedural Optimization of Bioresorbable Vascular Scaffolds


Procedural Optimization of Bioresorbable Vascular Scaffolds12:00 PM - 1:00 PM

Moderators: Antonio Colombo, Gary S. MintzDiscussants: Azeem Latib, Maurizio Menichelli, Ashok Seth

12:00 PM Case Presentations: Bioresorbable Scaffolds in Diffuse Disease – How to Do It Case Presenter: Ashok Seth


12:15 PM Case Presentations: Bioresorbable Scaffolds in STEMI – How to Do It Case Presenter: Maurizio Menichelli


12:30 PM Case Presentations: How to Use IVUS to Optimize Bioresorbable Scaffold Implantation Case Presenter: Antonio Colombo


12:45 PM Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions – How to Do It Case Presenter: Azeem Latib


Learn the Technique (Case Reviews): TAVR Tips and Tricks

Sunday, October 30 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: CME/ASRT/CNE

Learn the Technique (Case Reviews): TAVR Tips and Tricks12:00 PM - 1:00 PM

Moderators: Stanley J. Chetcuti, Susheel Kodali Discussants: Vasilis Babaliaros, Vinayak Bapat, Isaac George, Christian Spies

12:00 PM Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned Case Presenter: Hasan Jilaihawi

12:12 PM Case #2: Transcatheter Valve-in-Valve in a Patient With a Small Aortic Bioprosthesis:Optimizing Hemodynamics Case Presenter: Vasilis Babaliaros

12:24 PM Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have BeenPrevented? Case Presenter: Isaac George

12:36 PM Case #4: Transseptal Transcatheter Treatment of Failed Mitral Bioprosthesis (With Tips andTricks) Case Presenter: Christian Spies

12:48 PM Case #5: Suboptimal Transcatheter Treatment of Failed Prior Surgical Mitral Repair Case Presenter: Vinayak Bapat

Learn the Technique (Case Reviews): Transseptal Puncture


Transseptal Puncture12:00 PM - 1:00 PM

Moderators: Samir R. Kapadia, Horst Sievert Discussants: Saibal Kar, Paul Sorajja

12:00 PM Step-by-step Basic Transseptal Puncture Paul Sorajja

12:10 PM Complications of Transseptal Puncture: Recognition and Management Horst Sievert

12:20 PM Case #1: Transseptal Puncture for MitraClip Case Presenter: Saibal Kar


12:30 PM Case #2: Transseptal Puncture for Paravalvular Leak Closure Case Presenter: Samir R. Kapadia


12:40 PM Case #3: Transseptal Puncture for Left Atrial Appendage Closure Case Presenter: Brian K. Whisenant


12:50 PM Transseptal Puncture for Transcatheter Mitral Valve Repair Procedures: Technical andImaging Considerations Samir R. Kapadia

Learn the Technique (Case Reviews): Acute Infarct Angioplasty and Cardiogenic Shock


Acute Infarct Angioplasty and Cardiogenic Shock1:00 PM - 2:00 PM

Moderators: Stefan K. James, Holger Thiele Discussants: Anthony H. Gershlick, Jose P.S. Henriques, Morton J. Kern, Michael J. Lim, Michael Mooney, GoranK. Olivecrona

1:00 PM Treatment of Cardiogenic Shock With IABP: I Believe There Is Still a Role! Case Presenter: Morton J. Kern

1:12 PM Treatment of Cardiogenic Shock With Impella or Tandem Heart Case Presenter: Jose P.S. Henriques

1:24 PM Treatment of Refractory Cardiogenic Shock With ECMO Case Presenter: Michael Mooney

1:36 PM Multivessel PCI in Cardiogenic Shock Case Presenter: Anthony H. Gershlick

1:48 PM Recognition and Treatment of Right Ventricular Cardiogenic Shock Case Presenter: Michael J. Lim

Learn the Technique (Case Reviews): Bailout Techniques for Transradial Complications


Bailout Techniques for Transradial Complications1:00 PM - 2:00 PM

Moderators: Samir B. Pancholy, Tejas Patel Discussants: Rajiv Gulati, Sunil V. Rao

1:00 PM Case Presentation(s): How to Treat a Radial Artery Perforation Case Presenter: Sunil V. Rao


1:15 PM Case Presentation(s): How to Undo Catheter Kinks and Knots Case Presenter: Tejas Patel


1:30 PM Case Presentation(s): How to Remove Entrapped Hardware Case Presenter: Rajiv Gulati


1:45 PM Case Presentation(s): How to Treat a Radial Artery Pseudoaneurysm Case Presenter: Samir B. Pancholy


Learn the Technique (Case Reviews): Carotid and Stroke Intervention


Carotid and Stroke Intervention1:00 PM - 2:00 PM

Moderators: Zvonimir Krajcer, D. Christopher Metzger Discussants: Leo Nelson Hopkins, Rahul Sakhuja, Mark H. Wholey

1:00 PM Radial Access to Carotid Stenting Case Presenter: Sasko Kedev

1:10 PM Direct Carotid Access During Acute Stroke Intervention Case Presenter: Mark H. Wholey

1:20 PM Tips and Tricks for Use of Proximal Embolic Protection During Carotid Stenting: A CaseSeries Case Presenter: D. Christopher Metzger

1:30 PM Optimal Device Selection for Carotid Stenting Case Presenter: Rahul Sakhuja

1:40 PM Acute Stroke Intervention: Case #1 Case Presenter: Leo Nelson Hopkins

1:50 PM Acute Stroke Intervention: Case #2 Case Presenter: Bernhard Reimers

Learn the Technique (Case Reviews): Complex Congenital Interventions

Sunday, October 30 1:00 PM - 2:00 PM Cardiovascular Research Foundation Room 143B, Level 1Accreditation: CME/ASRT/CNE

Complex Congenital Interventions1:00 PM - 2:00 PM

Moderators: Ziyad M. Hijazi, Damien P. Kenny Discussants: Elchanan Bruckheimer, Matthew A Crystal, Clifford J. Kavinsky, Eustaquio Maria Onorato, Nathan WTaggart

1:00 PM Case #1: Creation of a Fenestration in a Failed Fontan With PLE Case Presenter: Nathan W Taggart


1:15 PM Case #2: Acquired Aortic Atresia (Coarctation of the Aorta) in the Adult Patient Case Presenter: Elchanan Bruckheimer


1:30 PM Case #3: Coronary Artery Fistula Closure Case Presenter: Damien P. Kenny


1:45 PM Case #4: ASD Closure in an Elderly Patient Case Presenter: Matthew A Crystal


Learn the Technique (Case Reviews): CTO Retrograde Reentry Techniques


CTO Retrograde Reentry Techniques1:00 PM - 2:00 PM

Moderators: Masahiko Ochiai, James C. Spratt Discussants: Kambis Mashayekhi, Hisayuki Okada, Ashish Pershad, Eugene B. Wu

1:00 PM Case #1: IVUS-Guided Stent Reverse CART Case Presenter: Hisayuki Okada


1:15 PM Case #2: Laser-Assisted Reverse CART Case Presenter: Ashish Pershad


1:30 PM Case #3: Stent Reverse CART-Troubles and Solutions Case Presenter: Eugene B. Wu


1:45 PM Case #4: Rendezvous After Successful Reverse CART Case Presenter: Kambis Mashayekhi


Learn the Technique (Case Reviews): LAA Occlusion Tips and Tricks


LAA Occlusion Tips and Tricks1:00 PM - 2:00 PM

Moderators: Matthew J. Price, Jason H. Rogers Discussants: Petr Neuzil, Ramon Quesada, Jacqueline Saw

1:00 PM Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away Case Presenter: Jacqueline Saw


1:15 PM Cases #3 and #4: Transseptal Puncture for LAA Closure - When Location Makes a Difference Case Presenter: Jason H. Rogers


1:30 PM Cases #5 and #6: Sheath Selection, Orientation, and Lobe Position to Optimize OccluderDeployment Case Presenter: Ramon Quesada


1:45 PM Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned Case Presenter: Petr Neuzil


Learn the Technique (Case Reviews): Left Main Intervention


Left Main Intervention1:00 PM - 2:00 PM

Moderators: David Hildick-Smith, Marie-Claude Morice Discussants: Alaide Chieffo, Philippe Garot, Talib Majwal, Seung-Jung Park

1:00 PM Case #1: One Stent Is Enough (for This and Most Patients)! Case Presenter: Philippe Garot


1:15 PM Case #2: Imaging Is Crucial! Case Presenter: Seung-Jung Park


1:30 PM Case #3: When Two Stents Are Needed: Nothing Is Better Than DK-Crush! Case Presenter: Shao-Liang Chen


1:45 PM Case #4: When Two Stents Are Needed: I Prefer Culotte! Case Presenter: David Hildick-Smith


Learn the Technique (Case Reviews): MitraClip Tips and Tricks

Sunday, October 30 1:00 PM - 2:00 PM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: CME/CNE/ASRT

MitraClip Tips and Tricks1:00 PM - 2:00 PM

Moderators: James B. Hermiller Jr, Paul Sorajja Discussants: Hüseyin Ince, Samir R. Kapadia, Scott Lim, Moody M Makar

1:00 PM Case #1: Advanced MitraClip Steering: When Guide Torque and M-Knob Aren’t Enough Case Presenter: Scott Lim


1:15 PM Case #2: I Can’t Grasp the Leaflets - Tips and Tricks for the Difficult Grasp Case Presenter: Samir R. Kapadia


1:30 PM Case #3: Commissural MitraClip: Maximizing Success in the Corners Case Presenter: Hüseyin Ince


1:45 PM Case #4: The ABCs of Efficient TEE During MitraClip Case Presenter: Moody M Makar


Learn the Technique (Case Reviews): Nuts and Bolts of IVUS and NIRS Imaging

Sunday, October 30 1:00 PM - 2:00 PM Walter E. Washington Convention Center Room 143A, Level 1Accreditation: CME/CNE/ASRT

Nuts and Bolts of IVUS and NIRS Imaging1:00 PM - 2:00 PM

Moderators: Subhash Banerjee, Akiko Maehara Discussants: Ryan D. Madder, Gary S. Mintz, Keith G. Oldroyd

1:00 PM Case #1: Five Essentials From IVUS and NIRS Imaging Case Presenter: Akiko Maehara

1:12 PM Case #2: Pre-PCI Assessment of the Distal Left Main Bifurcation With Imaging Both Branches Case Presenter: Jose M. de la Torre Hernandez

1:24 PM Case #3: Severe Calcification Leading to Stent Underexpansion Case Presenter: Keith G. Oldroyd

1:36 PM Case #4: Progressive Intramural Hematoma Case Presenter: Subhash Banerjee

1:48 PM Case #5: Large Lipid Rich Plaque With Distal Embolization Case Presenter: Ryan D. Madder

Learn the Technique (Case Reviews): Venous Disease Intervention

Sunday, October 30 1:00 PM - 2:00 PM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME/CNE/ASRT

Venous Disease Intervention1:00 PM - 2:00 PM

Moderator: Brian G DeRubertis Discussants: Gary M. Ansel, Matthew D. Bacchetta, Mahmood K. Razavi, Kenneth Rosenfield, Akhilesh K. Sista

1:00 PM Lysis of Deep Venous Thrombosis Case Presenter: Akhilesh K. Sista

1:12 PM Catheter-Directed Thrombolysis for Pulmonary Emboli Case Presenter: Gary M. Ansel

1:24 PM Role of Pulmonary Embolism Response Team Case Presenter: Kenneth Rosenfield

1:36 PM Surgical Pulmonary Embolectomy for Pulmonary Emboli Case Presenter: Matthew D. Bacchetta

1:48 PM Stenting Chronic Venous Obstruction Case Presenter: Mahmood K. Razavi

Learn the Technique (Case Reviews): When Bypass Grafts Fail


When Bypass Grafts Fail1:00 PM - 2:00 PM

Moderators: Barry D. Rutherford, Gerard T. Wilkins Discussants: David E. Kandzari, James M. McCabe, Masahisa Yamane, Robert J. de Winter

1:00 PM Case #1: LIMA-LAD Anastomotic Lesion With Heavily Calcified Native LAD Lesion Case Presenter: David E. Kandzari

1:08 PM Discussion and Roundtable Q&A

1:15 PM Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF Case Presenter: James M. McCabe


1:30 PM Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium Case Presenter: Masahisa Yamane


1:45 PM Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation Case Presenter: Colm Hanratty


CardioVascular Professionals (CVP) Course: 25th Annual Cardiovascular Nurse and Technologist Symposium Part II: Main Sessions

Sunday, October 30 8:00 AM - 5:30 PM Walter E. Washington Convention Center Room 204, Level 2Accreditation: CME/ASRT/CNE

Session I. Welcome and Introductory Keynote8:00 AM - 8:20 AM

8:00 AM Welcome and Introduction Marian C. Hawkey

8:05 AM The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime A. Pieter Kappetein

Session II. Transcatheter Aortic Valve Therapies8:20 AM - 9:45 AM

Moderator: Marian C. Hawkey Discussants: Patricia Keegan, Amanda M Kirby, Sandra Lauck, Tamim Nazif

8:20 AM TAVR 2016: Where We Are and Where We Are Going Tamim Nazif

8:35 AM TAVR 2016: Making the Case For New Patient Subsets (Low Risk, Bicuspid, etc.) Patricia Keegan

8:50 AM Processes for Individualized TAVR Patient Selection and Clinical Pathways Sandra Lauck

9:00 AM Integration of the Extended Heart Team for Clinical Decision-Making in Patients With AorticStenosis Amanda M Kirby

9:10 AM Case Presentations and Moderated Discussion Moderator: Thomas H. Maloney Discussants: Marian C. Hawkey, Patricia Keegan, Amanda M Kirby, Sandra Lauck, Tamim Nazif

9:35 AM Discussion/ Q&A

Session III. Transcatheter Mitral/Tricuspid Therapies – Current and Emerging Therapies9:45 AM - 10:30 AM

Moderator: Russell A. Brandwein Discussants: Rebecca T. Hahn, Elizabeth M. Perpetua

9:45 AM Transcatheter Mitral Valve Repair and Replacement: Today and Tomorrow Elizabeth M. Perpetua

10:00 AM From Surgical to Transcatheter Treatment of Tricuspid Regurgitation Russell A. Brandwein

10:15 AM Discussion

Session IV. Structural Heart Disease: It’s Not Only Valves!10:30 AM - 11:30 AM

Moderator: Sarah Clarke Discussants: John D. Carroll, Jessica Forman, Samir R. Kapadia, Saibal Kar, Megan M Kennison

10:30 AM LAA Closure Review: Brief Review of Anatomy, Rationale, and Trial Results Jessica Forman

10:40 AM LAA Closure: What Have We Learned 18 Months After Approval? Saibal Kar

10:55 AM PFO Closure: Rationale, Patient Selection and Outcomes Megan M Kennison

11:10 AM Paravalvular Leak Repair: An Emerging Structural Procedure Samir R. Kapadia

11:20 AM Discussion/Q&A

Session V. TCT 360 – Peripheral Vascular Intervention11:30 AM - 12:30 PM

Moderator: Julie Logan Discussants: George L Adams, Amanda Bailey, Jessica Forman, Michael Guiry, D. Christopher Metzger, Laurie Z.Ventura

11:30 AM Lower Extremity Vascular Disease Intervention: Live Case Review (Wellmont Holston ValleyHospital) Case Presenter: Julie Logan

Session VI. Visit Nurse Tech Exhibits/ Lunch12:30 PM - 1:00 PM

12:30 PM Nurse Tech Exhibits/ Lunch

Session VII. Keynote1:00 PM - 1:30 PM

1:00 PM 25th Anniversary Keynote Lecture Alexandre Abizaid

Session VIII. 25th Anniversary Special Session1:30 PM - 2:15 PM

Moderators: Regina Deible, Mary K. Egan Discussants: Marian C. Hawkey, Alexandra J. Lansky, Thomas H. Maloney, Christopher M. Nelson

1:30 PM Introduction Regina Deible, Mary K. Egan

1:35 PM 25th Anniversary Video Regina Deible, Mary K. Egan

1:40 PM Looking Back Over 25 Years of the Nurse/Tech Symposium Alexandra J. Lansky

1:47 PM Evolution of the Nurse/Tech Team Christopher M. Nelson

1:54 PM Evolution of the Nurse/Tech Role in the Cath Lab Mary K. Egan

2:01 PM What’s Next for the Nurse/Tech Team? Regina Deible

2:08 PM Moderated Discussion/Audience Q&A

Session IX. Complex Higher-Risk (and Indicated) Patients (CHIP)2:15 PM - 3:30 PM

Moderator: Martina Kelly Speight Discussants: Sarah Clarke, Regina Deible, Philippe Généreux, William L. Lombardi, Paul D. Mahoney, Thomas H.Maloney, Mathew Williams

2:15 PM Deep Dive into CHIP (TED Talk): What Is It, and Why Is It Important? Ajay J. Kirtane

2:30 PM Edited Taped Cases 1: TBD Lauren Morris

2:55 PM Edited Taped Cases 2: TBD Colin M. Barker

3:20 PM Resources Needed for CHIP Michael Guiry

Session X. Debates/ Controversies3:30 PM - 4:30 PM

Moderator: Russell A. Brandwein Discussants: Robert A. Guyton, Susheel Kodali, Marie-Claude Morice

3:30 PM Debate: TAVR for Low Risk Patients – Is It time? YES, the Data Is Sufficient and Our PatientsWant It! Susheel Kodali

3:40 PM Debate: TAVR for Low Risk Patients – Is It time? NO, We Don’t Yet Know if It’s as Durable asSurgical AVR! Isaac George

3:50 PM Rebuttal and Q&A

4:00 PM Debate: PCI vs CABG for Left Main Disease - CABG Is and Remains the Gold Standard! Robert A. Guyton

4:10 PM Debate: Move Aside - PCI is Taking Over! Marie-Claude Morice

4:20 PM Rebuttal and Q&A

Session XI. Cath Lab Challenge4:30 PM - 5:30 PM

4:30 PM Introduction of Session Sarah Clarke

4:35 PM Round 1: Twenty Questions Christopher M. Nelson

5:05 PM Round 2 (the Top 3 Players): Five Questions Julie Logan

5:25 PM Crown the Winner! Russell A. Brandwein

iASSESS, Day 1 - Sunday, Oct. 30

Sunday, October 30 8:00 AM - 5:30 PM Walter E. Washington Convention Center Room 102, Level 1Accreditation: CME/ASRT/CNE

iASSESS, Day 1: Morning Session8:00 AM - 12:30 PM

Moderators: Tayo A. Addo, George D. Dangas

8:00 AM Femoral Access Technique, Complications, and Vascular Closure Devices Moderator: Jose M. Wiley Arnold Seto

8:45 AM Radial Access for Angiography and PCI: Technique, Complications, and Comparison to theFemoral Approach Moderator: Sunil V. Rao Jordan Safirstein

9:15 AM Stable Angina Decision-making: PCI vs CABG vs OMT Moderator: Tayo A. Addo Robert T. Pyo

10:00 AM Break

10:15 AM NSTEACS: Risk Stratification and Treatment Moderator: Emmanouil S. Brilakis Dimitriy N. Feldman

11:00 AM STEMI Treatment Strategies: Drugs and Devices Moderator: Tayo A. Addo Dharam J. Kumbhani

11:45 AM Cardiogenic Shock and High-risk PCI: Patient Approach and Hemodynamic Support Devices Moderator: Manish A. Parikh Sahil A. Parikh

Break12:30 PM - 1:30 PM

iASSESS, Day 1: Afternoon Session1:30 PM - 5:30 PM

Moderators: Emmanouil S. Brilakis, Manish A. Parikh

1:30 PM Current Generation DES and Bioabsorbable Scaffolds Moderator: Dimitriy N. Feldman Rajesh V Swaminathan

2:15 PM Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments Moderator: George D. Dangas Rajesh V Swaminathan

3:00 PM Complex Coronary Lesions I: Left Mains, Bifurcations Moderator: Goran Stankovic Tayo A. Addo

3:30 PM Complex Coronary Lesions II: CTO, SVGs Moderator: Emmanouil S. Brilakis Kevin J. Croce

4:00 PM Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients With ACS and PCI Moderator: Frederick Feit Sripal Bangalore

4:45 PM Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation Moderator: Duane S. Pinto Dimitriy N. Feldman

International Session: Controversies in Left Main PCI Presented by: Bulgarian Society of Interventional Cardiology; Hungarian WorkingGroup of Interventional Cardiology; Hong-Kong Stent Group; Romanian Working Group of Interventional Cardiology

Sunday, October 30 8:30 AM - 10:30 AM Walter E. Washington Convention Center Presentation Theater 2Accreditation: none

Controversies in Left Main PCI8:30 AM - 10:30 AM

Moderator: Michael Kang-Yin Lee Discussants: Istvan F. Edes, Valeri L Gelev, Bela Merkely, Stefan Mot, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Li-Wah Tam, Vasil Velchev, Lucian Zarma

8:30 AM Romania Presents: Left Main PCI in the Patient With New Onset ACS Lucian Zarma

8:40 AM Bulgaria Presents: A Case of Left Main PCI in a Patient With ACS Case Presenter: Ivo Petrov

8:45 AM Romania Presents: How Would I Treat This Patient? Stefan Mot

8:50 AM Bulgaria Presents: How Did I Treat This Patient? Case Presenter: Ivo Petrov

8:55 AM Roundtable Discussion With Audience Q&A

9:00 AM Bulgaria Presents: Distal Left Main Stenting Techniques Valeri L Gelev

9:10 AM Romania Presents: A Case of Distal Left Main PCI With Self-aposable Stents Using the“Cullotte Technique” Case Presenter: Marin Postu

9:15 AM Bulgaria Presents: How Would I Treat This Patient? Case Presenter: Kiril Karamfiloff

9:20 AM Romania Presents: How Did I Treat This Patient? Case Presenter: Marin Postu


9:30 AM Hungary Presents: Use of Imaging for Left Main PCI Optimization Istvan F. Edes

9:40 AM Hong Kong Presents: A Case of Imaging Guidance During Left Main PCI Case Presenter: Li-Wah Tam

9:45 AM Hungary Presents: How Would I Treat This Patient? Zoltan Ruzsa

9:50 AM Hong Kong Presents: How Did I Treat This Patient? Case Presenter: Li-Wah Tam


10:00 AM Hong Kong Presents: Complications of Left Main PCI Michael Kang-Yin Lee

10:10 AM Hungary Presents: A Case of a Complication of Left Main PCI Case Presenter: Zoltan Ruzsa

10:15 AM Hong Kong Presents: How Would I Manage This Complication? Li-Wah Tam

10:20 AM Hungary Presents: How Did I Manage This Complication? Case Presenter: Zoltan Ruzsa


International Session: TAVR in Patients With Severe Mitral Regurgitation and Coronary Artery Disease, Presented by the CoronaryAtheroma and Interventional Cardiology Group (GACI); German Society of Cardiology, Working Group on Interventional Cardiology, CzechAssociation of Interventional Cardiology and the Polish Association of Cardiovascular Interventions

Sunday, October 30 8:30 AM - 10:30 AM Walter E. Washington Convention Center Presentation Theater 1Accreditation: none

Session I. Transfemoral TAVR in Patients With Severe Coronary Artery Disease8:30 AM - 9:30 AM

Moderators: Eric Van Belle, Jochen Wöhrle Discussants: Marian Branny, Dariusz Dudek, Michael Haude, Petr Kala, Jacek Legutko, Flavien Vincent

8:30 AM Introduction and Session Objectives Eric Van Belle

8:35 AM Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be TreatedPrior, During, or After TAVR (and in a Single or Staged Procedure)? Dariusz Dudek

8:45 AM France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged orSingle Procedure? Case Presenter: Flavien Vincent

8:52 AM Germany Responds: How Would I Treat This Case? Michael Haude

8:59 AM France Presents: How Did I Treat This Case? Flavien Vincent

9:05 AM Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or SingleProcedure? Case Presenter: Marian Branny

9:12 AM Poland Responds: How Would I Treat This Case? Marek Grygier

9:19 AM Czech Republic Presents: How Did I Treat This Case? Case Presenter: Marian Branny

9:25 AM Conclusions and Take-home Messages Jochen Wöhrle

Session II. Transfemoral TAVR in Patients With Severe Mitral Regurgitation9:30 AM - 10:30 AM

Moderators: Dariusz Dudek, Petr Kala Discussants: Michael Haude, Martin Mates, Eric Van Belle, Jochen Wöhrle

9:30 AM Introduction and Session Objectives Petr Kala

9:35 AM Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior,During or After TAVR (and in a Single or Staged Procedures)? Holger Thiele

9:45 AM Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single orStaged Procedure? Andrzej J. Ochala

9:52 AM France Responds: How Would I Treat This Case? Patrick Ohlmann

9:59 AM Poland Presents: How Did I Treat This Case? Case Presenter: Andrzej J. Ochala

10:05 AM Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single orStaged Procedure? Case Presenter: Michael Haude

10:12 AM Czech Republic Responds: How Would I Treat This Case? Martin Mates

10:19 AM Germany Presents: How Did I Treat This Case Michael Haude

10:25 AM Conclusions and Take-home Messages Dariusz Dudek

International Session: Management of Complex Cardiovascular and Structural Interventions Presented by the Working Group onInterventional Cardiology, Cardiology Society of Serbia; FYR Macedonian Society of Cardiology; Hellenic Society Working Group onInterventional Cardiology; Cyprus Society of Cardiology; and Slovenian Working Group for Interventional Cardiology

Sunday, October 30 1:00 PM - 2:30 PM Walter E. Washington Convention Center Room 208, Level 2Accreditation: none

Management of Complex Cardiovascular and Structural Interventions1:00 PM - 2:30 PM

Moderator: Georgios Sianos Discussants: Matjaz Bunc, Christos Christou, Milan A. Nedeljkovic, Sinisa StojkovicCo-Moderator: Sasko Kedev

1:00 PM Introduction and Session Objectives Sinisa Stojkovic

1:05 PM The Big Picture: CTO and TAVR in Everyday Practice? Georgios Sianos

1:15 PM Case Reviews: TAVR Valve-in-Valve Case Presenter: Matjaz Bunc

1:27 PM My Thoughts on TAVR Valve-in-Valve Procedures Milan A. Nedeljkovic


1:38 PM Case Reviews: Selecting the Optimal Strategy for Complex CTO Intervention Case Presenter: Georgios Sianos

1:50 PM My Thoughts on Strategy Selection for Complex CTOs Sinisa Stojkovic


2:01 PM Case Reviews: Transradial Approach in Complex Coronary Lesions Case Presenter: Sasko Kedev

2:13 PM My Thoughts on the Radial Approach in Complex PCI Christos Christou


2:25 PM Take-home Messages? Sasko Kedev

International Session: Challenging Complex Cases From Tunisia, Iran, and UAE Presented by Tunisian Working Group on InterventionalCardiology (GTCI), Iranian Society of Interventional Cardiology (ISOIC), and Emirates Cardiac Society

Sunday, October 30 2:30 PM - 4:00 PM Walter E. Washington Convention Center Presentation Theater 2Accreditation: none

Challenging Complex Cases From Tunisia, Iran, and UAE2:30 PM - 4:00 PM

Moderators: Habib Gamra, Mahmoud Hashemian, Abdullah Shehab

2:30 PM Introduction and Session Objectives Abdullah Shehab

2:35 PM BVS in Primary PCI Using A Robotic Cath Lab System Case Presenter: Arif Al Nooryani


2:55 PM Complicated CTO PCI Case Presenter: Negar Salehi

3:05 PM Complicated CTO PCI: Lessons From an Expert Case Presenter: Mahmoud Hashemian


3:25 PM Simultaneous TAVR and Endovascular Aortic Aneurysm Repair Case Presenter: Walid Ouertani

3:35 PM Management and Long-term Outcome of a Dislodged Stent in the Left Main Case Presenter: Zied Ben ElHadj


3:55 PM Conclusions and Take-home Messages Habib Gamra

International Session: Complex Cases and Complications in Coronary and Structural Intervention Presented by the PortugueseAssociation of Interventional Cardiology (APIC); Sociedade Brasileira de Hemodinâmica e Cardiología Intervencionista (SBHCI); PhilippineHeart Association and the Singapore Cardiac Society


Complex Cases and Complications in Coronary and Structural Intervention2:30 PM - 4:00 PM

Moderators: Rui Campante Teles, Marcelo Jose de Carvalho Cantarelli Discussants: Huay Cheem Tan, Richard Nicandro Torres

2:30 PM Portugal Presents a Case: MitraClip and LAA Closure - Both in the Same Procedure


2:45 PM Brazil Presents a Case: Complex Access in TAVI – the Transcaval Approach Case Presenter: Dimytri Alexandre Siqueira


3:00 PM Singapore Presents a Case: Complex PCI Case Presenter: Jack Wei Chieh Tan


3:15 PM Philippines Presents a Case: Cardiogenic Shock in Non-STEMI Case Presenter: Richard Nicandro Torres


3:30 PM Portugal Presents a Case: CHIP - Complete Revascularization in MVD With CTO Case Presenter: João AB Brum Silveira


3:45 PM Brazil Presents a Case: An Unusual Thrombus During Primary PCI Case Presenter: Alexandre Schaan Quadros


3:59 PM Closing Remarks Marcelo Jose de Carvalho Cantarelli

International Session: Our Most Educational Interventional Cases Presented by Colegio Argentino de Cardioangiólogos Intervencionistas(CACI) and Groupe Atheroma et Cardiologie Interventionnelle (GACI)


Our Most Educational Interventional Cases2:30 PM - 4:00 PM

Moderator: Alejandro Cherro Discussants: Matthieu Godin, Jose O. Gomez Moreno, Raul Solerno, Ernesto M. Torresani

2:30 PM Introduction and Session Objectives Alejandro Cherro

2:33 PM Argentina Presents a Case of a LIMA-Coronary Vein Fistula Post-CABG Case Presenter: Ernesto M. Torresani

2:41 PM Review of Postsurgical Iatrogenic Coronary Fistulae? Jose O. Gomez Moreno


2:57 PM Argentina Presents a Case of a Percutaneous Closure of Paravalvular Aortic Regurgitation Case Presenter: Raul Solerno

3:05 PM Management Options for Postsurgical Paravalvular Aortic Regurgitation Fernando Cura


3:20 PM France Presents a Case of an Aortic Valve in Valve Procedure

3:28 PM Treatment Options After Unsuccessful Aortic Valve Replacement Oscar A. Mendiz


3:41 PM France Presents a Case of Post-Myomectomy Subaortic Interventricular Communication:Endovascular Management Case Presenter: Matthieu Godin


International Session: Current PCI Controversies in Left Main Intervention Presented by the Canadian Association of InterventionalCardiology; Danish Cardiological Society; Vietnamese Cardiovascular Society; Korean Society of Interventional Cardiology.


Current PCI Controversies in Left Main Intervention4:00 PM - 6:00 PM

Moderators: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen Discussants: Evald H. Christiansen, Payam Dehghani, Kyung Woo Park, Hung Manh Pham, Erick Schampaert

4:00 PM Introduction Thomas Engstroem

4:03 PM Canada Presents: CABG vs PCI in Left Main Disease Samer Mansour

4:15 PM Denmark Presents: A Case of Restenosis in the Left Main Bifurcation Case Presenter: Jens Flensted Lassen

4:20 PM Canada Comments: How Would I Treat This Case? Case Presenter: Payam Dehghani

4:28 PM Denmark Presents: How Did I Treat This Case? Case Presenter: Jens Flensted Lassen

4:35 PM Canada Presents: A Case of "Ad Hoc" Left Main PCI Case Presenter: Erick Schampaert

4:40 PM Vietnam Comments: How Would I Treat This Case? Hung Manh Pham

4:48 PM Canada Presents: How Did I Treat This Case? Case Presenter: Erick Schampaert

4:55 PM Vietnam Presents: A Case of Recurrent, Subacute Left Main Stent Thrombosis Case Presenter: Quang Ngoc Nguyen

5:00 PM Denmark Comments: How Would I Treat This Case? Evald H. Christiansen

5:08 PM Vietnam Presents: How Did I Treat This Case? Case Presenter: Quang Ngoc Nguyen

5:15 PM South Korea Presents: A Case of Left Main Bifurcation Disease With LAD CTO in a YoungPatient Case Presenter: Kyung Woo Park

5:20 PM Denmark Comments: How Would I Treat This Case? Lisette Okkels Jensen

5:28 PM South Korea Presents: How Did I Treat This Case? Case Presenter: Kyung Woo Park

5:35 PM Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCIGuidance Jean-Michel Paradis

5:50 PM Conclusion and Take-home Messages Thomas Engstroem

International Session: Current PCI Hot Topics: Management of Complications and BRS for Complex Lesions presented by AICT (AsianInterventional Cardiovascular Therapeutics), APSIC (Asian Pacific Society of Interventional Cardiology), TSCI (Taiwan Society ofCardiovascular Interventions), ISIC (Indonesian Society of Interventional Cardiology), CIAT (Cardiovascular Intervention Association ofThailand), and CVIT (Japanese Association of Cardiovascular Intervention and Therapeutics)


Session I. Optimization of Outcomes After PCI With Bioresorbable Scaffolds4:00 PM - 4:47 PM

Moderators: Teguh Santoso, Wasan Udayachalerm Discussants: Jun-Jack Cheng, Muhammad Munawar, Mathew K. Samuel, Huay Cheem Tan, Damras Tresukosol,Chiung Jen Wu, Yoshito Yamamoto, Robaayah Zambahari

4:00 PM Introduction Wasan Udayachalerm

4:01 PM Treatment of Chronic Total Occlusions Naoki Masuda

4:09 PM Treatment of Bifurcation Stenosis Teguh Santoso

4:17 PM Treatment of In-Stent Restenosis Wasan Udayachalerm

4:25 PM Late Bioresorbable Scaffold Malapposition and Aneurysm Jun-Jack Cheng

4:33 PM Roundtable Discussion With Audience Q&A Moderators: Teguh Santoso, Wasan Udayachalerm

4:46 PM Conclusion and Take-home Message Teguh Santoso

Session II. PCI for Complex Lesions4:47 PM - 5:30 PM

Moderators: Jun-Jack Cheng, Yoshito Yamamoto Discussants: Muhammad Munawar, Mathew K. Samuel, Teguh Santoso, Huay Cheem Tan, Damras Tresukosol,Wasan Udayachalerm, Chiung Jen Wu, Robaayah Zambahari

4:47 PM Introduction Yoshito Yamamoto

4:49 PM Case #1 (From Japan): Perforation During CTO Intervention: Case Introduction Case Presenter: Satoru Sumitsuji

4:52 PM Comments on Case #1 (From Taiwan): How Would I Treat? Commentator: Paul Hsien-Li Kao

4:56 PM Case #1 (From Japan): Perforation During CTO Intervention: How Did I Treat? Case Presenter: Satoru Sumitsuji


5:02 PM Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified DiffuseStenosis: Case Introduction Case Presenter: Linda Lison

5:05 PM Comments on Case #2 (From Thailand): How Would I Treat? Commentator: Anuruck Jeamanukoolkit

5:09 PM Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified DiffuseStenosis: How Did I Treat? Case Presenter: Linda Lison


5:15 PM Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: CaseIntroduction Case Presenter: Wen-Lieng Lee

5:18 PM Comments on Case #3 (From Indonesia): How Would I Treat? Commentator: Muhammad Munawar

5:22 PM Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: How Did ITreat? Case Presenter: Wen-Lieng Lee

5:26 PM Roundtable Discussion With Audience Q&A Moderators: Jun-Jack Cheng, Yoshito Yamamoto

5:28 PM Conclusions and Take-home Message Jun-Jack Cheng

Partnership Session: SOLACI in Partnership With TCT: Complex Cinical Cases Resolved With Current Evidence

Sunday, October 30 4:00 PM - 5:00 PM Walter E. Washington Convention Center Room 143B, Level 1

Accreditation: none

SOLACI in Partnership With TCT: Complex Cinical Cases Resolved With Current Evidence4:00 PM - 5:00 PM

Moderators: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad

4:00 PM Introduction and Session Objectives Moderator: Ricardo Lluberas

4:02 PM Case 1: Primary PTCA With High Thrombotic Burden: How Did I Treat it? Case Presenter: Gustavo S. Vignolo

4:10 PM Comments and What I Might Have Done Differently Fausto Feres

4:15 PM Case 2: A Complex Left Main Bifurcation: How Did I Treat it? Case Presenter: Mario Araya

4:23 PM Comments and What I Might Have Done Differently Oscar A. Mendiz

4:28 PM A Proximal LAD Chronic Total Occlusion. How Did I Treat It? Fernando Cura

4:36 PM Comments and What I Might Have Done Differently Jose L. Leiva-Pons

4:41 PM Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did ITreat It? Antonio Enrique Dager

4:49 PM Comments and What I Might Have Done Differently Jose Armando Mangione

4:54 PM Session Evaluation and Take-home Messages Jeffrey W. Moses

Partnership Session: TCT Highlights at BIT

Sunday, October 30 4:00 PM - 5:00 PM Walter E. Washington Convention Center Room 144A, Level 1Accreditation: none

Percutaneous Intervention for Complex Lesions: "Keep It Simple!"4:00 PM - 5:00 PM

Moderator: Afzalur Rahman Discussants: Abdullah Al Shafi Majumder, Rabin dra Nath Chakraborty, Alaide Chieffo, Alok Mazumdar, ChristophK. Naber, Sanjeeb Roy

4:00 PM Welcome and Introductory Remarks Afzalur Rahman

4:05 PM Case #1: Left Main PCI: Keep It Simple Case Presenter: Afzalur Rahman


4:17 PM Case #2: Bifurcation PCI: Keep It Simple Case Presenter: Alaide Chieffo


4:29 PM Case #3: CTO PCI: Keep It Simple Case Presenter: Kaisar Nasrullah Khan


4:41 PM Case #4: Complex PCI From the Radial Artery: Keep It Simple Case Presenter: Rabin dra Nath Chakraborty


4:53 PM Take Home Messages: Keep it Simple, But Not Too Simple! Christoph K. Naber

4:57 PM Closing Remarks Rabin dra Nath Chakraborty

Interventional Innovation I: Interventional Innovation and Best Technological Concepts I

Sunday, October 30 8:00 AM - 12:10 PM Walter E. Washington Convention Center Room 209, Level 2Accreditation: none

Session I. Peripheral Vascular Innovations8:00 AM - 8:55 AM

Moderators: Lawrence A. Garcia, Jihad A. Mustapha Discussants: Robert M. Bersin, Salvatore Cassese, Eric J. Dippel, Alan B. Lumsden, D. Christopher Metzger,Stephen R. Ramee

8:00 AM Novel Sirolimus Eluting Coated Balloon (Med Alliance) John E. Shulze

8:07 AM A Novel System to Save Contrast During Coronary Angiography: The DyeVert RandomizedControlled Study Steffen Desch


8:19 AM Low Frequency Therapeutic Ultrasound (LOTUS) to Improve Outcomes of Acute and ChronicKidney Disease (Sonogenix) Michael Dae


8:31 AM Catheter-Based Venous Clot Retractor and Encapsulation Technology (XCoil) Paul Abrams


8:43 AM Novel Catheter for the Treatment of Acute Pulmonary Embolism and Large Vessel DVT(Thrombolex) Riyaz Bashir


Session II. Interventional Heart Failure8:55 AM - 9:51 AM

Moderators: Daniel Burkhoff, Ileana L. Pina Discussants: Jozef Bartunek, JoAnn Lindenfeld, William W. O'Neill, Atul Pathak, John S. Sapirstein, HirooTakayama

8:55 AM Caval Flow Regulator Catheter Balloon for Heart Failure Treatment Jose E. Herrera


9:07 AM Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction Samuel J. Asirvatham


9:19 AM Percutaneous Platform Technology for Intra-cardiac Sensing in Heart Failure Patients(CorVivo) James Coleman


9:31 AM Non-blood Contacting Cardiac Assist Device for Heart Failure Patients (CorInnova) William C Altman


9:43 AM Moderated Discussion: Interventional Heart Failure

Session III. Emerging Mitral Repair Technologies9:51 AM - 10:47 AM

Moderators: Ted Feldman, Juan F. Granada Discussants: Jeffrey S. Borer, Maurice Buchbinder, Marco Moscarelli, Jason H. Rogers, Carlos E. Ruiz, FrederickG. St. Goar

9:51 AM Transcatheter Leaflet Extender for Mitral Valve Repair (MitraPlug) Muralidhar Padala


10:03 AM Transcatheter Mitral Chordal Replacement (ChordArt) Alberto Weber


10:15 AM Percutaneous Plication of Mitral Valve Prolapse (MitraClamp) Rachid Zegdi


10:27 AM Transvascular Repair of Mitral Valve Prolapse: The Mitral Butterfly Werner Mohl


10:39 AM Moderated Discussion: Emerging Mitral Repair Technologies

Session IV. TAVR Innovations and Ancillary Devices10:47 AM - 12:10 PM

Moderators: Mark Reisman, Josep Rodés-Cabau Discussants: Jorge A. Belardi, Goran K. Olivecrona, Michael J. Reardon, Gerhard C. Schuler, Giuseppe Tarantini,Torsten P. Vahl

10:47 AM Anatomical Device Imaging Reconstruction for Procedural Planning in SHD Interventions(FEOPS) Matthieu De Beule


10:59 AM First-In-Human Experience With a Novel Active Fixation Temporary Pacing Lead: Safety andEfficacy of the Tempo Lead Mark W.I. Webster

11:06 AM The Role of Non-invasive Central Aortic Pressures In Cardiovascular Disease Eyal Ben -Assa


11:18 AM Total Embolic Protection in TAVR Procedures (Emboline) Scott Russell


11:30 AM A Novel Bioprosthesis Designed for Optimization of Valve-in-Valve Procedures Danny Dvir


11:42 AM Foldax: Preclinical Results With a Novel Thin-leaflet Synthetic Valve Steven J. Yakubov

11:49 AM Roundtable Discussion with Audience Q&A

11:54 AM Moderated Discussion: TAVR Innovations and Ancillary Devices

Special Session: Japan-USA Synergies 12th Year at TCT - HBD 2016 Think Tank West

Sunday, October 30 8:00 AM - 5:00 PM Walter E. Washington Convention Center Room 203, Level 2Accreditation: none

Session I. Introduction of HBD, Japan-USA Synergies8:00 AM - 9:20 AM

Moderators: Neal Fearnot, Hiroyoshi Yokoi Discussants: Mitchell W. Krucoff, Steve Rowland

8:00 AM “HBD” History and Significance Mitchell W. Krucoff

8:20 AM Lessons Learned Through HBD: The Regulator’s View Madoka Murakami

8:30 AM Lessons Learned Through HBD: The Industry’s View Steve Rowland


Session II. Harmonization by Data9:20 AM - 10:50 AM

Moderator: Mitchell W. Krucoff Discussants: Neal Fearnot, John C Laschinger, Danica Marinac-Dabic, Shigeru Saito Co-Moderator: Kazuhiro Sase, MD, PhD

9:20 AM Latest Discussion in MDEpiNet and IMDRF Registry WG Danica Marinac-Dabic

9:40 AM Efforts in Japan: JMACS, JTVAR Registry, CIN Akihide Konishi

9:50 AM Aims and Goals of the International TAVR Registry John C Laschinger

10:00 AM Utilization of Registry Data in Medical Care Taku Inohara

10:10 AM Significance of Post-Marketing Data for Industry Neal Fearnot


Session III. How Can Digital Technology Change Medical Care?10:50 AM - 12:30 PM

Moderators: Fumiaki Ikeno, Linda Ricci Discussants: Akihide Konishi, Michael McConnell, Joseph Robertson, John Stevens, Bradley Merrill Thompson

10:50 AM Digital Health Technology Peter J. Fitzgerald

11:00 AM Digital Health Products Handling in Japan Akihide Konishi

11:10 AM Current Status of US Medical Software Related Regulations Linda Ricci

11:20 AM Industry’s Challenges in the US and Japan John Stevens

11:30 AM Wearable Device Changes Medical Care Joseph Robertson

11:40 AM Digital Health Regulation Bradley Merrill Thompson


Lunch12:30 PM - 1:30 PM

Session IV. Atherectomy Device and Drug-Coated Balloon1:30 PM - 3:30 PM

Moderators: Schuyler Jones, Misti Malone Discussants: Shin Iwamoto, George Papandreou, Steve Rowland, Scott Ward, Eleni Whatley, Hiroyoshi Yokoi

1:30 PM US Academia View Michael R. Jaff

1:40 PM Japan Academia View Hiroyoshi Yokoi

1:50 PM Overview of the Clinical Trials for Drug-Coated Balloons George Papandreou

2:00 PM Overview of the Clinical Trials for Atherectomy Brad Martinsen, PhD

2:10 PM Points To Consider in the Review of Endovascular Treatment Devices: Japanese RegulatoryView Shin Iwamoto

2:20 PM Points to Consider in the Review of Endovascular Treatment Devices: US Regulatory View Eleni Whatley


Session V. Who Are the Most Appropriate Subjects for Left Atrial Appendage Closure Devices?3:30 PM - 4:40 PM

Moderators: Mitchell W. Krucoff, Shigeru Saito Discussants: Hidehiko Hara, Rachel Neubrander, Kenneth Stein, MD, Sara Takahashi

3:30 PM Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, andWho are the Best LAA Closure Device Candidates in Both Countries Christopher B. Granger

3:40 PM Appropriate Use Criteria of LAA Closure Devices: US Industry View Kenneth Stein, MD

3:50 PM Appropriate Use Criteria of LAA Closure Devices: FDA’s View Rachel Neubrander

4:00 PM Appropriate Use Criteria of LAA Closure Devices: PMDA’s View Sara Takahashi


Session VI. Novel HBD Approaches to Introduction in US and Japan4:40 PM - 5:00 PM

Moderator: Mitchell W. Krucoff Discussants: Neal Fearnot, Fumiaki Ikeno, Madoka Murakami

4:40 PM TVA Medical Approach Katherine Kumar

4:50 PM Summary Mitchell W. Krucoff

Special Session: Advances in Endovascular Treatment of Aortic Disease: Learning Through Cases and Debates

Sunday, October 30 10:30 AM - 12:00 PM Walter E. Washington Convention Center Room 146A, Level 1Accreditation: none

Advances in Endovascular Treatment of Aortic Disease: Learning Through Cases and Debates10:30 AM - 12:00 PM

Moderators: Robert M. Bersin, Brian G DeRubertis Discussants: Ehrin J. Armstrong, Michael D. Dake, Christoph A. Nienaber, Ivo Petrov

10:30 AM State of the Art Lecture: Limitations With Current EVAR Technology and What Lies Ahead Barry T. Katzen

10:40 AM Complex Endograft Cases: Sealing Techniques, Chimneys, and Snorkels Case Presenter: Venkatesh G Ramaiah

10:50 AM Case Presentation: Ruptured AAA Case Presenter: Brian G DeRubertis

10:55 AM Management of Ruptured Abdominal Aortic Aneurysms - Open vs Endovascular Repair Zvonimir Krajcer


11:19 AM Postdebate Vote: Should Most Ruptured Abdominal Aortic Aneurysms Be Treated With OpenSurgical Repair vs Endovascular Techniques ? Poll Moderators: Robert M. Bersin, Brian G DeRubertis

11:22 AM Management Strategies for Complicated Acute Type B Dissection: Case-Based Illustrations Case Presenter: Christoph A. Nienaber

11:32 AM Treatment Strategies to Rescue Failing Endografts Constantino S. Pena

11:42 AM State-of-the-Art Lecture: Latest Advances in a Large Bore Vascular Closure Devices - WhatDoes the Future Hold? Zvonimir Krajcer


Special Session: TCT 2016 Transcatheter Heart Valve Innovation Session


Session I. Bench to Bedside: The Conundrum of Pre-Clinical Testing for Transcatheter Valve Therapies –When Is My Device Ready for Human Testing?2:00 PM - 2:55 PM

Moderators: Elazer R. Edelman, Juan F. Granada, Changfu Wu Discussants: Aaron Chalekian, Robert Chang, Andrew Cleeland, Andrew Farb, Rick Geoffrion, Claire Hambright,Natalie Miller, Yoram Richter, Victoria Rodriguez, Jonas Runquist

2:00 PM FDA Perspectives Changfu Wu

2:10 PM Animal Testing: FDA Expectations Natalie Miller

2:20 PM Animal Testing: “Real-World” Experiences and Translational Challenges Juan F. Granada

2:30 PM Transcatheter Mitral Replacement Devices: An Update from the International Organization forStandardization (ISO) Cardiac Valves Committee Aaron Chalekian

2:40 PM Panel Discussion and Audience Q&A

Session II. First-In-Human Use: Device Failure Modes and Lessons Learned from Early Human Studies2:55 PM - 3:58 PM

Moderators: John G. Webb, Ajit Yoganathan Discussants: John P. Cheatham, James B. Hermiller Jr, Albert Markus Kasel, Timothy Kelley, Scott Lim, UlrichSteinseifer, Hendrik Treede

2:55 PM The TAVR Development Journey: Lessons Learned and Drivers of Success John G. Webb

3:07 PM Lessons Learned from Early FIH/EFS Trials: Mitral Valve Replacement and RepairTechnologies Vinayak Bapat

3:19 PM Lessons Learned from Early FIH/EFS Trials: Tricuspid Valve Repair Technologies Scott Lim

3:31 PM Lessons Learned from Early FIH/EFS Trials: Transcatheter Pulmonary Valve Replacement John P. Cheatham


Session III. The Transition to Pivotal Clinical Trials: How to Launch the Clinical Pathway…3:58 PM - 4:50 PM

Moderators: Charles J. Davidson, Nicole Ibrahim Discussants: Marco Barbanti, Andreas Baumbach, Stephen J.D. Brecker, Mayra Guerrero, John C Laschinger, DanMans, James M. McCabe

3:58 PM FDA Perspectives John C Laschinger

4:10 PM TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter MitralTherapy Clinical Trials Paul Sorajja

4:22 PM TMVR Clinical Trial Design: Early Insights from Industry Dan Mans


Session IV. Ongoing Controversies (Clinical and Otherwise) in Transcatheter Valve Therapies4:50 PM - 6:00 PM

Moderators: Carlos E. Ruiz, Ulrich Steinseifer Discussants: Danny Dvir, Wayne Falk, Rebecca T. Hahn, Hasan Jilaihawi, Russ Joseph, Raj Makkar, David Mester,Neelakantan Saikrishnan

4:50 PM Leaflet Thickening, Dysfunction, and Thrombosis: Latest Recommendations by the ISOCardiac Valves Committee Ulrich Steinseifer

4:57 PM Leaflet Thickening, Dysfunction, and Thrombosis: Clinical Perspectives- Are Problems Under-Reported? Are the Changes a Class Effect? Raj Makkar


5:14 PM Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on theAssessment of Paravalvular Regurgitation (Aortic and Mitral) Rebecca T. Hahn

5:21 PM Paravalvular Regurgitation - The Achilles Hell or Problem Solved: Better Assessment of PVLon the Bench - Recommendations by the ISO Cardiac Valves Committee Neelakantan Saikrishnan


5:38 PM Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges:Engineering Perspectives Ajit Yoganathan

5:45 PM Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: ClinicalUpdates Danny Dvir


Presentation Theater Program: LDL and the Interventional Cardiologist (Sponsored by AMGEN)

Sunday, October 30 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 4, Exhibit Hall, Level 2Accreditation: none

LDL and the Interventional Cardiologist11:30 AM - 12:30 PM

Faculty: C. Michael Gibson

11:30 AM LDL and the Interventional Cardiologist C. Michael Gibson

Presentation Theater Program: New FDA Indications for the Use of Percutaneous Hemodynamic Support: Improving Outcomes inProtected PCI and Cardiogenic Shock (Sponsored by CRF, Supported by ABIOMED,Inc.)


New FDA Indications for the Use of Percutaneous Hemodynamic Support: Improving Outcomes in ProtectedPCI and Cardiogenic Shock11:30 AM - 12:30 PM

Chair: William W. O'Neill Facultys: Navin K. Kapur, William L. Lombardi, James M. McCabe

11:30 AM Welcome William W. O'Neill

11:35 AM The Role of Hemodynamic Support Devices in Complex Patients and CompleteRevascularization William L. Lombardi

11:50 AM Implications of Public Reporting on the Treatment of Complex Patients James M. McCabe

12:00 PM Developing Algorithms, Protocols, and Heart Team Approach to Treating AMICGS: Detroit CSIExperience William W. O'Neill

12:15 PM Door to Unloading: Paradigm Shift for Heart Recovery Navin K. Kapur

Presentation Theater Program: The DAPT Decision: Do Polymers Matter? (Sponsored by Abbott)


The DAPT Decision: Do Polymers Matter?11:30 AM - 12:30 PM

Chair: George D. Dangas Facultys: Sripal Bangalore, Yoshihiro Morino, MD, Renu Virmani

11:30 AM Pre-Clinical Data on the Fluoropolymer Renu Virmani

11:45 AM Fluoropolymer’s Role in Healing – The MECHANISM Trial Yoshihiro Morino, MD

12:00 PM Clinical Data in Support of Fluoropolymer and Implications for DAPT Sripal Bangalore

12:15 PM Evolution of DAPT Perspectives in the United States Roxana Mehran

Presentation Theater Program: Trialign: The New Era of Tricuspid Repair (Sponsored by Mitralign)

Sunday, October 30 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: none

Trialign: The New Era of Tricuspid Repair11:30 AM - 12:30 PM

Chairs: Martin B. Leon, Scott Lim Facultys: Gorav Ailawadi, Charles J. Davidson, Rebecca T. Hahn, Azeem Latib, Christopher Meduri, MD, JoachimSchofer

11:30 AM Session Overview Scott Lim

11:30 AM Surgical Options for the Tricuspid Valve Gorav Ailawadi

11:40 AM Trialign Tricuspid Repair Approach Azeem Latib

11:48 AM SCOUT I Early Feasibility Results Rebecca T. Hahn

12:00 PM Trialign in Practice: System Versatility Charles J. Davidson

12:11 PM The Tricuspid Patient: From Forgotten to Found Christopher Meduri, MD

12:19 PM Trialign System Experience Curve Joachim Schofer

12:27 PM Session Summary Martin B. Leon

Presentation Theater Program: What Every Interventionalist Needs to Know About Atrial Fibrillation, Anticoagulation, and the Role ofAntidotes (Sponsored by CRF, Supported by Boehringer Ingelheim Pharmaceuticals, Inc., Boston Scientific Corporation, and Bristol-Myers Squibb /Pfizer Pharmaceuticals Partnership)

Sunday, October 30 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: CME

What Every Interventionalist Needs to Know About Atrial Fibrillation, Anticoagulation, and the Role ofAntidotes11:30 AM - 12:30 PM

Chair: Michael D. Ezekowitz Facultys: William A. Gray, Freek W.A. Verheugt

11:30 AM Pharmacology of Novel Anticoagulants and Their Antidotes Michael D. Ezekowitz

11:45 AM Anticoagulation, Atrial Fibrillation in the Setting of ACS Freek W.A. Verheugt

11:55 AM Anticoagulation and Atrial Fibrillation in the Setting of TAVR George D. Dangas

12:05 PM Anticoagulation and Atrial Fibrillation in the Setting of LAA Closure William A. Gray

12:15 PM Illustrative Cases Case Presenter: Michael D. Ezekowitz

Presentation Theater Program: ADVANCING Control With the Lotus Edge TAVR System (Sponsored by Boston Scientific Corporation)

Sunday, October 30 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 3, Exhibit Hall, Level 2Accreditation: none

ADVANCING Control With the Lotus Edge TAVR System1:00 PM - 2:00 PM

Chair: Michael J. Reardon Facultys: Ted Feldman, Matthias Gotberg, MD, Ian T. Meredith

1:00 PM The Lotus Valve and Lotus Edge: Technology Overview and Clinical Data Update Ted Feldman

1:15 PM Next Generation Lotus Edge in Everyday Practice Matthias Gotberg, MD

1:30 PM Lotus Edge: Features and Benefits of the Latest Technology and Beyond Ian T. Meredith

1:45 PM Q&A Moderator: Michael J. Reardon Discussants: Ted Feldman, Matthias Gotberg, MD, Ian T. Meredith

Presentation Theater Program: Beyond Bare Metal: Precise and Durable Outcomes With the GORE® TIGRIS® Vascular Stent (Sponsoredby Gore & Associates)


Beyond Bare Metal: Precise and Durable Outcomes With the GORE® TIGRIS® Vascular Stent1:00 PM - 2:00 PM

Faculty: Casey Becker, MD

1:00 PM Precise and Durable Outcomes With the GORE® TIGRIS® Vascular Stent Casey Becker, MD

Presentation Theater Program: Building Absorb Experience in the Lab (Sponsored by Abbott)


Building Absorb Experience in the Lab1:00 PM - 2:00 PM

Chair: David G. Rizik Facultys: Thomas Schmitz, MD, John Wang, MD, Nick E. J. West, Robert-Jan van Geuns

1:00 PM Welcome David G. Rizik

1:05 PM What Are the Potential Benefits With Absorb for Your Patients? Nick E. J. West

1:20 PM Launching BRS Therapy and Growing With Absorb John Wang, MD

1:35 PM The Dynamics of Patient Selection With Increased Absorb Experience Thomas Schmitz, MD

1:50 PM Discussion Moderator: David G. Rizik Discussants: Thomas Schmitz, MD, John Wang, MD, Nick E. J. West, Robert-Jan van Geuns

Presentation Theater Program: Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions (Sponsored by CRF, Supportedby SentreHEART, Inc.)

Sunday, October 30 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: CME

Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions1:00 PM - 2:00 PM

Chair: William A. Gray Facultys: Ori Ben-Yehuda, DJ Lakkireddy, Robert J. Sommer, Steven J. Yakubov

1:00 PM Welcome and Introductions William A. Gray

1:05 PM Left Atrial Appendage Occlusion (LAAO) in OAC-Ineligible Patients: Who Should BeConsidered and How Common Are They? Ori Ben-Yehuda

1:17 PM Does the Availability of Novel/Alternative Oral Anticoagulants Change the Conclusions Fromthe Watchman Trial Data? Robert J. Sommer

1:29 PM Are there Opportunities to Improve on the Watchman Outcomes? Current and Future DeviceApproaches Steven J. Yakubov

1:41 PM Ligation Meets Ablation: Early Data on the Synergistic Effects of PV Ablation With LAALigation, and the AMAZE Trial DJ Lakkireddy

1:53 PM Discussion

Presentation Theater Program: TAVR in 2016: Realities and Controversies! (Sponsored by CRF, Supported by Edwards Lifesciences)

Sunday, October 30 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: CME

TAVR in 2016: Realities and Controversies!1:00 PM - 2:00 PM

Co-Chairs: Martin B. Leon, Michael J. Mack Facultys: Vasilis Babaliaros, Philippe Généreux

1:00 PM Reality #1 Which Intermediate-Risk Patients are Candidates for TAVR vs. SAVR? Michael J. Mack

1:10 PM Controversy #1 How Should Potential Durability Differences Influence TAVR vs. SAVR Choicesin Younger and Lower Risk Patients? Martin B. Leon

1:20 PM Reality #2 How to Optimize the Clinical Care Pathway: From Referral to Treatment to Safe(Early) Discharge Home Vasilis Babaliaros

1:30 PM Controversy #2 The Evidence Pathway from Inoperable to Asymptomatic AS Philippe Généreux

1:40 PM Roundtable Discussion

Interactive Technology Center: Hands on Hearts

Sunday, October 30 8:00 AM - 2:00 PM Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none

Hands on Hearts8:00 AM - 2:00 PM

Moderators: Robert Kutys, Maria E. Romero, Nicole Singer

ITC Theater: LAA & Mitral

Sunday, October 30 9:00 AM - 2:00 PM Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none

Faculty Moderation9:00 AM - 9:30 AM

Moderator: Torsten P. Vahl

Evening Program: A New Era of P2Y12 Inhibitors: Transitioning From Intravenous to Oral Platelet Inhibition After PCI (Sponsored by CRF,Supported by CHIESI USA,Inc.)

Sunday, October 30 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 1-4, Level M2Accreditation: CME

Check In and Reception6:00 PM - 6:30 PM

A New Era of P2Y12 Inhibitors: Transitioning From Intravenous to Oral Platelet Inhibition After PCI6:30 PM - 8:00 PM

Co-Chairs: Gregg W. Stone, Harvey D. White Facultys: Dominick J. Angiolillo, Deepak L. Bhatt, C. Michael Gibson, Philippe Généreux, Christian W. Hamm,Robert A. Harrington

6:30 PM Is Oral Agent Preloading Before PCI Safe or Effective? Theory and Evidence C. Michael Gibson


6:45 PM Outcomes of Establishing Potent P2Y12 Receptor Inhibition With Intravenous Cangrelor:Lessons From the PHOENIX and the CHAMPION Trials Robert A. Harrington


7:00 PM Intraprocedural Stent Thrombosis: What Is It, Why Should We Care, and How Can We PreventIt? Philippe Généreux


7:15 PM Transitioning From Oral to Intravenous P2Y12 Receptor Blockade, and From Intravenous toOral P2Y12 Receptor Blockade: What the Practitioner Needs to Know Dominick J. Angiolillo

7:30 PM Patient Selection and Adjunct Pharmacology for Potent Intravenous Platelet Inhibition:Practical Considerations Deepak L. Bhatt


7:45 PM Case Reviews: Anti-platelet Agent Decision Making Case Presenter: Christian W. Hamm

Evening Program: Breaking Barriers Through Disruptive Technologies (Sponsored by Boston Scientific Corporation)

Sunday, October 30 6:00 PM - 8:00 PM Marriott Marquis Washington DC Liberty Ballroom, Level M4Accreditation: none


Breaking Barriers Through Disruptive Technologies6:30 PM - 8:00 PM

Chair: Charles Gibson Vivek Wadhwa Facultys: Samir R. Kapadia, Ian T. Meredith, Matthew J. Price, Michael J. Reardon

6:30 PM Welcome and Introduction of Program Host Moderator: Charles Gibson Ian T. Meredith

6:40 PM Disruptive Technology Panel Discussion (PCI, TAVR, LAAC) Discussants: Samir R. Kapadia, Ian T. Meredith, Matthew J. Price, Michael J. Reardon

7:20 PM Keynote Presentation Vivek Wadhwa

Evening Program: DESolve® NXT…The NEXT Breakthrough in BRS Innovation (Sponsored by Elixir Medical Corp.)

Sunday, October 30 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 6, Level M2Accreditation: none


DESolve® NXT…The NEXT Breakthrough in BRS Innovation6:30 PM - 8:00 PM

Chairs: Alexandre Abizaid, Martin B. Leon, Roxana Mehran Facultys: Niels R. Holm, Holger M. Nef, Jack Wei Chieh Tan

6:30 PM Session Objectives Martin B. Leon

6:35 PM DESolve NX Four-Year Clinical Update and Future Clinical Programs Martin B. Leon

6:50 PM DESolve NX Four-Year Clinical Update and Future Clinical Programs Andrea Abizaid

7:05 PM DESolve Real-world: Europe Experience Holger M. Nef

7:15 PM DESolve Real-world: Asia Experience Jack Wei Chieh Tan

7:25 PM BIFSORB Pilot I Niels R. Holm

7:35 PM AMITY Program Update Roxana Mehran

7:50 PM Session Key Learning Roxana Mehran

Evening Program: Interventional Management of Complex Patients: Cutting-edge Technologies for the Advanced Interventionalist(Sponsored by St. Jude Medical)

Sunday, October 30 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 5, Level M2Accreditation: none


Interventional Management of Complex Patients: Cutting-edge Technologies for the AdvancedInterventionalist6:30 PM - 8:00 PM

Facultys: Alexandre Abizaid, Ziad A. Ali, Navin K. Kapur, Ajay J. Kirtane, Martin B. Leon

6:30 PM Welcome/Objectives Ziad A. Ali

6:32 PM Management Strategies for the Complex Patient Ajay J. Kirtane

6:52 PM High-risk PCI Support Devices Navin K. Kapur

7:12 PM OCT Guided Precision PCI Ziad A. Ali

7:32 PM The Importance of Imaging With BRS Alexandre Abizaid

7:52 PM Closing Moderator: Martin B. Leon Discussants: Alexandre Abizaid, Ziad A. Ali, Navin K. Kapur, Ajay J. Kirtane

Moderated Challenging Cases: Coronary I

Sunday, October 30 4:00 PM - 5:00 PM Walter E. Washington Convention Center Mod Posters/Cases 1, Exhibit Hall, Level 2Accreditation: none

Moderated Challenging Cases: Coronary I4:00 PM - 5:00 PM

Moderators: Tayo A. Addo, Jose de Ribamar Costa Jr

4:00 PM TCT 1023: Treating an Extremely Rare Complication After Permanent Pacemaker ImplantationCase Presenter: Sankha Das

4:15 PM TCT 1088: Percutaneous Treatment of Giant Left Main Aneurysm Case Presenter: Thyago Furquim

4:30 PM TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusionto Treat Refractory Left Ventricular Dysfunction and Ischemia Case Presenter: Francesco Giannini

4:45 PM TCT 1239: Rotablation of the Tortuous Artery - Victory Declared Too Early Case Presenter: Muntaser Musameh

Moderated Challenging Cases: Coronary II


Moderated Challenging Cases: Coronary II4:00 PM - 4:45 PM

Moderators: Maurice Buchbinder, Marco A. Costa

4:00 PM TCT 1042: "Piggy-Back" PCI in a Heterotopic Donor Heart Case Presenter: Heath Adams

4:15 PM TCT 1112: Transradial Left Main PCI Nightmare: Two Embolized Stents Requiring Retrieval Case Presenter: Srikanth Adusumalli

4:30 PM TCT 1129: Safety and Efficacy of Percutaneous Implantable Right Ventricular Assist Devicefor Management of Right Ventricular Failure Secondary to Acute Inferior Myocardial InfarctionCase Presenter: Abhishek Sawant

Moderated Challenging Cases: Endovascular


Moderated Challenging Cases: Endovascular4:00 PM - 5:00 PM

Moderators: William A. Gray, Issam D. Moussa

4:00 PM TCT 1456: Novel Treatment of Luminal Dissection With Focal Using the Tack EndovascularSystem Case Presenter: Edward Koifman

4:15 PM TCT 1423: Antegrade Access and Retrograde SFA Recanalization: the Potential Impact ofProfunda Femoris Artery and Its Collateral Vessels Case Presenter: Franz Hafner

4:30 PM TCT 1418: Right Coronary Artery Chronic Total Occlusion Percutaneous Coronary Interventionwith a Rare Complication Case Presenter: Judit Karacsonyi

4:45 PM TCT 1162: Impella 5.0 Fracture And Transcatheter Retrieval Case Presenter: Moses Mathur

Moderated Challenging Cases: Structural I


Moderated Challenging Cases : Structural I4:00 PM - 5:00 PM

Moderators: Henrique B. Ribeiro, Dimytri Alexandre Siqueira

4:00 PM TCT 1600: Minimally Invasive Mitral Valve Replacement With Sapien S3 Valve in a Patient WithSevere MAC Case Presenter: Deborah Tabachnick

4:15 PM TCT 1611: Trialign: Transcatheter Repair of the Tricuspid Valve Case Presenter: Nadira Hamid

4:30 PM TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC,Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance ofPreprocedural Planning Case Presenter: Chris Meduri

4:45 PM TCT 1651: TAVI-in-Mitral Valve Ring for Annuloplasty Ring Stenosis, Using New Lotus ValveWith Depth-Guard Modification: Early Anchoring Facilitating Controlled and AccurateDeployment Within a High-risk Patient Case Presenter: Saib Khogali

Moderated Poster Session: Circulatory Support

Sunday, October 30 10:30 AM - 11:30 AM Walter E. Washington Convention Center Mod Posters/Cases 1, Exhibit Hall, Level 2Accreditation: none

Moderated Poster Session: Circulatory Support10:30 AM - 11:30 AM

Moderators: Simon R. Dixon, Kirk N. Garratt

10:30 AM TCT 114: Comparing Hemodynamic Profiles and Outcomes in Cardiogenic Shock RequiringVA-ECMO or Impella for Circulatory Support Michele Esposito

10:45 AM TCT 115: Clinical features and Outcomes in Patients with Acute Coronary SyndromeComplicated by Cardiogenic Shock Supported with Extracorporeal Membrane Oxygenation,Single Center Experience Sungsoo Cho

11:00 AM TCT 116: Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous CoronaryIntervention For ACS: Meta-Analysis of RCT’s Mohammad Ansari

11:15 AM TCT 117: Impact of Intra-Aortic Balloon Pump Use on Mortality in Patients with CardiogenicShock Treated with Primary Percutaneous Coronary Intervention: An Observational Study of21,210 Patients with ST-Elevation Myocardial Infarction from the London Hea Krishnaraj Rathod

Moderated Poster Session: PCI and Patients With Renal Insufficiency


Moderated Poster Session: PCI and Patients With Renal Insufficiency10:30 AM - 11:30 AM

Moderators: Joseph P. Carrozza Jr, Charles J. Davidson

10:30 AM TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Interventionin Advanced Chronic Kidney Disease Ziad A. Ali

10:45 AM TCT 314: The Impact of Chronic Kidney Disease on Outcomes Following PercutaneousCoronary Interventions Versus Coronary Artery Bypass Grafting in Patients with ComplexCoronary Artery Disease: 5-Year Follow-Up of the SYNTAX Trial Milan Milojevic

11:00 AM TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following PercutenousCoronary Intervention with Trans-Radial versus Trans-Femoral Approach Arie Steinvil

11:15 AM TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity –Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention Ingibjorg Gudmundsdottir

Moderated Poster Session: Primary PCI and Patient Subsets


Moderated Poster Session: Primary PCI and Patient Subsets10:30 AM - 11:30 AM

Moderators: Laurent Bonello, David Erlinge

10:30 AM TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute CoronarySyndrome Despite High Use of Early Invasive Procedures Celina Yong

10:45 AM TCT 141: Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in Patientswith Systemic lupus Erythematosus: Analysis from Nationwide Inpatient Sample (NIS) Konstantinos Voudris

11:00 AM TCT 142: Temporal Trends in Incidence of Acute Myocardial Infarction in Patients withMalignancy Undergoing Percutaneous Coronary Intervention (PCI) Konstantinos Voudris

11:15 AM TCT 143: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction inPatients with History of Malignancy Konstantinos Voudris

Moderated Poster Session: Thrombectomy and Primary PCI


Moderated Poster Session: Thrombectomy and Primary PCI10:30 AM - 11:30 AM

Moderators: Francesco Burzotta, Vasim Farooq

10:30 AM TCT 144: Impact of Thrombus Aspiration in Primary Percutaneous Coronary Intervention OnLong-Term Outcome Edward Koifman

10:45 AM TCT 145: Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated byCardiogenic Shock Ruben Vergara

11:00 AM TCT 146: Routine Aspiration Thrombectomy is Associated with Increased Stroke RatesDuring Primary Percutaneous Coronary Intervention for Myocardial Infarction Oliver Guttmann

11:15 AM TCT 147: Local Intracoronary Delivery of Eptifibatide Plus Verapamil via Thrombus AspirationCatheter to Prevent No-Reflow in Acute ST Elevation Myocardial Infarction Patients with largeThrombus Burden. Mohamed Hamza

Moderated Poster Session: Culprit vs Complete Revascularization in Primary PCI


Moderated Poster Session: Culprit vs Complete Revascularization in Primary PCI3:00 PM - 4:00 PM

Moderators: Warren J. Cantor, Thomas D. Stuckey

3:00 PM TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75Nationwide Registry Jose M. de la Torre Hernandez

3:15 PM TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-SegmentElevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry Ana Belen Cid Alvarez

3:30 PM TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization DuringPrimary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST ElevationMyocardial Infarction and Multi Vessel Disease Mohamed Hamza

3:45 PM TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO)and SYNTAX score. What are Lessons Learned? Ivo van Dongen

Moderated Poster Session: Physiologic Lesion Assessment


Moderated Poster Session: Physiologic Lesion Assessment3:00 PM - 4:00 PM

Moderators: Michalis Hamilos, Pim A.L. Tonino

3:00 PM TCT 512: Fractional Flow Reserve-Guided Deferred vs Complete Revascularisation in PatientsWith Diabetes Mellitus Elvin Kedhi

3:15 PM TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices ofStenosis Severity is Related to Differences in Coronary Flow Reserve – the RESOLVINGDISCORD Study Christoper Cook

3:30 PM TCT 514: Comparison of Angiographic Scores and Fractional Myocardial Mass: Use ofFractional Myocardial Mass for Comprehensive Evaluation of Coronary Artery Disease IL Park

3:45 PM TCT 515: Prognostic Implications of Instantaneous Wave-Free Ratio (iFR) and Resting Distal-to-Aortic Pressure Ratio (Pd/Pa) Compared with Fractional Flow Reserve (FFR). A 10-YearFollow-Up Study After Deferral of Revascularization G.W. Wijntjens

Moderated Poster Session: Pulmonary Thromboembolism and Pulmonary Hypertension


Moderated Poster Session: Pulmonary Thromboembolism and Pulmonary Hypertension3:00 PM - 4:00 PM

Moderators: Irene M. Lang, Ehtisham Mahmud

3:00 PM TCT 825: Simplicity Denervation System for Pulmonary Artery Denervation in Patients withChronic Thrombembolic Pulmonary Hypertension (first-in-man study) Boris Rudenko

3:15 PM TCT 769: Ultrasound-Assisted Catheter-Directed Thrombolysis in the Treatment of High RiskPulmonary Embolism: A Meta-Analysis Wissam Jaber

3:30 PM TCT 770: Catheter-Directed Thrombolysis Versus Systemic Thrombolysis in PulmonaryEmbolism: Predictors of in Hospital Mortality and Major Bleeding. Shilpkumar Arora

3:45 PM TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical OutcomeAfter Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension Shao-Liang Chen

Moderated Poster Session: TAVR Outcomes


Moderated Poster Session: TAVR Outcomes3:00 PM - 4:00 PM

Moderators: Jean-Claude Laborde, Azfar G. Zaman

3:00 PM TCT 647: The Failing Right Heart: Implication and Evolution in High-Risk Patients UndergoingTranscatheter Aortic Valve Implantation. Luca Testa

3:15 PM TCT 648: Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement Anna Sannino

3:30 PM TCT 649: Prognostic Value of Right Ventricular Dysfunction in Patients UndergoingTranscatheter Aortic Valve Replacement Islam Abdelkarim

3:45 PM TCT 650: Predictors of Mortality in Patients with Persistent Pulmonary HypertensionFollowing Transcatheter Aortic Valve Replacement Ahmad Masri

Edited Taped Cases I: Miscellaneous: LV Reduction, Renal Denervation, TAVR, and Virtual Reality Imaging

Sunday, October 30 9:00 AM - 10:20 AM Walter E. Washington Convention Center Presentation Theater 4, Exhbit Hall, Level 2Accreditation: none

Edited Taped Cases I: Miscellaneous: LV Reduction, Renal Denervation, TAVR, and Virtual Reality Imaging9:00 AM - 10:20 AM

Moderators: Oscar A. Mendiz, Giora Weisz Discussants: Richard R. Heuser, Alexandra J. Lansky, David W.M. Muller, Bernhard Reimers

9:00 AM LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients Horst Sievert

9:12 AM Discussion

9:20 AM Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor ParadiseSystem Case Presenter: Philipp Lurz

9:32 AM Discussion

9:40 AM A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi ProcedureWith Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve Case Presenter: Caterina Gandolfo

9:52 AM Discussion

10:00 AM Using Virtual Reality in Interventional Cardiology Case Presenter: Silvio J. Bezerra

10:12 AM Discussion

Edited Taped Cases II: Coronary and Peripheral Intervention

Sunday, October 30 3:00 PM - 4:00 PM Walter E. Washington Convention Center Presentation Theater 4, Exhbit Hall, Level 2Accreditation: none

Edited Taped Cases II: Coronary and Peripheral Intervention3:00 PM - 4:00 PM

Moderators: Mahmood K. Razavi, Gerald S. Werner Discussants: Roger Gammon, Paul Hsien-Li Kao, Tejas Patel, Sudhir Rathore

3:00 PM The Physiological Impact of CTO PCI on Donor Vessel Physiology and the Influence ofCollateral Regression Case Presenter: Thomas R. Keeble

3:12 PM Discussion

3:20 PM Transcatheter Repair of a Ruptured Coronary Mycotic Aneurysm Case Presenter: Ho-Ping Yu

3:32 PM Discussion

3:40 PM Hibernating Aneurysm and Ectatic SFA With Large Thrombus Burden Identified Using OCTGuided Atherectomy: Changing Algorithms of Care Using Real-Time Imaging During Therapy Case Presenter: Jaafer Golzar

3:52 PM Discussion

Exhibit Hall

Sunday, October 30 8:00 AM - 5:00 PM Walter E. Washington Convention Center Exhibit Hall, Level 2Accreditation: none

Visit the Exhibit Hall to learn, network, relax, and stay updated on the newest and latest in the industry. Morethan 120+ booths fill the large hall with the latest, cutting-edge products and services, selected just for you.Plan your visit today by sear8:00 AM - 5:00 PM

Monday, October 31, 2016

Breakfast Meeting: "Glad I had STENTYS on the Shelf”: Where a Self–Apposing Stent Fits Into Everyday Practice. An Interactive CaseReview Session (Sponsored by STENTYS S.A)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144B, Level 1Accreditation: none


"Glad I had STENTYS on the Shelf”: Where a Self–Apposing Stent Fits Into Everyday Practise. An InteractiveCase Review Session7:00 AM - 8:00 AM

Chair: Gennaro Sardella Facultys: Christoph A. Kaiser, Corrado Tamburino, Robert-Jan van Geuns

7:00 AM Introduction Gennaro Sardella

7:06 AM Case Presentation 1 Case Presenters: Christoph A. Kaiser, Corrado Tamburino, Robert-Jan van Geuns

7:16 AM Panel and Audience Discussion on Case 1 Moderator: Gennaro Sardella





7:54 AM Review and Conclusions Gennaro Sardella

Breakfast Meeting: Chemical Neuromodulation as a Novel Approach to Renal Denervation (Sponsored by Ablative Solutions, Inc.)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: none


Chemical Neuromodulation as a Novel Approach to Renal Denervation7:00 AM - 8:00 AM

Chair: Michael A. Weber Facultys: David E. Kandzari, Felix Mahfoud, Wojtek Wojakowski

7:00 AM Critical Elements for a Successful Study Design in Clinical Trials for Renal Denervation Michael A. Weber

7:15 AM TARGET BP I - Unique Drug/Device Combination Trial Design David E. Kandzari

7:30 AM Looking Ahead: The Potential for Interventional Hypertension Therapy With TargetedChemical Denervation Felix Mahfoud

7:45 AM Clinical Experience With the Peregrine System™ Infusion Catheter Wojtek Wojakowski

Breakfast Meeting: DCRI Evidence to Practice Series: Interventional Cardiology (Sponsored by Duke Clinical Research Institute)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME


DCRI Evidence to Practice Series: Interventional Cardiology7:00 AM - 8:00 AM

Chair: Sunil V. Rao Facultys: Mauricio G. Cohen, Kirk N. Garratt, James B. Hermiller Jr

7:00 AM Introduction to DCRI Evidence to Practice Series Sunil V. Rao

7:05 AM Latest Interventional Cardiology Research Findings: Journals, Guidelines, Breaking ClinicalResearch Sunil V. Rao

7:10 AM Complex PCI Management Approaches Moderator: Sunil V. Rao Case Presenter: Mauricio G. Cohen Discussants: Kirk N. Garratt, James B. Hermiller Jr

7:25 AM Management of the Complex Patient Needing Transcather Valve Moderator: Sunil V. Rao Case Presenter: James B. Hermiller Jr Discussants: Mauricio G. Cohen, Kirk N. Garratt

7:40 AM The PCI May Be Simple, but the Patient Is Complex! Moderator: Sunil V. Rao Case Presenter: Kirk N. Garratt Discussants: Mauricio G. Cohen, James B. Hermiller Jr

7:55 AM Conclusion and Podcast Instructions Sunil V. Rao

Breakfast Meeting: Drift-free FFR with a Workhorse Wire: Is it Truly Possible Now? (Sponsored by Opsens)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 145A, Level 1Accreditation: none

Check-In & Breakfast6:30 AM - 7:00 AM

Drift-free FFR with a Workhorse Wire: Is it Truly Possible Now?7:00 AM - 8:00 AM

Chair: Morton J. Kern Facultys: Olivier F. Bertrand, Bernard De Bruyne, Hitoshi Matsuo

7:00 AM Welcome / Review of FFR tools Morton J. Kern

7:10 AM What Makes OptoWire Special? - North American Experience Olivier F. Bertrand

7:20 AM Ooops, Pa ? Pd Bernard De Bruyne

7:30 AM OptoWire - Japanese Experience Hitoshi Matsuo

7:40 AM Q&A and Discussion Morton J. Kern

7:55 AM Wrap-Up/Conclusion

Breakfast Meeting: Establishing the New Standard: Definitive Treatment for Complex Bifurcation Lesions (Sponsored by Tryton Medical,Inc.)



Establishing the New Standard: Definitive Treatment for Complex Bifurcation Lesions7:00 AM - 8:00 AM

Chairs: Martin B. Leon, David G. RizikFacultys: Philippe Généreux, Jens Flensted Lassen, Maciej Lesiak, MD, Joel E. Schneider, MD

7:00 AM Introductory Remarks David G. Rizik

7:06 AM Review Tryton Safety and Efficacy Studies (RCT and Confirmatory Trials)- A DedicatedApproach to Treating Complex Bifurcation Lesions Philippe Généreux

7:15 AM Importance of Side Branch Ostial Scaffolding Jens Flensted Lassen

7:24 AM One Solution, Many Anatomies David G. Rizik

7:33 AM EU Perspective on Left Main: The Final Frontier Maciej Lesiak

7:42 AM How Tryton Will Change My Daily Practice Joel E. Schneider

7:51 AM Closing Remarks Martin B. Leon

Breakfast Meeting: Management of Complex PCI Patients: Award-Winning Case Presentations (Sponsored by CRF, Supported byABIOMED, Inc.)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 143A, Lower LevelAccreditation: none


Management of Complex PCI Patients7:00 AM - 8:00 AM

Chairs: George D. Dangas, Amir Kaki Panelists: Michael P. Flaherty, Perwaiz M. Meraj, George W. Vetrovec Facultys: Sukhdeep Singh Basra, Nileshkumar Patel, Nishtha Sareen

7:00 AM A Case of Assisted Emergent PCI With Biventricular Impella Case Presenter: Nishtha Sareen

7:15 AM Q&A

7:20 AM Impella for Hemodynamic Support During Percutaneous Intervention of a Distal Left MainBifurcation Lesion in a Patient With a CoreValve and Aortic Endograft Case Presenter: Nileshkumar Patel

7:35 AM Q&A

7:40 AM A Challenging Case of Extreme Risk Anatomy Undergoing Successful Complex PCI of OstialLM, Distal LM, Ostial LAD, Ostial LCx, and Proximal LAD - Using Impella Support in a PatientWith Severe LV Dysfunction Without Surgical Backup Case Presenter: Sukhdeep Singh Basra

7:55 AM Q&A

Breakfast Meeting: Percutaneous Mitral Interventions Where Are We And Where Do We Go? (Sponsored by CRF, Supported by Abbott)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 149, Level 1Accreditation: CME


Percutaneous Mitral Interventions: Where Are We And Where Do We Go?7:00 AM - 8:00 AM

Chair: Alec S. Vahanian Facultys: Ted Feldman, Saibal Kar, Martin J Swaans

7:00 AM Accepted and Controversial Indications of Mitraclip in Primary MR Saibal Kar

7:15 AM Do the Latest Data in Secondary MR Already Predict COAPT Outcomes? Martin J. Swaans

7:30 AM In Light of More Than 30,000 Patients Treated With Mitraclip, What Will Be the RespectiveRole of Repair vs Replacement? Ted Feldman


Breakfast Meeting: Precision Coronary Interventions: Tools for Success (Sponsored by ACIST Medical Systems & Medtronic, Inc.)



Precision Coronary Interventions: Tools for Success7:00 AM - 8:00 AM

Chair: Roxana Mehran Co-Chair: Azeem Latib Facultys: Michael C. Kim, Adhir Shroff

7:00 AM Not All PCIs Are the Same. Diagnosis and a Plan Matter. How to Use Your Tools Roxana Mehran

7:10 AM Transradial - Safely Doing PCI Adhir Shroff

7:25 AM Optimize PCI With High-Definition IVUS Azeem Latib

7:40 AM Optimize Physiological Outcomes With Rapid Exchange FFR Microcatheter Michael C. Kim

7:55 AM Wrap Up/Conclusion Azeem Latib

Breakfast Meeting: Robotic Therapy - Current Applications and Future Vision (Sponsored by Corindus Vascular Robotics)

Monday, October 31 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144A, Level 1Accreditation: none


Robotic Therapy - Current Applications and Future Vision7:00 AM - 8:00 AM

Chair: Martin B. Leon Facultys: Gregory A. Helmer, MD, Ryan D. Madder, Ehtisham Mahmud, MD, Giora Weisz

7:00 AM Opening Remarks Martin B. Leon

7:05 AM Robotic Therapy: Past, Present, and Future Martin B. Leon

7:15 AM Building a Successful Vascular Robotic Program Gregory A. Helmer, MD

7:25 AM Evidence for Robotic Therapy: From Cath Lab Wellness to Patient Benefits Ryan D. Madder

7:35 AM Complex Robotic Intervention Ehtisham Mahmud, MD

7:45 AM Moderated Discussion and Q&A Moderator: Giora Weisz

Main Arena II, Monday, Oct. 31

Monday, October 31 8:00 AM - 1:00 PM Walter E. Washington Convention Center Ballroom, Level 3Accreditation: CME/ASRT/CNE


Live Case Moderator: Gregg W. Stone Live Case Co-Moderator: Ian T. Meredith Live Case Discussants: Stephan Baldus, Olaf Franzen, Cindy L. Grines, Michael Haude, James B. Hermiller Jr,Scott Lim, Yves R. Louvard, Reginald I. Low, Jeffrey J. Popma, Pieter C. Smits, Corrado Tamburino Digital Moderator: Adam Witkowski Digital Panelists: Anita Asgar, Francesco Saia, Darren L. Walters Factoid Facultys: Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow,Myong Hwa Yamamoto

8:00 AM Heart Center Bonn, University Hospital Bonn, Bonn, Germany Live Case Operators: Eberhard Grube, Georg Nickenig, Wolfgang Schiller, MD, Jan-MalteSinning, MD, Armin Welz, MD

8:30 AM Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands Live Case Operators: Peter De Jaegere, MD, Roberto Diletti, Nicolas M. Van Mieghem

Plenary Session II. Late-Breaking Clinical Trials 29:00 AM - 9:45 AM

Moderator: Martin B. Leon Digital Moderator: Keith G. Oldroyd Digital Panelists: Afzalur Rahman, Simon J. Walsh, Bernhard Witzenbichler Discussants: Bagrat Alekyan, Yaron Almagor, Evald H. Christiansen, Ted Feldman, David E. Kandzari, RuedigerLange, D. Christopher Metzger, Seung-Jung Park, Marc Ruel, Craig R. Smith, Gregg W. Stone Co-Moderator: Marie-Claude Morice

9:00 AM EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and BypassGraft Surgery in Selected Patients With Left Main Coronary Artery Disease Gregg W. Stone

9:15 AM NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and BypassGraft Surgery in Selected Patients With Left Main Coronary Artery Disease Evald H. Christiansen

9:27 AM Moderated Roundtable Discussion


Live Case Moderator: Martin B. Leon Live Case Co-Moderator: Michael J. Reardon Live Case Discussants: Steven F. Bolling, Robert A. Guyton, Jose P.S. Henriques, Omar K. Khalique, John M.Lasala, Alexander Lauten, Patrick M. McCarthy, Stephen R. Ramee, Simon J. Walsh, Gerald S. Werner, Grayson H.Wheatley, R. Michael Wyman Digital Moderator: David J. Cohen Digital Panelists: Gary Gershony, Gary L. Schaer, Jean-François Tanguay Factoid Facultys: Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow,Myong Hwa Yamamoto

9:45 AM University of Missouri Kansas City and Saint Luke's Mid America Heart Institute, Kansas City,MO Live Case Operators: J. Aaron Grantham, James Sapontis, MD

10:15 AM NewYork-Presbyterian/Columbia University Medical Center, New York, NY Live Case Operators: Michael A. Borger, Isaac George

Plenary Session IV: Geoffrey O. Hartzler Master Operator Award10:45 AM - 11:00 AM

Award Presenters: Martin B. Leon, Gregg W. Stone Award Recipient: Patrick L. Whitlow, MD

Plenary Session V. TCT Focus Session #2: New Directions for FDA and the European Commission11:00 AM - 12:00 PM

Moderator: Michael J. Mack Digital Moderator: Aaron V. Kaplan Digital Panelists: Ori Ben-Yehuda, Alexandra J. Lansky, Roxana Mehran Discussants: Angeles Alonso Garcia, Robert M. Califf, Gregory Daniel, Alan G. Fraser, Louis B. Jacques, MitchellW. Krucoff, Martin B. Leon, Thomas F. Luscher, Patrick W. Serruys, Gregg W. Stone, Stephan Windecker Co-Moderator: Jeffrey Shuren

11:00 AM Featured Lecture: My Vision of the FDA - Dynamic Evolutionary Changes Robert M. Califf

11:20 AM Featured Lecture: The Rationale and Impact of New European Device Regulations Alan G. Fraser



Moderator: Patrick W. Serruys Digital Moderator: Joanna J. Wykrzykowska Digital Panelists: Niels R. Holm, Stephen WL Lee, Wojtek Wojakowski Discussants: Salvatore Brugaletta, Jose de Ribamar Costa Jr, Carlo Di Mario, Nicolas Foin, Thomas A. Ischinger,Jens Flensted Lassen, Manel Sabate, Rogerio Sarmento-Leite

12:00 PM REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent Stephen G. Worthley

12:08 PM Moderated Roundtable Discussion Discussant: Stephen G. Worthley

12:13 PM FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a RadiopaqueDesaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold inPatients With Coronary Artery Disease Alexandre Abizaid

12:21 PM MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary ArteryDisease Ashok Seth

12:29 PM FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary ArteryDisease Antonio Colombo

12:37 PM FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary ArteryDisease Bo Xu

12:45 PM Moderated Roundtable Discussion Discussant: Bo Xu

Coronary Theater II, Monday, Oct. 31

Monday, October 31 8:00 AM - 12:00 PM Walter E. Washington Convention Center Coronary Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: CHIP8:00 AM - 10:00 AM

Live Case Moderator: Jonathan M. Hill Live Case Co-Moderator: Vladimir Dzavik Live Case Discussants: Herbert D. Aronow, Vinay K. Bahl, Stephen Balter, Laurent Bonello, Marc Etienne Jolicoeur,Christoph A. Kaiser, Tanveer Rab, Gert Richardt, Mohamed Ahmed Sobhy Digital Moderator: Michael J. Cowley Digital Panelists: Nabil Dib, Prakash Krishnan, Expedito E. Ribeiro Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

8:00 AM University of Missouri Kansas City and Saint Luke's Mid America Heart Institute, Kansas City,MO Live Case Operators: J. Aaron Grantham, David Safely, MD

9:00 AM NewYork-Presbyterian Hospital/Columbia University Medical Center NY, NY Live Case Operators: Michael B. Collins, Khady Fall, Ajay J. Kirtane, Manish A. Parikh

Session II. Live Cases: BRS10:00 AM - 12:00 PM

Live Case Moderator: Dean J. Kereiakes Live Case Co-Moderator: Vincent On-Hing Kwok Live Case Discussants: Arif Al Nooryani, Ronald Caputo, John S. Douglas Jr, Antoine Lafont, Talib Majwal,Maurizio Menichelli, Sunao Nakamura, Giulio G. Stefanini, Clemens von Birgelen Digital Moderator: David G. Rizik Digital Panelists: Kevin Bainey, Sreenivas Arramraju Kumar, Ian Menown Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

10:00 AM Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands Live Case Operators: Joost Daemen, Peter De Jaegere, MD, Roberto Diletti, Nicolas M. VanMieghem

11:00 AM Clinique Pasteur Toulouse, Toulouse, France Live Case Operators: Farah Bruno, MD, Jean Fajadet

Structural Theater I, Monday, Oct. 31

Monday, October 31 8:00 AM - 12:00 PM Walter E. Washington Convention Center Structural Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: TAVR8:00 AM - 10:00 AM

Live Case Moderator: Francesco Maisano Live Case Co-Moderator: Charles J. Davidson Live Case Discussants: Vasilis Babaliaros, Antonio L. Bartorelli, Stefan C. Bertog, Bernard R. Chevalier, PhilippeGarot, Biswajit Kar, Clifford J. Kavinsky, Michael J. Mullen, Duane S. Pinto Digital Moderator: Neal S. Kleiman Digital Panelists: Stanley J. Chetcuti, Dharam J. Kumbhani, Binita Shah Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

8:00 AM NewYork-Presbyterian Hospital/Columbia University Medical Center NY, NY Live Case Operators: Isaac George, Rebecca T. Hahn, Susheel Kodali, Tamim Nazif, Torsten P.Vahl

9:00 AM Clinique Pasteur Toulouse, Toulouse, France Live Case Operators: Nicolas Dumonteil, MD, Didier Tchetche

Session II. Live Cases: Mitral and Tricuspid Interventions10:00 AM - 12:00 PM

Live Case Co-Moderators: Ian T. Meredith, William W. O'Neill Live Case Discussants: Saif Anwaruddin, Peter C. Block, Justin E. Davies, Hans R. Figulla, A. Pieter Kappetein,Jan Kovac, Roger J. Laham, Oscar A. Mendiz, Maurice E. Sarano Digital Moderator: Jeroen J. Bax Digital Panelists: Marco Barbanti, Verghese Mathew, Jose Luis Navia Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

10:00 AM Heart Center Bonn, University Hospital Bonn, Bonn, Germany Live Case Operators: Eberhard Grube, Fritz Mellert, MD, Georg Nickenig, Wolfgang Schiller, MD,Jan Malte Sinning, MD, Armin Welz, MD, Nikos Werner, MD

11:00 AM NewYork-Presbyterian Hospital/Columbia University Medical Center NY, NY Live Case Operators: Isaac George, Rebecca T. Hahn, Susheel Kodali, Torsten P. Vahl

Didactic Session: Bioresorbable Vascular Scaffolds, Part 1: Devices and Data

Monday, October 31 2:00 PM - 6:15 PM Walter E. Washington Convention Center Room 151, Level 1Accreditation: CME/ASRT/CNE

Session I. BRS Design and Preclinical Learnings2:00 PM - 2:45 PM

Moderators: Elazer R. Edelman, Juan F. Granada Discussants: Aloke V. Finn, Michael Joner, Greg L. Kaluza, Richard J. Rapoza, Habib Samady, Renu Virmani

2:00 PM Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, andOther Variables on Mechanical Properties, Vascular Compatibility, and Healing I: PathologicPerspectives Renu Virmani

2:07 PM Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, andOther Variables on Mechanical Properties, Vascular Compatibility, and Healing II:Biomechanical Perspectives Elazer R. Edelman

2:14 PM Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion,Recoil, Side Branches, and More Richard J. Rapoza

2:21 PM Assessment and Implications of Vasomotion: Implications for BRS Habib Samady

2:28 PM Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations)to the Novel (Intraluminal Scaffold Dismantling) Juan F. Granada


Session II. Absorb BVS Update2:45 PM - 4:22 PM

Moderators: Stephen G. Ellis, Corrado Tamburino Discussants: Bernard R. Chevalier, Andrejs Erglis, Dean J. Kereiakes, Yoshinobu Onuma, Huay Cheem Tan, JoseM. de la Torre Hernandez

2:45 PM BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb andXience from the ABSORB II trial Patrick W. Serruys

2:53 PM ABSORB II Clinical Outcomes at 3 Years Bernard R. Chevalier

3:00 PM ABSORB China Clinical Outcomes at 2 Years Runlin Gao

3:07 PM ABSORB Japan Clinical Outcomes at 2 Years Takeshi Kimura

3:14 PM Outcome Registries I: Extended Results From ABSORB EXTEND Alexandre Abizaid

3:19 PM Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First Robert-Jan van Geuns

3:26 PM Outcome Registries III: 2-Year Results From ASSURE Detlef G. Mathey

3:32 PM Outcome Registries IV: The UK Absorb Registry Andreas Baumbach

3:38 PM Outcome Registries V: New Insights From GHOST Corrado Tamburino

3:44 PM Outcome Registries VI: France ABSORB Didier Carrié

3:50 PM Outcome Registries VII: IT-DISAPPEARS Anna Sonia Petronio


4:08 PM The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes –With Proper Technique And Planning, Nearly All PCI Patients Can Benefit From BVS! Massimo Napodano

4:14 PM The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No –Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-TermData Is Scant – Best To Wait! Daniel I. Simon

4:20 PM Audience Vote: In What Percentage of Patients Should Absorb Be Used? Poll Moderators: Stephen G. Ellis, Corrado Tamburino

Session III. The Vast BRS World Beyond Absorb4:22 PM - 6:20 PM

Moderators: Ron Waksman, Robert-Jan van Geuns Discussants: Antonio L. Bartorelli, Salvatore Cassese, Kenneth Chin, Hector M. Garcia-Garcia, Vincent On-HingKwok, Stephen G. Worthley

4:22 PM Desolve Nx, Cx and Amity: Unique Properties and Results From 150 Um To 120 Um Alexandre Abizaid

4:31 PM FANTOM: Novel Design Attributes and 6-Month FANTOM II Results Jose de Ribamar Costa Jr

4:39 PM MeRes100 – Design Specifications and the 6-months MeRes-1 Results Ashok Seth

4:47 PM AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents Michael Haude

4:54 PM MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS Patrick W. Serruys

5:01 PM FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results Bo Xu

5:08 PM From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled NovelPLLA-based Polymeric BRS Juan F. Granada

5:16 PM NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion Guosheng Fu

5:23 PM BRS Snapshots: Renuvia FAST Ian T. Meredith

5:28 PM BRS Snapshots: ART and Progress Toward a Drug-Eluting Device Antoine Lafont

5:33 PM BRS Snapshots: XINSORB Lei Ge

5:38 PM BRS Snapshots: The Biolute BRS Dinesh Shah

5:43 PM BRS Snapshots: ArterioSorb Patrick W. Serruys

5:48 PM BRS Snapshots: Lifetech Iron-Based BRS Runlin Gao

5:53 PM BRS Snapshots: A Novel Biodegradable FE/316L Stent Olivier F. Bertrand

5:58 PM Back to BRS: Falcon, the Next Generation Richard J. Rapoza


Didactic Session: CHIP: Calcified Lesions, Multivessel/Diffuse Disease, Vein Grafts, Shock, and More


Session I. Practical/Logistical Aspects of CHIP2:00 PM - 3:05 PM

Moderators: Emmanouil S. Brilakis, Jeffrey W. Moses Discussants: Rajiv Gulati, Jonathan M. Hill, Christoph K. Naber, Robert F. Riley, Adam C Salisbury, Robert W. Yeh Co-Moderator: Ajay J. Kirtane

2:00 PM Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where WeNeed to Go Jeffrey W. Moses

2:08 PM Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or WorkingTogether? Robert W. Yeh

2:16 PM Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, andWhy to Train: A Mid-Career Perspective - On-the-job Training With Proctoring Is the MostReliable Method! Emmanouil S. Brilakis

2:21 PM Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, andWhy to Train: An Early Career Perspective - A Dedicated Fellowship Is Necessary for NewTrainees to Get Into the CHIP Space! Robert F. Riley


2:31 PM Clinical Risk Assessment and Health Status Goals in the CHIP Population Adam C Salisbury

2:39 PM Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIPProgram Jonathan M. Hill

2:47 PM Featured Lecture: Mitigating Legal Risk in Higher-Risk Coronary Procedures Elizabeth A. Leedom


Session II. CHIP A-Z: Technique in Complex and High-risk PCI3:05 PM - 5:03 PM

Moderators: Jonathan M. Hill, Dimitrios Karmpaliotis

3:05 PM Flash Perspectives on Vascular Access: Nearly All CHIP Cases Can Be Done Transradially! Khaldoon Alaswad

3:10 PM Flash Perspectives on Vascular Access: If You Want to Succeed in CHIP, You Will Use 8French Femoral Guides Jeffrey W. Moses

3:15 PM CHIP Tricks: Improving Guide Support With Wires, Guide Extensions, and More Dimitrios Karmpaliotis

3:23 PM Roundtable Discussion With Audience Q&A Discussants: Khaldoon Alaswad, Ronald Caputo, Richard R. Heuser, Jeffrey W. Moses, RamonQuesada, Stéphane Rinfret

3:28 PM Flash Perspective - All Complex PCI Programs Need Dedicated CHIP Operators: Pro! William L. Lombardi

3:33 PM Flash Perspective - All Complex PCI Programs Need Dedicated CHIP Operators: Con! Robert J. Applegate

3:38 PM Using Intravascular Imaging and Physiology to Guide CHIP Cases: The Essentials Gary S. Mintz

3:46 PM Roundtable Discussion With Audience Q&A Discussants: Robert J. Applegate, Morton J. Kern, William L. Lombardi, Gary S. Mintz, KirtiPunamiya, Bernhard Witzenbichler

3:51 PM Flash Perspectives on Calcium Management: The Case for Specialty Balloons WithoutAtherectomy for Most Cases! Carlo Di Mario

3:56 PM Flash Perspectives on Calcium Management: The Case for Rotational Atherectomy! Jasvindar Singh

4:01 PM Flash Perspectives on Calcium Management: The Case for Orbital Atherectomy! Jeffrey Chambers

4:06 PM Flash Perspectives on Calcium Management: The Case for Laser Atherectomy! Steven P. Marso

4:11 PM Importance of Calcification on PCI Techniques and Outcomes: The Costs of “Atherectomy-Regret” Philippe Généreux

4:16 PM Calcium Disruption With Coronary Lithoplasty. Use of the SHOCKWAVE Balloon in ComplexDisease Ian T. Meredith

4:21 PM Roundtable Discussion With Audience Q&A Discussants: Jeffrey Chambers, Philippe Généreux, Steven P. Marso, Ian T. Meredith, KirtiPunamiya, Samin K. Sharma, Jasvindar Singh

4:26 PM 2016 Treatment of Saphenous Vein Grafts, Including Management of Acute Occlusions Joseph P. Carrozza Jr

4:34 PM Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of ComplexPCI Strategies Gennaro Sardella

4:42 PM How to Treat Diffuse Disease With Current PCI Devices Corrado Tamburino

4:50 PM When There Are No Revascularization Options: Indications and Evidence for the CoronarySinus Reducer in the CHIP Patient Gregg W. Stone

4:58 PM Roundtable Discussion With Audience Q&A Discussants: Joseph P. Carrozza Jr, Fazila T. Malik, Gennaro Sardella, Samin K. Sharma, Gregg W.Stone, Corrado Tamburino, Robert J. de Winter

Session III. Ventricular Dysfunction and Hemodynamics in the CHIP Patient5:03 PM - 6:00 PM

Moderators: Ulrich P. Jorde, William W. O'Neill Discussants: Adam B. Greenbaum, Sanjog Kalra, Biswajit Kar, Gert Richardt, Hiroo Takayama, Eric Jose Velazquez

5:03 PM The Impact of Ventricular Dysfunction on Prognosis After Coronary Revascularization Eric Jose Velazquez

5:11 PM Flash Perspectives on Percutaneous Circulatory Support: An IABP Is Really All a GoodInterventionalist Needs! Gert Richardt

5:16 PM Flash Perspectives on Percutaneous Circulatory Support: The Impella Series of Devices Is theCurrent Gold Standard for Mechanical Support! William W. O'Neill

5:21 PM Flash Perspectives on Percutaneous Circulatory Support: ECMO and ECMO CircuitModifications Are the Best Methods to Achieve True Maximal Circulatory Support! Hiroo Takayama

5:26 PM Novel Maximal Circulatory Support Devices on the HORIZON Ulrich P. Jorde

5:31 PM The Role of Right Ventricular and Biventricular Support in CHIP and Shock Cases Sanjog Kalra

5:39 PM Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcavaland Subclavian/Axillary Advancements Adam B. Greenbaum


Didactic Session: Interventional Heart Failure Therapies, Part 1

Monday, October 31 2:00 PM - 6:00 PM

Walter E. Washington Convention Center Room 209, Level 2Accreditation: CME/ASRT/CNE

Session I. Acute Cardiogenic Shock: What Is the Right Treatment Algorithm?2:00 PM - 2:54 PM

Moderators: Simon R. Dixon, Holger Thiele Discussants: Jerry D Estep, A. Reshad Garan, Ulrich P. Jorde, Susan M Joseph, John C Laschinger

2:00 PM Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation Ulrich P. Jorde

2:15 PM Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP Susan M Joseph

2:23 PM Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella Jerry D Estep

2:31 PM Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO A. Reshad Garan


Session II. Chronic Heart Failure: State of the Art2:54 PM - 3:54 PM

Moderators: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld Discussants: Angeles Alonso Garcia, Peter Carson, Anthony N. DeMaria, Robert E. Michler, Ileana L. Pina

2:54 PM Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEFIleana L. Pina

3:09 PM Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies forHFpEF Peter Carson

3:24 PM Coronary Revascularization in Severe Heart Failure: STICH and Beyond Robert E. Michler


Session III. Therapies for Valve Pathologies in Advanced Heart Failure: When to Treat, When NOT to Treat3:54 PM - 4:54 PM

Moderators: Jeroen J. Bax, Ileana L. Pina Discussants: Ori Ben-Yehuda, John C Laschinger, Marco Moscarelli, Joachim Schofer, David P. Slovut, Alec S.Vahanian

3:54 PM Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and Highand Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders Ori Ben-Yehuda

4:09 PM Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failureand Primary and Secondary MR: Magnitude of Benefit and Prediction of Responders Marco Moscarelli

4:24 PM Role of Surgical and Transcatheter Tricuspid Valve Repair for Patients With Heart Failure Joachim Schofer


Session IV. Ventricular Reverse Remodeling4:54 PM - 5:58 PM

Moderator: James E. Udelson Discussants: Peter Carson, Arielle Drummond, P.F. Adrian Magee, Petr Neuzil, Teguh Santoso, Anwar Tandar

4:54 PM State-of-the-Art: Surgical and Device-based LV Remodeling as a Treatment for CHF Ileana L. Pina

5:11 PM The Bioventrix SVR Procedure and Outcomes Petr Neuzil

5:21 PM The Parachute Device: Updated Studies and Results Anwar Tandar

5:31 PM Electrical Therapies for CHF Peter Carson


Didactic Session: Late Breaking Interventional Trials 2016 - The Game Changers


Session I. PCI, CABG, and ACS2:00 PM - 4:15 PM

Moderators: Sunil V. Rao, Harvey D. White Discussants: Sripal Bangalore, Giuseppe Biondi-Zoccai, Warren J. Cantor, Christian Hengstenberg, Stefan K.James, Marc Etienne Jolicoeur, Expedito E. Ribeiro

2:00 PM Trial #1 - The Essentials of ... ABSORB III – Everolimus-Eluting Bioresorbable VascularScaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease Stephen G. Ellis

2:08 PM ABSORB III Critique: Pros and Cons Ron Waksman

2:14 PM Roundtable Discussion With Audience Q&A. Key Question: Which Patients Are Appropriatefor ABSORB?

2:26 PM Trial #2 - The Essentials of ... the MATRIX Trial – Access Site and Anticoagulation Type (AndInfusion Duration) in ACS Salvatore Brugaletta

2:36 PM MATRIX Critique: Pros and Cons Frederick Feit

2:43 PM Roundtable Discussion With Audience Q&A. Key Questions: Bivalirudin vs Heparin With orWithout GP IIb/IIIa Inhibitors in PCI in NSTEACS and STEMI? Does Access Site Affect ThisDecision? Infusion Duration?

2:55 PM Trial #3 - The Essentials of ... the LEADERS FREE trial Philip M. Urban

3:03 PM LEADERS FREE: Pros and Cons Donald Cutlip

3:09 PM Roundtable Discussion With Audience Q&A. Key Questions: Are BMS Appropriate for AnyPatients? Stent Selection for Short and Very Short DAPT Scenarios

3:21 PM Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up Robert A. Guyton

3:29 PM STICH and STICHES Critique: Pros and Cons James E. Udelson

3:35 PM Roundtable Discussion With Audience Q&A. Key Question: Which Patients With IschemicCAD and Depressed LV Function Benefit by Revascularization (And What Type)?

3:47 PM Trial #5 - The Essentials of … TOTAL - One-Year Outcomes of Aspiration in STEMI Warren J. Cantor

3:55 PM TOTAL Critique: Pros and Cons Francesco Burzotta

4:01 PM Roundtable Discussion With Audience Q&A. Key Questions: In Whom Should Aspiration BePerformed? Is Aspiration Harmful?

Session II. Structural Heart Disease and Peripheral Vascular Intervention4:13 PM - 6:00 PM

Moderators: William A. Gray, Stephan Windecker Discussants: Tony Das, Michael R. Jaff, Petr Kala, Saibal Kar, Maurice E. Sarano, Bruno Scheller, Paul Sorajja

4:13 PM Trial #6 - The Essentials of…PARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients,and Improved TAVR Devices Vinod H. Thourani

4:23 PM PARTNER 2 and SAPIEN 3 Critique: Pros and Cons Stephan Windecker

4:30 PM Roundtable Discussion With Audience Q&A. Key Question: Are We Ready for TAVR in LowRisk Patients?

4:42 PM Trial #7 - The Essentials of…CTSN SMR Trial - Two-Year Outcomes Following Mitral ValveRepair or Replacement for Severe Ischemic Mitral Regurgitation Michael Argenziano

4:50 PM CTSN Severe MR 2-Year Critique: Pro and Con Patrick M. McCarthy

4:56 PM Roundtable Discussion With Audience Q&A. Key Question: Which Patients With SevereIschemic MR Should Undergo Mitral Valve Surgery? Repair Or Replacement?

5:08 PM Trial #8 - The Essentials of…The ACT I Trial: Carotid Stenting vs Surgery In AsymptomaticPatients Kenneth Rosenfield

5:16 PM ACT I Critique: Pro and Con Klaus D. Mathias

5:22 PM Roundtable Discussion With Audience Q&A. Key question: Carotid Stenting vsEndarterectomy vs Medical Therapy in Asymptomatic Carotid Disease?

5:34 PM Trial #9 - The Essentials of…IN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloonfor Femoropopliteal Lesions John R. Laird Jr

5:42 PM IN.PACT SFA 3-year Outcomes Critique: Pro and Con Sriram S. Iyer

5:48 PM Roundtable Discussion With Audience Q&A. Key Question: Is There a Single Best Treatmentfor Most Patients With SFA Disease?

Didactic Session: Peripheral Vascular Intervention, Part 2: SFA, Popliteal, and Below the Knee

Monday, October 31 2:00 PM - 6:05 PM Walter E. Washington Convention Center Room 146A, Level 1Accreditation: CME/ASRT/CNE

Session I. SFA Intervention: Knowns and Unknowns2:00 PM - 3:08 PM

Moderators: Tony Das, Koen Deloose Discussants: Brian G DeRubertis, Peter A. Schneider, Ido Weinberg

2:00 PM The Worldwide Epidemic of Peripheral Artery Disease, and Medical Interventions WhichReally Work Ido Weinberg

2:10 PM SFA CTO Crossing Techniques: Choosing Between Intraluminal Crossing, AntegradeSubintimal Dissection With Re-entry, and Retrograde SFA Access Brian G DeRubertis

2:20 PM SFA Intervention: Options and When to Switch Krishna J. Rocha-Singh

2:30 PM The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE Ehrin J. Armstrong

2:40 PM No Metallic Implants Anymore: The Case for Routine DCB! Subhash Banerjee

2:50 PM No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results Michael R. Jaff


Sessions II. Live Case Demonstrations and Debates: SFA Intervention3:08 PM - 4:18 PM

Live Case Moderators: Michael R. Jaff, Kenneth Rosenfield Live Case Discussants: Tony Das, Brian G DeRubertis, Koen Deloose, Kenneth Ouriel, John H. Rundback

3:08 PM Live Case Demonstration: SFA Intervention- Riverside Methodist Hospital, Columbus OH Live Case Operators: Gary M. Ansel, Charles F. Botti, Jr., MD, FACC, Michael A. Jolly, MD, FACC,John A. Phillips, MD, Mitchell J. Silver, DO, FACC

3:38 PM Pre-debate Vote: Does Atherectomy Improve the Results of DCB? Poll Moderator: Michael R. Jaff

3:40 PM Great Debate 2: Atherectomy Adds Nothing to DCB Success Except Time and Cost! Koen Deloose

3:48 PM Great Debate 2: Atherectomy Is Critical for Success of DCB! Eric J. Dippel


4:06 PM Post-debate Vote (Who Won?): Does Atherectomy Improve the Results of DCB? Poll Moderator: Michael R. Jaff


Session III. Popliteal and BTK Intervention: Case Demonstrations4:18 PM - 4:58 PM

Live Case Moderators: Michael D. Dake, Zvonimir Krajcer Live Case Discussants: Subhash Banerjee, R. Stefan Kiesz, Ethan C. Korngold, Sahil A. Parikh, Mehdi H.Shishehbor

4:18 PM A Complex Case Presentation (With Discussion): BTK CTO Case Presenter: Peter A. Schneider

4:28 PM Live Case Demonstrations: Complex Popliteal/BTK Intervention- Riverside MethodistHospital, Columbus OH Live Case Operators: Gary M. Ansel, Charles F. Botti, Jr., MD, FACC, Michael A. Jolly, MD, FACC,John A. Phillips, MD, Mitchell J. Silver, DO, FACC

Session IV. Popliteal and BTK Intervention: Techniques and Unsettled Issues4:58 PM - 6:05 PM

Moderators: George L Adams, John F Angle Discussants: Koen Deloose, Patrick J Geraghty, Raghu Kolluri, Jihad A. Mustapha, Craig M. Walker

4:58 PM My Favorite Infrapopliteal CTO Techniques: Case Examples Craig M. Walker

5:08 PM When and How Do I Perform Retrograde Tibial Access? Jihad A. Mustapha

5:18 PM Best Practices for BTK Angioplasty and When to Debulk Koen Deloose

5:28 PM What Are the Right Endpoints for CLI Clinical Trials? Patrick J Geraghty

5:36 PM Liberty 360: A Prospective, Multicenter Registry Examining the Outcomes of DifferentAtherectomy Devices and No Atherectomy in Patients With Symptomatic Peripheral ArterialDisease Jihad A. Mustapha

5:46 PM Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical LimbCenter Raghu Kolluri


Didactic Session: STEMI, Cardiogenic Shock, and Cardiac Arrest: Unsettled Issues and Emerging Device-Based Approaches

Monday, October 31 2:00 PM - 6:00 PM Walter E. Washington Convention Center Room 201, Level 2

Accreditation: CME/ASRT/CNE

Session I. Primary PCI for STEMI and Multivessel Disease2:00 PM - 3:03 PM

Moderators: Ran Kornowski, Michel R. Le May Discussants: Giuseppe De Luca, Thomas Engstroem, William D. Knopf, Maurizio Menichelli, Tej Sheth, Marco V.Wainstein

2:00 PM Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials andUnanswered Questions Kevin Bainey

2:10 PM Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them? Jose P.S. Henriques

2:17 PM Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only? Henning Kelbæk

2:24 PM Pre-debate Vote: What Is the Most Important Factor in Predicting Future Thrombotic Eventsin Patients With STEMI and Multivessel Disease? Poll Moderators: Ran Kornowski, Michel R. Le May

2:26 PM DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: TheDegree of Stenosis/Ischemia Is Most Important! Anthony H. Gershlick

2:33 PM DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease:Vulnerable Plaque Is the Single Most Important Factor! Tej Sheth

2:40 PM Post-debate Vote (Who Won?): What Is the Most Important Factor in Predicting FutureThrombotic Events in Patients With STEMI and Multivessel Disease? Poll Moderators: Ran Kornowski, Michel R. Le May

2:42 PM Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCACulprit and Proximal LAD Non-Culprit Lesion Case Presenter: Natalia Pinilla-Echeverri

2:48 PM Roundtable Discussion With Q&A

Session II. Cardiac Arrest and Cardiogenic Shock3:03 PM - 4:41 PM

Moderators: Cindy L. Grines, Holger Thiele Discussants: Ulrich P. Jorde, Jacques J. Koolen, Sundeep Mishra, Tanveer Rab, Ivan C. Rokos, Nir Uriel

3:03 PM Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy? Christian M. Spaulding

3:13 PM Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and CoolingProtocols David Erlinge

3:23 PM Case Presentation: A Patient Presenting With Cardiac Arrest Case Presenter: Michael Mooney


3:37 PM From Severe LV Dysfunction Without Heart Failure to Killip Class III and IV: Who NeedsMechanical Hemodynamic Support During Primary PCI? Vladimir Dzavik

3:45 PM When Mechanical Support During Primary PCI for LV Dysfunction Is Needed: When to UseIABP, Impella, TandemHeart, and/or ECMO Holger Thiele

3:53 PM Support for Hemodynamically Severe RV Infarction: When to Use Impella RP, TandemHeart,and/or CentriMag A. Reshad Garan

4:01 PM Outcomes of Impella in 347 Patients With Cardiogenic Shock: The US Impella Registry William W. O'Neill

4:08 PM Establishing ECMO in the Severe Shock and Cardiac Arrest Patient: Practical Issues andPatient Outcomes Hiroo Takayama

4:15 PM Benefit of Supersaturated Oxygen for Large Anterior STEMI: From ICI-HOT to Approval? Gregg W. Stone

4:22 PM PICSO to Improve Myocardial Salvage and Reduce Infarct Size in STEMI: Emerging Data Azfar G. Zaman


Session III. All the Rest: Thrombus Aspiration, Radial Intervention, Intracoronary Therapeutics, and NovelStent Designs4:41 PM - 6:00 PM

Moderators: Deepak L. Bhatt, Stefan K. James Discussants: Eric R. Bates, Sorin J. Brener, Vasim Farooq, Bill J. French, Christopher Overgaard, RogerioSarmento-Leite

4:41 PM Aspiration Thrombectomy in STEMI: Data Synthesis, and How to Identify Patients Who MightBenefit Eric A. Cohen

4:51 PM New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL AngiographicCore Lab Christopher Overgaard


5:03 PM Pre-debate Vote: Does Radial Access Really Improve Survival for STEMI? Poll Moderators: Deepak L. Bhatt, Stefan K. James

5:05 PM Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention forSTEMI Improves Survival and Should Be Standard Practice! Michael A. Kutcher

5:12 PM Debate: Does Radial Access Really Improve Survival for STEMI? No - Radial Intervention inSTEMI Is Not Clearly Superior to Femoral Access! Discussant: E. Magnus Ohman

5:19 PM Post-debate Vote (Who Won?): Does Radial Access Really Improve Survival for STEMI? Poll Moderators: Deepak L. Bhatt, Stefan K. James


5:26 PM Ticagrelor vs. Prasgurel in STEMI: What have we learned from PRAGUE-18 Salvatore Cassese

5:33 PM Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI? C. Michael Gibson

5:40 PM Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices? Tullio Palmerini

5:47 PM Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) andTROFI II 2-year Results Manel Sabate


Didactic Session: The CTO Summit: Conquering the Final Frontier, Part 1


Session I. Develop a CTO Skill Set and Build a CTO Program: Learn From Those Who Have Done It2:00 PM - 4:00 PM

Moderators: James C. Spratt, Simon J. Walsh Discussants: Christopher E. Buller, Tony J. DeMartini, Farouc Jaffer, Steven P. Marso, Satoru Sumitsuji

2:00 PM Why I Became a CTO Operator and What It Means to Me Nicholas J. Lembo


2:20 PM What Is a CTO Skill Set? Why Is It Different and How Do You Build It? Ashish Pershad


2:40 PM How to Establish and Grow a CTO Program: Essentials and Pitfalls Farouc Jaffer


3:00 PM Individual and Programmatic CTO Development: Lessons Learned the Hard Way Steven P. Marso


3:20 PM The Latest Guidewires for CTO PCI: Construction and How to Choose and Use Christopher E. Buller


3:40 PM Microcatheters and Guide Extensions: What Do I Really Need and When/How Should I UseThem? Satoru Sumitsuji


Session II. Fundamental Skills and Algorithms for Success4:00 PM - 5:40 PM

Moderators: William L. Lombardi, Etsuo Tsuchikane Discussants: Sudhir Rathore, Simon J. Walsh, Gerald S. Werner, R. Michael Wyman

4:00 PM Asia Pacific Algorithm Etsuo Tsuchikane


4:20 PM Hybrid 2.0: Lessons From OPEN CTO R. Michael Wyman


4:40 PM Antegrade Wire Approach Sudhir Rathore


5:00 PM Parallel Wires and Antegrade IVUS Guided Re-entry Gerald S. Werner


5:20 PM Antegrade Dissection and Re-entry Simon J. Walsh


Didactic Session: The Left Main and Bifurcation Summit, Part 2: Left Main Stenting and EXCEL/NOBLE Deep Dive


Session I. Left Main Stenting: Evidence-Based Medicine Pre-EXCEL/NOBLE2:00 PM - 3:23 PM

Moderators: Seung-Jung Park, Leif Thuesen Discussants: Mohamed Abdel-Wahab, Carlo Briguori, Francesco Burzotta, Michalis Hamilos, Margaret B.McEntegart, Alexander Grigorievich Osiev

2:00 PM Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection andTechnique to Optimize Outcomes Seung-Jung Park

2:07 PM What Have We Learned From Contemporary Left Main Observational Studies I? French andLEMAX Registries Philippe Garot

2:14 PM What Have We Learned From Contemporary Left Main Observational Studies II? ESTROFA-LM Jose M. de la Torre Hernandez

2:20 PM What Have We Learned From Contemporary Left Main Observational Studies III? ERACI IV Alfredo E. Rodriguez

2:26 PM What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry David Antoniucci

2:32 PM Early Insights From the DELTA-2 Registry Alaide Chieffo

2:38 PM Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main RandomizedTrials? Marie-Claude Morice

2:46 PM Cost-effectiveness of PCI vs CABG in Left Main Disease: Final SYNTAX Results David J. Cohen

2:53 PM Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG Davide Capodanno

3:01 PM Impact of Operator Experience on Left Main PCI Outcomes: Fu Wai Experience Bo Xu


Session II: EXCEL Deep-Dive3:23 PM - 4:31 PM

Moderators: A. Pieter Kappetein, Marie-Claude Morice Discussants: Adrian P. Banning, Dietmar H. Glogar, Nicholas J. Lembo, Jamil Abdalla Saad, Erick Schampaert,Terje K. Steigen

3:23 PM EXCEL Top Line Results Revisited Gregg W. Stone

3:31 PM Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vsCABG in EXCEL Philippe Généreux

3:39 PM EXCEL Outcomes in Diabetic and Non-diabetic Patients A. Pieter Kappetein

3:47 PM EXCEL Outcomes in Men and Women Patrick W. Serruys

3:55 PM EXCEL Outcomes in Patients With and Without Chronic Kidney Disease Joseph F. Sabik

4:03 PM IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From theEXCEL IVUS Core Laboratory Akiko Maehara


Session III. NOBLE Deep-Dive4:31 PM - 5:26 PM

Moderators: Evald H. Christiansen, Per Hostrup Nielsen Discussants: Pawel E. Buszman, Sreenivas Arramraju Kumar, Ramon Quesada, Bernhard Reimers, Marco V.Wainstein

4:31 PM NOBLE Top Line Results Revisited Evald H. Christiansen

4:39 PM Diabetes in the NOBLE Trial Olli A. Kajander

4:47 PM NOBLE Left main Bifurcation Stent Techniques Mitchell Lindsay

4:55 PM SYNTAX Stratified NOBLE Results Ian Menown

5:03 PM OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBERTrial Niels R. Holm


Session IV. The Closing Debate: Is PCI Now Standard of Care in Left Main Disease?5:26 PM - 6:00 PM

Moderators: Robert A. Guyton, Martin B. Leon Discussants: Adrian P. Banning, Bernard R. Chevalier, Keith G. Oldroyd, Joseph F. Sabik, Mohamed Ahmed Sobhy,Leif Thuesen, Grayson H. Wheatley

5:26 PM Pre-debate Vote: After EXCEL and NOBLE, What Proportion of All Patients With Left MainDisease Needing Revascularization Should Undergo PCI? Poll Moderators: Robert A. Guyton, Martin B. Leon

5:28 PM Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes – theIssue Is No Longer in Doubt! David E. Kandzari

5:38 PM Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So ManyQuestions Are Still Unanswered! Marc Ruel


5:58 PM Post-debate Vote: After EXCEL and NOBLE, What Proportion of All Patients With Left MainDisease Needing Revascularization Should Undergo PCI? Poll Moderators: Robert A. Guyton, Martin B. Leon

Didactic Session: Transcatheter Aortic Valve Therapies Part 2: Controversies and Complications

Monday, October 31 2:00 PM - 6:12 PM Walter E. Washington Convention Center Room 146B/C, Level 1Accreditation: CME/ASRT/CNE

Session I. TAVR 2016: Controversies2:00 PM - 4:20 PM

Moderators: Raj Makkar, Lars Sondergaard Discussants: Stephan Baldus, Lutz Buellesfeld, Michael Haude, Dominique Himbert, Albert Markus Kasel,Alexandra J. Lansky, Grayson H. Wheatley

2:00 PM Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: ObservationsFrom DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials Samir R. Kapadia

2:10 PM Flash Debate: Point – Cerebral Protection Is a “Must” for All Patients! Axel Linke

2:15 PM Flash Debate: Counterpoint – Cerebral Protection Is an Unnecessary and Costly Accessory! Haim Danenberg


2:25 PM Controversy 2. Global Clinical Trial Experiences on Bioprosthetic LeafletThickening/Thrombosis: Updates and Insights Raj Makkar

2:35 PM Flash Debate: Point – 4D-CT Leaflet Thickening Is an Imaging Curiosity With No ClinicalRelevance! Ganesh Manoharan

2:40 PM Flash Debate: Counterpoint – 4D-CT Leaflet Imaging Findings Will Help to DirectAnticoagulation Therapy! Raj Makkar


2:50 PM Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability A. Pieter Kappetein

2:58 PM Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience Helene Eltchaninoff

3:06 PM Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience John G. Webb


3:20 PM Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinicaland Economic Data Ganesh Manoharan

3:28 PM Flash Debate: Point – In Lower Risk Patients, the Minimalist Strategy Should Be the “Default”Approach! Antonio Colombo

3:33 PM Flash Debate: Counterpoint – In Lower Risk Patients, A Thoughtful “Hybrid” Strategy IsPreferred! Stephen J.D. Brecker


3:43 PM Featured Lecture: The Current Symptom-Based Paradigm for When to Treat Aortic Stenosis IsFlawed - A Hypothesis to Integrate Hemodynamic, Structural, and Functional Parameters Elazer R. Edelman


4:03 PM Controversy 5. Adjunctive Pharmacotherapy for TAVR: “Real World” Usage Patterns ofAntiplatelet and Antithrombotic Agents Luis Nombela-Franco

4:09 PM Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR Davide Capodanno


Session II. TAVR 2016: Complications4:20 PM - 6:12 PM

Moderators: Neil E. Moat, John G. Webb Discussants: Anita Asgar, Marco Barbanti, Nirat Beohar, David J. Cohen, Kendra J. Grubb, Mayra Guerrero, ThierryLefevre, Mark A. de Belder

4:20 PM Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation AfterTAVR Be Treated? Jeffrey J. Popma

4:28 PM A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR Scott Lim

4:36 PM Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-ValvularRegurgitation Eric Van Belle

4:44 PM The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI WithSapien 3 or CoreValve Using Mulit-Modality Imaging Pieter R. Stella


5:00 PM Complications 2. How to Prevent and Treat Transfemoral Access Site Complications Stephen R. Ramee

5:08 PM The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian,Carotid, and Caval) Adam B. Greenbaum


5:20 PM Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC Alexandra J. Lansky

5:28 PM Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors – Clinical, Anatomic,Technique-related, and Device-specific Samir R. Kapadia


5:40 PM Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and NewPacemakers After TAVR Marina Urena

5:48 PM Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural,and Device-Related Factors Ian T. Meredith


6:00 PM Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, andAssociations Philippe Généreux


Didactic Session: Transcatheter Mitral Valve Therapies Part 2: Emerging Device-Based Solutions


Session I. Emerging Transcatheter Repair Devices for Mitral Regurgitation2:00 PM - 4:00 PM

Moderators: Ted Feldman, Scott Lim Discussants: Krzysztof Bartus, Steven L. Goldberg, Omar K. Khalique, Helge Möllmann, Jai Raman, JoergSeeburger, Frederick G. St. Goar

2:00 PM Next Generation MitraClip: What’s Better and What’s Not Ralph Stephan von Bardeleben

2:07 PM Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR:Implications of the CTSN SMR Trial and Other Experiences Steven F. Bolling

2:14 PM Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions Francesco Maisano

2:22 PM Direct Annuloplasty II: Mitralign Trial Results and Future Directions Azeem Latib

2:29 PM Direct Annuloplasty III: Guided Delivery Systems – Results, Device Iterations, and FutureDirections Horst Sievert

2:36 PM Direct Annuloplasty IV: Millipede Jason H. Rogers

2:43 PM Direct Annuloplasty V: Valcare David Meerkin

2:50 PM Direct Annuloplasty VI: Cardiac Implants Karl-Heinz Kuck


3:07 PM Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans Samir R. Kapadia

3:15 PM Indirect Annuloplasty via the Coronary Sinus II: MVRx David Hildick-Smith

3:22 PM Indirect Annuloplasty via the Coronary Sinus II: Mitral Cerclage Robert J. Lederman

3:29 PM Update on Artificial Chords I: Neochord Joerg Seeburger

3:36 PM Update on Artificial Chords II: Harpoon James S. Gammie

3:43 PM Ventricular Reshaping: From CorCap to VenTouch Ted Feldman


Session II. Transcatheter Mitral Valve Replacement: Devices and Early Experiences4:00 PM - 6:00 PM

Moderators: Michael J. Mack, Ralph Stephan von Bardeleben Discussants: Anson Cheung, Jose Luis Navia, Wesley R. Pedersen, Michael J. Reardon, Lars Sondergaard, AlfredoTrento

4:00 PM Design Challenges in TMVR: Impossible or Just Near Impossible? Juan F. Granada

4:07 PM Complications That Can Occur After Transcatheter Mitral Valve Replacement Neil E. Moat

4:14 PM CardiAQ: Design and Clinical Trial Updates Gian Paolo Ussia

4:22 PM Tendyne: Design and Clinical Trial Updates David W.M. Muller

4:30 PM Neovasc Tiara: Design and Clinical Trial Updates Anson Cheung

4:38 PM Intrepid: Design and Clinical Trial Updates Vinayak Bapat


4:56 PM HighLife: Design and Clinical Trial Updates Ruediger Lange

5:02 PM Sinomed: Design and Clinical Trial Updates Maurizio Taramasso

5:08 PM Caisson: Design and Clinical Trial Updates Mathew Williams

5:14 PM M-Dock: Design and Clinical Trial Updates Maurice Buchbinder

5:19 PM Valtech TMVR: Design Development Update Karl-Heinz Kuck

5:24 PM Direct Flow TMVR: Design Development Update Azeem Latib

5:29 PM St. Jude TMVR: Design Development Update Anson Cheung

5:34 PM Cephea: Design Development Update Juan F. Granada

5:39 PM Grand Summary: TMVR Outcomes to Date – Successes, Failures, and Implications Michael J. Mack


Featured Clinical Research: Presentations to the Editors of Circulation

Monday, October 31 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 150, Level 1Accreditation: none

Presentations to the Editors of Circulation12:00 PM - 1:00 PM

Moderators: Joseph A. Hill, Steven P. Marso Discussants: Emmanouil S. Brilakis, Stefan K. James, Dharam J. Kumbhani, Laura Mauri, David O. Williams

12:00 PM OPINION: OCT Follow-Up Substudy from a Randomized Trial of OFDI-Guided PCI vs. IVUS-Guided PCI Hiromasa Otake

12:08 PM Moderated Roundtable Discussion

12:12 PM EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTOIntervention after Primary PCI in Patients with STEMI Jose P.S. Henriques


12:24 PM PERFECT: A Prospective Registry Evaluating the Effects of Pan-Pelvic EndovascularIntervention on Erectile Function and Lower Urinary Tract Symptoms Tzung-Dau Wang


12:36 PM A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aorticvalve replacement Adam B. Greenbaum


12:48 PM DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty priorto stent implantation in heavily calcified coronary lesions Todd J. Brinton


Featured Clinical Research: Presentations to the Editors of the Journal of the American College of Cardiology


Presentations to the Editors of the Journal of the American College of Cardiology12:00 PM - 1:00 PM

Moderators: Spencer B. King III, Jagat Narula Discussants: Stephen G. Ellis, James K. Min, John G. Webb

12:00 PM FAME I and FAME II: Predictive Value of Fractional Flow Reserve After Drug-Eluting StentImplantation Zsolt Piroth


12:12 PM A Prospective, Single-Center, Randomized Study to Assess Whether Co-Registration of OCTand Angiography can Reduce Geographic Miss Kohei Koyama


12:24 PM YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-CulpritLesions to HDL Efflux, Inflammation and Transcriptome Perturbations in Response to High-Dose Statin Therapy Annapoorna Kini


12:36 PM TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic ValveImplantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis Henrique B. Ribeiro


12:48 PM A Single Center Study Evaluating the Long-Term Durability of Self-Expanding TranscatheterHeart Valves After Treatment of Severe Aortic Stenosis Erik W. Holy


Featured Clinical Research: Presentations to the Editors of the European Heart Journal


Presentations to the Editors of the European Heart Journal1:00 PM - 2:00 PM

Moderators: Thomas F. Luscher, Patrick W. Serruys Discussants: Carlo Di Mario, Ted Feldman, Felix Mahfoud, Christoph A. Nienaber

1:00 PM DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stentsin Patients with Obstructive Left Main Coronary Artery Disease Alaide Chieffo


1:12 PM GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous CoronaryIntervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy Francisco Fdez-Aviles


1:24 PM A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation inPatients with Cardiogenic Shock Jose P.S. Henriques


1:36 PM FORWARD: Multicenter, Prospective Registry Evaluating a Repositionable Self-ExpandingAortic Bioprosthesis in Patients with Severe Aortic Stenosis Stephan Windecker


1:48 PM Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-CoatedBalloon in Patients with Complex Femoropopliteal Lesions D. Christopher Metzger


Oral Abstract Session: ACS/AMI I: Predictors and Prognosis

Monday, October 31 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 103A, Level 1Accreditation: none

ACS/AMI I: Predictors and Prognosis12:00 PM - 1:00 PM

Moderators: Andreas Baumbach, Kurt Huber Discussants: Andrea Abizaid, Jun-Jack Cheng, Rajiv Gulati, Jamil Abdalla Saad

12:00 PM TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are NotExplained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 RandomizedTrials Bjorn Redfors

12:12 PM Discussion

12:15 PM TCT 1: Microvascular Obstruction Is Independently Associated With Adverse EventsFollowing Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials ISCTR Lecturer: Suzanne De Waha

12:27 PM Discussion

12:30 PM TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With ImprovedPatency of Infarct Related-Artery in STEMI – A Report from SCAAR Elmir Omerovic

12:42 PM Discussion

12:45 PM TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients Seiichi Hiramori

12:57 PM Discussion

Oral Abstract Session: Adjunct Pharmacology I: Dual Antiplatelet Agents


Adjunct Pharmacology I: Dual Antiplatelet Agents12:00 PM - 1:00 PM

Moderators: Dimitrios Alexopoulos, Laurent Bonello Discussants: Eric A. Cohen, Germano Di Sciascio, Dimitriy N. Feldman, Francesco Saia

12:00 PM TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass GraftSurgery: Insights From the ACUITY Trial Ramin Ebrahimi

12:12 PM Discussion

12:15 PM TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry Usman Baber

12:27 PM Discussion

12:30 PM TCT 8: Impact of Aspirin Resistance on Outcomes After Coronary Events Christine Chung

12:42 PM Discussion

12:45 PM TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and ThromboticEvents: A Mediation Analysis From ADAPT-DES Bjorn Redfors

12:57 PM Discussion

Oral Abstract Session: CT or Angiography-Derived FFR

Monday, October 31 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: none

CT or Angiography-Derived FFR12:00 PM - 1:00 PM

Moderators: Daniel S. Berman, Pamela S. Douglas Discussants: Lampros K. Michalis, Johan HC Reiber, Jennifer A. Tremmel, Tim P. van de Hoef

12:00 PM TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies: Implications for Clinical Decision-making Justin E. Davies

12:12 PM Discussion

12:15 PM TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of InvasiveCoronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study Jelmer Westra

12:27 PM Discussion

12:30 PM TCT 11: Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional FlowReserve From Diagnostic Coronary X-ray Angiography in the International Multicenter FAVOR(Functional Assessment by Various FlOw Reconstructions) Pilot Study Shengxian Tu

12:42 PM Discussion

12:45 PM TCT 12: Real-world Utilization of Computed Tomography Derived Fractional Flow Reserve:Single Center Initial Experience in the United States Anas Fares

12:57 PM Discussion

Oral Abstract Session: CTO Techniques and Outcomes I

Monday, October 31 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 143B, Level 1Accreditation: none

CTO Techniques and Outcomes I12:00 PM - 1:00 PM

Moderators: Christopher E. Buller, Sudhir Rathore Discussants: David Antoniucci, Mauro Carlino, Paul Hsien-Li Kao, Barry D. Rutherford

12:00 PM TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention Accordingto Dissection/Reentry vs Wire Escalation Techniques Lorenzo Azzalini

12:12 PM Discussions

12:15 PM TCT 14: Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes After CTOPercutaneous Coronary Interventions: An Observational Study of 5,496 Patients From thePan-London CTO Cohort Daniel Jones

12:27 PM Disscussion

12:30 PM TCT 15: Use of Antegrade Dissection Reentry in Coronary Chronic Total OcclusionPercutaneous Coronary Intervention in a Contemporary Multicenter Registry Barbara Danek

12:42 PM Discussion

12:45 PM TCT 16: Patient and Procedural Characteristics and In-Hospital Outcomes Associated Withthe Use of Retrograde Recanalization Techniques for Chronic Total Occlusion PCI: A ReportFrom the Open CTO Registry Sanjog Kalra

12:57 PM Discussion

Oral Abstract Session: Endovascular Interventions


Endovascular Interventions12:00 PM - 1:00 PM

Moderators: Sriram S. Iyer, Craig M. Walker Discussants: Mark C. Bates, Koen Deloose, Zaza Kavteladze, Klaus D. Mathias

12:00 PM TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and PatientOutcomes Daniel Ortiz

12:12 PM Discussion

12:15 PM TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System inJapanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI). Takahiro Tokuda

12:27 PM Discussion

12:30 PM TCT 19: Vascular Response to Paclitaxiel-Eluting Nitinol Self-Expanding Stent in SuperficialFemoral Artery Lesions: Angioscopic Findings at Two, Six, and Twelve Months AfterImplantation Toshiro Shinke

12:42 PM Discussion

12:45 PM TCT 17: The Lutonix Global DCB Registry Real World Patients With Complex Femero-PoplitealLesions – 24 Month Outcomes D. Christopher Metzger

12:57 PM Discussion

Oral Abstract Session: Hemodynamic Support of Cardiogenic Shock: Prognosis, Devices, and ECMO


Hemodynamic Support of Cardiogenic Shock: Prognosis, Devices, and ECMO12:00 PM - 1:00 PM

Moderators: Tanveer Rab, Richard Smalling Discussants: Biswajit Kar, William D. Knopf, Michael Mooney, Molly Szerlip

12:00 PM TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO MightImprove the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock Chi-Cheng Huang

12:12 PM Discussion

12:15 PM TCT 22: Dual Mechanical Support Combining Impella Microaxial Pump and Veno-ArterialECMO Rescues High-risk Patients in Refractory Cardiogenic Shock Joern Tongers

12:27 PM Discussion

12:30 PM TCT 23: Contemporary Trends in Utilization of Mechanical Circulatory Support in PatientsHospitalized After Out-of-Hospital Cardiac Arrest Nileshkumar Patel

12:42 PM Discussion

12:45 PM TCT 24: Global cVAD Registry: A Global Initiative in Percutaneous Circulatory Support Fromthe cVAD Steering Committee on Behalf of All cVAD Investigators Brij Maini

12:57 PM Discussion

Oral Abstract Session: LAA and PFO Closure: New Devices and Outcomes


LAA and PFO Closure: New Devices and Outcomes12:00 PM - 1:00 PM

Moderators: Zahid Amin, Jacqueline Saw Discussants: Steven L. Almany, Hans R. Figulla, Glenn Van Langenhove, Nina C. Wunderlich

12:00 PM TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in AtrialFibrillation: A Network Meta-Analysis From Randomized Trials Luis Nombela-Franco

12:12 PM Discussion

12:15 PM TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN:PROTECT AF Five-Year and PREVAIL Three-Year Follow-up Vivek Y. Reddy

12:27 PM Discussion

12:30 PM TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-ImplantAntithrombotic Therapy Jens Erik Nielsen-Kudsk

12:42 PM Discussion

12:45 PM TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE) David Hildick-Smith

12:57 PM Discussion

Oral Abstract Session: New Bioresorbable Scaffolds


New Bioresorbable Scaffolds12:00 PM - 1:00 PM

Moderators: Jacques J. Koolen, Yoshinobu Onuma Discussants: Ricardo A. Costa, Vasim Farooq, Aloke V. Finn, Nick E. J. West

12:00 PM TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-ElutingBioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in theFANTOM II Study Jo Simonsen

12:12 PM Discussion

12:15 PM TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug ElutingAbsorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in NativeCoronary Arteries at 12-Month Follow-Up-BIOSOLVE-II Michael Haude

12:27 PM Discussion

12:30 PM TCT 31: Impact of Strut Thickness on Short-term Healing Response After BioresorbableScaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus-Eluting BRS vsThick Strut Everolimus-Eluting BRS in Porcine Coronary Arteries Pawel Gasior

12:42 PM Discussion

12:45 PM TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting BioresorbableCoronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results Alexandre Abizaid

12:57 PM Discussion

Oral Abstract Session: Outcomes After TAVR and SAVR


Outcomes After TAVR and SAVR12:00 PM - 1:00 PM

Moderators: Charles J. Davidson, Michael J. Reardon Discussants: Amit N Patel, Wesley R. Pedersen, E. Murat Tuzcu, Grayson H. Wheatley

12:00 PM TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement James Harvey

12:12 PM Discussion

12:15 PM TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients withSevere Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial Suzanne Baron

12:27 PM Discussion

12:30 PM TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-ExpandingTranscatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program James B. Hermiller Jr

12:42 PM Discussion

12:45 PM TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical AorticValve Replacement, Cut Points and Relationship With Outcomes: An Analysis of thePlacement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial Philip Green

12:57 PM Discussion

Oral Abstract Session: TAVR Results With Emerging THV Systems


TAVR Results With Emerging THV Systems12:00 PM - 1:00 PM

Moderators: Lutz Buellesfeld, Raj Makkar Discussants: Dominique Himbert, Jean-Claude Laborde, Reginald I. Low, Ganesh Manoharan

12:00 PM TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-ExpandingBioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-YearResults From the Evolut R US Pivotal Study Jeffrey J. Popma

12:12 PM Discussion

12:15 PM TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes AfterTranscatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve Philippe Pibarot

12:27 PM Discussion

12:30 PM TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus™Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe AorticStenosis: Results From the REPRISE II CE-Mark Study Ian T. Meredith

12:42 PM Discussion

12:45 PM TCT 40: One-Year Outcome of a Multicenter Clinical Study Evaluating a Novel Self-Expandingand Resheathable Transcatheter Aortic Valve System Ganesh Manoharan

12:57 PM Discussion

Oral Abstract Session: Transcatheter Mitral Valve Repair


Transcatheter Mitral Valve Repair12:00 PM - 1:00 PM

Moderators: Stephan Baldus, Allan Schwartz Discussants: Philipp Blanke, Steven L. Goldberg, Helge Möllmann, Joerg Seeburger

12:00 PM TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty Systemfor Mitral Reconstruction Multicenter Trial Karl-Heinz Kuck

12:12 PM Discussion

12:15 PM TCT 42: Transcatheter Echo Guided Mitral Valve Repair With Neochord Implantation forPosterior Leaflet Disease: Results From Neochord Independent International Registry Andrea Colli

12:27 PM Discussion

12:30 PM TCT 43: Outcomes After Paravalvular Leak Closure: Percutaneous Versus SurgicalApproaches John Wells

12:42 PM Discussion

12:45 PM TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral BalloonValvuloplasty in a Large, Consecutive Cohort Followed for More Than Two Decades Alfredo Nunes Ferreira Neto

12:57 PM Discussion

Oral Abstract Session: Treatment of Specific Coronary Lesion Subsets


Treatment of Specific Coronary Lesion Subsets12:00 PM - 1:00 PM

Moderators: Javier Escaned, Christoph K. Naber Discussants: Kevin Bainey, Graham A. Cassel, Walter Desmet, Pim A.L. Tonino

12:00 PM TCT 45: Five-Year Mortality Predictors After Provisional T-Stenting in Coronary BifurcationLesions, With Intracoronary Electrocardiogram Change Defined Strategy. From IntracoronaryElectrocardiogram (ECG) and Myonecrosis After Bifurcation Stenting (COSIB Kiril Karamfiloff

12:12 PM Discussion

12:15 PM TCT 46: Coronary Artery Aneurysms: Incididence, Etiology, Management, and Outcomes in aLong-term Follow-up Antonio Gomez Menchero

12:27 PM Discussion

12:30 PM TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients WithUnprotected Left Main Coronary Artery Disease Over Two Decades Duk-Woo Park

12:42 PM Discussion

12:45 PM TCT 48: Medical Therapy and Clinical Outcomes With Spontaneous Coronary ArteryDissection Jaya Chandrasekhar

12:57 PM Discussion

Oral Abstract Session: ACS/AMI II: Anatomy, DES, and BRS Treatment


ACS/AMI II: Anatomy, DES, and BRS treatment1:00 PM - 2:00 PM

Moderators: Michael J. Cowley, Franz-Josef Neumann Discussants: Tayo A. Addo, Bill J. French, Petr Kala, Christopher Pyne

1:00 PM TCT 49: Two-Year Clinical Outcome of Everolimus-Eluting Bioresorbable Scaffold vs DurablePolymer Everolimus-Eluting Metallic Stent in Patients With ST-Segment Elevation MyocardialInfarction: Results of the Randomized ABSORB ST-Segment Elevation Myocardi Stephan Windecker

1:12 PM Discussion

1:15 PM TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction:Procedural Success, Clinical Outcome, and Five-Year Follow-up Pablo Salinas

1:27 PM Discussion

1:30 PM TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With BioresorbableVascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers,Controlled, Multicenter, FRANCE ABSORB Registry Joel Sainsous

1:42 PM Discussion

1:45 PM TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute CoronarySyndrome in Different Timings of Target Lesion Revascularization After Sirolimus-ElutingStent Implantation Shunsuke Kubo

1:57 PM Discussion

Oral Abstract Session: Adjunct Pharmacology II: Acute and Chronic Antithrombotic Treatments


Adjunct Pharmacology II: Acute and Chronic Antithrombotic Treatments1:00 PM - 2:00 PM

Moderators: Neal S. Kleiman, David F. Kong Discussants: Kevin J. Beatt, Eli I. Lev, Jorge F. Saucedo, Thomas D. Stuckey

1:00 PM TCT 53: Thromboembolic Event Rate Is Elevated With Lower Adherence to Warfarin andNOACs Jeffrey R Winterfield

1:12 PM Discussion

1:15 PM TCT 54: LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients RequiringOral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial Didier Carrié

1:27 PM Discussion

1:30 PM TCT 55: Risk–Benefit Analysis of Upstream Antithrombotic Therapy in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography Bjorn Redfors

1:42 PM Discussion

1:45 PM TCT 56: Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results From aLarge Single-Center Registry Usman Baber

1:57 PM Discussion

Oral Abstract Session: Bioresorbable Scaffold Outcomes: Simple and Complex Lesions


Bioresorbable Scaffold Outcomes: Simple and Complex Lesions1:00 PM - 2:00 PM

Moderators: Antonio L. Bartorelli, Kenneth Chin Discussants: Olivier F. Bertrand, Ronald Caputo, Salvatore Cassese, Detlef G. Mathey

1:00 PM TCT 57: Impact of Lesion Length on One-Year Outcomes of Absorb Bioresorbable VascularScaffolds Rony Lahoud

1:12 PM Discussion

1:15 PM TCT 58: Long-term Clinical Outcomes of Patients Treated With Everolimus-ElutingBioresorbable Scaffolds During Daily Practice – Two-Year Results From the ISAR-ABSORBRegistry Jens Wiebe

1:27 PM Discussion

1:30 PM TCT 59: Overlapping Bioresorbable Coronary Devices: Immediate Results and Six-MonthFollow-up of the REPARA Registry Felipe Hernandez

1:42 PM Discussion

1:45 PM TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic andNon-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials Ariel Furer

1:57 PM Discussion

Oral Abstract Session: CTO Techniques and Outcomes II


CTO Techniques and Outcomes II1:00 PM - 2:00 PM

Moderators: Julinda Mehilli, Georgios Sianos Discussants: Omer Goktekin, Colm Hanratty, Annapoorna Kini, Paul Knaapen

1:00 PM TCT 61: Long-term Outcomes of Patients With Left Ventricular Dysfunction UndergoingPercutaneous Coronary Intervention for Chronic Total Occlusion Kambis Mashayekhi

1:12 PM Discussion

1:15 PM TCT 62: Outcomes of Reattempt Percutaneous Coronary Intervention for Chronic TotalOcclusion: Two-year Data From Retrograde Summit Registry Shozo Ishihara

1:27 PM Discussion

1:30 PM TCT 63: Impact of Chronic Total Occlusions on Revascularization Scores and OutcomePrediction Philippe Généreux

1:42 PM Discussion

1:45 PM TCT 64: Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion: Proceduraland Long-term Outcomes Lorenzo Azzalini

1:57 PM Discussion

Oral Abstract Session: Diabetes Mellitus and PCI Outcomes


Diabetes Mellitus and PCI Outcomes1:00 PM - 2:00 PM

Moderators: Sorin J. Brener, Jean-François Tanguay Discussants: Upendra Kaul, Alfredo E. Rodriguez, Binita Shah, Giuseppe Tarantini

1:00 PM TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes MellitusAfter PCI With DES Michela Faggioni

1:12 PM Discussion

1:15 PM TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With andWithout Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials Jaya Chandrasekhar

1:27 PM Discussion

1:30 PM TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/orMultivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From theSYNTAX, PRECOMBAT and BEST Trials Rafael Cavalcante

1:42 PM Discussion

1:45 PM TCT 68: One-Year Clinical Outcomes in Patients With Insulin-Treated Diabetes Mellitus andNon-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics After Deployment of theAbluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-Comers Regi Deborah Kalkman, MD

1:57 PM Discussion

Oral Abstract Session: New Metallic DES


New Metallic DES1:00 PM - 2:00 PM

Moderators: Giuseppe De Luca, Christoph A. Kaiser Discussants: Fausto Feres, Julio C. Palmaz, Thomas Pilgrim, Michael J. Rinaldi

1:00 PM TCT 69: A Randomized Comparison of the Second Generation Biodegradable PolymerSirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With DeNovo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial Li Zhi

1:12 PM Discussion

1:15 PM TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the DurablePolymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable PolymerCoated Biolimus-Eluting Nobori Stent in All-Comer Population Pieter C. Smits

1:27 PM Discussion

1:30 PM TCT 71: The NIREUS Randomized Trial: One-Year Results of the BioNIR Ridaforolimus-ElutingCoronary Stent System (BioNIR) European Angiography Study Pieter C. Smits

1:42 PM Discussion

1:45 PM TCT 72: Short and Medium-term Clinical Outcome of Amphilimus Polymer-Free Drug-ElutingStent in Diabetic Patients: An All-Comers Multicenter Spanish Registry (Control-8 Registry) Antonio Gomez Menchero

1:57 PM Discussion

Oral Abstract Session: Serial IVUS and OCT Studies


Serial IVUS and OCT Studies1:00 PM - 2:00 PM

Moderators: Hector M. Garcia-Garcia, Ik-Kyung Jang Discussants: Vasileios D. Gkogkas, Vijay Kunadian, Junya Shite, Richard Shlofmitz

1:00 PM TCT 73: Serial Three-Vessel Optical Coherence Tomography and Intravascular UltrasoundAnalysis of Changing Morphologies Associated of Plaque Progression in Patients With StableAngina Pectoris Myong Hwa Yamamoto

1:12 PM Discussion

1:15 PM TCT 74: A Serial Three-Year and Nine-Year Optical Coherence Tomography Assessment ofVascular Healing Response to Sirolimus and Paclitaxel-Eluting Stents Mariusz Tomaniak

1:27 PM Discussion

1:30 PM TCT 75: Qualitative and Quantitative Evaluation of Dynamic Changes in Non-Culprit CoronaryAtherosclerotic Lesion Morphology by Optical Coherence Tomography Bu-Chun Zhang

1:42 PM Discussion

1:45 PM TCT 76: Temporal Change of In-Stent Thrombus Immediately After Percutaneous CoronaryIntervention Within Five Minutes Using Optical Coherence Tomography Hyuck Jun Yoon

1:57 PM Discussion

Oral Abstract Session: TAVR Outcomes


TAVR Outcomes1:00 PM - 2:00 PM

Moderators: John M. Lasala, Philippe Pibarot Discussants: Jorge A. Belardi, Jose Armando Mangione, Gerhard C. Schuler, Gian Paolo Ussia

1:00 PM TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic ValveReplacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1 John Petersen

1:12 PM Discussion

1:15 PM TCT 78: Incidence and Outcomes of Vascular Complications and Bleeding Events in PatientsUndergoing TAVR in Contemporary U.S. Practice: Insights From the STS/ACC TVT Registry® Matthew Sherwood

1:27 PM Discussion

1:30 PM TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic ValveReplacement With or Without Oral Anticoagulation Jürgen Rothe

1:42 PM Discussion

1:45 PM TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation afterTranscatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of theSociety of Thoracic Surgeons/American College of Cardiology Transcatheter Valv Saif Anwaruddin

1:57 PM Discussion

Oral Abstract Session: TAVR Techniques and Real-World Practice Outcomes


TAVR Techniques and Real-World Practice Outcomes1:00 PM - 2:00 PM

Moderators: Mayra Guerrero, Roger J. Laham Discussants: Omar K. Khalique, Ran Kornowski, John C. Messenger

1:00 PM TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic ValveReplacement Versus Pre-Implantation Balloon Aortic Valvuloplasty. A Case-Matched Analysis Luis Nombela-Franco

1:12 PM Discussion

1:15 PM TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: TheWRITTEN (Worldwide TAVR Experience)Survey Luis Nombela-Franco

1:27 PM Discussion

1:30 PM TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for EllipticAortic Annulus Shape Yoshio Maeno

1:42 PM Discussion

1:45 PM TCT 84: Outcomes of Transcatheter Aortic Valve Replacement Without Predilation of theAortic Valve: Insights From 1942 Patients Included in the SOURCE 3 Registry Thomas Walther

1:57 PM Discussion

Oral Abstract Session: Transcatheter Tricuspid Valve Repair


Transcatheter Tricuspid Valve Repair1:00 PM - 2:00 PM

Moderators: Alexander Lauten, Stephen G. WorthleyDiscussants: Sameer Gafoor, Jose Luis Navia, Toby Rogers, Robert S. Schwartz

1:00 PM TCT 85: Prevalence of Tricuspid Regurgitation and Its Impact on Mid-Term Outcomes:Insights From a Tertiary Referral Center Claudio Montalto

1:12 PM Discussion

1:15 PM TCT 86: Early Experience With the Trialign System for Transcatheter Tricuspid Valve Repair: AMulticenter Experience Ermela Yzeiraj

1:27 PM Discussion

1:30 PM TCT 87: Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip®System: 30-day Clinical Results in 13 Consecutive Patients. Jörg Hausleiter

1:42 PM Discussion

1:45 PM TCT 88: Innovative Transcatheter Tricuspid Valve Repair System. Initial Outcomes From theFirst in Human Multi-Centre Study Paolo Denti

1:57 PM Discussion

Oral Abstract Session: Treatment of Chronic Thromboembolic Pulmonary Hypertension


Treatment of Chronic Thromboembolic Pulmonary Hypertension1:00 PM - 2:00 PM

Moderators: Ori Ben-Yehuda, Ehtisham Mahmud Discussants: Shao-Liang Chen, Stephen P. Hoole, Gagan D Singh

1:00 PM TCT 89: Balloon Pulmonary Angioplasty for Chronic Thromboembolic Hypertension: Report ofa Two-Year Experience in a Surgical Center Carlos Garcia Alonso

1:12 PM Discussion

1:15 PM TCT 90: Efficacy and Safety of Sequential Hybrid Therapy with Pulmonary Endarterectomyand Additional Balloon Pulmonary Angioplasty for Chronic Thromboembolic PulmonaryHypertension Kenichi Yanaka

1:27 PM Discussion

1:30 PM TCT 91: Efficacy of Aggressive Balloon Pulmonary Angioplasty on Chronic ThromboembolicPulmonary Hypertension Beyond Normalized Mean Pulmonary Arterial Pressure Yuto Shinkura

1:42 PM Discussion

1:45 PM TCT 92: Short and Long-term Remodeling of Pulmonary Arteries After Balloon Angioplasty inPatients With Inoperable Chronic Thromboembolic Pulmonary Hypertension Nicolay Danilov

1:57 PM Discussion

Oral Abstract Session: Vulnerable Plaque: Imaging and Prognosis


Vulnerable Plaque: Imaging and Prognosis1:00 PM - 2:00 PM

Moderators: Farouc Jaffer, Amir Lerman Discussants: Patrick A. Calvert, James A. Goldstein, Jonathan Leor, Guillermo Tearney

1:00 PM TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major AdverseCardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up Eric Boersma

1:12 PM Discussion

1:15 PM TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in MedicallyTreated Patients With Diabetes Mellitus: Insights From the PROSPECT Study Elvin Kedhi

1:27 PM Discussion

1:30 PM TCT 95: The Interplay Between Features of Plaque Vulnerability and Hemodynamic Relevanceof Coronary Artery Stenoses Sabahattin Umman

1:42 PM Discussion

1:45 PM TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in DiabeticPatients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and VirtualHistology Tomas Kovarnik

1:57 PM Discussion

iASSESS, Day 2 - Monday, Oct. 31

Monday, October 31 8:00 AM - 5:00 PM Walter E. Washington Convention Center Room 102, Level 1Accreditation: CME/ASRT/CNE

iASSESS, Day 2: Morning Session8:00 AM - 12:15 PM

Moderators: George D. Dangas, Morton J. Kern

8:00 AM FFR, iFR and Microvascular Assessment Moderator: Verghese Mathew Arnold Seto

8:45 AM Intravascular Imaging: IVUS, OCT, and NIRS Moderator: John McB. Hodgson Stephen P. Hoole

9:30 AM Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR Moderator: Dimitriy N. Feldman Rahul Sakhuja

10:15 AM Break

10:30 AM Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR Moderator: Michael J. Lim Molly Szerlip

11:00 AM Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation Moderator: Michael J. Lim Payam Dehghani

11:30 AM Structural Intervention IV: LAA Closure, HOCM, Paravalvular Leak Moderator: Srihari S. Naidu Adnan K. Chhatriwalla

Break12:15 PM - 1:30 PM

iASSESS, Day 2: Afternoon Session1:30 PM - 5:00 PM

Moderators: Tayo A. Addo, Dimitriy N. Feldman, Srihari S. Naidu

1:30 PM Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal Moderator: Kenneth Rosenfield Sahil A. Parikh

2:00 PM Endovascular Intervention II: Popliteal, BTK and Carotid Moderator: Prakash Krishnan Karthik R. Gujja

2:30 PM Intervention for Venous Disease Moderator: Raghu Kolluri Vishal Kapur

3:00 PM Congenital Heart Disease: PFO, ASD, PDA and Coarctation Moderator: Harsimran Sachdeva SinghJohn P. Breinholt

3:30 PM Complications of Coronary and Peripheral Vascular Intervention Moderator: Sahil A. Parikh Ehrin J. Armstrong

4:15 PM Complications of Structural Heart Disease Intervention Moderator: George S. Hanzel Mauricio G. Cohen

FDA Town Hall Meeting at TCT 2016, Part 1: Overarching Concepts


Session I. FDA and European Regulatory Priorities and Course12:30 PM - 1:30 PM

Moderators: Matthew G. Hillebrenner, Gregg W. Stone Discussants: Angeles Alonso Garcia, Alan G. Fraser, Aaron V. Kaplan, Jeffrey Shuren, Bram D. Zuckerman

12:30 PM The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, and Payors Gregg W. Stone

12:35 PM Key Note Lecture I. FDA/CDRH State of the Union Jeffrey Shuren

12:50 PM Key Note Lecture II. Regulatory Reform of Medical Device Approvals by the EuropeanCommission – Motivating Factors, Anticipated Changes, and Timelines Alan G. Fraser


Session II. National Evaluation System for Health Technology1:30 PM - 2:40 PM

Moderators: Owen Faris, Mitchell W. Krucoff Discussants: Gregory Daniel, David R. Holmes Jr., Louis B. Jacques, Danica Marinac-Dabic, Roxana Mehran,Michael Minogue, Gregory Pappas, Jeffrey Shuren, Tamara Syrek Jensen, Craig A. Thompson

1:30 PM Device Performance in Pre-Approval Studies vs Unrestricted “Real-World” Use: LessonsLearned and Future Opportunities Mitchell W. Krucoff

1:38 PM Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and InformDevice Label Expansion David R. Holmes Jr.

1:43 PM Keynote Lecture III. National Evaluation System for Health Technology (NEST): Objectives,Accomplishments and Future Directions Gregory Daniel

1:58 PM CMS Perspectives On Post-Approval Device Evaluation (Including NEST) and Reimbursement Tamara Syrek Jensen

2:08 PM MDIC and Industry Perspectives: Potential Effects of NEST on Research, Innovation andPatient Outcomes Michael Minogue


Session III. Moving Towards Simple Trials and Big Data2:40 PM - 3:20 PM

Moderators: Deepak L. Bhatt, Roxana Mehran Discussants: Owen Faris, Robert A. Harrington, Harlan Krumholz, Michael S. Lauer, William H. Maisel, E. MagnusOhman, Stuart J. Pocock, Gregg W. Stone, Pascal Vranckx, Clyde W. Yancy

2:40 PM Pragmatic Simple Trials and Big Data: Advantages and Caveats Robert A. Harrington

2:50 PM Pragmatic Simple Trials and Big Data: Implications for NIH Funding Michael S. Lauer


Session IV. Implications of Data Sharing3:20 PM - 4:10 PM

Moderators: C. Michael Gibson, A. Michael Lincoff Discussants: Keith D. Dawkins, Rosemarie Hakim, Robert A. Harrington, Harlan Krumholz, Michael S. Lauer,William H. Maisel, Gregory Pappas, Manesh R. Patel, Stuart J. Pocock, Stuart Spencer

3:20 PM The Moral Imperative and Potential Benefits of Data Sharing: Journalist Perspective Eric D. Peterson

3:27 PM Opportunities and Risks of Data Sharing I: YODA Proposal Harlan Krumholz

3:34 PM Opportunities and Risks of Data Sharing II: ACCESS CV Proposal Manesh R. Patel

3:41 PM Opportunities and Risks of Data Sharing III: International Consortium Proposal Philip James Devereaux


Session V. Early Feasibility Studies: A Critical Appraisal4:10 PM - 5:00 PM

Moderators: Andrew Farb, Aaron V. Kaplan Discussants: Steven R. Bailey, Joseph Chin, Elazer R. Edelman, Juan F. Granada, Martin B. Leon, Stanton J. Rowe,Sean Salmon, Renu Virmani, Carla M Wiese, Changfu Wu

4:10 PM Early Feasibility Studies in USA: Progress Report From the FDA Carla M Wiese

4:20 PM Early Feasibility Studies in the USA: Early Example With Success Steven R. Bailey

4:30 PM EFS in the USA: Challenges and Developments (An Investigator’s Perspective) Martin B. Leon


International Session: PCI Techniques Beyond DES: Multinational Experiences Presented by the Working Group on Invasive andInterventional Cardiology, Croatian Cardiac Society; Working Group on Interventional Cardiology, Belgian Working Group of Interventional

Cardiology (BWGIC); Austrian Society of Cardiology; Swiss Working Group Interventional Cardiology and Acute Coronary Syndrome;Slovak Society of Cardiology, Working Group of the Interventional Cardiology

Monday, October 31 8:30 AM - 10:30 AM Walter E. Washington Convention Center Presentation Theater 1Accreditation: none

PCI Techniques beyond DES: Multinational Experiences8:30 AM - 10:30 AM

Moderators: Guy J. Friedrich, Kurt Huber Discussants: Viliam Fridrich, Petr Kala, Jochen Wöhrle

8:30 AM Introduction and Session Objectives Kurt Huber

8:35 AM Rotablation: What Are the Current Indications? Walter Desmet


8:55 AM BVS in Complex Lesions: Ready or Not? Guy J. Friedrich


9:20 AM DEB: What Are the Potential Indications? Eduard Margetic


9:40 AM New Techniques, New Antithrombotic Therapies Matej Samos


10:00 AM Do We Need New Technologies Beyond/Beside DES? Stephane Cook


10:20 AM Closing Comments and Take-home Messages Guy J. Friedrich, Kurt Huber

International Session: Trends in Treatment of Acute Coronary Syndromes: Insights From Asia, Europe and the Americas, Presented by theSpanish WG on Interventional Cardiology, Dutch Working Group Interventional Cardiology, Turkish Working Group of InterventionalCardiology, Panamanian Society of Cardiology, Peruvian Society of Cardiology

Monday, October 31 9:00 AM - 10:30 AM

Walter E. Washington Convention Center Presentation Theater 2Accreditation: none

Trends in Treatment of Acute Coronary Syndromes: Insights From Asia, Europe, and the Americas9:00 AM - 10:30 AM

Moderators: Murat Sezer, Niels van Royen Discussants: Javier Escaned, Bertha Gonzales

9:00 AM Panama Presents: Trends in Treatment and Outcomes of ACS in Latin America

9:15 AM Peru Presents: Use of Bioabsorbable Scaffolds in Patients With ACS Bertha Gonzales

9:30 AM Turkey Presents: Strategies to Limit Reperfusion Injury in ACS patients Murat Sezer

9:45 AM Spain Presents: Detection and Treatment of Flow-Limiting Lesions in ACS Patients Javier Escaned

10:00 AM The Netherlands Presents: Detection and Treatment of High-risk Plaques in ACS Patients Niels van Royen


International Session: Interventional Worst Case Scenarios and Best Saves, Presented By the Egyptian Society of Cardiology (EgSC),Kuwait Cardiac Society, National Heart Association of Malaysia NHAM, Colegio Colombiano de Intervencionismo Cardiovascular, and theLatin American Society of Interventional Cardiology (SOLACI)


Interventional Worst Case Scenarios and Best Saves1:00 PM - 2:30 PM

Moderators: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari Discussants: Khalid Almerri, Pablo Charry, Ariel Duran, Sameh Shaheen, Muhamad Ali Sheikh Abdul Kader

1:00 PM Introduction and Session Objectives Ahmed Magdy

1:02 PM Egypt Presents: A Case of a High-Risk STEMI Intervention: How Did I Treat? Case Presenter: Ahmed Magdy

1:10 PM Kuwait Responds: How Would I Have Treated This Case in My Cath Lab? Khalid Almerri


1:19 PM Colombia Presents : A Case of Aorto-Cameral Fistula Management: How Did I Treat? Case Presenter: Jorge Villegas

1:27 PM Uruguay Responds: How Would I Have Treated This Case in My Cath Lab? Ricardo Lluberas


1:36 PM Malaysia Presents: A Case of Ischemic Bowel Intervention: How Did I Treat? Case Presenter: Muhamad Ali Sheikh Abdul Kader

1:44 PM Colombia Responds: How Would I Have Treated This Case in My Cath Lab? Pablo Charry


1:53 PM Kuwait Presents: A Case of a Challenging Left Main PCI: How Did I Treat? Case Presenter: Wael Aboushokka

2:01 PM Malaysia Responds: How Would I Have Treated This Case in My Cath Lab? Robaayah Zambahari


2:10 PM Egypt Presents: A Case of a Challenging Bifurcation Intervention: How Did I Treat? Sameh Shaheen

2:18 PM Uruguay Responds: How Would I Have Treated This Case in My Cath Lab? Case Presenter: Ariel Duran


2:27 PM Closing Remarks and Take-home Messages Ahmed Magdy

International Session: Complex PCI and Complication Management, Presented by: Bangladesh Society of Cardiovascular Intervention,Hong Kong College of Cardiology, the Israeli Working Group for Interventional Cardiology, Italian Society of Invasive Cardiology (GISE)



Session I: Complex PCI3:00 PM - 4:00 PM

Moderators: Kam-Tim Chan, Afzalur Rahman Discussants: Syed Ali Ashan, Chris Kwok Yiu Wong

3:00 PM Introduction and Learning Objectives Ariel Finkelstein

3:05 PM Bangladesh Presents: Case 1 Introduction - Complex Left Main Intervention Case Presenter: Afzalur Rahman

3:10 PM Hong Kong Responds: How Would I Treat? Kam-Tim Chan

3:15 PM Bangladesh Responds: How Would I Treat? Syed Ali Ashan

3:20 PM Bangladesh Presents: How I Managed This Case Afzalur Rahman


3:30 PM Hong Kong Presents: Case 2 Introduction - PCI of a Calcified Lesion With a Stuck Balloon Case Presenter: Kam-Tim Chan

3:35 PM Hong Kong Presents: Case 2 Introduction - PCI of a Calcified Lesion With a Stuck Balloon Case Presenter: Afzalur Rahman

3:40 PM Hong Kong Responds: How Would I Treat? Case Presenter: Chris Kwok Yiu Wong

3:45 PM Hong Kong Presents: How I Managed This Case Case Presenter: Kam-Tim Chan


Session II: Management of Complications4:00 PM - 5:00 PM

Moderators: Ariel Finkelstein, Ugo Limbruno Discussants: Giovanni Esposito, Alessio G La Manna

4:00 PM Israel Presents: Case 3 Introduction - A Complication of an Antegrade CTO Recanalization Case Presenter: Yaron Almagor

4:05 PM Italy Responds: How Would I Treat? Alessio G La Manna

4:10 PM Israel Responds: How Would I Treat? Haim Danenberg

4:15 PM Israel Presents: How I Managed This Case Case Presenter: Yaron Almagor


4:30 PM Italy Presents: Case 4 Introduction – A Complication of Primary PCI during STEMI Case Presenter: Giovanni Esposito

4:35 PM Israel Responds: How Would I Treat? Haim Danenberg

4:40 PM Italy Responds: How Would I Treat? Ugo Limbruno

4:45 PM Italy Presents: How I Managed This Case Case Presenter: Giovanni Esposito


4:55 PM Closing Comments and Take-home Messages Ariel Finkelstein

International Session: Tough Daily Interventional Cases: A Three-Continent Solution; Presented by British Cardiovascular InterventionSociety (BCIS); South African Society of Cardiovascular Intervention (SASCI); Irish Cardiac Society Working Group; Russian ScientificSociety of Endovascular Therapies; Scottish Cardiac Society Working Group

Monday, October 31 3:00 PM - 5:00 PM Walter E. Washington Convention Center Presentation Theater 2Accreditation: none

Session 1. TAVR in Low-Risk Patients3:00 PM - 3:42 PM

Moderator: Niall T. Mulvihill Discussants: Sergey A. Abugov, Peter F Ludman, Michael Mahmoudi

3:00 PM Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis Niall T. Mulvihill

3:03 PM Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable BeAllowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? ProPosition Antoniette Neylon

3:13 PM Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable BeAllowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? ConPosition Hellmuth Weich

3:23 PM TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature Michael Mahmoudi

3:33 PM Roundtable Discussion With Audience Q&A and Rebuttal to the Debates

3:41 PM Audience Vote: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable BeAllowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Moderator: Niall T. Mulvihill

Session 2. How Should We Treat TAVR Restenosis?3:42 PM - 4:20 PM

Moderator: Nick Curzen Discussants: Sergey A. Abugov, Bagrat Alekyan, Peter F Ludman, Michael Mahmoudi

3:42 PM Introduction: TAVR Restenosis Nick Curzen

3:45 PM Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR Case Presenter: Michael Mahmoudi

3:50 PM Roundtable Discussion With Audience Q&A: How Should We Evaluate and Treat This Patient?

4:00 PM TAVR Restenosis: Review of the Literature Nick Curzen

4:08 PM Case Resolution: How Did We Treat this Patient? Case Presenter: Michael Mahmoudi


Session 3. PCI of Non-Culprit Lesions in STEMI4:20 PM - 5:00 PM

Moderator: Graham A. Cassel Discussants: Sergey A. Abugov, Bagrat Alekyan, Peter F Ludman, Margaret B. McEntegart

4:20 PM Introduction: PCI of Non-Culprit Lesions in STEMI Graham A. Cassel

4:22 PM Case #1: STEMI in Patient With Moderate Bystander Disease Case Presenter: Sergey A. Abugov


4:30 PM Case #2: STEMI in Patient With Left Main and Multivessel Disease Case Presenter: Narek Zakaryan


4:40 PM PCI of Non-Culprit Lesion in STEMI: Literature Review Margaret B. McEntegart

4:50 PM PCI of Non-Culprit Lesions in STEMI: Flaws in the Previous Trials Nick Curzen

4:58 PM PCI of Non-Culprit Lesions in STEMI: Take-home Messages Graham A. Cassel

International Session: Featured Session for International Advisory Faculty Opportunities and Challenges: Meeting CHIPs from China -10/31

Monday, October 31 5:00 PM - 6:30 PM Walter E. Washington Convention Center Presentation Theater 2Accreditation: none

Featured Session for International Advisory Faculty Opportunities and Challenges: Meeting CHIPs from China5:00 PM - 6:30 PM

Moderators: Shao-Liang Chen, Ajay J. Kirtane, Manish A. Parikh, Bo Xu Discussants: Kefei Dou, Zening Jin, Paul Hsien-Li Kao, Michael Kang-Yin Lee, Jianfang Luo

5:00 PM Welcome and Introduction Shao-Liang Chen, Ajay J. Kirtane

5:05 PM My Most Challenging Case 2016: Severe Calcified Lesion Case Presenter: Juying Qian

5:13 PM Discussion

5:25 PM My Most Challenging Case 2016: Chronic Total Occlusion Case Presenter: Bin Zhang

5:33 PM Discussion

5:45 PM My Most Challenging Case 2016: Severe LV Dysfunction Case Presenter: Qi Zhang

5:53 PM Discussion

6:05 PM My Most Challenging Case 2016: STEMI with Multivessel Disease Case Presenter: Ning Guo

6:13 PM Discussion

6:25 PM Summary Bo Xu

Partnership Session: CACI at TCT: Complex Coronary Angioplasty With Current Generation DAn Update From Registries and RandomizedStudies


CACI at TCT: Complex Coronary Angioplasty With Current Generation DES - An Update From Registries andRandomized Studies4:00 PM - 5:00 PM

Moderators: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez

4:00 PM Welcome! Alejandro Cherro

4:02 PM Rationale and Principal Results of the Excel Trial Tullio Palmerini

4:08 PM Case Presentation: A Complex Distal Left Main Bifurcation Case Presenter: Jose A. Alvarez

4:14 PM Roundtable Discussion With Audience Q&A Discussants: Diego D Grinfeld, Oscar A. Mendiz, Alejandro O. Palacios

4:20 PM Left Main and MVD Stenting With Second Generation DES: The Florence Registry David Antoniucci

4:26 PM Case Presentation: Bifurcation Stenting Strategies in Multivessel Disease Case Presenter: Alejandro D Fernandez

4:32 PM Roundtable Discussion With Audience Q&A Discussants: Ruben A. Piraino, Omar Anibal Santaera, Ernesto M. Torresani

4:38 PM Duration of DAPT Therapy With Contemporary DES (Including BVS) Gustavo A Samaja

4:44 PM Case Presentation: Difficult DAPT Duration Decision After PCI Case Presenter: Marcelo Bettinotti

4:50 PM Roundtable Discussion With Audience Q&A Discussants: Jorge H. Leguizamon, Antonio A Pocovi, Gustavo A Samaja

4:56 PM Take Home Messages: Rationale for a Conservative Strategy During DES Implantation Alfredo E. Rodriguez

Partnership Session: CardioVascular Summit TCTAP in Partnership With TCT: Complex PCI (Left Main, Bifurcation, and CTO): The Simpler,the Better


Complex PCI (Left Main, Bifurcation, and CTO): The Simpler, the Better4:00 PM - 5:00 PM

Moderators: Seung-Jung Park, Alan C. Yeung Discussants: Takashi Akasaka, Alaide Chieffo, Seung-Whan Lee, Nico H.J. Pijls

4:00 PM Welcome and Introductory Remarks Moderator: Seung-Jung Park

4:01 PM Trends in Outcomes of Treatment for LM Artery Disease: IRIS-MAIN Registry Data (N=5,020) Seung-Jung Park

4:09 PM What Really Matters in Bifurcation PCI? Technique or Concept Duk-Woo Park

4:17 PM Should Every CTO Be Opened? From the IRIS-CTO Registry to the Randomized (DECISION-CTO Trial) Seung-Whan Lee

4:25 PM FFR-Guided Decision Making Is Now Standard Nico H.J. Pijls

4:33 PM Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry(N=7,013) Jung-Min Ahn

4:41 PM Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization Akiko Maehara


Partnership Session: JIM in Partnership With TCT


Session 1. Two Challenging TAVR Complications4:00 PM - 4:30 PM

Moderators: Antonio Colombo, Jeffrey W. Moses Discussants: Samir R. Kapadia, Augusto D. Pichard

4:00 PM Case #1: A TAVR Complication to Learn From Case Presenter: Samir R. Kapadia


4:15 PM Case #2: A TAVR Complication to Learn From Case Presenter: Augusto D. Pichard


Session 2. Problems and Solutions With Bioresorbable Scaffolds4:30 PM - 5:00 PM

Moderators: Antonio Colombo, Jeffrey W. Moses Discussants: Carlo Di Mario, Azeem Latib

4:30 PM Case #1: A Novel Issue With a Bioresorbable Scaffold Case Presenter: Patrick W. Serruys


4:40 PM Case #2: A Novel Issue With a Bioresorbable Scaffold Case Presenter: Azeem Latib


4:50 PM Case #3: A Novel Issue With a Bioresorbable Scaffold Case Presenter: Carlo Di Mario


Partnership Session: TCT India Next at TCT2016


Session I. Practice in India4:00 PM - 4:28 PM

Moderators: Vinay K. Bahl, Amal Kumar Banerjee, Jamshed J. Dalal, Ajay J. Kirtane, C. Venkata S. Ram, Kamal K.Sethi

4:00 PM Pharmacoinvasive Strategy for Treating Acute MI: Is It The Way Forward in India? Sreenivas Arramraju Kumar

4:07 PM Bifurcation Lesions: Available Devices and How to Choose Balbir Singh

4:14 PM Bioresorbable Vascualr Scaffolds: The Future of PCI? Sundeep Mishra

4:21 PM Internal Pudendal Artery Stenting for Male Erectile Dysfunction: An Emerging (Urological)Realm for the Interventional Cardiologist

Session II. My Worst Cases: How it Happened, and How I Bailed-Out the Problem4:28 PM - 5:00 PM

Moderators: Parag Barwad, Raju Narasa Kavalipati, Fazila T. Malik, Manotosh Panja, Gokul M. Reddy, Kamal K.Sethi

4:28 PM Case 1: Case Presenter: M.S. Hiremath

4:34 PM Case 2: Moderator: Sundeep Mishra

4:40 PM Case 3: Case Presenter: Rabin dra Nath Chakraborty

4:46 PM Case 4: Case Presenter: Jamshed J. Dalal

4:52 PM Case 5: TCT India Next Award Winner Case Presenter: Parag Barwad

Partnership Session: TTT in Partnership With TCT: Tough Cases - How Would I Treat and How Did I Treat?


TTT in Partnership With TCT: Tough Cases - How Would I Treat and How Did I Treat?4:00 PM - 5:00 PM

Moderators: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu Discussants: Paul Hsien-Li Kao, John R. Laird Jr, Wen-Lieng Lee

4:00 PM Case 1: Complex Peripheral Intervention Case Presenter: Chun-Chi Chen

4:05 PM How Would I Treat This Case? Hiroyoshi Yokoi

4:10 PM How Did I Treat This Case? Case Presenter: Chun-Chi Chen


4:20 PM Case 2: Complex PCI Case Presenter: Hsiu-Yu Fang

4:25 PM How Would I Treat This Case? Satoru Sumitsuji

4:30 PM How Did I Treat This Case? Case Presenter: Hsiu-Yu Fang


4:40 PM Case 3: Heavily Calcified Vessel Case Presenter: Wen-Lieng Lee

4:45 PM How Would I Treat This Case? Augusto D. Pichard

4:50 PM How Did I Treat This Case? Case Presenter: Wen-Lieng Lee


Interventional Innovation II: Shark Tank Innovation Competition

Monday, October 31 8:00 AM - 12:00 PM Walter E. Washington Convention Center Room 202, Level 2Accreditation: none

Shark Tank Innovation Competition8:00 AM - 12:00 PM

Chairs: Louis A. Cannon, Juan F. Granada, Chaim S. Lotan Judges: Tony Das, Peter J. Fitzgerald, Frank Litvack, Julio C. Palmaz, Martin T. Rothman, Marvin J. Slepian, Paul G.Yock

8:00 AM Roundtable Discussion: Reflections on Developing a Breakthrough Interventional Technology:A Bioresorbable Vascular Scaffold “Case-Study” Discussants: Stan Fink, Peter J. Fitzgerald, Juan F. Granada, Julio C. Palmaz, Richard J. Rapoza,Chuck Simonton

8:20 AM Introduction: Shark Tank Innovation Competition 2016 Juan F. Granada

8:25 AM Innovative Shock-Wave Wire for CTOs (Soundbite) Christopher E. Buller

8:33 AM Editorial Perspective: CTO Therapies: Market Size and Technical Needs in 2016 Craig A. Thompson

8:38 AM Moderated Discussion: Soundbite and the Unmet Need for CTO Therapies Moderator: Frank Litvack

8:48 AM Noninvasive Assessment of Pedal Reperfusion in CLI Patients (Pedra) Kareen Looi

8:56 AM Editorial Perspective: The World of Diagnostics in BTK Intervention Mahmood K. Razavi

9:01 AM Moderated Discussion: Pedra and BTK Interventions Moderator: Tony Das

9:11 AM Implantable Thermo-reactive Pulmonary Venous Stent for Atrial Fibrillation (Fulgur) Glenn Van Langenhove

9:19 AM Editorial perspective: Interventional Treatment of Atrial Fibrillation: Current Strategy andUnmet Needs Vivek Y. Reddy

9:24 AM Moderated Discussion: Fulger and Atrial Fibrillation Approaches Moderator: Louis A. Cannon

9:34 AM Double-edged Sealing Embolic Protection Device (Transverse) Eric Goslau

9:42 AM Editorial Perspective: Embolic Protection in TAVR Intervention Josep Rodés-Cabau

9:47 AM Moderated Discussion: Transverse and TAVR Embolic Protection Devices Moderator: Chaim S. Lotan

9:57 AM Neuroprotection by Selective Endovascular Brain Cooling (Twinflow) Ronald J. Solar

10:05 AM Editorial Perspective: Interventional Stroke Intervention Leo Nelson Hopkins

10:10 AM Moderated Discussion: Twinflow and Interventional Stroke Therapies Moderator: Paul G. Yock

10:20 AM Pacemaker-Based Treatment for Hypertension (Backbeat) Darren Sherman

10:28 AM Editorial Perspective: Interventional Treatment of Hypertension: A Chance for A SecondWind? Felix Mahfoud

10:32 AM Moderated Discussion: Backbeat and Interventional Hypertension Devices Moderator: Martin T. Rothman

10:42 AM Peer-to-peer Learning In a Global Physician Network (MedShr) Asif Qasim

10:50 AM Editorial Perspective: Digital Health in Interventional Cardiology Giora Weisz

10:55 AM Moderated Discussion: MedShr and the Digital Health Revolution Moderator: Peter J. Fitzgerald

11:05 AM Finalists Selection Announcement: Top 4 Scores Louis A. Cannon

11:10 AM Rebuttal Finalist #1




11:50 AM Final Discussion

12:00 PM Adjourn

Special Session: Fellows Conversations with the Masters

Monday, October 31 10:30 AM - 12:30 PM Walter E. Washington Convention Center Room 206, Level 2Accreditation: none

Session I10:30 AM - 11:15 AM

Moderator: Roxana Mehran Discussants: Antonio Colombo, Bernard J. Gersh, Robert A. Harrington, Alice K. Jacobs, Spencer B. King III

Session II11:15 AM - 12:30 PM

Moderator: George D. Dangas Discussants: Bernard J. Gersh, Alice K. Jacobs, Jeffrey W. Moses, Kenneth Rosenfield, Ron Waksman

Special Session: Venous Interventions: Pulmonary Emboli, Acute Deep Venous Thrombosis, and Chronic Venous Insufficiency

Monday, October 31 10:30 AM - 12:00 PM Walter E. Washington Convention Center Room 146A, Level 1Accreditation: none

Venous Interventions: Pulmonary Emboli, Acute Deep Venous Thrombosis, and Chronic Venous Insufficiency10:30 AM - 12:00 PM

Moderators: Michael D. Dake, Michael R. Jaff Discussants: Brian G DeRubertis, Raghu Kolluri, Lindsay S. Machan, Constantino S. Pena

10:30 AM State of the Art Lecture: Latest Medical Therapies for DVT and PE - What the InterventionistMust Know! Michael R. Jaff

10:38 AM Catheter-Directed Thrombolysis and Pharmacomechanical Lysis for Acute DVT: PatientSelection and Outcomes Mahmood K. Razavi

10:46 AM Does This Patient Need an IVC Filter? Rapid Fire Cases Case Presenter: Ido Weinberg

10:54 AM Complex IVC Filter Retrievals: Case Reviews Case Presenter: John H. Rundback

11:02 AM Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-ThurnerSyndrome Case Presenters: Mark J. Goodwin, Constantino S. Pena


11:20 AM Latest Results on Catheter Assisted Thrombolysis and Thrombectomy for Submassive andMassive PE Akhilesh K. Sista

11:28 AM Case Presentation: Chronic Venous Insufficiency with Superficial Venous Reflux Case Presenter: Raghu Kolluri

11:36 AM Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower ExtremitySuperficial Venous Disease Zvonimir Krajcer

11:44 AM EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease Sanjiv Lakhanpal


Special Session: TCT International Fellows Session

Monday, October 31 5:00 PM - 6:35 PM Cardiovascular Research Foundation Room 102, Level 1Accreditation: none

Session I. Top Three International Fellows Cases5:00 PM - 5:36 PM

Moderator: George D. Dangas Discussants: Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Afzalur Rahman, Balbir Singh, Mohamed AhmedSobhy, Wojtek Wojakowski

5:00 PM Introduction of Top Three Selected Winners Moderator: George D. Dangas

5:05 PM Coronary Venous Angioplasty for CRT-D LV Lead Placement Arindam Pande

5:12 PM Treatment of an Undilatable Stenosis; Coronary Lithoplasty - A New Tool in the Box? Kalpa De Silva

5:19 PM Nightmare in the Cath Lab Khaled Hammad

5:26 PM Discussion

Session II. Fellows Got Talent - Case Competition!5:36 PM - 6:12 PM

Moderator: Wojtek Wojakowski Discussants: Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, George D. Dangas, Afzalur Rahman, BalbirSingh

5:36 PM Fellows Got Talent! (International Case Competition) Moderator: Wojtek Wojakowski

5:42 PM 3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement Florian Deuschl

5:48 PM Tunnelling Under the Cage, Rather Than Bending the Jail Bars, Enabled Successful Treatmentof a Jailed Left Anterior Descending Artery Jerrett K Lau

5:54 PM Trans-radial (7 French) Rotational Atherectomy in a Patient With Myasthenia Gravis, Chronic(CKD) and Idiopathic Thrombocytopenia Purpura (ITP) Akhlaque Uddin

6:00 PM Treatment of a Rare Complication in the 21st Century Balint Kittka

6:06 PM Voting Commences and Winner Announced Moderator: Wojtek Wojakowski

Session III Fellows Quiz6:12 PM - 6:30 PM

Moderator: Afzalur Rahman Discussants: Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Balbir Singh, Mohamed Ahmed Sobhy, WojtekWojakowski

TCTMD Global PCI Map Project6:30 PM - 6:35 PM

6:30 PM TCTMD Global PCI Map Project Ivan C. Rokos


Monday, October 31 8:00 AM - 2:00 PM Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none


Moderators: Robert Kutys, Maria E. Romero Nicole Singer

ITC Theater: TAVR, Peripheral Vascular Access

Monday, October 31 9:00 AM - 2:00 PM Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none

Presentation Theater Program: How Far Can We Go With MitraClip NT (Sponsored by Abbott)

Monday, October 31 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: none

How Far Can We Go With MitraClip NT?11:30 AM - 12:30 PM

Chair: Francesco Maisano Facultys: Saibal Kar, Mathew Williams, Ralph Stephan von Bardeleben

11:30 AM Welcome Francesco Maisano

11:35 AM MitraClip NT – The Foundation and Future for Transcatheter Mitral Valve Repair Francesco Maisano

11:45 AM MitraClip NT: Design Changes Make Big Differences Ralph Stephan von Bardeleben

11:55 AM Clinical Decision Making with MitraClip NT Mathew Williams

12:05 PM Making the Complex Less Complex Saibal Kar

12:15 PM Panel Discussion Discussants: Saibal Kar, Francesco Maisano, Mathew Williams, Ralph Stephan von Bardeleben

Presentation Theater Program: IN.PACT Admiral DCB: Does the Evidence Provide the Power to Change Practice? (Sponsored byMedtronic, Inc.)

Monday, October 31 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 4, Exhibit Hall, Level 2Accreditation: none

IN.PACT Admiral DCB: Does the Evidence Provide the Power to Change Practice?11:30 AM - 12:30 PM

Chair: John R. Laird Jr Facultys: Juan F. Granada, Prakash Krishnan, D. Christopher Metzger

11:30 AM Durability (3Y IP SFA Data) Moderator: John R. Laird Jr D. Christopher Metzger

11:50 AM Consistency and Case Review (IPG Data) Moderator: John R. Laird Jr Prakash Krishnan

12:10 PM Understanding the Strength of the Data Moderator: John R. Laird Jr Juan F. Granada

Presentation Theater Program: Optimizing Outcomes in Complex Coronary Disease (Sponsored by Spectranetics)


Optimizing Outcomes in Complex Coronary Disease11:30 AM - 12:30 PM

Facultys: Antonio Colombo, Dimitrios Karmpaliotis, William L. Lombardi, Steven P. Marso, Sahil A. Parikh

11:30 AM Optimizing Outcomes in Complex Coronary Disease Moderator: William L. Lombardi

11:35 AM Cross Reliably - A Contemporary Approach to CTO and Complete Revascularization Steven P. Marso

11:50 AM How You Prep Coronary Vessels Matters - The Evolution of CAD Intervention Antonio Colombo

12:05 PM Improving ISR Outcomes With Laser and AngioSculpt Sahil A. Parikh

Presentation Theater Program: The Future of Physiology: Exploring iFR Co-Registration and Ischemia-Guided PCI (Sponsored by PhilipsVolcano)

Monday, October 31 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: none

The Future of Physiology: Exploring iFR Co-Registration and Ischemia-Guided PCI11:30 AM - 12:30 PM

Chair: Habib SamadyFacultys: Justin E. Davies, Allen Jeremias, Bruce Samuels, MD, Andrew Sharp, MD

11:30 AM What’s the fascination of a cut point? Ischemia is continuous Moderator: Habib Samady Justin E. Davies

11:45 AM Using physiology to guide PCI Moderator: Habib Samady Bruce Samuels, MD

12:00 PM Can iFR co-registration improve PCI results? (Case-based approach) Moderator: Habib Samady Andrew Sharp, MD

12:15 PM Discussion Moderator: Habib Samady

Presentation Theater Program: Treating Calcified Peripheral Vascular Arteries with the Shockwave Medical Lithoplasty(r) System(Sponsored by Shockwave Medical, Inc.)


Treating Calcified Peripheral Vascular Arteries with the Shockwave Medical Lithoplasty(r) System11:30 AM - 12:30 PM

Chair: Todd J. Brinton Facultys: William A. Gray, Michael R. Jaff, Kenneth Rosenfield, Martin Werner, MD

11:30 AM Calcification in Vascular Disease Kenneth Rosenfield

11:40 AM Shockwave Medical Lithoplasty® System Early Experience Todd J. Brinton

11:50 AM Impact of Lithoplasty: DISRUPT PAD Study Results William A. Gray

12:00 PM Case Review and Panel Discussion Moderator: Martin Werner, MD Discussants: Todd J. Brinton, William A. Gray

12:10 PM DISRUPT PAD III Study Design Moderator: William A. Gray

12:20 PM Q&A Discussants: Todd J. Brinton, William A. Gray, Michael R. Jaff, Martin Werner, MD

Presentation Theater Program: Antiplatelet Therapy for Contemporary PCI (Sponsored by Chiesi USA)

Monday, October 31 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 4, Exhibit Hall, Level 2Accreditation: none

Antiplatelet Therapy for Contemporary PCI1:00 PM - 2:00 PM

Facultys: C. Michael Gibson, Duane S. Pinto, Matthew J. Price

1:00 PM Understand the Need for Platelet Inhibition During PCI; Identify the Biologic Targets toAchieve Platelet Inhibition C. Michael Gibson

1:15 PM Review the Clinical Data and Current Clinical Guideline Recommendations for AntiplateletTherapy Matthew J. Price

1:30 PM Understanding the Role of Cangrelor in Current Practice Duane S. Pinto

1:45 PM Session Q&A Discussants: C. Michael Gibson, Duane S. Pinto, Matthew J. Price

Presentation Theater Program: Approaching Ideal PCI With Absorb (Sponsored by Abbott)

Monday, October 31 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: none

Approaching Ideal PCI With Absorb1:00 PM - 2:00 PM

Chair: Nick E. J. West Facultys: William Bachinsky, MD, Hiram G Bezerra, Salvatore Brugaletta, Christoph K. Naber, Chuck Simonton

1:00 PM Welcome Nick E. J. West

1:05 PM Absorb and Unmet Needs in PCI Chuck Simonton

1:20 PM Impact of Technique on Clinical Outcomes Salvatore Brugaletta

1:35 PM Insights From Real-world Cases Christoph K. Naber

1:50 PM Discussion Discussants: William Bachinsky, Hiram G Bezerra, Salvatore Brugaletta, Christoph K. Naber,Chuck Simonton

Presentation Theater Program: Clinical Kaleidoscope of Novel Interventional Technologies (Sponsored by Meril Life Sciences)

Monday, October 31 1:00 PM - 2:00 PM Cardiovascular Research Foundation Presentation Theater 5, Exhibit Hall, Level 2Accreditation: none

Clinical Kaleidoscope of Novel Interventional Technologies1:00 PM - 2:00 PM

Chair: Teguh Santoso Facultys: Alexandre Abizaid, Ricardo A. Costa, Upendra Kaul, Sasko Kedev, V.K. Ajit Kumar, Martin B. Leon,Yoshinobu Onuma, Ashok Seth, Robaayah Zambahari, Robert-Jan van Geuns

1:00 PM My Experience With BioMime Morph - World's First Tapered Coronary SES Robaayah Zambahari

1:10 PM Optimizing BRS in Your Daily Practice and MeRes-1 Clinical Update Ashok Seth

1:20 PM My Experience With MeRes100 and MeRes-1 Extend Clinical Update Alexandre Abizaid

1:30 PM My Experience From Substance to Sublime - BioMime to MeRes100 Upendra Kaul

1:40 PM MyVal Science and Preclinical and Clinical Update Martin B. Leon

1:50 PM Panel Discussion

Presentation Theater Program: Direct Flow Medical: Evidence, Evolution, and Equipoise (Sponsored by Direct Flow Medical)

Monday, October 31 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 3, Exhibit Hall, Level 2Accreditation: none

Direct Flow Medical: Evidence, Evolution, and Equipoise1:00 PM - 2:00 PM

Chairs: Kendra J. Grubb, Jeffrey J. Popma, Michael J. Reardon Facultys: Daniel Burkhoff, Marc R. Katz, MD, Azeem Latib, Scott Lim, Axel Linke

1:00 PM Introduction and Objectives Jeffrey J. Popma

1:04 PM Clinical Evidence Deep Dive Into the DFM TAVR System Marc R. Katz, MD

1:12 PM Discussion

1:16 PM Physician-Developed Technique Evolution of the DFM TAVR System Scott Lim

1:24 PM Discussion

1:28 PM PVL: Implications for Heart Failure and Hemodynamics Daniel Burkhoff

1:36 PM PVL Equipoise: Balancing Procedure and Patient Outcomes Axel Linke

1:44 PM Discussion

1:48 PM The Direct Flow Medical TMVR System Evolution From Prototype to FIM Azeem Latib

1:53 PM Discussion and Close

Presentation Theater Program: Magmaris, the Resorbable Magnesium Scaffold: Magnesium BRS Features, Benefits, and FirstExperiences in Daily Practice (Sponsored by Biotronik)

Monday, October 31 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: none

Magmaris, the Resorbable Magnesium Scaffold: Magnesium BRS Features, Benefits, and First Experiences inDaily Practice1:00 PM - 2:00 PM

Chairs: Ron Waksman, Clemens von Birgelen Facultys: Michael Haude, Michael Joner, Jacques J. Koolen, Jeanette Maier

1:00 PM Objectives and Outline of the Session Ron Waksman

1:02 PM Magnesium: The Underestimated Electrolyte Crucial for Healthy Arteries Jeanette Maier

1:09 PM Magmaris: Understanding the Key Components of Magnesium Degradation Michael Joner

1:16 PM Discussion Moderators: Ron Waksman, Clemens von Birgelen

1:19 PM Expert Magmaris User Shares His Experience: Insights From the BIOSOLVE-II Data andRegular Practice Michael Haude


1:42 PM Magmaris Patient Indications: Consensus and Recommendations by a Panel of Experts Jacques J. Koolen


1:57 PM Key Learnings and Take Away Clemens von Birgelen

Evening Program: Current Perspectives on BTK Intervention: Case-Based Discussion (Sponsored by CRF, Supported by Abbott, BostonScientific Corporation, Cook Medical, and Intact Vascular)

Monday, October 31 6:00 PM - 8:00 PM Cardiovascular Research Foundation Marquis Ballroom, Salon 6, Level M2Accreditation: CME


Current Perspectives on BTK Intervention: Case-Based Discussion6:30 PM - 8:00 PM

Co-Chairs: Juan F. Granada, Michael R. Jaff Facultys: Koen Deloose, William A. Gray, Zaza Kavteladze, Jihad A. Mustapha, Mahmood K. Razavi

6:30 PM Impact of CLI on Mortality, Quality of Life, and Disability Michael R. Jaff

6:40 PM Moderated Discussion

6:50 PM CLI Intervention 101: Mainstream Interventional Strategies and Basic RecanalizationApproaches Mahmood K. Razavi

7:00 PM Advanced Interventional Techniques: Available Tools and Outcomes Jihad A. Mustapha


7:20 PM How to Optimize Short and Long-term Durability of BTK Interventions William A. Gray

7:30 PM Emerging Devices: BTK Interventional Pipeline Juan F. Granada


Evening Program: DAPT and Beyond: A Case-Based Guide to Optimal Antiplatelet Therapies (Sponsored by CRF, Supported by Abbott,Boston Scientific, and The Medicines Company)

Monday, October 31 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 5, Level M2Accreditation: CME


DAPT and Beyond: A Case-Based Guide to Optimal Antiplatelet Therapies6:30 PM - 8:00 PM

Co-Chairs: Ajay J. Kirtane, Roxana Mehran Facultys: John A. Bittl, George D. Dangas, James B. Hermiller Jr, John J. Lopez

6:30 PM Welcome, Introductions, and Session Goals Roxana Mehran

6:35 PM Risk Scores Can Help Ajay J. Kirtane

6:40 PM Risk Scores Are Useless- Just Talk to the Patient John J. Lopez

6:45 PM Commentary: How Do You Balance Bleeding Risk vs Ischemic Benefit? John A. Bittl

7:00 PM Roundtable Discussion

7:10 PM Case 1: A Complex LM Bifurcation PCI in an Elderly Woman Case Presenter: James B. Hermiller Jr

7:15 PM Panel and Synthesis

7:25 PM Case 2: An Elderly Patient With Hip Fracture Two Months After PCI Case Presenter: Roxana Mehran


7:40 PM Case 3: A Patient Who Develops A-Fib After TAVR Case Presenter: George D. Dangas


Evening Program: The PCI Future Today: Bioresorbable Vascular Scaffolds(Sponsored by CRF, Supported by Abbott)

Monday, October 31 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 1-4, Level M2Accreditation: CME


The PCI Future Today: Bioresorbable Vascular Scaffolds6:30 PM - 8:00 PM

Co-Chairs: Patrick W. Serruys, Gregg W. Stone Facultys: Alexandre Abizaid, David G. Rizik, Manel Sabate, Ashok Seth, Corrado Tamburino

6:30 PM What Have We Learned From Randomized Trials and Registries About the Safety and Efficacyof Bioresorbable Vascular Scaffolds? Gregg W. Stone


6:45 PM So You Want to Implant Absorb? Essential Techniques for Simple and Complex Lesions David G. Rizik


7:00 PM Tips and Tricks for Complex Lesions: Bifurcations, Diffuse Disease, STEMI, ISR, and More Manel Sabate


7:15 PM Beyond Absorb: Novel Attributes and Outcomes of Emerging Scaffolds Alexandre Abizaid


7:30 PM Long-term Imaging Findings With Absorb and Other Scaffolds: Sophisticated Insights IntoPotential Long-term Benefits and Failure Modes Patrick W. Serruys


7:45 PM A Great BRS Case With Long-term Documented Success Case Presenter: Corrado Tamburino

7:50 PM A Challenging BRS Case With Complications That I Learned A Lot From! Case Presenter: Ashok Seth

Moderated Challenging Cases: Coronary III

Monday, October 31 4:00 PM - 5:00 PM Walter E. Washington Convention Center Mod Posters/Cases 1, Exhibit Hall, Level 2Accreditation: none

Moderated Challenging Cases: Coronary III4:00 PM - 5:00 PM

Moderators: Emmanouil S. Brilakis, Ricardo A. Costa

4:00 PM TCT 1272: T Modified Bifurcation Technique Guided by IVUS for Left Main Bifurcation Case Presenter: Alexandre Zago

4:15 PM TCT 1483: How to Treat Big Yellow? Is the Use of a Filter Wire Justified? Case Presenter: Jurgen Ligthart

4:30 PM TCT 1033: An Iatrogenic Circumflex Coronary Occlusion Post-Mitral Valve Surgery:Procedural and Management Considerations Case Presenter: Po Fun Chan

4:45 PM TCT 1136: When a Retrograde CTO Unseals Unexpected Pathways Case Presenter: Pierre Deharo

Moderated Challenging Cases: Coronary IV


Moderated Challenging Cases: Coronary IV4:00 PM - 5:00 PM

Moderators: Jonathan M. Tobis, Giora Weisz

4:00 PM TCT 1239: Subintimal Balloon Rescue: A Novel Technique for Successful Retrieval of anEntrapped Rotablator Burr Case Presenter: Asif Khan

4:15 PM TCT 1278: Similar Complication Different Ways to Tackle Case Presenter: Jeet Ram Kashyap

4:30 PM TCT 1490: Use of Near Infra-Red Spectroscopy With IVUS to Confirm Coronary Vasospasm asa Cause of ACS Case Presenter: Nilesh Pareek

4:45 PM TCT 1013: PCI of the LAD With ECMO Support in a Young Patient With No Cardiac Activity Case Presenter: Berglind Libungan

Moderated Challenging Cases: Structural II


Walter E. Washington Convention Center Mod Posters/Cases 3, Exhibit Hall, Level 2Accreditation: none

Moderated Challenging Cases: Structural II4:00 PM - 5:00 PM

Moderators: Jean-Claude Laborde, Thomas Walther

4:00 PM TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic ValveProsthesis to Treat Concomitant Aortic and Mitral Stenosis Case Presenter: Ulrich Schafer

4:15 PM TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements Case Presenter: Hellmuth Weich

4:30 PM TCT 1515: The Dance of the Corevalve Case Presenter: Smriti Saraf

4:45 PM TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following AorticValvuloplasty Case Presenter: Jalal Zamani

Moderated Challenging Cases: Structural III


Moderated Challenging Cases: Structural III4:00 PM - 5:00 PM

Moderators: David R. Holmes Jr., Clifford J. Kavinsky

4:00 PM TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient Case Presenter: Farzin Beygui

4:15 PM TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time Case Presenter: M. Rizwan Sardar

4:30 PM TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With AtrialSeptal Occluder Case Presenter: shantanu Deshpande

4:45 PM TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves ReplacementUtilizing Sapien 3 Valves in Native Aortic and Mitral Valves Case Presenter: Firas Zahr

Moderated Poster Session: Out-of-Hospital Cardiac Arrest and Primary PCI

Monday, October 31 10:30 AM - 11:30 AM Walter E. Washington Convention Center Mod Posters/Cases 1, Exhibit Hall, Level 2Accreditation: none

Moderated Poster Session: Out-of-Hospital Cardiac Arrest and Primary PCI10:30 AM - 11:30 AM

Moderators: Michel R. Le May, Ivan C. Rokos

10:30 AM TCT 487: Predictors of All-Cause Mortality in Sudden Cardiac Arrest Patients Referredfor Cardiac Catheterization James Xu

10:45 AM TCT 118: Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, andOutcomes During Hospitalization After Out of Hospital Cardiac Arrest with VentricularFibrillation or Pulseless Ventricular Tachycardia Nileshkumar Patel

11:00 AM TCT 845: Regional Differences in the Incidence and Outcomes of Hospitalization After Out-of-Hospital Cardiac Arrest in the United States Nish Patel

11:15 AM TCT 545: Use of Optical Coherence Tomography to Detect Acute Coronary Syndrome inSurvivors of Out-of-Hospital Cardiac Arrest without ST-Segment Elevation on ECG. Philippe Degrell

Moderated Poster Session: Percutaneous MV Therapies


Moderated Poster Session: Percutaneous MV Therapies10:30 AM - 11:30 AM

Moderators: Brij Maini, James E. Muller

10:30 AM TCT 627: Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart FailurePatients With Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics andPreliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort Michael J. Mack

10:45 AM TCT 626: Validating a Prediction Modeling Tool for LVOT obstruction After TranscatheterMitral Valve Replacement Dee Dee Wang

11:00 AM TCT 628: Very Long-Term (Up To 23 Years) Follow-Up After Successful Mitral BalloonValvuloplasty In A Large Series Of Patients With Rheumatic Mitral Stenosis Rafael A Meneguz-Moreno

11:15 AM TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion andMitral Regurgitation Associated with Hypertrophic Cardiomyopathy Saurabh Gupta

Moderated Poster Session: SCAD or Anomalous Coronary Arteries


Moderated Poster Session: SCAD or Anomalous Coronary Arteries10:30 AM - 11:30 AM

Moderators: Theodore A. Bass, Jan J. Piek

10:30 AM TCT 101: Predictors for Recurrent Dissection After Spontaneous Coronary Artery Dissection Jacqueline Saw

10:45 AM TCT 606: Can we justify conservative treatment in adults with Anomalous Coronary ArteryOriginating from the Opposite Sinus of Valsalva (ACAOS) with Inter-Arterial Course (IAC)? Bart Driesen

11:00 AM TCT 607: Trans-Catheter Closure of Coronary Artery Fistulae in Adult Patients & Long-TermOutcomes: A Single Centre Experience Ashish Shah

11:15 AM TCT 488: Congenital Coronary Anomalies of Origin and Distribution in Adult Patients Referredfor Coronary Angiography Suchit Majumdar

Moderated Poster Session: Stent Fracture


Moderated Poster Session: Stent Fracture10:30 AM - 11:30 AM

Moderators: Nicolas Foin, Giampaolo Niccoli

10:30 AM TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and16482 Drug-Eluting Stents From Four Centers Shao-Liang Chen

10:45 AM TCT 315: Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting StentImplantation: 5-Year Clinical Outcome katsuya Miura

11:00 AM TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on Target Lesion Revascularization Kohei Osakada

11:15 AM TCT 442: 3-Year Clinical Outcomes of Complete Versus Partial Stent Fracture AfterPercutaneous Coronary Intervention with Second-Generation Drug-Eluting Stent Dong-Kie Kim

Moderated Poster Session: CTO Techniques


Moderated Poster Session: CTO Techniques3:00 PM - 4:00 PM

Moderators: Mauro Carlino, Alfredo R. Galassi

3:00 PM TCT 273: Predictors of Successful Stingray-Assisted Antegrade Dissection Re-entry: Datafrom the Progress CTO Registry Catalin Toma

3:15 PM TCT 274: Size And Tortuosity of A Collateral Channel Are Important Predictors of SuccessfulTracking in Retrograde Percutaneous Coronary Intervention (PCI) For Chronic Total Occlusion(CTO) Ching-Chang Huang

3:30 PM TCT 275: Management Strategies for Wire Crossable Undilatable CTO Lesions Antoinette Neylon

3:45 PM TCT 276: Prevalence and 5-Year Outcomes of Full Metal Jacket Drug-Eluting Stenting forCoronary Chronic Total Occlusion Seung-Whan Lee

Moderated Poster Session: Diabetes and PCI Outcomes


Moderated Poster Session: Diabetes and PCI Outcomes3:00 PM - 4:00 PM

Moderators: Kevin J. Beatt, Frederick Feit

3:00 PM TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VIITrial Julia Ellert

3:15 PM TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected LeftMain Percutaneous Coronary Intervention with Drug-Eluting Stents Jonathan Murphy

3:30 PM TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve inPatients With and Without Diabetes Mellitus Elvin Kedhi

3:45 PM TCT 260: Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes – Insights fromthe OPEN CTO Registry Adam C Salisbury

Moderated Poster Session: Radiation Protection


Moderated Poster Session: Radiation Protection3:00 PM - 4:00 PM

Moderators: John A. Ambrose, Norman E. Lepor

3:00 PM TCT 846: Efficient Reduction of Radiation Exposure in the Cathlab Alejandro Gutierrez

3:15 PM TCT 847: Radiation Dose and Radiation Protection for the Head and Neck of InterventionalPhysicians Kenneth Fetterly

3:30 PM TCT 848: Prevalence of Eye Abnormalities in Cardiac Cath Lab: Results from the Healthy CathLab study. Emanuela Piccaluga

3:45 PM TCT 849: Radiation-Associated Lens Changes in the Cardiac Catheterization Laboratory: theIC-CATARACT (CATaracts Attributed to Radiation in the CaTh Lab) Initiative Aris Karatasakis

Moderated Poster Session: Renal Denervation


Moderated Poster Session: Renal Denervation3:00 PM - 4:00 PM

Moderators: Melvin D. Lobo, Adam Witkowski

3:00 PM TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter:Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry Felix Mahfoud

3:15 PM TCT 763: Alcohol-Mediated Renal Denervation – Current Status and Future Directions Wojtek Wojakowski

3:30 PM TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITYRegistry of Renal Denervation in a Real World Patient Population With UncontrolledHypertension Felix Mahfoud

3:45 PM TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity andInsulin Resistance in Metabolic Syndrome Vasilios Papademetriou

Edited Taped Cases III: Percutaneous Mitral Valve Intervention

Monday, October 31 8:30 AM - 9:50 AM Walter E. Washington Convention Center Presentation Theater 4, Exhbit Hall, Level 2Accreditation: none

Edited Taped Cases III: Percutaneous Mitral Valve Intervention8:30 AM - 9:50 AM

Moderators: Danny Dvir, Marco Moscarelli Discussants: Eric Horlick, Jose Luis Navia, Joachim Schofer, Joerg Seeburger

8:30 AM Transcatheter Mitral Valve Repair With MitraClip for Severe Functional Mitral InsufficiencyAfter Heart Transplant Case Presenter: Caterina Gandolfo

8:42 AM Discussion

8:50 AM Changing the Way of Treating Mitral Valve Prolapse: Sutureless Neochordal Replacement Case Presenter: Alberto Weber

9:02 AM Discussion

9:10 AM TransMitral Valve Replacement (VIV) Within a St. Jude Mechanical Mitral Valve Case Presenter: J. Bradley Oldemeyer

9:22 AM Discussion

9:30 AM Transapical Off–Pump Mitral Valve Repair in Patient With Severe Degenerative Mitral ValveRegurgitation After Two Renal Transplants Case Presenter: Krzysztof Wrobel

9:42 AM Discussion

Edited Taped Cases IV: LAA Closure and Congenital Heart Disease Intervention

Monday, October 31 8:30 AM - 9:50 AM Walter E. Washington Convention Center Presentation Theater 3, Exhibit Hall, Level 2Accreditation: none

Edited Taped Cases IV: LAA Closure and Congenital Heart Disease Intervention8:30 AM - 10:10 AM

Moderators: Maurice Buchbinder, Horst Sievert Discussants: Steven R. Bailey, Hüseyin Ince, Frank F. Ing, Eustaquio Maria Onorato

8:30 AM Native RVOT Modification and Hybrid Transcatheter Pulmonary Valve Replacement Case Presenter: C. Huie Lin

8:42 AM Discussion

8:50 AM LAA Closure With Amplatzer Amulet: A Step-by-Step Approach Case Presenter: Apostolos Tzikas

9:02 AM Discussion

9:10 AM Real-time 3D Guidance in Recanalization of Interrupted Aorta Case Presenter: C. Huie Lin

9:22 AM Discussion

9:30 AM Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closureof the Left Atrial Appendage in a Elderly Comorbid Patient Case Presenter: Caterina Gandolfo

9:42 AM Discussion

Edited Taped Cases V: Percutaneous Tricuspid Valve Intervention

Monday, October 31 3:00 PM - 4:00 PM Walter E. Washington Convention Center Presentation Theater 4, Exhbit Hall, Level 2Accreditation: none

Edited Taped Cases V: Percutaneous Tricuspid Valve Intervention3:00 PM - 4:00 PM

Moderators: Eric Horlick, Josep Rodés-Cabau Discussants: Philipp Blanke, Sameer Gafoor, Alexander Lauten, Toby Rogers

3:00 PM Trialign for Functional TR: Early US Experience Case Presenter: Charles J. Davidson

3:12 PM Discussion

3:20 PM Transcatheter Valve Repair Solution - When, After the Mitral Valve, the Tricuspid Should BeTreated Case Presenter: Maurizio Taramasso

3:32 PM Discussion

3:40 PM Tricuspid Repair with the Trialign System Case Presenter: Charles J. Davidson

3:52 PM Discussion

Exhibit Hall

Monday, October 31 8:00 AM - 5:00 PM Walter E. Washington Convention Center Exhibit Hall, Level 2Accreditation: none


Tuesday, November 1, 2016

Breakfast Meeting: Advancements in Diagnosis of Cardiovascular Disease: Integrating FFRct Into Daily Clinical Practice (Sponsored byHeartFlow, Inc.)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 145A, Level 1Accreditation: none


Advancements in Diagnosis of Cardiovascular Disease: Integrating FFRct Into Daily Clinical Practice7:00 AM - 8:00 AM

Chair: Manesh R. Patel Facultys: Hiram G Bezerra, Nick Curzen, Simon R. Dixon

7:00 AM Introduction Manesh R. Patel

7:05 AM The PLATFORM trial - Achieving the Triple Aim of Healthcare With FFRCT Manesh R. Patel

7:15 AM Utilization of FFRct - Today and Beyond Faculty: Nick Curzen

7:25 AM Utilization of FFRCT and the Institutional Impact Hiram G Bezerra

7:35 AM Expansion of FFR CT From the Cath Lab to the Emergency Department Simon R. Dixon

7:45 AM Roundtable Discussion Manesh R. Patel

Breakfast Meeting: Best Management for Complex Patients With Complex Disease: The Next Frontier Beyond Revascularization(Sponsored by CRF, Supported by Sanofi-Aventis)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME


Best Management for Complex Patients With Complex Disease: The Next Frontier Beyond Revascularization7:00 AM - 8:00 AM

Chair: Roxana Mehran Facultys: C. Michael Gibson, Duane S. Pinto

7:00 AM Introduction and Session Objectives Roxana Mehran

7:05 AM Case Presentation: Patient With ACS and DM and Multi-Vessel Disease- Beyond PCI- Focuson Best Management Case Presenter: Duane S. Pinto

7:13 AM Case Discussion

7:23 AM Beyond Revascularization: Role of PCSK9 Inhibition in Patients Post PCI C. Michael Gibson

7:33 AM Clinical Trials of PCSK9 Inhibitors: Role of Alirocoumab and Evolocumab in Patients With CADand High LDL Roxana Mehran

7:43 AM Panel Discussion

Breakfast Meeting: Groundbreaking Solutions for Complex PCI and Structural Heart Procedures (Sponsored by GE Healthcare)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: none


Groundbreaking Solutions for Complex PCI and Structural Heart Procedures7:00 AM - 8:00 AM

Facultys: Tanvir Bajwa, MD, K. Dean Boudoulas, MD

7:00 AM Innovative Imaging in Structural Heart Procedures Tanvir Bajwa, MD

7:30 AM Innovative Imaging for Complex PCI Solutions K. Dean Boudoulas, MD

Breakfast Meeting: Interventional Therapies for Hypertension: Current Evidence and Controversies (Sponsored by CRF, Supported byBoston Scientific Corporation, Medtronic, Inc., ReCor Medical and St. Jude Medical, Inc.)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 143A, Level 1Accreditation: CME


Interventional Therapies for Hypertension: Current Evidence and Controversies7:00 AM - 8:00 AM

Co-Chairs: Ajay J. Kirtane, Martin B. Leon Facultys: Justin E. Davies, Juan F. Granada, Felix Mahfoud

7:00 AM Welcome and Introductions Martin B. Leon

7:02 AM Rapid Data Download: Current State of the Evidence for RDN in Hypertension Ajay J. Kirtane

7:12 AM Audience Q&A

7:15 AM Preclinical Insights and Advances in the Understanding of Interventional HypertensionTherapies Juan F. Granada


7:32 AM Ongoing and Emerging Studies in the Renal Denervation Space Felix Mahfoud


7:50 AM Thinking Outside of the Kidney: Alternative Interventional Therapies for Hypertension Justin E. Davies

Breakfast Meeting: PCI Complications: The Best of the Worst (Sponsored by CRF, Supported by Medtronic, Inc.)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 149, Level 1Accreditation: CME


PCI Complications: The Best of the Worst7:00 AM - 8:00 AM

Co-Chairs: James B. Hermiller Jr, Manish A. Parikh Facultys: Nirat Beohar, David A. Cox, Azeem Latib, Steven J. Yakubov

7:00 AM The Coronary Perforation Nightmare Steven J. Yakubov

7:10 AM Discussion

7:15 AM The Coronary That “Spiraled Out of Control” Azeem Latib

7:25 AM Discussion

7:30 AM The "Slam Dunk" STEMI – No Reflow and Beyond David A. Cox

7:40 AM Discussion

7:45 AM My Worst Vascular Complication of the Year Nirat Beohar

7:55 AM Discussion

Breakfast Meeting: Precision Coronary Interventions: The Role of Physiology and Imaging (Sponsored by ACIST Medical & Medtronic)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144A, Level 1Accreditation: none


Precision Coronary Interventions: The Role of Physiology and Imaging7:00 AM - 8:00 AM

Chair: Morton J. Kern Facultys: Ziad A. Ali, Clemens von Birgelen

7:00 AM Welcome/Appropriate Use of Physiology and Imaging in PCI - Precision CoronaryInterventions Morton J. Kern

7:15 AM The Value of Rapid Exchange Microcatheter-Based FFR in Multi-lesions and Multi-vessels Clemens von Birgelen

7:35 AM The Importance of High Definition IVUS in Complex and Higher Risk Indicated PCI Ziad A. Ali

7:55 AM Wrap-up/Conclusion Morton J. Kern

Breakfast Meeting: TAVR in the US: Navigating the Economic Landscape in 2016 and Beyond (Sponsored by CRF, Supported by EdwardsLifesciences)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 144B, Level 1Accreditation: CME


TAVR in the US: Navigating the Economic Landscape in 2016 and Beyond7:00 AM - 8:00 AM

Chair: Hemal Gada Facultys: Thomas Buckingham, David J. Cohen, James Harvey, J.Brad Oldemeyer, Michael J. Rinaldi

7:00 AM Introduction to Perspective-Based Health Economic Analysis Hemal Gada

7:05 AM An Analysis of Societal Cost-effectiveness of TAVR in Current and Lower-Risk Populations David J. Cohen

7:17 AM Provider Perspective of Current TAVR Cost-Effectiveness: Hard Dollars, Hard Sense Michael J. Rinaldi

7:27 AM Nurturing the Minimalist/Optimalist Approach: The Past, The Present, The Future J.Bradley Oldemeyer

7:35 AM Bundled Payments and Accountable Care Organizations: The Restructuring of Operationsand Reimbursement Thomas Buckingham

7:47 AM Before and After TAVR: Preparing Patients and Reducing Post-Procedure ResourceConsumption James Harvey

7:54 AM Discussion

Breakfast Meeting: What's New or Next in the CHIP Tool Kit? (Sponsored by Boston Scientific Corporation)

Tuesday, November 1 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 145B, Level 1Accreditation: none


What's New or Next in the CHIP Tool Kit?7:00 AM - 8:00 AM

Facultys: Khaldoon Alaswad, William W. O'Neill, Simon J. Walsh

7:00 AM Meet the New CHIP Tools: Sentai, Wolverine, and RotaPro Khaldoon Alaswad

7:20 AM Sentai: Experience with BSC's New Family of Guidewires Simon J. Walsh

7:40 AM When You Need Rota, You Need Rota William W. O'Neill

Main Arena III, Tuesday, Nov. 1

Tuesday, November 1 8:00 AM - 1:15 PM Walter E. Washington Convention Center Ballroom, Level 3Accreditation: CME/ASRT/CNE


Live Case Moderator: Martin B. Leon Live Case Co-Moderator: Vinod H. Thourani Live Case Discussants: M Chadi Alraies, G. Michael Deeb, Helene Eltchaninoff, Paul A. Grayburn, Eric Horlick,Samir R. Kapadia, Susheel Kodali, Ruediger Lange, Paul Sorajja, E. Murat Tuzcu, John G. Webb, Brian K.Whisenant Digital Moderator: Roger J. Laham Digital Panelists: Pawel E. Buszman, Eric A. Cohen, Jonathan M. Tobis Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan,Jonathan Soverow, Myong Hwa Yamamoto

8:00 AM University Hospital Zürich, Zürich, Switzerland Live Case Operators: Bettex Dominique, MD, Thomas Horisberger, MD, Francesco Maisano,Fabian Nietlispach, Michel Zuber, MD

8:30 AM St Thomas’ Hospital, London, United Kingdom Live Case Operators: Jane Hancock, MD, PhD, Bernard Prendergast, MD, FRCP, SimonRedwood, Chris Young, MD, FRCP

Plenary Session II. Late-Breaking Clinical Trials 3: Cosponsored by the Journal of the American MedicalAssociation9:00 AM - 10:00 AM

Moderator: Gregg W. Stone Digital Moderator: Philippe Pibarot Discussants: Jeroen J. Bax, Philipp Blanke, Stephen J.D. Brecker, Jean-Claude Laborde, Patrizio Lancellotti,Ruediger Lange, Axel Linke, G. Burkhard Mackensen, Raj Makkar, Michael J. Mullen, John A. Spertus Co-Moderators: Robert O. Bonow, Eric D. Peterson

9:00 AM SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients WithSevere Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Susheel Kodali

9:12 AM Moderated Roundtable Discussion Discussant: Susheel Kodali

9:20 AM PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trialof Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients WithSevere Aortic Stenosis David J. Cohen

9:32 AM Moderated Roundtable Discussion Discussant: David J. Cohen

9:40 AM PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes AfterTranscatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With AorticStenosis Pamela S. Douglas

9:52 AM Moderated Roundtable Discussion Discussant: Pamela S. Douglas


Live Case Moderator: Gregg W. Stone Live Case Co-Moderator: Ted Feldman Live Case Discussants: Steven R. Bailey, Koen Deloose, David Hildick-Smith, Reda Ibrahim, Christoph A.Nienaber, Manish A. Parikh, Jan J. Piek, Bernhard Reimers, Kenneth Rosenfield, Jacqueline Saw, Brian K.Whisenant, Steven J. Yakubov Digital Moderator: William A. Gray Digital Panelists: Ehrin J. Armstrong, D. Christopher Metzger, Jean-Michel Paradis Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan,Jonathan Soverow, Myong Hwa Yamamoto

10:00 AM CardioVascular Center (CVC) Frankfurt, Frankfurt, Germany Live Case Operators: Markus Reinartz, MD, Horst Sievert, Lauran Vaskelyte, MD

10:30 AM NewYork-Presbyterian Hospital/Columbia University Medical Center, NY, NY Live Case Operators: Philip Green, Akiko Maehara, Anthony L. Pucillo Live Case Guest Operator: Sahil A. Parikh

Plenary Session IV: Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award11:00 AM - 11:15 AM

Award Presenters: Martin B. Leon, Gregg W. Stone Discussants: Nikhil Vilas Joshi, Rishi Puri, Hiroki Shiomi

Plenary Session V. TCT Focus Session #3: Global Cardiovascular Healthcare Initiatives and Data Sharing11:15 AM - 12:15 PM

Moderator: Robert O. Bonow Digital Moderator: Mitchell W. Krucoff Discussants: Bagrat Alekyan, Rafael Beyar, Valentin Fuster, Runlin Gao, Jack C. Lewin, William H. Maisel, ManeshR. Patel, Eric D. Peterson, Stuart J. Pocock, Stuart Spencer Co-Moderator: Roxana Mehran

11:15 AM Featured Lecture: A Personal Mission to Impact Cardiovascular Health: It Must Start WithChildren! Valentin Fuster

11:35 AM Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial EnterpriseManesh R. Patel



Moderator: Howard C. Herrmann Digital Moderator: Robert J. de Winter Digital Panelists: Mark B. Effron, Asif Qasim, Giulio G. Stefanini Discussants: Eric Boersma, Ricardo A. Costa, Rajesh M. Dave, Nabil Dib, Dariusz Dudek, Francisco Fdez-Aviles,Marc D. Feldman, Stephen P. Hoole, Bradley H. Strauss, Bonnie H. Weiner

12:15 PM RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closurein Patients With Cryptogenic Stroke David E. Thaler

12:25 PM Moderated Roundtable Discussion Discussant: David E. Thaler

12:30 PM COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-RichPlaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary ArteryDisease Giora Weisz

12:40 PM Moderated Roundtable Discussion Discussant: Giora Weisz

12:45 PM PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of CoronaryArtery Stent Implantation in Women and Minorities Wayne B. Batchelor

12:55 PM Moderated Roundtable Discussion Discussant: Wayne B. Batchelor

1:00 PM ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After CoronaryArtery Stent Implantation Hiroki Shiomi

1:10 PM Moderated Roundtable Discussion Discussant: Hiroki Shiomi

Coronary Theater III, Tuesday, Nov. 1

Tuesday, November 1 8:00 AM - 12:00 PM Walter E. Washington Convention Center Coronary Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: CTOs8:00 AM - 10:00 AM

Live Case Moderator: J. Aaron Grantham Live Case Co-Moderator: Masahiko Ochiai Live Case Discussants: Yaron Almagor, Mauro Carlino, Colm Hanratty, Richard R. Heuser, Jacques J. Koolen,Sudhir Rathore, Bradley H. Strauss, Etsuo Tsuchikane, Gerald S. Werner Digital Moderator: Stéphane Rinfret Digital Panelists: Arif Al Nooryani, Kevin J. Beatt, Sanjog Kalra Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

8:00 AM NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY Live Case Operators: Dimitrios Karmpaliotis, Jeffrey W. Moses Live Case Guest Operator: William L. Lombardi

Session II. Live Cases: CTOs10:00 AM - 12:00 PM

Live Case Moderator: James C. Spratt Live Case Co-Moderator: Paul Hsien-Li Kao Live Case Discussants: David Antoniucci, Alfredo R. Galassi, Omer Goktekin, Stephen P. Hoole, Nicholas J.Lembo, Thomas F. Luscher, Sundeep Mishra, Alexander Grigorievich Osiev, Asif Qasim Digital Moderator: Farouc Jaffer Digital Panelists: Kevin J. Croce, Anthony H. Gershlick, Paul Knaapen Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng

10:00 AM York Hospital, York, PA Live Case Operators: Tony J. DeMartini, James Harvey, MD, William J. Nicholson, MD

Structural Theater II, Tuesday, Nov. 1

Tuesday, November 1 8:00 AM - 12:00 PM Walter E. Washington Convention Center Structural Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: Mitral Neochord & LAA Closure8:00 AM - 10:00 AM

Live Case Moderator: James B. Hermiller Jr Live Case Co-Moderator: Jason H. Rogers Live Case Discussants: Mohamed Abdel-Wahab, Steven F. Bolling, Joseph P. Carrozza Jr, Eulogio J. Garcia,Hüseyin Ince, Chaim S. Lotan, Carlos E. Ruiz, Wilson Y. Szeto, Nina C. Wunderlich Digital Moderator: Martin W Bergmann Digital Panelists: Christian Frerker, Sameer Gafoor, Anuj Gupta Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

8:00 AM CardioVascular Center (CVC) Frankfurt, Frankfurt, Germany Live Case Operators: Markus Reinartz, MD, Horst Sievert, Lauran Vaskelyte, MD

9:00 AM NewYork-Presbyterian Hospital/Columbia University Medical Center Live Case Operators: Angelo B. Biviano, Omar K. Khalique, Robert J. Sommer

Session II. Live Cases: Valve Interventions10:00 AM - 12:00 PM

Live Case Moderator: Alec S. Vahanian Live Case Co-Moderator: Vinod H. Thourani Live Case Discussants: Robert J. Applegate, Jozef Bartunek, John D. Carroll, Goran K. Olivecrona, Joseph F.Sabik, Gerhard C. Schuler, Jonathan M. Tobis, Alfredo Trento, Wojtek Wojakowski Digital Moderator: Michael J. Rinaldi Digital Panelists: Stephen H. Little, Giuseppe Tarantini, Glenn Van Langenhove Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

10:00 AM University Hospital Zürich, Zürich, Switzerland Live Case Operators: Dominique Bettex, MD, Francesco Maisano, Fabian Nietlispach, MichelZuber, MD

11:00 AM St. Thomas' Hospital, London, United Kingdom Live Case Operators: Jane Hancock, MD, PhD, Bernard Prendergast, MD, Simon Redwood, ChrisYoung, MD, FRCP

Didactic Session: Atrial Fibrillation Management in Patients With ACS and PCI: Decisions and Dilemmas

Tuesday, November 1 2:00 PM - 5:53 PM Walter E. Washington Convention Center Room 201, Level 2Accreditation: CME/ASRT/CNE

Session I. Management of the Patient With Atrial Fibrillation and Coronary Artery Disease (ACS and PCI)2:00 PM - 3:28 PM

Moderators: David P. Faxon, C. Michael Gibson Discussants: Dominick J. Angiolillo, Deepak L. Bhatt, Davide Capodanno, Christopher B. Granger, Norman E.Lepor, Roxana Mehran, Freek W.A. Verheugt

2:00 PM The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic OralAnticoagulants Plus DAPT Christopher B. Granger

2:10 PM What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients onChronic Oral Anticoagulants Plus DAPT Freek W.A. Verheugt

2:20 PM European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Davide Capodanno

2:30 PM General Overview and Highlights of the North American Consensus Document onAnticoagulation in the Atrial Fibrillation Patient With ACS or PCI Dominick J. Angiolillo

2:40 PM Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: OptimizingEfficacy While Minimizing Bleeding C. Michael Gibson

2:50 PM When and Which Antiplatelet Agent Should be Dropped When Using Oral AnticoagulantTherapy? Roxana Mehran

3:00 PM Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AFPatient Who Requires PCI Deepak L. Bhatt


Session II: Ongoing Dual vs Triple Antithrombotic Trials in Atrial Fibrillation3:28 PM - 4:23 PM

Moderators: Freek W.A. Verheugt, Pascal Vranckx Discussants: Deepak L. Bhatt, Mark B. Effron, C. Michael Gibson, Duk-Woo Park, Asif Qasim, Jan Tijssen, GlennVan Langenhove

3:28 PM The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design,Rationale, and Status C. Michael Gibson

3:38 PM The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design,Rationale, and Status Pascal Vranckx

3:48 PM The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design,Rationale, and Status Roxana Mehran

3:58 PM The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design,Rationale, and Status Deepak L. Bhatt


Session III: Left Atrial Appendage Closure and Ablation as an Alternative to Triple Therapy4:23 PM - 5:53 PM

Moderators: Martin W Bergmann, Samir R. Kapadia Discussants: Philippe Garot, Ashish Pershad, Vivek Y. Reddy, Brian K. Whisenant, Harvey D. White

4:23 PM Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient Ashish Pershad

4:33 PM Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High BleedingRisk? Current Dataset Brian K. Whisenant

4:45 PM Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy:Occluder, Ligation, or Clipping Jason H. Rogers

4:55 PM Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vsLAA Closure? Harvey D. White

5:01 PM Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Vivek Y. Reddy


5:30 PM Audience Vote Question #1 (With Discussion): In the Low Bleeding-Risk Patient With ChronicAtrial Fibrillation Undergoing Non-complex PCI for Stable CAD, What Is the Best Post-PCIRegimen? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

5:36 PM Audience Vote Question #2 (With discussion): In the High Bleeding-Risk Patient With ChronicAtrial Fibrillation Undergoing Non-Complex PCI for Stable CAD, What Is the Best Post-PCIRegimen? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

5:42 PM Audience Vote Question #3 (With Discussion): In the Low Bleeding-Risk Patient With ChronicAtrial Fibrillation Undergoing Complex Multi-Stent PCI or Any PCI for ACS, What Is the BestPost-PCI Regimen ? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

5:48 PM Audience Vote Question #4 (With Discussion): In the High Bleeding-Risk Patient With ChronicAtrial Fibrillation Undergoing Complex Multi-Stent PCI or Any PCI for ACS, What Is the BestPost-PCI Regimen? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

Didactic Session: Bioresorbable Vascular Scaffolds, Part 2: Technique and Cases

Tuesday, November 1 2:00 PM - 6:17 PM


Session I. BRS Technology, Implantation Technique, and Patient Selection2:00 PM - 3:13 PM

Moderators: Stephen G. Ellis, Patrick W. Serruys Discussants: Bernardo Cortese, Aloke V. Finn, Vasileios D. Gkogkas, Julinda Mehilli, Massimo Napodano, Nick E.J. West

2:00 PM Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorbto DESolve to Fantom to Manli and More Alexandre Abizaid

2:07 PM BRS Benchtop Findings: Implications for Implantation Techniques Nicolas Foin

2:14 PM Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided? Christoph K. Naber

2:22 PM Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch Patrick W. Serruys

2:30 PM PSP: A Synthesis of Technique Imperatives for Absorb Implantation David G. Rizik

2:36 PM A Critical Review of Technique Across the Absorb Trials Stephen G. Ellis

2:42 PM Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience Serban Puricel

2:49 PM Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry Holger M. Nef

2:55 PM Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical BenchTesting Ron Waksman


Session II. Drilling Down: Optimal BRS Technique and Procedural Considerations3:13 PM - 4:17 PM

Moderators: Jonathan M. Hill, Christoph K. Naber Discussants: Vincent On-Hing Kwok, Michael Maeng, Evelyn S. Regar, Giuseppe Tarantini, Jose M. de la TorreHernandez, Clemens von Birgelen

3:13 PM Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CADand ACS Manel Sabate

3:20 PM Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With CaseExamples) Corrado Tamburino

3:27 PM BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA orIntracoronary Imaging (With Case Examples)? Alexandre Abizaid

3:33 PM Can QCA Be Trusted? Insights From OCT and More Yoshinobu Onuma

3:39 PM Pre-Debate Vote: In What Proportion Of BRS Cases Do You Use Intravascular Imaging forGuidance ? Poll Moderators: Jonathan M. Hill, Christoph K. Naber

3:41 PM Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective! Joanna J. Wykrzykowska

3:47 PM Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine! Ricardo A. Costa

3:53 PM Post-Debate Vote (Who Won?): After the Debate, in What Proportion of BRS Cases Will YouUse Intravascular Imaging for Guidance? Poll Moderators: Jonathan M. Hill, Christoph K. Naber

3:55 PM If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT? Carlo Di Mario

4:01 PM Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With CaseExamples) Azeem Latib


Session III. Lesion-Specific Techniques With Case Examples4:17 PM - 5:39 PM

Moderators: Dean J. Kereiakes, Robert-Jan van Geuns Discussants: Christophe Dubois, Jacques J. Koolen, Detlef G. Mathey, Sundeep Mishra, Anna Sonia Petronio

4:17 PM Bifurcations and BRS: Techniques, Full Polymer, or Hybrid? Azeem Latib

4:24 PM BRS Bifurcation Rapid-Fire Case Reviews Case Presenter: Manuel Pan


4:35 PM BRS in CTOs: Why and How Jochen Wöhrle

4:42 PM BRS CTO Rapid-Fire Case Reviews Case Presenter: Julinda Mehilli


4:53 PM BRS in Small Vessels and Diffuse Disease: Managing Overlapping Scaffolds; When to UseDES or Balloon Only Jorge A. Belardi

5:00 PM BRS in Small Vessels and Diffuse Disease Rapid-Fire Case Reviews Case Presenter: Kenneth Chin


5:11 PM BRS in STEMI: Rationale and Technique Differences Compared to Stable Lesions Roberto Diletti

5:17 PM BRS STEMI Rapid-Fire Case Reviews Case Presenter: Arif Al Nooryani


5:29 PM BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and CaseExamples) Case Presenter: Wojtek Wojakowski


Session IV. Mini-Lectures: How to Manage BRS Challenges and Failures5:39 PM - 6:17 PM

Moderators: Ashok Seth, Pieter C. Smits Discussants: Vladimir Dzavik, Andrejs Erglis, David F. Kong, Jens Flensted Lassen, Maurizio Menichelli, SunaoNakamura

5:39 PM How to Overcome Challenges in Delivering BRS (With Case Examples) Ashok Seth

5:45 PM How to Manage BRS Stent Loss (With Case Examples) Omer Goktekin

5:51 PM Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal ScaffoldDismantling and Fractures (With Case Examples) Yoshinobu Onuma

5:57 PM How to Manage BRS Thrombosis (With Case Examples) Anuruck Jeamanukoolkit

6:03 PM How to Treat BRS Restenosis (With Case Examples) Pieter C. Smits




Session I. Implanted and Non-invasive Sensors for Outpatient Monitoring2:00 PM - 2:56 PM

Moderators: JoAnn Lindenfeld, Ileana L. Pina Discussants: William T. Abraham, Daniel R. Bensimhon, Neal L. Eigler, Brad Quinn, Barbara Riegel

2:00 PM Featured Lecture: Device Overviews and the Promises and Pitfalls of Home Monitoring ofCHF William T. Abraham

2:17 PM Cardiomems Results, Practicality, Integration, and Finances Barbara Riegel

2:29 PM Sensible Medical for Preventing Heart Failure Rehospitalizations Daniel R. Bensimhon


Session II. Interatrial Shunts2:56 PM - 3:36 PM

Moderators: Josep Rodés-Cabau, Nir Uriel Discussants: William T. Abraham, Daniel Burkhoff, Irene M. Lang, David W.M. Muller, Sanjiv Shah, Katherine Wallon

2:56 PM Interatrial Shunts: Theoretical Basis and Unanswered Questions Daniel Burkhoff

3:06 PM Interatrial Shunts in HFpEF: Focus on Corvia Sanjiv Shah

3:16 PM Interatrial Shunts in HFrEF: Focus on V-Wave William T. Abraham


Session III. Percutaneous Mechanical Circulatory Support3:36 PM - 4:56 PM

Moderators: David E. Kandzari, Navin K. Kapur Discussants: Fernando Aguel, Matthew D. Bacchetta, Christian Bermudez, Graham A. Cassel, ValluvanJeevanandam, Biswajit Kar, William W. O'Neill, Robert T. Pyo

3:36 PM State-of-the-Art: Matching Patient and Pump in the New Era of Percutaneous MechanicalCirculatory Support Navin K. Kapur

3:51 PM The Impella Family of Devices: Utility of Different Tools for Different Conditions William W. O'Neill

3:59 PM HeartMate PHP: Expanding the Armamentarium for Percutaneous Mechanical CirculatorySupport Robert T. Pyo

4:07 PM TandemHeart: Breathing New Life Into an Established Therapy Biswajit Kar

4:15 PM NuPulse: Implantable Counterpulsation for Advanced CHF Valluvan Jeevanandam

4:23 PM Right Ventricular Support Options and Outcomes Christian Bermudez

4:31 PM ECMO: A Primer of Current Devices and Configurations Matthew D. Bacchetta


Session IV. Durable LVADs4:56 PM - 6:21 PM

Moderators: Daniel Burkhoff, Yoshifumi Naka Discussants: James W Long, John S. Sapirstein, Keyur Bharat Shah, Palak Shah, Marvin J. Slepian, Nir Uriel,Changfu Wu

4:56 PM State-of-the-Art: Recent LVAD Advances and Ongoing Challenges James W Long

5:11 PM State-of-the Art: Mechanisms and Treatment of Gastrointestinal Bleeding in LVAD Patients Nir Uriel

5:26 PM HVAD & MVAD Palak Shah

5:34 PM Heart Mate III: Has the Problem of Thrombus Been Solved? James W Long

5:42 PM Jarvik: Has the Problem of Driveline Infections Been Solved? Yoshifumi Naka

5:50 PM Heart Assist 5: The Role of Continuous, Remote Flow Monitoring in Patient Care Nir Uriel

5:58 PM Syncardia: The Irreplaceable Role of the Total Artificial Heart Keyur Bharat Shah


Didactic Session: Left Atrial Appendage Closure, Part 2: Devices and Technique


Session I: Imaging the LAA Before and During Closure2:00 PM - 2:59 PM

Moderators: Samir R. Kapadia, Apostolos Tzikas Discussants: Brij Maini, James K. Min, Bushra S Rana, Carlos E. Ruiz, Teguh Santoso, Nina C. Wunderlich

2:00 PM TEE Before and During LAA Closure: A Case Based Overview Case Presenter: Bushra S Rana

2:12 PM CT Evaluation Step by Step: Taped Live Demonstration Apostolos Tzikas

2:24 PM Additional LAA Imaging Techniques (Beyond TEE and CT): ICE, Fusion Imaging, and More Carlos E. Ruiz

2:34 PM The Potential for 3D Printing and Imaging for LAA Closure James K. Min


Session II: Access Technique and Complications2:59 PM - 3:41 PM

Moderators: Maurice Buchbinder, Saibal Kar Discussants: Stefan C. Bertog, Patrick A. Calvert, Sameer Gafoor, Eulogio J. Garcia, G. Burkhard Mackensen,Issam D. Moussa

2:59 PM Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and PunctureSite Closure Sameer Gafoor

3:09 PM How to Perform Transseptal Puncture Safely and Effectively Stefan C. Bertog

3:19 PM Pericardial Access Tips and Tricks Issam D. Moussa


Session III: Device Descriptions and Specific Implant Technique (Case Based)3:41 PM - 5:08 PM

Moderator: Krzysztof Bartus Discussants: Yat-Yin Lam, Randall J. Lee, Jai-Wun Park, Vivek Y. Reddy, Josep Rodés-Cabau, Apostolos Tzikas

3:41 PM General Principles of LAA Closure Case Presenter: Apostolos Tzikas

3:51 PM Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder Case Presenter: Saibal Kar

4:03 PM Special Tips and Tricks for LAA Closure Using the ACP/Amulet LAA Occluder Case Presenter: Jai-Wun Park

4:15 PM Special Tips and Tricks for LAA Closure Using the WaveCrest LAA Occluder Case Presenter: Vivek Y. Reddy

4:22 PM Special Tips and Tricks for LAA Closure Using the Occlutech LAA Occluder Case Presenter: Eustaquio Maria Onorato

4:29 PM Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder Case Presenter: Josep Rodés-Cabau

4:36 PM Special Tips and Tricks for LAA Closure Using the Lifetech LAA Occluder Case Presenter: Yat-Yin Lam

4:43 PM Special Tips and Tricks for LAA Closure Using the Lariat Case Presenter: Randall J. Lee


Session IV: Post-Procedural Management5:08 PM - 6:00 PM

Moderators: David R. Holmes Jr., Jacqueline Saw Discussants: Steven L. Almany, George S. Hanzel, David Meerkin, Bushra S Rana, Marina Urena

5:08 PM DAPT, Warfarin, NOAC or Nothing After LAA Closure? Maurice Buchbinder

5:18 PM Follow-up Evaluation After LAA Closure Bushra S Rana

5:26 PM Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA ClosureDavid R. Holmes Jr.

5:36 PM Management of Residual Leaks After LAA Closure Case Presenter: Jacqueline Saw


Didactic Session: Optimizing Outcomes With Intravascular Imaging and Physiologic Lesion Assessment, Part I


Session I. Coronary Physiology: Core Concepts, Part I2:00 PM - 3:00 PM

Moderators: Bernard De Bruyne, Allen Jeremias Discussants: Emanuele Barbato, Angela Hoye, Morton J. Kern, Michael J. Lim

2:00 PM Standard and Novel Pressure Measuring Devices: Differences, Similarities, and PracticalRecommendations Morton J. Kern

2:10 PM IMPACT: Randomized Evaluation of a Rapid Exchange FFR Microcatheter in IntermediateCoronary Stenoses Tim P. van de Hoef

2:18 PM Standardization of FFR Acquisition and Storage Bernard De Bruyne

2:28 PM Non-Hyperemic Indices: Glossary and Clinical Outcome Data Allen Jeremias

2:38 PM FFR in the setting of CABG and AS/AVR/TAVR Emanuele Barbato


Session II. Coronary Physiology: Outcomes Data and Focus on ACS3:00 PM - 4:00 PM

Moderators: Nick Curzen, Nils Johnson Discussants: Justin E. Davies, Thomas Engstroem, Javier Escaned, Habib Samady, Frederik M. Zimmermann

3:00 PM FFR in ACS: Specifics and Timing of Measurements Habib Samady

3:10 PM FFR in ACS: Current Data Including DOCTORS and Upcoming Studies Thomas Engstroem

3:20 PM iFR in Acute Coronary Syndromes Justin E. Davies

3:30 PM Very Long Term Outcomes after FFR-Based Decision-Making Frederik M. Zimmermann


Session III. Intracoronary Imaging: Focus on Clinical Outcomes3:52 PM - 5:12 PM

Moderators: John McB. Hodgson, Neil J. Weissman Discussants: Takashi Akasaka, Ziad A. Ali, Ning Guo, Ryan D. Madder, Francesco Prati

3:52 PM IVUS, NIRS, and OCT Dictionary: Recognizing the Structure of the Coronary Wall and Plaque,and Evaluating Acute Results of Intervention Ziad A. Ali

4:04 PM Overview of IVUS-based Outcomes Data Ryan D. Madder

4:16 PM Overview of OCT-based Outcomes Data: Ilumien, Opinion and Beyond Francesco Prati

4:28 PM Reproducibility and Standardization of OCT Measurements: Historical Review and a NewApproach Annapoorna Kini

4:38 PM My Top Uses for IVUS and/or OCT: A Clinician’s Perspective Takashi Akasaka


Session IV. Coronary Imaging: New Technologies and Strategies5:02 PM - 6:02 PM

Moderators: Adrian P. Banning, Ryan D. Madder Discussants: Ziad A. Ali, Eric Boersma, Marc D. Feldman, Akiko Maehara, Guillermo Tearney

5:02 PM Intravascular Imaging Guidance of BRS Implantation and Follow-up Yoshinobu Onuma

5:12 PM Next Generation IVUS and OCT: HD-IVUS, Heartbeat-OCT, Micro-OCT, Combination Devices,and More Evelyn S. Regar

5:22 PM Angiographic Coregistration of IVUS, OCT, FFR, iFR, and More Giulio Guagliumi

5:32 PM No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to AvoidContrast-Induced Nephropathy Ziad A. Ali

5:42 PM Culprit and Non-Culprit Lesion Assessment in STEMI: A Paradigm Shift Based onIntravascular Imaging (and Physiology)? Ik-Kyung Jang


Didactic Session: Peripheral Vascular Intervention, Part 3: Carotid, Subclavian, Innominate, and Stroke

Tuesday, November 1 2:00 PM - 6:00 PM Walter E. Washington Convention Center Room 146A, Level 1Accreditation: CME/ASRT/CNE

Session I. Carotid Disease Management – Current Status and New Developments2:00 PM - 3:35 PM

Moderators: Sriram S. Iyer, John R. Laird Jr Discussants: Brian G DeRubertis, William A. Gray, Leo Nelson Hopkins, Klaus D. Mathias, D. Christopher Metzger

2:00 PM Train Interventionalists in Carotid Stenting: Case Volume Requirements and More Klaus D. Mathias

2:10 PM Are Mesh-Covered Stents the Future of CAS? Evaluation With OCT and IVUS William A. Gray


2:35 PM LIVE CASE DEMONSTRATION: Carotid Intervention- Gates Vascular Institute, Buffalo GeneralMedical Center, Buffalo, NY Live Case Operators: Elad Levy, Adnan Siddiqui, Kenneth Snyder

3:00 PM Pre-debate Vote: What Is the Optimal Technique for Embolic Protection During CarotidStenting? Poll Moderators: Sriram S. Iyer, John R. Laird Jr

3:02 PM Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? DistalEmbolic Protection With Contemporary Devices and Techniques Provides Optimal CASOutcomes William A. Gray

3:09 PM Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting?Proximal Embolic Protection Should Be Utilized for the Majority of CAS Cases D. Christopher Metzger

3:16 PM Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting?Proximal Embolic Protection Isn’t Enough – Transcervical Access With Flow Reversal Is theIdeal Strategy for CAS Brian G DeRubertis


3:33 PM Post-debate Vote (Who Won?): What Is the Optimal Technique for Embolic Protection DuringCarotid Stenting? Poll Moderators: Sriram S. Iyer, John R. Laird Jr

Session II. Acute Stroke Intervention3:35 PM - 4:55 PM

Moderators: D. Christopher Metzger, Bernhard Reimers Discussants: Alex Abou-Chebl, Omer Goktekin, Klaus D. Mathias, Aman B Patel, Gary S. Roubin, Rahul Sakhuja

3:35 PM Stenting for Intracranial Atherosclerosis: Who, When, and How Alex Abou-Chebl

3:45 PM Mechanical Thrombectomy in Acute Stroke: Tips, Devices and Acute Results Aman B Patel

3:55 PM VIDEOTAPED CASE DEMONSTRATION: Interventional Management of Acute Stroke Case Presenter: D. Christopher Metzger

4:20 PM Stroke Interventions: Parallels to Primary PCI for Acute MI and the Potential Role of theCardiologist Bernhard Reimers

4:27 PM Managing Complications of Carotid Interventions Aman B Patel

4:37 PM Building A Multidisciplinary Team for Interventional Acute Stroke Management Bernhard Reimers


Session III: Subclavian and Innominate Intervention: From Occlusive Disease to Aneurysmal Involvement4:55 PM - 6:00 PM

Moderators: William A. Gray, Mehdi H. Shishehbor Discussants: Jacques Busquet, Koen Deloose, Leo Nelson Hopkins, Thomas A. Ischinger, Sriram S. Iyer, SaskoKedev, Jose M. Wiley

4:55 PM LIVE CASE DEMONSTRATION: Innominate/Subclavian Intervention- Gates Vascular Institute,Buffalo General Medical Center, Buffalo, NY Live Case Operators: Elad Levy, MD, FACS, Adnan Siddiqui, Kenneth Snyder, MD, PhD

5:20 PM Overview of Subclavian and Innominate Artery Interventions Jacques Busquet

5:30 PM Transradial Access for Subclavian, Innominate, and Carotid Artery Disease Sasko Kedev

5:40 PM The Right Choice: Endovascular Therapy vs Surgical Bypass for CLI Koen Deloose


Didactic Session: Right Heart Interventions: Pulmonary Hypertension, Pulmonary Emboli, and Pulmonic/Tricuspid Valve Interventions


Session I: Pulmonary Hypertension and Thromboembolism2:00 PM - 3:33 PM

Moderators: Ori Ben-Yehuda, Ehtisham Mahmud Discussants: Christopher F Barnett, Shao-Liang Chen, Mardi Gomberg-Maitland, William W. O'Neill

2:00 PM Acute and Chronic Pulmonary Hypertension: Etiology, Pathophysiology, Diagnosis, andClassification Ori Ben-Yehuda

2:08 PM Acute Pulmonary Thromboembolism: Outcomes of Medical Therapy, Including Lytics Christopher F Barnett

2:14 PM Catheter-directed Interventions For Acute Pulmonary Emboli: Pigtails, Ekos, Angiojet, andAngiovac- Description, Data, and Cases Lindsay S. Machan

2:27 PM Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and CasePresentation William W. O'Neill


2:41 PM Medical Therapy for Chronic Pulmonary Hypertension: Which Drugs, Which Patients, HowEffective? Mardi Gomberg-Maitland

2:48 PM Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work? Matthew D. Bacchetta

2:54 PM Atrial Septostomy for Chronic Pulmonary Hypertension Gagan D Singh

3:00 PM Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights Alex M. K. Rothman

3:05 PM Pulmonary Artery Denervation for Pulmonary Hypertension II: Catheter Development,Procedure, and Acute and Late Hemodynamic Results Shao-Liang Chen

3:13 PM Pulmonary Artery Angioplasty for Chronic Pulmonary Thromboembolic Disease: An Option forNo Option Patients? Ehtisham Mahmud

3:19 PM Pulmonary Vein Interventions: Indications, Tips and Tricks, Case Presentation Ehtisham Mahmud


Session II: Pulmonic Valve and Vessel Interventions3:33 PM - 4:33 PM

Moderators: Ziyad M. Hijazi, C. Huie Lin Discussants: Zahid Amin, Matthew J. Gillespie, Bryan H. Goldstein, Thomas K. Jones, Carlos E. Ruiz, Nathan WTaggart

3:33 PM Pulmonic Stenosis and Regurgitation: Pathophysiology and Review of Indications forIntervention Bryan H. Goldstein

3:40 PM Native RVOT and RV-PA Conduit Transcatheter Pulmonary Valve Replacement Frank F. Ing

3:48 PM PA Stenting During Transcatheter Pulmonary Valve Replacement Procedures Lee N. Benson

3:54 PM Transcatheter Pulmonary Valve Replacement 1: Melody John P. Cheatham

4:01 PM Transcatheter Pulmonary Valve Replacement 2: Sapien Eric Horlick

4:08 PM The Pulmonary Valve Pipeline: Harmony Valve, Venus P-Valve and More Ziyad M. Hijazi

4:14 PM Preparing for Catastrophe During Right Heart Valve Procedures: Covered Stents and ConduitRupture, Coronary Compression, ECMO, Interventional Bronchoscopy, Coils, Plugs Thomas K. Jones


Session III: Tricuspid Valve Therapies4:33 PM - 6:20 PM

Moderators: Joachim Schofer, Alec S. Vahanian Discussants: Colin M. Barker, Danny Dvir, Hans R. Figulla, James S. Gammie, Patrizio Lancellotti, Toby Rogers

4:33 PM Anatomy and Pathology of the Tricuspid Valve With a Focus on Feasibility of PercutaneousInterventions Colin M. Barker

4:39 PM Impact and Natural History of Functional Tricuspid Regurgitation Maurice E. Sarano

4:45 PM Surgical Approach to Functional Tricuspid Regurgitation Joerg Seeburger

4:51 PM Interventional Imaging of the Tricuspid Valve Rebecca T. Hahn


5:03 PM Transcatheter Tricuspid Valve Therapies 1: Trialign Description, Results and a Case Rebecca T. Hahn

5:10 PM Transcatheter Tricuspid Valve Therapies 2: 4-Tech Description, Results and a Case Alec S. Vahanian

5:17 PM Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case Josep Rodés-Cabau

5:24 PM Transcatheter Tricuspid Valve Therapies 4: Tricuspid MitraClip Procedure, Results and a Case Joachim Schofer

5:31 PM Transcatheter Tricuspid Valve Therapies 5: Millipede Description, Results and a Case Jason H. Rogers

5:38 PM Transcatheter Tricuspid Valve Therapies 6: Cardioband TR Description, Results and a Case Karl-Heinz Kuck

5:45 PM Transcatheter Tricuspid Valve Therapies 7: TRAIPTA Description, Results and a Case Toby Rogers

5:52 PM Transcatheter Tricuspid Valve Therapies 8: IVC/SVC Valved Stents - Results and a Case Alexander Lauten

5:59 PM Tricuspid Valve-in-Valve and Valve-in-Ring Procedures and Outcomes Saif Anwaruddin



Tuesday, November 1 2:00 PM - 6:00 PM Walter E. Washington Convention Center Room 151, Level 1


Session I. Retrograde Techniques2:00 PM - 3:00 PM

Moderators: Alfredo R. Galassi, Masahiko Ochiai Discussants: Yasushi Asakura, David Hildick-Smith, Paul Knaapen, Jacques J. Koolen, James C. Spratt, MasahisaYamane

2:00 PM Retrograde Step-by-step James C. Spratt


2:20 PM Contemporary Reverse CART Masahisa Yamane


2:40 PM Hybrid/Guide Extension Reverse CART Paul Knaapen


Session II: Case-Based Education: Learning From Others3:00 PM - 4:00 PM

Moderators: Colm Hanratty, Paul Hsien-Li Kao Discussants: Arun Kalyanasundaram, Paul Knaapen, Jianfang Luo, Sudhir Rathore, James C. Spratt

3:00 PM My Best Antegrade Case(s) of the Last Year Case Presenter: Jianfang Luo


3:20 PM How to Manage the Impenetrable Proximal Cap (Case Presenation) Case Presenter: Arun Kalyanasundaram


3:40 PM My Best Retrograde Case(s) of Last Year Case Presenter: James C. Spratt


Session III. Risks of CTO Intervention4:00 PM - 5:00 PM

Moderators: Christopher E. Buller, Masahisa Yamane Discussants: Emmanouil S. Brilakis, Kambis Mashayekhi, Margaret B. McEntegart, Sunao Nakamura, MasahikoOchiai, Stéphane Rinfret

4:00 PM Risks of Retrograde CTO PCI: Lessons From Registry Data and Personal Experience Emmanouil S. Brilakis


4:20 PM Risks of Antegrade CTO PCI: Lessons From Registry Data and Personal Experience Kambis Mashayekhi


4:40 PM How to Avoid Complications Masahiko Ochiai


Session IV: Learning From Complications5:00 PM - 6:00 PM

Moderators: Talib Majwal, Barry D. Rutherford, Gerald S. Werner Discussants: Emmanouil S. Brilakis, J. Aaron Grantham, William L. Lombardi, R. Michael Wyman, Jochen Wöhrle

5:00 PM My Worst Complication(s) of the Last Year Case Presenter: William L. Lombardi


5:20 PM My Worst Complication (s) of the Last Year Case Presenter: J. Aaron Grantham


5:40 PM My Worst Complication(s) of the Last Year Case Presenter: Emmanouil S. Brilakis


Didactic Session: The TCT 2016 Late Breaking Trials: Live Discussion Forum


Session I. Drug-Eluting Stents and Bioresorbable Vascular Scaffolds2:00 PM - 3:47 PM

Moderators: Philip M. Urban, Stephen G. Worthley Discussants: Wayne B. Batchelor, Salvatore Cassese, Bernard R. Chevalier, Runlin Gao, David E. Kandzari, AshokSeth, Clemens von Birgelen

2:00 PM Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) andBIONICS Sigmund Silber


2:22 PM Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year andRevElution Christian M. Spaulding


2:44 PM Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE andFUTURE-I (6-9 Month Results) Robert-Jan van Geuns


3:09 PM Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3Year Results) Stephen G. Ellis


3:31 PM Highlights (and my Interpretations) From: PLATINUM DIVERSITY Bonnie H. Weiner


Session II: Left Main PCI vs CABG3:47 PM - 4:22 PM

Moderators: Yves R. Louvard, John D. Puskas Discussants: Adrian P. Banning, Evald H. Christiansen, Ajay J. Kirtane, Ian Menown, Joseph F. Sabik, Leif Thuesen

3:47 PM Highlights (and my Interpretations) from: EXCEL and NOBLE Davide Capodanno


Session III: Imaging Studies4:22 PM - 5:02 PM

Moderators: Giulio Guagliumi, Ik-Kyung Jang Discussants: Ziad A. Ali, Takashi Kubo, Akiko Maehara, Gary S. Mintz, James E. Muller, Hiroki Shiomi, Giora Weisz

4:22 PM Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR Ron Waksman


4:46 PM Highlights (and my Interpretations) From: ReACT Niels R. Holm


Session IV. Transcatheter Aortic Valve Replacement and Structural Heart Intervention5:02 PM - 5:54 PM

Moderators: Jeffrey J. Popma, E. Murat Tuzcu Discussants: David J. Cohen, Susheel Kodali, Axel Linke, Vasilios Papademetriou, Mladen I. Vidovich

5:02 PM Highlights (and my Interpretations) From: SENTINEL Alexandra J. Lansky


5:18 PM Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes Michael J. Mullen


5:38 PM Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality ofLife Ganesh Manoharan


Didactic Session: Transcatheter Aortic Valve Therapies Part 3: New Technology Forum

Tuesday, November 1 2:00 PM - 6:05 PM Walter E. Washington Convention Center Room 146B/C, Level 1Accreditation: CME/ASRT/CNE

Session I. TAVR 2016: Frequently Used TAVR Systems2:00 PM - 3:40 PM

Moderators: Eberhard Grube, James B. Hermiller Jr Discussants: Mohamed Abdel-Wahab, Stephan Baldus, Anson Cheung, Charles J. Davidson, Ariel Finkelstein,Isaac George, Neal S. Kleiman, Azeem Latib

2:00 PM Sapien 3 and ULTRA: Design Features, Special Attributes, and Clinical Trial Program John G. Webb


2:20 PM Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program Jeffrey J. Popma


2:40 PM Portico: Design Features, Special Attributes, and Clinical Trial Program Raj Makkar


2:55 PM Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program Ted Feldman


3:10 PM Direct Flow: Design Features, Special Attributes, and Clinical Trial Program Azeem Latib


3:25 PM Accurate: Design Features, Special Attributes, and Clinical Trial Program Helge Möllmann


Session II. TAVR 2016: Anatomic Decision-making and TAVR Systems II3:40 PM - 5:05 PM

Moderators: Ganesh Manoharan, Hendrik Treede Discussants: Stephen J.D. Brecker, Chandan Devireddy, Howard C. Herrmann, Hasan Jilaihawi, Jan Kovac, AxelLinke, Michael J. Reardon, Richard Smalling

3:40 PM Which Device and Technique for This Patient? Case Presenters: Tamim Nazif, Torsten P. Vahl

4:20 PM Jena Valve: Design and Clinical Updates Hendrik Treede

4:28 PM Venus A Valve: Design and Clinical Updates Hasan Jilaihawi

4:36 PM Centera: Design and Clinical Updates Stephen G. Worthley

4:44 PM Xeltis: Design and Clinical Updates Christian M. Spaulding

4:52 PM Surveying the Global Landscape of TAVR Newcomers Martin B. Leon


Session III. TAVR 2016: TAVR Accessories5:05 PM - 6:05 PM

Moderators: Helene Eltchaninoff, Neal S. Kleiman Discussants: Alexandre Abizaid, Peter C. Block, Stephen J.D. Brecker, Haim Danenberg, Hemal Gada, AlbertMarkus Kasel, Augusto D. Pichard, Molly Szerlip

5:05 PM New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy Michael Jonas

5:13 PM New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages andClinical Applications Wesley R. Pedersen

5:21 PM New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - TechnicalAdvantages and Clinical Applications Cheng-Han Chen


5:33 PM Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others Alexandre Abizaid


5:45 PM Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates fromCLEAN-TAVI, SENTINEL RCT, and Others Axel Linke

5:53 PM Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates FromDeflect III and Reflect Clinical Trials Andreas Baumbach


Hot Topic Lunch: Fellows Sessions: ACS and Pharmacotherapy Year-in-Review (Sponsored by the American College of Cardiology)

Tuesday, November 1 11:00 AM - 12:00 PM Walter E. Washington Convention Center Room 145A, Level 1Accreditation: CME/ASRT/CNE

Fellows Sessions: ACS and Pharmacotherapy Year-in-Review (Sponsored by the American College ofCardiology)11:00 AM - 12:00 PM

Moderators: George D. Dangas, Debabrata Mukherjee Discussants: Rajesh M. Dave, Dean J. Kereiakes, Duane S. Pinto, Gary L. Schaer

11:00 AM Achieving Effective and Safe Platelet Inhibition in ACS Paul A. Gurbel


11:18 AM Deciding on the Duration of DAPT Neal S. Kleiman


11:33 AM Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, OngoingStudies C. Michael Gibson


11:48 AM ACS and Pharmacotherapy Guidelines Update John A. Bittl


Hot Topic Lunch: Cath Lab Radiation Hazards, Part 1: Managing Patient, Operator, and Staff Risks


Part 1: Managing Patient, Operator, and Staff Risks12:00 PM - 1:00 PM

Moderator: Stephen Balter Discussants: Charles E. Chambers, Sanjog Kalra, Donald L. Miller

12:00 PM Ethics of Irradiating Patients and Staff Charles E. Chambers

12:10 PM Hot: Is High Dose Due to Operator Preferences or Patient Characteristics? Sanjog Kalra

12:20 PM How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QAPolicies Donald L. Miller

12:30 PM Does Newer Equipment Lower Dose? Does Physician Education Help? Stephen Balter


Hot Topic Lunch: Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 1 - Pharmacology and STEMI Care


Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 1 - Pharmacology and STEMI Care12:00 PM - 1:00 PM

Moderators: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung Discussants: Eric R. Bates, Deepak L. Bhatt, Hitinder S. Gurm, Timothy D. Henry, Daniel I. Simon

12:00 PM Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in MostPatients Undergoing PCI! Gennaro Giustino

12:08 PM Return Fire: The Contrarian View: DAPT Should Be Continued Beyond 12 Months in MostPatients Undergoing PCI! Discussant: Daniel I. Simon


12:20 PM Opening Salvo: I Don't Believe That Cangrelor Is Needed for Most PCI Procedures in ACS! Eric R. Bates

12:28 PM Return Fire: The Contrarian View: Cangrelor Is Needed for Most PCI Procedures in ACS! Discussant: Deepak L. Bhatt


12:40 PM Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCIIn 2016! Hitinder S. Gurm

12:48 PM Return Fire: The Contrarian View - Door-to-Balloon Time Is a Critical Metric for Primary PCI In2016! Discussant: Timothy D. Henry


Hot Topic Lunch: CT Imaging for the Valve and Structural Heart Disease Interventionalist (Sponsored by the Society of CardiovascularComputed Tomography [SCCT])

Tuesday, November 1 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 144B, Level 1


CT Imaging for the Valve and Structural Heart Disease Interventionalist (Sponsored By the Society ofCardiovascular Computed Tomography [SCCT])12:00 PM - 1:00 PM

Moderators: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min Discussants: João L Cavalcante, Swaminatha V Gurudevan, Hasan Jilaihawi

12:00 PM Comprehensive CT Algorithm Before TAVR João L Cavalcante

12:10 PM Post-TAVR Valve Thickening: Current Data and Open Questions Hasan Jilaihawi

12:20 PM Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions Jonathon A. Leipsic

12:30 PM Criteria to Select Candidates for Transcatheter Tricuspid Valve Interventions Jeroen J. Bax

12:40 PM Can CT Help to Select LAA Closure Devices? Swaminatha V Gurudevan


Hot Topic Lunch: Early Career Development for the New Interventionalist

Tuesday, November 1 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 103A, Level 1Accreditation: CME

Early Career Development for the New Interventionalist12:00 PM - 1:00 PM

Moderators: Ehtisham Mahmud, Manish A. Parikh Discussants: Saif Anwaruddin, David A. Cox, Ethan C. Korngold, Molly Szerlip

12:00 PM Balancing Multiple Skills: Coronary, Peripheral and Structural Ehrin J. Armstrong

12:08 PM Roundtable Discussion: When Am I Really Done Training?

12:15 PM Learning the Business of Interventional Cardiology Ethan C. Korngold

12:23 PM Roundtable Discussion: Avoiding "Rookie" Mistakes

12:30 PM Staying Current and Remaining Relevant: Evolving With the Field David A. Cox

12:38 PM Roundtable Discussion: Learning New Skills in an Ever-Changing Field

12:45 PM A Plan for the First Five Years to Grow Your Career Manish A. Parikh

12:53 PM Roundtable Discussion: What If the First Job Isn't Right for Me?

Hot Topic Lunch: Echo Guidance of Interventional Procedures, Part 1: Imaging for Transcatheter Aortic Valve Replacement. An ASE-Sponsored Symposium

Tuesday, November 1 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 143B, Level 1Accreditation: CME/ASRT/CNE

Part 1: Imaging for Transcatheter Aortic Valve Replacement12:00 PM - 1:00 PM

Moderators: Patrizio Lancellotti, Sunil V. Mankad Discussants: Thomas Bartel, Rebecca T. Hahn, Stamatios Lerakis, Stephen H. Little, Jeremy J Thaden

12:00 PM Debate: Imaging For TAVR- The Case for TTE and the Minimalist Approach! Stephen H. Little

12:10 PM Debate: Imaging For TAVR- The Case for TEE and MAC/GA! Rebecca T. Hahn


12:30 PM Use of Intracardiac Echocardiography During TAVR Thomas Bartel


12:45 PM Fusion Imaging for TAVR: Is There Added Utility? Jeremy J Thaden


Hot Topic Lunch: Emerging Data and Controversies in the Use of Peripheral Drug-Coated Balloons


Emerging Data and Controversies in the Use of Peripheral Drug-Coated Balloons12:00 PM - 1:00 PM

Moderators: Koen Deloose, William A. Gray Discussants: Lawrence A. Garcia, Juan F. Granada, Prakash Krishnan, John R. Laird Jr, Mahmood K. Razavi,Kenneth Rosenfield

12:00 PM Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA John R. Laird Jr

12:05 PM Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix Kenneth Rosenfield

12:10 PM Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex Prakash Krishnan

12:15 PM "DCB Efficacy In the SFA: Class-Effect or Device Specific" Salvatore Cassese

12:21 PM Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world" Koen Deloose

12:27 PM Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy inSFA Intervention? Lawrence A. Garcia

12:33 PM DCB in BTK Intervention: Necessary Technical and Clinical Improvements to “Unlock" theBTK Application Mahmood K. Razavi

12:39 PM Designing a Complication-Free DCB: Is It Possible or Necessary? Juan F. Granada

12:45 PM Roundtable Discussion: With a Question and Answer

Hot Topic Lunch: Fellows Sessions: PCI Year-in-Review (Sponsored by the American College of Cardiology)


Fellows Sessions: PCI Year-in-Review (Sponsored by the American College of Cardiology)12:00 PM - 1:00 PM

Moderators: Sripal Bangalore, George D. Dangas Discussants: Theodore A. Bass, Stephen G. Ellis, Lisette Okkels Jensen, Thomas M Tu

12:00 PM Bioabsorbable Vascular Scaffolds: Landscape in 2016 Alexandre Abizaid


12:12 PM Lesion Optimization Before PCI: Role of Imaging/Atherectomy Philippe Généreux


12:24 PM 2016 DAPT Update: Evidence and Guidelines Adnan K. Chhatriwalla


12:36 PM 2016 STEMI PCI Update: Evidence and Guidelines Sanjit S. Jolly


12:48 PM 2016 CTO Revascularization Update Khaldoon Alaswad


Hot Topic Lunch: Focus on Chronic Kidney Disease and Contrast Nephropathy


Focus on Chronic Kidney Disease and Contrast Nephropathy12:00 PM - 1:00 PM

Moderators: Somjot S. Brar, Richard Solomon Discussants: Antonio L. Bartorelli, Carlo Briguori, Anuj Gupta, Roxana Mehran, Anand Prasad

12:00 PM CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Anand Prasad


12:15 PM Planning and Performing TAVR in the Patient With CKD Anuj Gupta


12:30 PM Contrast Reduction Strategies in the Patient With CKD Roxana Mehran


12:45 PM Optimizing Fluid Administration for Contrast Nephropathy Prevention Richard Solomon


Hot Topic Lunch: Hybrid Coronary Revascularization: Ready for Prime Time? (Cosponsored by AATS)

Tuesday, November 1 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 144C, Level 1Accreditation: CME/ASRT/CNE

Hybrid Coronary Revascularization: Ready for Prime Time? (Cosponsored by AATS)12:00 PM - 1:00 PM

Moderators: John D. Puskas, Gregg W. Stone Discussants: John S. Douglas Jr, Michael E. Halkos, Marc Ruel, Leif Thuesen

12:00 PM Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and TechnicalConsiderations John S. Douglas Jr

12:12 PM Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIHMulticenter Observational Study) John D. Puskas

12:24 PM Announcing the NIH-sponsored HYBRID Revascularization Trial Gregg W. Stone

12:32 PM Case Introduction: How Would You Revascularize This Patient? Case Presenter: Michael E. Halkos


12:43 PM Case Conclusion: How Did We Revascularize This Patient? Michael E. Halkos


Hot Topic Lunch: Late Career Decisions for the “Experienced” Interventionalist

Tuesday, November 1 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME

Late Career Decisions for the “Experienced” Interventionalist12:00 PM - 1:00 PM

Moderator: David O. Williams Discussants: Peter C. Block, Michael J. Cowley, Keith D. Dawkins, Spencer B. King III

12:00 PM Overview and Scope of the Problem David O. Williams

12:05 PM “I Used to Be an Interventional Cardiologist”: Psychological Impact George W. Vetrovec

12:20 PM When to Stop Being an Interventionalist: Age Alone? Augusto D. Pichard

12:35 PM Staying in Medicine: Potential Options William W. O'Neill


1:00 PM Adjourn

Hot Topic Lunch: Secondary Prevention After PCI (Today and Tomorrow)- Guideline Therapies, Ranolazine, and PCSK9 Inhibitors


Secondary Prevention After PCI (Today and Tomorrow): Guideline Therapies, Ranolazine, and PCSK9Inhibitors12:00 PM - 1:00 PM

Moderators: Bernard J. Gersh, Felix Mahfoud Discussants: Ori Ben-Yehuda, Evan A. Stein

12:00 PM Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control Felix Mahfoud


12:20 PM Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in RoutineClinical Practice Evan A. Stein


12:40 PM Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - AreThey Effective? Ori Ben-Yehuda


Hot Topic Lunch: The Experts Clash – Debates in Structural Heart Disease (sponsored by BCIS)


The Experts Clash – Debates in Structural Heart Disease (sponsored by BCIS)12:00 PM - 1:00 PM

Moderators: Andreas Baumbach, David Hildick-Smith Discussants: Stephen J.D. Brecker, Eberhard Grube, David R. Holmes Jr., Hüseyin Ince

12:00 PM Pre-debate #1 Poll: Should TAVR Be Offered to Every Patient With Aortic Stenosis? Poll Moderators: Andreas Baumbach, David Hildick-Smith

12:02 PM Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only toAvoid a Disfiguring Sternotomy! Michael J. Mullen

12:10 PM Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All theUncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients! Wilson Y. Szeto

12:18 PM Crossfire and Roundtable Discussion

12:28 PM Post-debate #1 Poll: Should TAVR Be Offered to Every Patient With Aortic Stenosis? Poll Moderators: Andreas Baumbach, David Hildick-Smith

12:30 PM Pre-debate #2 poll: Is Left Atrial Appendage Closure Underutilized? Poll Moderators: Andreas Baumbach, David Hildick-Smith

12:32 PM Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to AllPatients With Atrial Fibrillation (I Would Want It!) Ted Feldman

12:40 PM Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacyand Safety Profile for Most Patients! Jai-Wun Park


12:58 PM Post-debate #2 poll: Is Left Atrial Appendage Closure Underutilized? Poll Moderators: Andreas Baumbach, David Hildick-Smith

Hot Topic Lunch: Vulnerable Plaque Detection and Treatment, Part 1



Vulnerable Plaque Detection and Treatment, Part 112:00 PM - 1:00 PM

Moderators: John A. Ambrose, Peter H. Stone Discussants: Vasileios D. Gkogkas, Ik-Kyung Jang, Bon-Kwon Koo, Ryan D. Madder, Yasunori Ueda, Nick E. J.West

12:00 PM The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients:Reflections From a Pioneer James E. Muller

12:10 PM What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? John A. Ambrose

12:20 PM NIRS Detection of Vulnerable Plaque: The Story Is Intensifying David Erlinge

12:28 PM Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Guillermo Tearney

12:36 PM Detecting and Differentiating Plaque Erosion vs Rupture – and Does It Matter? Giulio Guagliumi

12:44 PM Diagnosis and Treatment of Erosion in ACS: The EROSION Study Ik-Kyung Jang




Part 2: Managing Patient, Operator, and Staff Risks1:00 PM - 2:00 PM

Moderators: Stephen Balter, Donald L. Miller Discussants: James A. Goldstein, Cari M. Kitahara, Edwin M. Leidholdt, Jr., Madan M Rehani

1:00 PM Are You Wearing Your Radiation Monitor? Edwin M. Leidholdt, Jr.

1:10 PM Why Does My Back Hurt? Nonradiation Risks In The Lab James A. Goldstein

1:20 PM Why Can't I See You Anymore? Radiation Effects On The Eye Madan M Rehani

1:30 PM Where Did My Cancer Come From? Radiation Epidemiology, Including Brain Cancer David Borrego, Cari M. Kitahara


Hot Topic Lunch: Challenging PFO Cases: Closure Versus Medical Management


Challenging PFO Cases: Closure Versus Medical Management1:00 PM - 2:00 PM

Moderators: John D. Carroll, David E. Thaler Discussants: Ted Feldman, Clifford J. Kavinsky, Michael J. Mullen, Mark Reisman, Christian Spies

1:00 PM Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke Case Presenter: Mark Reisman

1:03 PM Roundtable Discussion With Audience Q&A and Vote: Should the PFO be Closed?

1:09 PM Case #1 – Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Mark Reisman

1:12 PM Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved? Case Presenter: Ted Feldman


1:21 PM Case #2 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Ted Feldman

1:24 PM Case #3 - Introduction: Professional Diver With Decompression Illness Case Presenter: Michael J. Mullen


1:33 PM Case #3 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Michael J. Mullen

1:36 PM Case #4 - Introduction: Retinal Artery Occlusion and PFO Case Presenter: Clifford J. Kavinsky


1:45 PM Case #4 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Clifford J. Kavinsky

1:48 PM Case #5 - Introduction: History of VTE and New Cortical Stroke Case Presenter: Christian Spies


1:57 PM Case #5 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Christian Spies

Hot Topic Lunch: Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 2 – Devices


Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 2 – Devices1:00 PM - 2:00 PM

Moderators: Sanjay Kaul, Jeffrey J. Popma Discussants: Salvatore Cassese, Michael Haude, Raj Makkar, John D. Puskas

1:00 PM Opening Salvo: I Don't Believe TAVR Should Be the Predominant Form of Valve Replacementfor Low and Intermediate Risk Patients With Severe AS!

1:08 PM Return Fire: The Contrarian View: TAVR Should Be The Predominant Form of ValveReplacement For Low and Intermediate Risk Patients With Severe AS! Discussant: Jeffrey J. Popma


1:20 PM Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for MostPatients Undergoing PCI! Salvatore Cassese

1:28 PM Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for MostPatients Undergoing PCI! Discussant: Michael Haude


1:40 PM Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the StandardRevascularization Strategy for Most Patients With Left Main CAD! John D. Puskas

1:48 PM Return Fire: The Contrarian View - PCI Should Be the Standard Revascularization Strategy forMost Patients With Left Main CAD! Discussant: Raj Makkar


Hot Topic Lunch: Coronary Drug-Coated Balloons: Devices, Applications, and Emerging Data


Coronary Drug-Coated Balloons: Devices, Applications, and Emerging Data1:00 PM - 2:00 PM

Moderators: Fernando Alfonso, Juan F. Granada Discussants: Bernardo Cortese, Germano Di Sciascio, Bruno Scheller

1:00 PM DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes!The Data is Solid and DCB Should be the Treatment of Choice! Bruno Scheller

1:08 PM DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? No!Current Data Indicates DCB Is a Second Line Therapy! Fernando Alfonso


1:21 PM DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls Bernardo Cortese


1:34 PM Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use? Azeem Latib


1:47 PM Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road? Juan F. Granada


Hot Topic Lunch: CT Imaging for the Coronary Interventionalist (Sponsored by the Society of Cardiovascular Computed Tomography[SCCT])


CT Imaging for the Coronary Interventionalist (Sponsored by the Society of Cardiovascular ComputedTomography [SCCT])1:00 PM - 2:00 PM

Moderators: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min Discussants: Farouc Jaffer, Paul Knaapen, Manesh R. Patel

1:00 PM CT for Automated Quantification of Coronary Artery Stenosis Paul Knaapen

1:10 PM Understanding FFRct Jonathon A. Leipsic

1:20 PM Integrated Anatomical and Functional Assessment of Coronary Artery Stenosis Manesh R. Patel

1:30 PM CT For Procedural Planning in CTO and Complex Coronary Interventions Farouc Jaffer

1:40 PM Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction? James K. Min


Hot Topic Lunch: Echo Guidance of Interventional Procedures, Part 2: The Integral Role of Imaging in Structural Heart Disease Innovation.An ASE-Sponsored Symposium


Part 2: The Integral Role of Imaging in Structural Heart Disease Innovation1:00 PM - 2:00 PM

Moderators: Stephen H. Little, G. Burkhard Mackensen Discussants: Paul A. Grayburn, Rebecca T. Hahn, Patrizio Lancellotti, Neil J. Weissman

1:00 PM From Pre-Clinical to Post-Approval: The Essential Role of Imaging Neil J. Weissman


1:15 PM Imaging for Tanscatheter Mitral Valve Interventions Paul A. Grayburn


1:30 PM Imaging for Tricuspid Valve Interventions Rebecca T. Hahn


1:45 PM Imaging and New Approaches to Valve Research Patrizio Lancellotti


Hot Topic Lunch: Fellows Sessions: Valvular Heart Disease Year-in-Review (Sponsored by the American College of Cardiology)


Fellows Sessions: Valvular Heart Disease Year-in-Review (Sponsored by the American College of Cardiology)1:00 PM - 2:00 PM

Moderators: Blase A. Carabello, George D. Dangas Discussants: Verghese Mathew, Tamim Nazif, Azfar G. Zaman

1:00 PM TAVR: Current Status of Devices and Indications Vinod H. Thourani

1:10 PM Future TAVR Devices and Adjunctive Therapies George D. Dangas

1:20 PM Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS) Alec S. Vahanian

1:30 PM Transcatheter Mitral Valve Replacement Howard C. Herrmann

1:40 PM Devices for the Right Heart (Tricuspid and Pulmonic Valves) Colin M. Barker


Hot Topic Lunch: Interventional and Surgical Valve Procedures: Case Studies in Conflict and Consensus (Cosponsored by AATS)


Session I: Intermediate Risk Patients With Severe Aortic Stenosis1:00 PM - 1:30 PM

Moderators: Michael A. Borger, Vinod H. Thourani Discussants: Martin Misfeld, Josep Rodés-Cabau, Brian K. Whisenant

1:00 PM The Case for TAVR Brian K. Whisenant

1:10 PM The Case for Sutureless/ Rapid Deployment Valves Michael A. Borger


Session II: Management of Isolated Severe TR Postcardiac Surgery1:30 PM - 2:00 PM

Moderators: Michael A. Borger, Vinod H. Thourani Discussants: Martin Misfeld, Josep Rodés-Cabau, Brian K. Whisenant

1:30 PM The Case for Transcatheter Therapy Josep Rodés-Cabau

1:40 PM The Case for Surgery Martin Misfeld


Hot Topic Lunch: Revascularization Decisions and Therapies for the Diabetic Patient


Revascularization Decisions and Therapies for the Diabetic Patient1:00 PM - 2:00 PM

Moderators: John A. Bittl, David J. Maron Discussants: Michael E. Farkouh, John A. Spertus, Jennifer A. Tremmel, Stephen D. Wiviott

1:00 PM Introduction David J. Maron

1:02 PM Case Presentation: Diabetes, Comorbidities, and Multivessel Disease Case Presenter: Kishore J. Harjai

1:05 PM The Case for a Trial of Medical Therapy Case Presenter: Michael E. Farkouh

1:15 PM The Case for CABG Case Presenter: A. Pieter Kappetein

1:25 PM The Case for Multivessel PCI Case Presenter: Sripal Bangalore

1:35 PM When Equipoise Exists: Is Unbiased, Informed Consent Possible? Case Presenter: John A. Spertus

1:45 PM Case Resolution: What Was Done Case Presenter: Kishore J. Harjai


Hot Topic Lunch: The Experts Clash – Debates in Coronary Heart Disease (sponsored by BCIS)


The Experts Clash – Debates in Coronary Heart Disease (sponsored by BCIS)1:00 PM - 2:00 PM

Moderators: Adrian P. Banning, Nick Curzen Discussants: Anthony H. Gershlick, Stefan K. James, Jens Flensted Lassen, Mark A. de Belder

1:00 PM Pre-debate #3 Poll: Is Upper Extremity Dysfunction After Radial Access Frequent andClinically Important? Poll Moderators: Adrian P. Banning, Nick Curzen

1:02 PM Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and ClinicallyImportant? Yes, We Have to Start Paying Attention to This Phenomenon! Robert-Jan van Geuns

1:10 PM Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and ClinicallyImportant? No, Much Ado About Nothing! Samir B. Pancholy


1:28 PM Post-debate #3 Poll: Is Upper Extremity Dysfunction After Radial Access Frequent andClinically Important? Poll Moderators: Adrian P. Banning, Nick Curzen

1:30 PM Pre-debate #4 Poll: Should Complete Revascularization in STEMI and Multivessel Disease BePerformed During the Index Procedure? Poll Moderators: Adrian P. Banning, Nick Curzen

1:32 PM Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be PerformedDuring the Index Procedure? No, in the Middle of the Night and With Complex Anatomy ... AreYou Kidding?! Herbert D. Aronow

1:40 PM Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be PerformedDuring the Index Procedure? Yes, in Most Patients, to Improve Prognosis and Reduce Costs! Keith G. Oldroyd


1:58 PM Post-debate #4 poll: Should Complete Revascularization in STEMI and Multivessel Disease BePerformed During the Index Procedure? Poll Moderators: Adrian P. Banning, Nick Curzen



Vulnerable Plaque Detection and Treatment, Part 21:00 PM - 2:00 PM

Moderators: Gregg W. Stone, Ron Waksman Discussants: Patrick A. Calvert, Vasim Farooq, Hector M. Garcia-Garcia, Takashi Kubo, Amir Lerman, Ryan D.Madder

1:00 PM Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, EarlyClinical Experiences, and Will it Succeed?! Vasim Farooq

1:10 PM To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT Seung-Jung Park

1:20 PM Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Aroundthe Corner? Sanjit S. Jolly

1:30 PM Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque Jonathan Leor

1:38 PM My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From aSoothsayer John A. Ambrose


Maintenance of Certification (MOC) Course I


Interventional Cardiology 2016 Module Review8:00 AM - 9:30 AM

Moderator: Emmanouil S. Brilakis Discussants: Tayo A. Addo, Nicola Corvaja, Dimitriy N. Feldman, Robert T. Pyo

8:00 AM Welcome and Introduction Tayo A. Addo

Maintenance of Certification (MOC) Course II


Interventional Cardiology 2015 Module Review9:30 AM - 11:00 AM

Moderator: Tayo A. Addo Discussants: Nicola Corvaja, Dimitriy N. Feldman, Robert T. Pyo, Elias Sanidas

9:30 AM Welcome and Introduction George D. Dangas

Maintenance of Certification (MOC) Course III

Tuesday, November 1 11:00 AM - 12:30 PM Walter E. Washington Convention Center Room 102, Level 1Accreditation: CME

Interventional Cardiology 2014 Module Review11:00 AM - 12:30 PM

Moderator: Tayo A. Addo Discussants: Nicola Corvaja, Dimitriy N. Feldman, Robert T. Pyo, Elias Sanidas

11:00 AM Welcome and Introduction Tayo A. Addo

FDA Town Hall Meeting at TCT 2016, Part 2: Device Specifics


Session I. Bioresorbable Scaffolds and New Metallic DES: Pathways to Regulatory Approval2:00 PM - 3:00 PM

Moderators: Michael C. John, Gregg W. Stone Discussants: Jeffrey A. Anderson, Elazer R. Edelman, Andrew Farb, Gerardine Finn, David E. Kandzari, Martin B.Leon, Semih Oktay, Chuck Simonton, George W. Vetrovec, Jason R. Weidman

2:00 PM FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES andBioresorbable Scaffolds P.F. Adrian Magee

2:10 PM FDA Perspectives on Short DAPT IDE Trials Andrew Farb

2:20 PM Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: IndustryPerspectives Chuck Simonton

2:30 PM Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation WithDeclining DES Use and Reimbursement Jason R. Weidman


Session II. TAVR Revolution: Lessons Learned, Future Expectations3:00 PM - 4:00 PM

Moderators: Nicole Ibrahim, Martin B. Leon Discussants: Samir R. Kapadia, A. Pieter Kappetein, Alexandra J. Lansky, John C Laschinger, Michael J. Mack, RajMakkar, Azin Parhizgar, Jaime Raben, Rhonda J Robb, Larry L. Wood

3:00 PM FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid AorticStenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways Jaime Raben

3:15 PM Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance Raj Makkar

3:25 PM Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons,Neuroprotection Systems, and More) Martin B. Leon


Session III. Mitral and Tricuspid Repair/Replacement Devices4:00 PM - 5:00 PM

Moderators: Matthew G. Hillebrenner, Michael J. Mack Discussants: Ori Ben-Yehuda, Juan F. Granada, John C Laschinger, Martin B. Leon, Scott Lim, JoAnn Lindenfeld,Stanton J. Rowe, John A. Spertus, Gregg W. Stone, Changfu Wu

4:00 PM Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies John C Laschinger

4:15 PM Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPTParadigm Be Shortened? Gregg W. Stone

4:25 PM The Tricuspid Valve: Challenges for Clinical Investigation Rebecca T. Hahn


Session IV. LAA Closure: Approval Pathways and Reimbursement Challenges5:00 PM - 6:00 PM

Moderators: Aaron V. Kaplan, Rachel Neubrander Discussants: Steven R. Bailey, Keith D. Dawkins, Andrew Farb, David Hildick-Smith, Saibal Kar, Russell Seiber,Tamara Syrek Jensen, Katherine Wallon, Brian K. Whisenant, Steven J. Yakubov

5:00 PM Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions –What FDA Would Like to See Katherine Wallon

5:15 PM Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control ArmAnticoagulation Durations, NOAC Considerations and More – Industry and ClinicianPerspectives Brian K. Whisenant

5:25 PM Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs.Societal Economic Considerations Tamara Syrek Jensen


International Session: Case-Based Complications: Interventional Flavors From Latin America, Mexico, and the Middle East Presented by:Sociedad de Cardiología Intervencionista de México (SOCIME), Venezuelan Society of Cardiology, Saudi Arabian Cardiac InterventionalSociety (SACIS), Colegio Argentino CardioAngiólogos Intervencionistas (CACI)

Tuesday, November 1 9:00 AM - 10:30 AM Walter E. Washington Convention Center Presentation Theater 1Accreditation: none

Case-Based Complications: Interventional Flavors From Latin America, Mexico, and the Middle East9:00 AM - 10:30 AM

Moderators: Juan F. Granada, Oscar A. Mendiz Discussants: Waqar H. Ahmed, Mirvat Alasnag, Ricardo Lluberas

9:00 AM Introduction and Session Goals Moderators: Juan F. Granada, Oscar A. Mendiz

9:05 AM Saudi Arabia Presents: A Case When TAVR Crashes Case Presenter: Khaled F Al-Shaibi


9:20 AM Mexico Presents: A PCI Case With a Major Complication Case Presenter: Carlos Cabrera Arroyo


9:35 AM Saudi Arabia Presents: A Case of Coronary Compression After TAVR Case Presenter: Fawaz AlMotairi


9:50 AM Argentina Presents: A Case of a TAVR Complication Case Presenter: Oscar A. Mendiz


10:05 AM Venezuela Presents: A Case of a TAVR Complication Case Presenter: Carlos D Calderas


10:20 AM Conclusions and Take-home Messages Moderator: Waqar H. Ahmed

International Session: Interventional Cardiology in India: Coordinated by NIC

Tuesday, November 1 9:00 AM - 10:34 AM Walter E. Washington Convention Center Presentation Theater 2Accreditation: none

Introduction – Dr. Amal K. Banerjee, Dr. Narenda N. Khanna9:00 AM - 9:02 AM

Session I: Indian Panorama 1 – Unique Knowledge from India9:02 AM - 9:52 AM

Moderators: Vinay K. Bahl, Amal Kumar Banerjee

9:02 AM Imaging-Guided Left Main Intervention Brian V Pinto

9:12 AM The Science and Technique of Bifurcation Stenting Vinay K. Bahl

9:22 AM Takayasu’s Arteritis: Lessons From a Large Interventional

9:32 AM Rationale and Experience With the Pharmacoinvasive Strategy in STEMI Upendra Kaul

9:42 AM Roundtable Discussion and Audience Q&A

Session II. Indian Panorama 2: The Great Cases9:52 AM - 10:34 AM

Moderators: M.S. Hiremath, Kamal K. Sethi

9:52 AM My Most Rewarding Case: Case #1 Case Presenter: Sreenivas Arramraju Kumar

9:58 AM My Most Rewarding Case: Case #2 Case Presenter: Jamshed J. Dalal

10:04 AM My Most Rewarding Case: Case #3 Case Presenter: Rabin dra Nath Chakraborty

10:10 AM My Worst Nightmare Case I Learned From: Case #1 Case Presenter: Amal Kumar Banerjee

10:16 AM My Worst Nightmare Case I Learned From: Case #2 Case Presenter: M.S. Hiremath

10:22 AM My Worst Nightmare Case I Learned From: Case #3

10:28 AM My Worst Nightmare Case I Learned From: Case #4 Case Presenter: Sundeep Mishra

International Session: Optical Coherence Tomography in Bifurcation Lesions Present by the Nordic-Baltic-British Study Group forInterventional Cardiology

Tuesday, November 1 9:00 AM - 11:00 AM Walter E. Washington Convention Center Room 103B, Level 1

Accreditation: none

Optical Coherence Tomography in Bifurcation Lesions9:00 AM - 11:00 AM

Moderators: Evald H. Christiansen, Simon J. Walsh Discussants: Adrian P. Banning, Andrejs Erglis, Niels R. Holm, Olli A. Kajander

Session I. ”Simple” Bifurcation Treatment Guided by OCT9:00 AM - 9:30 AM

9:00 AM Case #1: OCT in a Bifurcation: Is Seeing the Same As Believing? Case Presenter: Giovanni Luigi De Maria

9:07 AM Case #2: Optimized Treatment of a Not So Simple LMCA Case Bifurcation Case Presenter: Rikard B.A. Linder

9:14 AM Case #3: Simple Stenting With a Kiss and OCT Case Presenter: Julian Strange


Session II. OCT Guided Two-Stent Treatment of Bifurcation Lesions9:30 AM - 10:00 AM

9:30 AM Case #4: Where are the Guide Wires? Two-stent Treatment by OCT Case Presenter: Hannu Romppanen

9:37 AM Case #5: This is Why OCT is Encouraged by EBC for Complex Bifurcations Case Presenter: Jens Flensted Lassen

9:44 AM Case #6: No Guessing Needed Using OCT for This Bifurcation Case Presenter: Henning Kelbæk


Session III. BRS in Bifurcations I10:00 AM - 10:30 AM

10:00 AM Case #7: All the Steps for This Absorb BRS Implanted in a Bifurcation Case Presenter: Andreas Kristensen

10:07 AM Case #8: Absorb and Permanent DES in an LMCA Bifurcation With 3-year Follow-up Case Presenter: Indulis Kumsars

10:14 AM Case #9: Value of Self-Expanding Properties Using Desolve BRS in a Bifurcation Case Presenter: Niels R. Holm


Session VI. BRS in Bifurcations II10:30 AM - 11:00 AM

10:30 AM Case #10: OCT Was Crucial Implanting BRS in This Bifurcation Case Presenter: Jonathan M. Hill

10:37 AM Case #11: Kissing the Magnesium BRS Case Presenter: Evald H. Christiansen

10:44 AM Case #12: Magnesium BRS in Cross-Over Stenting Case Presenter: Trine Ørhøj Barkholt

10:51 AM Summary Evald H. Christiansen

International Session: Global Hearts Africa Presented by PASCAR and CRF

Tuesday, November 1 3:00 PM - 5:00 PM Walter E. Washington Convention Center Room 103A, Level 1Accreditation: none

Global Hearts Introduction3:00 PM - 3:05 PM

Jack C. Lewin

Session I: Ischemic Heart Disease and ACS in Africa3:05 PM - 3:29 PM

Moderators: Graham A. Cassel, Awad AA Mohamed Discussants: Habib Gamra, Bernard J. Gersh, Mpiko Ntsekhe, Mohamed Ahmed Sobhy

3:05 PM Summary & Update of the 2016 Presentations Awad AA Mohamed

3:12 PM Delivery System and Therapeutic Challenges and Opportunities in Africa Harun A Otieno

3:19 PM Roundtable Discussion & Audience Q&A

Session II: Rheumatic Heart Disease in Africa3:29 PM - 4:00 PM

Moderators: Habib Gamra, Ahmed Suliman Discussants: Graham A. Cassel, Hugh J. Linnehan, Awad AA Mohamed, Mpiko Ntsekhe, Mohamed Ahmed Sobhy

3:29 PM Update on Epidemiology, Prevention, Screening, and Control Bernard J. Gersh

3:36 PM Delivery System and Therapeutic Challenges with RHD in Africa Mohamed Ahmed Sobhy

3:43 PM Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes Hugh J. Linnehan

3:50 PM Roundtable Discussion & Audience Q&A Moderators: Habib Gamra, Ahmed Suliman

Session III: Improving CV Outcomes in Africa Through the Global Hearts Initiative4:00 PM - 5:00 PM

Moderators: Jack C. Lewin, Hugh J. Linnehan Discussants: Awad AA Mohamed, Harun A Otieno, Mohamed Ahmed Sobhy

4:00 PM PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results Habib Gamra

4:15 PM Needs Assessment for Cath Lab Improvement and Support Graham A. Cassel

4:30 PM Global Hearts Action Plan for 2017 Mpiko Ntsekhe

4:45 PM Roundtable Discussion and Audience Q&A

International Session: TAVR in Developing Countries Presented by: Qatar, Algeria, Morocco, Jordan, Australia, and New Zealand


TAVR in Developing Countries5:00 PM - 6:30 PM

Moderators: Ziyad M. Hijazi, David W.M. Muller Discussants: Mohamed Chettibi, Stephen G. Worthley

5:00 PM Current Indications for TAVR: When Is TAVI Better Than Surgical AVR? David W.M. Muller

5:08 PM Preinterventional Selection of Patients: What Tests Must Be Done Prior to TAVR? Clifford J. Kavinsky

5:16 PM Role of Echocardiography in TAVR Muhamed Saric

5:24 PM Valve Selection for TAVR: Similarities and Differences; How to Choose Mohamed Chettibi

5:32 PM Experience With the Balloon Expandable Valves Imad A. Alhaddad

5:40 PM TAVR Case Study With a Balloon Expandable Valve Case Presenter: Said Benghezel

5:48 PM TAVR Case Study: Rheumatic AS - Is TAVR Appropriate? Case Presenter: Imad A. Alhaddad

5:56 PM TAVR Case Study With a Self-Expanding Valve Case Presenter: Salem Abujalala

6:04 PM First-in-Human TAVR Studies in New Zealand and Australia: Why There? Darren L. Walters

6:12 PM TAVR Complications: Have We Made Progress Over the Last Five Years? Cherradi rhizlan

6:20 PM Roundtable Discussion With Q&A

International Session: TCT Francophone: New Tip and Tricks From the Francophone Cath Lab

Tuesday, November 1 5:15 PM - 6:15 PM Cardiovascular Research Foundation Room 103B, Level 1Accreditation: none

TCT Francophone: New Tip and Tricks from the Francophone Cath Lab5:15 PM - 6:15 PM

Moderators: Bernard R. Chevalier, Philippe Généreux Commentators: Walid Jomaa, Christian M. Spaulding Discussants: Khaldoun Ben Hamda, Marc Etienne Jolicoeur, Samer Mansour, Stéphane Rinfret, Jean-FrançoisTanguay, Eric Van Belle

5:15 PM Bifurcations et Trifurcations Avec Angles Extrèmes/Extreme Angulation Bifurcation Yves R. Louvard

5:27 PM Le Ballon Ne Passe Pas/The Ballon Doesn’t Go/CTO Perspectives Stéphane Rinfret

5:39 PM STEMI: Le Gros Caillot Récalcitrant Et Autres Mésaventures Nocturnes/The Big Clot andOther Crazy Night Stories Marc Etienne Jolicoeur

5:51 PM Pousser La Limite Du TAVI Transfemoral En Toute Prudence/How to Push the TF-TAVR LimitSafely! Eric Van Belle

6:03 PM Ma Valve Ne Passes Pas La Valve!/My Valve Doesn’t Cross the Valve! Bernard R. Chevalier

Partnership Session: China Interventional Therapeutics in Partnership With TCT: Left Main Revascularization in the Era of EXCEL


Case 1: Left Main and Multivessel Disease (Syntax Score >32)4:00 PM - 4:30 PM

Moderators: Runlin Gao, Bo Xu Discussants: Guosheng Fu, Philippe Généreux, Shubin Qiao, Ling Tao

4:00 PM Case Introduction: How Should I Treat? Case Presenter: Kefei Dou

4:04 PM How Would I Treat? (Option 1) Philippe Généreux

4:09 PM How Would I Treat? (Option 2) Zening Jin


4:24 PM Case Conclusion: How Did I Treat? Case Presenter: Kefei Dou

Case 2: Distal Left Main Bifurcation (Medina 1,1,1 and Syntax Score < 32)4:30 PM - 5:00 PM

Moderators: Runlin Gao, Bo Xu Discussants: Guosheng Fu, Philippe Généreux, Shubin Qiao, Ling Tao

4:30 PM Case Introduction: How Should I Treat? Case Presenter: Junjie Zhang

4:34 PM How Would I Treat? (Option 1) Jian Liu

4:39 PM How Would I Treat? (Option 2) Qi Zhang


4:54 PM Case Conclusion: How Did I Treat? Case Presenter: Junjie Zhang

Partnership Session: GISE Highlights at TCT: Clinical Crossroads for the Optimal Management of Complex Patients in InterventionalCardiology

Tuesday, November 1 4:00 PM - 5:00 PM Walter E. Washington Convention Center Room 143B, Level 1Accreditation: none

Session I. Antiplatelet Therapy Optimization in NSTE-ACS4:00 PM - 4:30 PM

Moderators: Roxana Mehran, Ferdinando Varbella Discussants: Dominick J. Angiolillo, Caterina Gandolfo, Ugo Limbruno, Giuseppe Tarantini, Fabio Felice Tarantino

4:00 PM Case Introduction: An Elderly Patient With NSTE-ACS Case Presenter: Alberto Menozzi

4:03 PM To Pretreat or Not to Pretreat? The DUBIUS Trial Giuseppe Tarantini

4:10 PM Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCIIs Performed Is Optimal Treatment in NSTE-ACS Dominick J. Angiolillo

4:17 PM Case Conclusion: How Did We Treat Our Patient? Case Presenter: Alberto Menozzi


Session II. Stent and Scaffold Selection in Complex PCI4:30 PM - 5:00 PM

Moderators: George D. Dangas, Fabio Felice Tarantino Discussants: Dariusz Dudek, Stephen G. Ellis, Giovanni Esposito, Ugo Limbruno, Giampaolo Pasquetto, StefanoRigattieri

4:30 PM Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS? Massimo Fineschi

4:33 PM Choose a Drug-Eluting Stent: Here’s Why Carlo Cernetti

4:40 PM Think Twice: BRS First Francesco Saia

4:47 PM Case Conclusion: How Did We Treat Our Patient? Case Presenter: Massimo Fineschi


Partnership Session: TCT Russia: The Hottest Topics and Cases

Tuesday, November 1 4:00 PM - 5:00 PM Walter E. Washington Convention Center Room 143C, Level 1Accreditation: none

TCT Russia: The Hottest Topics and Cases4:00 PM - 5:00 PM

Moderators: Bagrat Alekyan, Greg L. Kaluza Discussants: Mitchell W. Krucoff, Mahmood K. Razavi, Thomas D. Stuckey

4:00 PM Case Presentation: ACS Intervention in the Emerging BRS Era Case Presenter: Evgeny V. Merkulov

4:07 PM Editorial Comment: BRS Safety in ACS Intervention, Technical, and Clinical Considerations Mitchell W. Krucoff

4:15 PM Case Presentation: LAA Intervention in the TAVR Patient Case Presenter: Alexey Protopopov

4:22 PM Editorial Comment: Technical, Procedural, and Clinical Considerations William A. Gray

4:30 PM Case Presentation: Complex PCI in STEMI and Cardiogenic Shock Case Presenter: Vladimir Ganyukov

4:37 PM Editorial Comment: Current Guidelines, Device, and Anticoagulation Strategies Thomas D. Stuckey

4:45 PM Case Presentation: BTK Intervention in Critical Limb Ischemia Case Presenter: Zaza Kavteladze

4:52 PM Editorial Comment: Current Techniques, Device Selection, and Outcomes Mahmood K. Razavi

Special Session: Complex Lower Extremity Arterial Interventions

Tuesday, November 1 10:30 AM - 12:00 PM Walter E. Washington Convention Center Room 146A, Level 1Accreditation: none

Complex Lower Extremity Arterial Interventions10:30 AM - 12:00 PM

Moderators: Jihad A. Mustapha, Craig M. Walker Discussants: Lawrence A. Garcia, Sriram S. Iyer, R. Stefan Kiesz, Krishna J. Rocha-Singh, Mitchell Weinberg

10:30 AM State of the Art Lecture: Lessons From Coronary CTOs and the Hybrid Algorithm Relevant toPeripheral CTOs Mark J. Goodwin

10:40 AM Case Presentation: Long SFA CTO Case Presenter: Ethan C. Korngold

10:45 AM Atherectomy in SFA CTOs: How to Maximize Outcomes and Prevent Complications Roger Gammon

10:53 AM CTO Crossing and Re-entry Devices: Case-Based Illustrations for How and When to Use Mehdi H. Shishehbor


11:11 AM Tools of the Trade: Devices Selection for Challenging BTK Interventions Jihad A. Mustapha

11:19 AM Case Presentation: Failed Endovascular Intervention Case Presenter: Mehdi H. Shishehbor

11:24 AM Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples Case Presenter: Koen Deloose

11:32 AM Endovascular Treatment Options in Patients With Chronic Kidney Disease: IVUS, CO2Assisted, and Hybrid Craig M. Walker

11:40 AM How to Overcome Recoil, Dissection, and Suboptimal Lumen Gain for Treatment ofInfrapopliteal Disease Eric J. Dippel


Presentation Theater Program: Cardioband: Clinical Reality for Mitral and Tricuspid Valve Repair (Sponsored by Valtech Cardio)

Tuesday, November 1 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 5, Exhibit Hall, Level 2Accreditation: none

Cardioband: Clinical Reality for Mitral and Tricuspid Valve Repair11:30 AM - 12:30 PM

Chairs: Martin B. Leon, Michael J. Mack Facultys: Paul A. Grayburn, Karl-Heinz Kuck, Azeem Latib

11:30 AM Session Objectives Martin B. Leon

11:35 AM Percutaneous Annuloplasty: Another Step Towards Surgical Standards Michael J. Mack

11:43 AM 24 Months Results and Future Clinical Studies Martin B. Leon

12:01 PM Echo Guidance: Anatomy and Physiology Paul A. Grayburn

12:09 PM How Quick Can You Master Cardioband? Azeem Latib

12:17 PM Tricuspid Repair With Cardioband Karl-Heinz Kuck

12:25 PM Session Evaluation and Key Learnings Michael J. Mack

Presentation Theater Program: Challenging Cases in a Real-world Patient Population (Sponsored by Medtronic, Inc.)


Challenging Cases in a Real-world Patient Population11:30 AM - 12:30 PM

Chair: George D. Dangas Facultys: M.S. Hiremath, MD, PhD, Elvin Kedhi, MD, PhD, Juying Qian, MD, Ramesh S.A. Singh, MD

11:30 AM Welcome and Session Objectives George D. Dangas

11:35 AM Perspectives From China: Heavily Calcified Lesions in Elderly Patient Juying Qian, MD

11:43 AM Perspectives From Belgium: Management of Dual Vessel Disease Elvin Kedhi, MD

11:51 AM Discussion Panel Moderator: George D. Dangas

12:01 PM Perspectives From Malaysia: MVD in Diabetic Patient With Small Vessels Ramesh SA Singh, MD

12:09 PM Perspectives From India: Management of Large Vessels M.S. Hiremath, MD

12:17 PM Discussion Panel Moderator: George D. Dangas

Presentation Theater Program: Rethink DAPT: Optimizing PCI in high-bleeding risk patients With the COBRA PzF NanoCoated Stent(NCS) (Sponsored by CeloNova BioSciences, Inc.)

Tuesday, November 1 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: none

Rethink DAPT: Optimizing PCI in High-Bleeding Risk Patients With the COBRA PzF NanoCoated Stent (NCS)11:30 AM - 12:30 PM

Chairs: Ajay J. Kirtane, Sigmund Silber, Renu Virmani Facultys: Donald Cutlip, Aloke V. Finn, Rajiv Jauhar, MD, Philip M. Urban

11:30 AM Welcome to Faculty Ajay J. Kirtane

11:33 AM High-Bleeding Risk Patients: Why We Still Need Newer Devices for These Patients Michael Joner

11:45 AM Preclinical Evaluation of the COBRA PzF NanoCoated Stent Faculty: Aloke V. Finn

11:55 AM Clinical Evidence: PzF SHIELD Data and the Introduction to the COBRA REDUCE Trial Donald Cutlip

12:10 PM Moderated Case Presentation: Two-Week DAPT COBRA Case With Follow-up Rajiv Jauhar, MD

12:20 PM Discussion Renu Virmani

Presentation Theater Program: SCAI WIN Complex Coronary Intervention Coast to Coast: A Case-Based Review (Sponsored by Abbott)

Tuesday, November 1 11:30 AM - 12:30 PM Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: none

SCAI WIN Complex Coronary Intervention Coast to Coast: A Case-Based Review11:30 AM - 12:30 PM

Chair: Cindy L. Grines Facultys: Alaide Chieffo, MD, Amir Kaki, MD, Srihari S. Naidu, Ruby Satpathy, MD, Molly Szerlip

11:30 AM Introduction Cindy L. Grines

11:35 AM Fellow Case Review #1

11:45 AM Q&A Moderator: Cindy L. Grines Discussants: Alaide Chieffo, MD, Amir Kaki, MD, Srihari S. Naidu, Ruby Satpathy, MD, MollySzerlip

11:50 AM Fellow Case Review #2

12:00 PM Q&A Moderator: Cindy L. Grines Discussants: Alaide Chieffo, MD, Amir Kaki, MD, Srihari S. Naidu, Ruby Satpathy, MD, MollySzerlip

12:05 PM Fellow Case Review #3

12:15 PM Q&A Moderator: Cindy L. Grines Discussants: Alaide Chieffo, MD, Amir Kaki, MD, Srihari S. Naidu, Ruby Satpathy, MD, MollySzerlip

12:20 PM Summary and Questions

Presentation Theater Program: The SYNERGY Stent: Clinical Evidence for Optimal Healing and Safety (Sponsored by Boston ScientificCorporation)


The SYNERGY Stent: Clinical Evidence for Optimal Healing and Safety11:30 AM - 12:30 PM

Chair: Adrian P. Banning Facultys: Colm Hanratty, Takafumi Ueno, MD, Renu Virmani

11:30 AM Introductions/Lunch Adrian P. Banning

11:45 AM Vascular Responses of Bioabsorable Polymer DES Renu Virmani

11:55 AM Differential Angioscopic Findings of Neointimal Coverage Among First-, Second-, and NextGeneration Drug-eluting Stents Takafumi Ueno, MD

12:05 PM The Belfast Experience: SYNERGY in Real World Practice Colm Hanratty

12:15 PM Discussion/Q&A

12:25 PM The Promise of Reduced DAPT Duration with BP DES Adrian P. Banning

Presentation Theater Program: Advancing Treatment Strategies in Complex Calcified Lesions to Help Optimize Stent Expansion WithOrbital Atherectomy (Sponsored by Cardiovascular Systems, Inc.)

Tuesday, November 1 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: none

Advancing Treatment Strategies in Complex Calcified Lesions to Help Optimize Stent Expansion With OrbitalAtherectomy1:00 PM - 2:00 PM

Facultys: Ehrin J. Armstrong, Philippe Généreux, Michael C. Kim

1:00 PM Welcome Philippe Généreux

1:05 PM Impact of Severe Coronary Calcification on Clinical Outcomes Philippe Généreux

1:20 PM Case Review: Complex PCI With OAS in High-risk Patients Michael C. Kim

1:30 PM OAS Vessel Prep: Considerations for Facilitating BVS Placement in Severe Calcium Ehrin J. Armstrong

1:40 PM ECLIPSE Announcement Philippe Généreux

1:47 PM Q&A Moderator: Philippe Généreux Discussants: Ehrin J. Armstrong, Michael C. Kim

Presentation Theater Program: Built on Results - Stellarex DCB Outcomes From the ILLUMENATE Clinical Program (Sponsored bySpectranetics)

Tuesday, November 1 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 4, Exhibit Hall, Level 2Accreditation: none

Built on Results: Stellarex DCB Outcomes From the ILLUMENATE Clinical Program1:00 PM - 2:00 PM

Facultys: Koen Deloose, Prakash Krishnan, Sean P Lyden, Martin Werner, MD

1:00 PM Built on Results: Stellarex DCB Outcomes From the ILLUMENATE Clinical Program Moderator: Prakash Krishnan

1:10 PM Insights from ILLUMNATE FIH Study 2-year Results Sean P Lyden

1:20 PM Interim 1-year Results from the ILLUMENATE Global Trial Koen Deloose

1:35 PM Latest 1-year results from the ILLUMENATE European Randomized Clinical Trial Martin Werner, MD

1:50 PM Panel Discussion With Q&A

Presentation Theater Program: Redesigning DES – What Matters and Why? (Sponsored by CRF, Supported by Medinol, Inc)


Redesigning DES – What Matters and Why?1:00 PM - 2:00 PM

Co-Chairs: David E. Kandzari, Martin B. Leon Facultys: Ariel Finkelstein, Rajiv Jauhar, Manish A. Parikh, Yoram Richter

1:00 PM Medinol’s Credo – Setting the Bar for Innovation Martin B. Leon

1:08 PM How Are DES Made and Why Do I Care? Yoram Richter

1:18 PM BIONICS and NIREUS - One Year Follow-up David E. Kandzari

1:30 PM Discussion: Are Durable Polymers Really Durable, and Does It Matter? Manish A. Parikh

1:38 PM Discussion: Designing for the Vessel – An Innovative Approach to Stent Design Ariel Finkelstein

1:46 PM Discussion: Deliverability – Does the Journey Make a Difference? Rajiv Jauhar

1:54 PM Closing Remarks – How Do You Pick the Right Stent? David E. Kandzari

Presentation Theater Program: SENTINEL Science: Compelling New Evidence for Cerebral Protection in TAVR (Sponsored by ClaretMedical)


SENTINEL Science: Compelling New Evidence for Cerebral Protection in TAVR1:00 PM - 2:00 PM

Chairs: Martin B. Leon, Axel Linke, Raj Makkar Facultys: Jeffrey Browndyke, MD, Michael Dwyer, MD, Samir R. Kapadia, Susheel Kodali, Ronald Lazar, MD,Roxana Mehran, Renu Virmani

1:00 PM Key findings From the Landmark SENTINEL Pivotal Trial Moderator: Samir R. Kapadia Discussant: Raj Makkar

1:15 PM New Neuroimaging Insights Into the Predictors of Cerebral Ischemic Insult During TAVR Michael D. Dwyer, MD Discussant: Axel Linke

1:30 PM Observations From the Neurocognitive Function Substudy of the SENTINEL Trial: ClinicalImplications Ronald Lazar, MD Discussant: Jeffrey Browndyke, MD

1:45 PM Concluding Comments Martin B. Leon

1:55 PM Panel Discussion Moderators: Martin B. Leon, Axel Linke, Raj Makkar Discussants: Susheel Kodali, Roxana Mehran, Renu Virmani

Presentation Theater Program: Succeeding with CHIP & Complex PCI (Sponsored by Abbott)

Tuesday, November 1 1:00 PM - 2:00 PM Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: none

Succeeding with CHIP & Complex PCI1:00 PM - 2:00 PM

Chair: Srihari S. Naidu Facultys: Ajay J. Kirtane, Chuck Simonton, James C. Spratt

1:00 PM Introductions and Welcome Srihari S. Naidu

1:05 PM Defining “Complex” PCI & CHIP Ajay J. Kirtane

1:20 PM Modern DES: The EXCEL Trial Chuck Simonton

1:40 PM CHIP Case Reviews James C. Spratt

Interventional Innovation III: Early Feasibility and First in Human Studies

Tuesday, November 1 8:00 AM - 12:00 PM Walter E. Washington Convention Center Room 209, Level 2Accreditation: none

Session I. Structural Heart Disease Technologies8:00 AM - 8:42 AM

Moderators: Ted Feldman, David Hildick-Smith Discussants: Michael A. Borger, John P. Cheatham, Rebecca T. Hahn, Ziyad M. Hijazi, Saibal Kar

8:00 AM Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of aSeptal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD orPFO Kolja Sievert

8:08 AM Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial MulticenterClinical Experience Michael J. Mullen


8:21 AM One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-CatheterPulmonary Valve Lee N. Benson

8:29 AM Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for SymptomaticChronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial Rebecca T. Hahn


Session II. Peripheral Vascular Disease Technologies I8:42 AM - 9:24 AM

Moderators: Michael D. Dake, Kenneth Rosenfield Discussants: Shao-Liang Chen, Eric J. Dippel, John R. Laird Jr, Alex M. K. Rothman

8:42 AM Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE TrialMehdi H. Shishehbor

8:50 AM Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in CriticalLimb Ischemia: Immediate and Midterm Results of the PACUS Trial Costantino Del Giudice


9:03 AM Safety and Performance of the Shockwave Medical Lithoplasty System in Treating CalcifiedPeripheral Vascular Lesions: 6-Month Results from the Two-Phase DISRUPT PAD Study Todd J. Brinton

9:11 AM Long Term Outcomes after Revascularization of Long SFA Occlusions with OCT GuidedAtherectomy OCELOT Catheter: Results from the Pivotal FIH Study Przemek Nowakowski


Session III. Peripheral Vascular Disease Technologies II9:24 AM - 10:06 AM

Moderators: Robert M. Bersin, John R. Laird Jr Discussants: Eric J. Dippel, Sriram S. Iyer, Ethan C. Korngold, Kenneth Rosenfield, Mehdi H. Shishehbor

9:24 AM Simplicity Denervation System for Pulmonary Artery Denervation in Patients with ChronicThromboembolic Pulmonary Hypertension: FIH Results Boris Rudenko

9:32 AM Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System:Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke RiskAsymptomatic Patients: The PARADIGM All-Comer Prospective Study Piotr Musialek


9:45 AM Early Results of the PQ Bypass Endovascular Femoro-Popliteal Artery Bypass Study (EFAB) Dainis K Krievins

9:53 AM Arterial Dilatation with Recombinant Human Elastase: A Novel Approach to TreatingPeripheral Vascular Disease Ehrin J. Armstrong


Session IV. Emerging Coronary Technologies10:06 AM - 11:17 AM

Moderators: Fernando Alfonso, Ran Kornowski Discussants: Louis A. Cannon, Christian Hengstenberg, David E. Kandzari, Julio C. Palmaz, Giora Weisz

10:06 AM Physiological Testing of Coronary Artery Stenosis by Computation of Invasive CoronaryAngiography. The Wire-Free Functional Imaging (WIFI-II) Study Jelmer Sybren Westra

10:14 AM FFRangio: Image-Based FFR During Coronary Catheterisation Bernard De Bruyne


10:27 AM Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an OpticalCoHerence TOmogRaphy Study. The “ANCHOR” Study Josep Rodés-Cabau

10:35 AM Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results fromthe Nanolute Registry Bernardo Cortese

10:43 AM Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographicand 1-Year Clinical Follow Up Pieter R. Stella


10:57 AM The First Clinical Experience with a Novel Directional Coronary Atherectomy Catheter Maoto Habara

11:05 AM Initial Results of First-In-Human Study on the PlasmaWire: A Novel Radiofrequency Wire forRecanalization of Chronic Total Occlusions Etsuo Tsuchikane


Section V. Interventional Heart Failure and Hypertension11:17 AM - 12:00 PM

Moderator: Emerson C. Perin Discussants: Angeles Alonso Garcia, Joost Daemen, William W. O'Neill, Ileana L. Pina, Ramon Quesada, MichaelA. Weber

11:17 AM First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF Valluvan Jeevanandam


11:32 AM Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical) William T. Abraham


11:45 AM Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation ofan Implanted Median Nerve Stimulator Mark W.I. Webster



Tuesday, November 1 8:00 AM - 2:00 PM Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none


Moderators: Robert Kutys, Maria E. Romero, Nicole Singer

ITC Theater: CTO and Complex PCI

Tuesday, November 1 9:00 AM - 2:00 PM Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none

Evening Program: Controversies in PCI Optimization: Case-Based Discussion (Sponsored by Philips Volcano)

Tuesday, November 1 6:00 PM - 8:00 PM Marriott Marquis Washington DC Independence Ballroom A-E, Level M4Accreditation: none


Controversies in PCI Optimization: Case-Based Discussion6:30 PM - 8:00 PM

Facultys: Javier Escaned, Allen Jeremias, Akiko Maehara, Manesh R. Patel, Bruce Samuels, MD

6:30 PM I Have a Mismatch With iFR/FFR, Now What? Allen Jeremias

6:45 PM You Placed a Stent, So Why Is Your FFR Still Ischemic? Manesh R. Patel

7:00 PM Discussion Moderator: Javier Escaned

7:15 PM Could Adding IVUS and SyncVision to Your Routine Make BRS Implantation Easier? Bruce Samuels, MD

7:30 PM Why Would I Not Use IVUS to Guide Left Main PCI? Lessons From EXCEL Akiko Maehara

7:45 PM Discussion

Evening Program: Next Generation DES Technology: Let the Future Begin! (Sponsored by CRF, Supported by Abbott, Amaranth, ElixirMedical, Medtronic, Inc., OrbusNeich, Reva Medical, Inc., and Sino Medical)

Tuesday, November 1 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 1-4, Level M2Accreditation: CMECo-Chairs: Alexandre Abizaid, Martin B. Leon, Gregg W. Stone Facultys: Juan F. Granada, Ajay J. Kirtane, Roxana Mehran, Patrick W. Serruys, Philip M. Urban, Ron Waksman


Session I: MAKING THE CASE FOR BIORESORBABLE POLYMER DES6:30 PM - 6:54 PM

6:30 PM Update on Bioresorbable Polymer DES: Rationale, Device Landscape, and Data Martin B. Leon

6:40 PM Bioresorbable Polymer-Based Drug Delivery With Endothelial Progenitor Cells to AccelerateHealing: The COMBO Stent Roxana Mehran


Session II: MAKING THE CASE FOR POLYMER-FREE TECHNOLOGIES6:54 PM - 7:15 PM

6:54 PM 1 Year After LEADERS FREE: Have the Results Changed Practice? Philip M. Urban

7:01 PM Development of a Drug-Filled Stent and the RevElution Study Ajay J. Kirtane


Session III: MAKING THE CASE FOR A FULLY BIORESORBABLE FUTURE7:15 PM - 8:00 PM

7:15 PM Proven Outcomes (Absorb) Patrick W. Serruys

7:22 PM Thin Struts With Self-Correcting Property (DESolve) Alexandre Abizaid

7:29 PM Optimized Polymer (AMARANTH) Juan F. Granada

7:36 PM Radiopacity (FANTOM) Alexandre Abizaid

7:43 PM Metallic-DES-Like Performance (Magmaris) Ron Waksman


Evening Program: The Interventional Toolbox for Complex Higher-Risk (and Indicated) Patients (CHIP)( Sponsored by CRF, Supported byABIOMED, Inc., Abbott, Boston Scientific Corporation, Cardiovascular Systems, Inc., and Vascular Solutions)

Tuesday, November 1 6:00 PM - 8:00 PM Marriott Marquis Washington DC Marquis Ballroom, Salon 5, Level M2

Accreditation: CMECo-Chairs: Ajay J. Kirtane, William L. Lombardi, Jeffrey W. Moses Facultys: Emmanouil S. Brilakis, Susheel Kodali, Manish A. Parikh, Gregg W. Stone, Simon J. Walsh


Part I: CTO PCI6:30 PM - 7:02 PM

Moderator: Jeffrey W. Moses

6:30 PM The Hybrid Approach to CTO PCI: What It Is, and How It Has Changed CTO PCI William L. Lombardi

6:41 PM Hybrid CTO Case Review - Clinical Presentation/Angiogram Case Presenter: Simon J. Walsh

6:44 PM Discussion of Strategies Moderator: Simon J. Walsh

6:49 PM Discussion of What Was Done Moderator: Simon J. Walsh

6:54 PM Summary With Q&A

Part II: Atherectomy and Calcium7:02 PM - 7:32 PM

Moderator: Gregg W. Stone

7:02 PM The Importance of Coronary Calcification in Complex PCI: Data and Devices Gregg W. Stone

7:13 PM Calcified Anatomy Case Review-Clinical Presentation/Angiogram Case Presenter: Susheel Kodali

7:16 PM Discussion of Strategies Moderator: Susheel Kodali

7:21 PM Discussion of What Was Done Moderator: Susheel Kodali


Part III: High-Risk PCI7:32 PM - 8:00 PM

Moderator: Ajay J. Kirtane

7:32 PM PCI of High-Risk Patients Under Hemodynamic Support: For Whom and With What? Ajay J. Kirtane

7:40 PM High-Risk PCI Case Review - Clinical Presentation/Angiogram Case Presenter: Emmanouil S. Brilakis

7:43 PM Discussion of Strategies Moderator: Emmanouil S. Brilakis

7:48 PM Discussion of What Was Done Moderator: Emmanouil S. Brilakis


Moderated Challenging Cases: Coronary V

Tuesday, November 1 4:00 PM - 5:00 PM Walter E. Washington Convention Center Mod Posters/Cases 1, Exhibit Hall, Level 2Accreditation: none

Moderated Challenging Cases: Coronary V4:00 PM - 5:00 PM

Moderators: M Chadi Alraies, Jose Armando Mangione

4:00 PM TCT 1055: Retrograde Treatment of a Flush Right Coronary Artery Chronic Total Occlusion Case Presenter: Judit Karacsonyi

4:15 PM TCT 1066: A Successful Case of Left Main Shock Syndrome Due to Thrombosed CoronaryDissection Case Presenter: Weiping Zhang

4:30 PM TCT 1097: Successful Revascularization for Double-Vessel CTO Case Presenter: Dai-Yin Lu

4:45 PM TCT 1103: Retrograde LAD Chronic Total Occlusion via RIMA Case Presenter: Elizabeth Shaw

Moderated Challenging Cases: Coronary VI



Moderated Challenging Cases: Coronary VI4:00 PM - 5:00 PM

Moderators: Massoud A. Leesar, Adam Witkowski

4:00 PM TCT 1116: Iatrogenic Left Main Dissection With Flap Extending to Ascending Aorta- ANightmare Case Presenter: Jabir Abdullakutty

4:15 PM TCT 1128: A Very Complicated Coronary Perforation Case Presenter: Li-Wah Tam

4:30 PM TCT 1176: Calcified Aorto-Ostial Occlusion - A Terrible Combination for Chronic TotalOcclusion Case Presenter: Chi Hong Chau

4:45 PM TCT 1035: Entrapment of Intracoronary Optical Frequency Domain Imaging Catheter Case Presenter: Yu Ho Chan

Moderated Challenging Cases: Structural IV


Moderated Challenging Cases: Structural IV4:00 PM - 5:00 PM

Moderators: Ruediger Lange, John F. Rhodes

4:00 PM TCT 1620: First-In-Human of Transapical Off-Pump Mitral Valve Repair With CatheterDelivered Annuloplasty Ring for Functional Mitral Regurgitation Case Presenter: Andrea Colli

4:15 PM TCT 1499: Percutaneous Treatment of Ruptured Chronic False Aneurysm of the AscendingAorta and Valsalva Sinus in the Right Ventricule Case Presenter: Jamel Langar

4:30 PM TCT 1570: Transcatheter Closure of a Sinus Venosus Atrial Septal Defect in a Poor SurgicalCandidate Case Presenter: Akanksha Thakkar

4:45 PM TCT 1605: Managing an Acute Aortic Dissection in Transcatheter Aortic Valve Implantation Case Presenter: Oscar Millan-Iturbe

Moderated Challenging Cases: Structural V


Moderated Challenging Cases: Structural V4:00 PM - 4:45 PM

Moderators: Massimo Napodano, Alfredo E. Rodriguez

4:00 PM TCT 1567: "Catch Me If You Can" Case Presenter: Rahul Sharma

4:15 PM TCT 1606: Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic ValveDysfunction Using a Lotus Valve System Case Presenter: Oscar Millan-Iturbe

4:30 PM TCT 1614: Clip in SAM Case Presenter: Nadira Hamid

Moderated Poster Session: Bioresorable Scaffold or Drug-Eluting Stent Thrombosis

Tuesday, November 1 10:30 AM - 11:45 AM Walter E. Washington Convention Center Mod Posters/Cases 1, Exhibit Hall, Level 2

Accreditation: none

Moderated Poster Session: Bioresorable Scaffold or Drug-Eluting Stent Thrombosis10:30 AM - 11:45 AM

Moderators: Serban Puricel, Clemens von Birgelen

10:30 AM TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: APooled Analysis of ABSORB Trials Patrick W. Serruys

10:45 AM TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gaugingcoronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry Niel Ruparelia

11:00 AM TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive PulmonaryDisease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of theBASKET-PROVE I and II trials. Tannas Jatene

11:15 AM TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After MetallicStents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials Mahesh V Madhavan

11:30 AM TCT 830: Difference in Hemodynamic Micro-Environment in Vessels Scaffolded with AbsorbBVS or Mirage Microfiber Siromilus Eluting Scaffold: A Pre-Clinical Study of Endothelial ShearStress Rafael Cavalcante E. Silva

Moderated Poster Session: Sirolimus-Coated Balloons

Tuesday, November 1 10:30 AM - 11:15 AM Cardiovascular Research Foundation Mod Posters/Cases 2, Exhibit Hall, Level 2Accreditation: none

Moderated Poster Session: Sirolimus-Coated Balloons10:30 AM - 11:15 AM

Moderators: Germano Di Sciascio, Bruno Scheller

10:30 AM TCT 390: Influence of Diabetes on the Safety and Efficacy of Sirolimus-Coated Balloon in AReal-World Multi-Center Nanolutè Registry Dinesh Shah

10:45 AM TCT 388: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Resultsfrom the Nanolutè Registry Keyur Parikh

11:00 AM TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small VesselDisease: Insights From the Nanoluté Registry Bernardo Cortese

Moderated Poster Session: Treatment of Bifurcation Lesions

Tuesday, November 1 10:30 AM - 11:30 AM Walter E. Washington Convention Center Mod Posters/Cases 3, Exhibit Hall, Level 2Accreditation: none

Moderated Poster Session: Treatment of Bifurcation Lesions10:30 AM - 11:30 AM

Moderators: Michael A. Kutcher, Issam D. Moussa

10:30 AM TCT 403: Bioresorbable Coronary Devices in Bifurcations: Immediate and 6-month Results ofthe REPARA Registry Felipe Hernandez

10:45 AM TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of CoronaryArtery Bifurcation Lesions in the Randomized Nordic Bifurcation Study Terje K. Steigen

11:00 AM TCT 319: Side Branch Mortality Score for Prediction of Five Year Mortality After ProvisionalSide Branch Coronary Bifurcation Stenting – A New Tool Based on IntracoronaryElectrocardiogram (iECG) From iECG and Myonecrosis After Bifurcation Stenting Kiril Karamfiloff

11:15 AM TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with BifurcationLesions After Recanalization of Chronic coronary Arteries Occlusions. Comparative Analysis Vitaly Baystrukov

Moderated Poster Session: Vascular Access

Tuesday, November 1 10:30 AM - 11:30 AM


Moderated Poster Session: Vascular Access10:30 AM - 11:30 AM

Moderators: Ivo Bernat, Thomas M Tu

10:30 AM TCT 547: Radial Artery Changes After Transradial PCI – A Serial Optical CoherenceTomography Volumetric Study Jan Kanovsky

10:45 AM TCT 358: Bleeding and Vascular Complication Rates Before and After Implementation of aRadial Coronary Catheterization Programme – an Observational Study in 12 745 Patients Daniel Kiblboeck

11:00 AM TCT 202: Interaction Between Choice of Anticoagulation, Antiplatelet Therapy and AccessSite on Mortality and Bleeding After Percutaneous Coronary Intervention: Insights from theCalifornia NCDR Registry. Femi Philip

11:15 AM TCT 359: Ulnar Artery Transient Compression Facilitating Radial Artery patent hemostasis(ULTRA). A Novel Technique to Reduce Radial Artery Occlusion Michail Koutouzis

Moderated Poster Session: Bioresorable Scaffold Implantation Techniques


Moderated Poster Session: Bioresorable Scaffold Implantation Techniques3:00 PM - 4:00 PM

Moderators: Ronald Caputo, Maurizio Menichelli

3:00 PM TCT 397: Effect of Post-Dilatation on Device Expansion and Arterial Healing FollowingEverolimus-Eluting Bioresorbable Stent (Absorb BVS) Versus Durable Polymer Everolimus-Eluting Metallic Stent (EES) Implantation in STEMI Patients: Substudy of ABSORB STE Kyohei Yamaji

3:15 PM TCT 398: Impact of Scaffold Oversizing, Underexpansion and Post-Dilatation on AcuteAngiographic and One Year clinical Outcomes in Patients with ACS Treated withBioresorbable Vascular Scaffolds. A Pooled Analysis from BVS STEMI First and BVS EXPANDStudi Mariusz Tomaniak

3:30 PM TCT 399: Impact of Post-Dilatation on Angiographic and Clinical Outcomes of PatientsUndergoing Bioresorbable Scaffold Implantation in Clinical Practice Jen Wiebe

3:45 PM TCT 400: The Importance of Implantation Technique in Ensuring Optimal Outcomes AfterBioresorbable Scaffold Implantation: Implications From a Real-World Cohort Akihito Tanaka

Moderated Poster Session: PCI Complications


Moderated Poster Session: PCI Complications3:00 PM - 4:00 PM

Moderators: Mauricio G. Cohen, Bernhard Witzenbichler

3:00 PM TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow FollowingPercutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry Stavroula Papapostolou

3:15 PM TCT 251: Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention Gaurav Patel

3:30 PM TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation DuringPercutaneous Coronary Intervention in the United Kingdom Between 2006–2013: an analysisof 527,121 Cases from the British Cardiovascular Intervention Society Database Tim Kinnaird

3:45 PM TCT 259: Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidenceand Outcomes Oliver Guttmann

Moderated Poster Session: Physiologic Lesion Assessment and Aortic Stenosis


Moderated Poster Session: Physiologic Lesion Assessment and Aortic Stenosis3:00 PM - 4:00 PM

Moderators: Alan C. Yeung, Tim P. van de Hoef

3:00 PM TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patientswith and Without Severe Aortic Valve Stenosis. Gabriele Pesarini

3:15 PM TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in PatientsUndergoing TAVI. Gabriele Pesarini

3:30 PM TCT 518: The Interaction between Aortic and Coronary Pressures for Fractional Flow ReserveValue in Patients with an Intermediate Coronary Artery Stenosis Yuhei Kobayashi

3:45 PM TCT 519: Correlation Between Invasive CFR AND Echocardiographic Parameters in SevereAortic Stenosis Alejandro Gutierrez

Moderated Poster Session: Vulnerable Plaque


Moderated Poster Session: Vulnerable Plaque3:00 PM - 4:00 PM

Moderators: Eric Boersma, James E. Muller

3:00 PM TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left AnteriorCoronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? –Results from Computational Fluid Dynamics Simulation by CT-FFR Takayoshi Toba

3:15 PM TCT 598: Plaque Rupture in Coronary Atherosclerosis is Associated with Increased PlaqueStructural Stress Charis Costopoulos

3:30 PM TCT 599: Not All Plaque Ruptures Are Born Equal: An Optical Coherence Tomography Study Hesham R.M. Sherif

3:45 PM TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: ThePROSPECT Study Tadayuki Kadohira

Exhibit Hall

Tuesday, November 1 8:00 AM - 5:00 PM Walter E. Washington Convention Center Exhibit Hall, Level 2Accreditation: none


Wednesday, November 2, 2016

Breakfast Meeting: Guidewire Design and Selection: A User’s Guide (Sponsored by CRF, Supported by Abbott, Boston ScientificCorporation, and Medtronic, Inc.)

Wednesday, November 2 6:30 AM - 8:00 AM Walter E. Washington Convention Center Room 147, Level 1Accreditation: CME


Guidewire Design and Selection: A User’s Guide7:00 AM - 8:00 AM

Co-Chairs: Martin B. Leon, Jeffrey W. Moses Facultys: Christopher E. Buller, Dimitrios Karmpaliotis, Ajay J. Kirtane, James C. Spratt

7:00 AM Welcome and Introductions Jeffrey W. Moses

7:05 AM Anatomy and Design of Coronary Guidewires 101: Engineering for the Interventionalist Christopher E. Buller

7:15 AM Hydrophilic and Support Wires Ajay J. Kirtane

7:30 AM Applied Use of Coronary Guidewires: Basic Principles for Wire Manipulation James C. Spratt

7:45 AM CTO Wires: Antegrade and Retrograde Approaches Case Presenter: Dimitrios Karmpaliotis

7:55 AM Discussion

Breakfast Meeting: Integrating Physiology and Imaging Into the Cath Lab: What Technology Should I Use and How and When Should IUse It? (Sponsored by CRF, Supported by Boston Scientific Corporation, GE Healthcare and St. Jude Medical, Inc.)

Wednesday, November 2 6:30 AM - 8:00 AM Cardiovascular Research Foundation Room 145B, Level 1Accreditation: CME


Integrating Physiology and Imaging Into the Cath Lab: What Technology Should I Use and How and WhenShould I Use It?7:00 AM - 8:00 AM

Co-Chairs: John McB. Hodgson, Gary S. Mintz Facultys: Allen Jeremias, Bon-Kwon Koo, Yoshinobu Onuma

7:00 AM How Do I Assess an Intermediate Lesion? FFR? iFR? Angio-FFR? Allen Jeremias

7:10 AM How Do I Optimize Metallic Stent Implantation? John McB. Hodgson

7:20 AM How Do I Optimize Bioresorbable Vascular Scaffold Implantation? Yoshinobu Onuma

7:30 AM How and When Do I Assess a Jailed Side Branch After Provisional Stenting? Bon-Kwon Koo

7:40 AM How Do I Assess Causes of Stent Thrombosis and In-Stent Restenosis? Gary S. Mintz

7:50 AM Discussion

Main Arena IV, Wednesday, Nov 2

Wednesday, November 2 8:00 AM - 1:15 PM Walter E. Washington Convention Center Ballroom, Level 3Accreditation: CME/ASRT/CNE


Live Case Moderator: Gregg W. Stone Live Case Co-Moderator: Michael J. Mack Live Case Discussants: Shmuel Banai, Maurice Buchbinder, Vladimir Dzavik, Steven L. Goldberg, Howard C.Herrmann, Samir R. Kapadia, Massoud A. Leesar, Sigmund Silber, Jean-François Tanguay, Leif Thuesen, Nicolas M.Van Mieghem Digital Moderator: Alexandre Abizaid Digital Panelists: Kenneth Chin, Stamatios Lerakis, Ashish Pershad, Harsimran Sachdeva Singh Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan,Jonathan Soverow, Myong Hwa Yamamoto

8:00 AM San Raffaele Scientific Institute, Milan Italy Live Case Operators: Alaide Chieffo, Antonio Colombo, Azeem Latib, Matteo Montorfano, MD

8:30 AM The Mount Sinai Hospital, New York, NY Live Case Operator: David H. Adams

Plenary Session II. Late-Breaking Clinical Trials 49:00 AM - 10:00 AM

Moderator: Martin B. Leon Digital Moderator: Louis A. Cannon Digital Panelists: Gary Gershony, Aaron V. Kaplan Discussants: Peter C. Block, Maurice Buchbinder, William A. Gray, David R. Holmes Jr., Sriram S. Iyer, DavidMeerkin, Sahil A. Parikh, Josep Rodés-Cabau, Pieter R. Stella, Craig M. Walker Co-Moderator: Robert J. Sommer

9:00 AM ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs anUncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries Sean P Lyden

9:12 AM Moderated Roundtable Discussion Discussant: Sean P Lyden

9:20 AM WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With aLeft Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation David R. Holmes Jr.

9:32 AM Moderated Roundtable Discussion Discussant: David R. Holmes Jr.

9:40 AM AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a LeftAtrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation David Hildick-Smith

9:52 AM Moderated Roundtable Discussion Discussant: David Hildick-Smith


Live Case Moderator: Martin B. Leon Live Case Co-Moderator: Josep Rodés-Cabau Live Case Discussants: Anson Cheung, Tony J. DeMartini, Chandan Devireddy, Anthony H. Gershlick, Linda D.Gillam, Mayra Guerrero, Nicholas J. Lembo, Brij Maini, Jeffrey W. Moses, David W.M. Muller, Harsimran SachdevaSingh, Hadley Wilson Digital Moderator: Tamim Nazif Digital Panelists: Antonio L. Bartorelli, Pieter R. Stella, Torsten P. Vahl Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan,Jonathan Soverow, Myong Hwa Yamamoto

10:00 AM Henry Ford Hospital, Detroit, MI Live Case Operators: Marvin Eng, MD, FACC, Adam B. Greenbaum, William W. O'Neill, GaetanoPaone, MD

10:30 AM Scripps Clinic and Research Foundation, La Jolla, CA Live Case Operators: Matthew J. Price, Curtiss Stinis, MD, Paul S. Teirstein

Plenary Session IV. Best Abstract Award (Cosponsored by EuroIntervention and Cardiac Catheterization andInterventions)11:00 AM - 11:15 AM

Moderators: Steven R. Bailey, Patrick W. Serruys

11:00 AM Announcement of the Winning Submission and Presenter Moderators: Steven R. Bailey, Patrick W. Serruys

11:02 AM Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety andEffectiveness of a Septal Occluder With Bioresorbable Framework in Patients With ClinicallySignificant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) Horst Sievert

11:12 AM Presentation of the Award Horst Sievert

Plenary Session V. Innovation Highlights at TCT 201611:15 AM - 11:30 AM

Moderators: Juan F. Granada, Greg L. Kaluza

11:15 AM The TCT 2016 Innovation Award Competition: Session Highlights and Winners AnnouncementJuan F. Granada

11:22 AM Shark Tank Innovation Award Competition Winner (Presentation)

Plenary Session VI. TCT Focus Session #4: Rediscovering Cardiovascular Hemodynamics11:30 AM - 12:15 PM

Moderator: William T. Abraham Digital Moderator: Srihari S. Naidu Digital Panelists: Mark Goldberger, Susan M Joseph, Jens Kastrup Discussants: M Chadi Alraies, Daniel Burkhoff, Francisco Fdez-Aviles, Hans R. Figulla, Navin K. Kapur, David W.M.Muller, Marvin J. Slepian, Hiroo Takayama, James E. Udelson, Nicolas M. Van Mieghem Co-Moderator: Ajay J. Kirtane

11:30 AM Featured Lecture: New Tools to Understand and Teach Cardiovascular Hemodynamics Daniel Burkhoff

11:45 AM Featured Lecture: Hemodynamic and Device-Directed Approaches to Patients With Shockand Heart Failure Navin K. Kapur

12:00 PM Animated Discussion

Plenary Session VII. First Report Investigations 412:15 PM - 1:15 PM

Moderator: Gary S. Mintz Digital Moderator: Robert-Jan van Geuns Digital Panelists: Tony J. DeMartini, Roberto Diletti, Michael Haude Discussants: M Chadi Alraies, Mauro Carlino, Evald H. Christiansen, Kevin J. Croce, Lei Ge, Dimitrios Karmpaliotis,Manuel Pan, Georgios Sianos, Giulio G. Stefanini, Bradley H. Strauss, Mladen I. Vidovich, Wojtek Wojakowski

12:15 PM PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients WithCoronary Artery Chronic Total Occlusions Koen Teeuwen

12:25 PM Moderated Roundtable Discussion Discussant: Koen Teeuwen

12:30 PM TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients WithCoronary Artery Chronic Total Occlusions Christopher E. Buller

12:40 PM Moderated Roundtable Discussion Discussant: Christopher E. Buller

12:45 PM TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate StrutCoverage at Three Months and Neoatherosclerosis at Eighteen Months in BioresorbablePolymer-Based and Durable Polymer-Based Drug-Eluting Stents Giulio Guagliumi

12:55 PM Moderated Roundtable Discussion Discussant: Giulio Guagliumi

1:00 PM RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in PatientsWith Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis – Six Month-Nine MonthClinical and Angiographic Follow-up Results Fernando Alfonso

1:10 PM Moderated Roundtable Discussion Discussant: Fernando Alfonso

Coronary Theater IV, Wednesday, Nov. 2

Wednesday, November 2 8:00 AM - 12:00 PM Walter E. Washington Convention Center Coronary Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: Imaging, Physiology and Atherectomy8:00 AM - 10:00 AM

Live Case Moderator: Ajay J. Kirtane Live Case Co-Moderator: Ziad A. Ali Live Case Discussants: Kevin J. Croce, Marc D. Feldman, Angela Hoye, David F. Kong, Jorge H. Leguizamon,Mathew K. Samuel, Mladen I. Vidovich, Marco V. Wainstein Digital Moderator: Nick E. J. West Digital Panelists: Dimitriy N. Feldman, Roger Gammon, Pim A.L. Tonino Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

8:00 AM Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom Live Case Operators: Rasha Al-Lamee, MD, Christopher Baker, MD, PhD, Justin E. Davies, IqbalMalik, MD, PhD, Sayan Sen, MD, PhD

9:00 AM The Mount Sinai Hospital, NY, NY Live Case Operators: George D. Dangas, Annapoorna S. Kini, MD, Samin K. Sharma

Session II: Live Cases: Imaging, Physiology and Atherectomy10:00 AM - 12:00 PM

Live Case Moderator: John McB. Hodgson Live Case Co-Moderator: Alexey Protopopov Live Case Discussants: Joost Daemen, Giulio Guagliumi, Michael C. Kim, Jacek Legutko, James R. Margolis,Evelyn S. Regar, Thomas M Tu, Pascal Vranckx, Tim P. van de Hoef Digital Moderator: Allen Jeremias Digital Panelists: Ioannis Iakovou, Jasvindar Singh, Christian M. Spaulding Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

10:00 AM Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom Live Case Operators: Rasha Al-Lamee, MD, Christopher Baker, MD, PhD, Justin E. Davies, IqbalMalik, MD, PhD, Sayan Sen, MD, PhD

11:00 AM Scripps Clinic and Research Foundation, La Jolla, CA Live Case Operators: Curtiss Stinis, MD, Paul S. Teirstein

Structural Theater III, Wednesday, Nov. 2

Wednesday, November 2 8:00 AM - 12:00 PM Walter E. Washington Convention Center Structural Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I: Live Cases: Lampoon & TAVR8:00 AM - 10:00 AM

Live Case Moderator: Ted Feldman Live Case Co-Moderator: Brian K. Whisenant Live Case Discussants: Colin M. Barker, Philipp Blanke, Mauricio G. Cohen, Amit N Patel, Ramon Quesada, TobyRogers, Glenn Van Langenhove, Adam Witkowski, Jochen Wöhrle Digital Moderator: Kishore J. Harjai Digital Panelists: Nicola Corvaja, Tamim Nazif, Bushra S Rana Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

8:00 AM Henry Ford Health System, Detroit, MI Live Case Operators: Marvin Eng, MD, FACC, Adam B. Greenbaum, William W. O'Neill, GaetanoPaone, MD Live Case Guest Operators: Vasilis Babaliaros, Robert J. Lederman

9:00 AM San Raffaele Scientific Institute, Milan, Italy Live Case Operators: Alaide Chieffo, Antonio Colombo, Azeem Latib, Matteo Montorfano, MD

Session II: Live Cases: LAA Closure10:00 AM - 12:00 PM

Live Case Moderator: Philippe Généreux Live Case Co-Moderator: Krzysztof Bartus Live Case Discussants: Haim Danenberg, Isaac George, George S. Hanzel, Michael J. Lim, Paul D. Mahoney,Massimo Napodano, Augusto D. Pichard, Eric Van Belle, Grayson H. Wheatley Digital Moderator: Jeffrey J. Popma Digital Panelists: David A. Cox, Petr Kala, Kambis Mashayekhi Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

10:00 AM The Mount Sinai Hospital, NY, NY Live Case Operators: Srinivas Dukkipati, MD, Vivek Y. Reddy

11:00 AM Henry Ford Health System, Detroit, MI Live Case Operators: Marvin Eng, MD, FACC, Adam B. Greenbaum, William W. O'Neill, GaetanoPaone, MD

SPECIAL VIRTUAL SESSIONSContent for these sessions will be available online, exclusively to TCT attendees, within several weeks after the meeting.

TCT360

Last updated November 2, 2016 at 4:05 pm

The agenda listed below may not be as up to date as our website. Please refer to our conference website for the latest agenda details.

CardioVascular Professionals (CVP) Course: 25th Annual Cardiovascular Nurse and Technologist Symposium, Part I: RegisteredCardiovascular Invasive Specialists (RCIS) Review Course


Session I. Fundamental KnowledgeModerator: Thomas H. Maloney Discussants: Robert Kutys, Tim J. Lapp, Maria E. Romero, George W. Vetrovec

Introduction and Session Objectives Thomas H. Maloney

In-depth Coronary Angiography, and Coronary Complication Review Matched With Interactive Cadaver Heart Dissection and PCIRobert Kutys, Maria E. Romero, George W. Vetrovec

In-depth Cardiac Structure, Conduction System, and Hemodynamic Review of the Normal Heart Matched With Interactive CadaverHeart Dissection by the Pathologist Robert Kutys, Tim J. Lapp, Maria E. Romero

Keynote Lecture: Enter the Bioresorbable Scaffold Era: Similarities and Differences From Metallic DES Azeem Latib

Session II. The Aortic Valve: A Deep DiveModerator: Thomas H. Maloney Discussants: Sarah Clarke, Jeff Davis, Paul D. Mahoney

Fundamental Knowledge: Aortic Valve Anatomy, Function, and Relational Pathology Sarah Clarke

Hemodynamics of Aortic Stenosis: You CAN Do This Jeff Davis

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance Paul D. Mahoney

Live Demo: Transcatheter Aortic Valve Replacement Paul D. Mahoney

Visit Nurse Tech Exhibits/ Break

Nurse Tech Exhibits/ Break

Session III. The Mitral Valve: A Deep DiveModerator: Jeff Davis Discussants: Zachary M. Gertz, James B. Hermiller Jr, Tim R. Martin

Fundamental Knowledge: Mitral Valve Anatomy, Function, and Relational Pathology Tim R. Martin

Hemodynamics of Mitral Regurgitation, Making it Simple and Understandable Zachary M. Gertz

How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair Clinical Decision-Making and ProceduralGuidance James B. Hermiller Jr

Live Demo: Transcatheter Mitral Valve Repair Zachary M. Gertz, James B. Hermiller Jr

Session IV. The Right Heart: A Deep DiveModerator: Jeff Davis Discussants: Kenneth A. Gorski, Tim J. Lapp, David A. Wood

Fundamental Knowledge: Pulmonic Valve Anatomy, Function, and Relational Pathology Kenneth A. Gorski

Fundamental Knowledge: Tricuspid Valve Anatomy, Function, and Relational Pathology David A. Wood

Hemodynamics of the Right Heart: The Essentials Tim J. Lapp

Session V. Hands on Hearts Bioskills Session - Cadaver Hearts (Courtesy of CVPath)Moderators: Marsha Holton, Robert Kutys, Thomas H. Maloney, Maria E. Romero, Torie Samuda Discussant: Jeff Davis

Session V. Hands on Hearts Bioskills Session - Cadaver Hearts (Courtesy of CVPath)

CardioVascular Professionals (CVP) Course: 25th Annual Cardiovascular Nurse and Technologist Symposium - Evening Reception

Walter E. Washington Convention Center

204 Foyer, Level 2Accreditation: none

ABCs of Interventional Cardiology 2016: An Introductory Course


Session I. Basics of Cardiac Anatomy and AngiographyModerators: George D. Dangas, Vijay Kunadian Discussants: Hemal Gada, Philippe Généreux, Alexandra J. Lansky, Gennaro Sardella

Overview of Cardiac and Coronary Anatomy Vijay Kunadian

Discussion With Audience Q&A

Right and Left Heart Catheterization: Technique and Hemodynamics Robert T. Pyo


Coronary Angiography: Set-up, Views, Artifacts, and Pitfalls Philippe Généreux


Intravascular Imaging: Core Concepts Gennaro Sardella


Vascular Access Routes and Complications Robert T. Pyo


Session II. Overview of Cardiovascular Pathophysiology and TreatmentModerators: Peter Barlis, Greg L. Kaluza Discussants: Ziad A. Ali, Nicola Corvaja, David A. Cox, Hitinder S. Gurm, Allen Jeremias, Michael C. Kim

Coronary Artery Disease: Pathology and Pathogenesis Greg L. Kaluza


Coronary Pathophysiology and FFR Allen Jeremias


Acute Coronary Syndromes: NSTE-ACS Ziad A. Ali


Acute Coronary Syndromes: STEMI Michael C. Kim


Valvular Heart Disease: Diagnosis and Treatment Options Nicola Corvaja


Break

Session III. Introduction to Coronary Angioplasty and StentingModerators: Bonnie H. Weiner, Jose M. Wiley Discussants: Piera Capranzano, Joseph P. Carrozza Jr, Robert J. Gil, John M. Lasala, Robert T. Pyo, Gennaro Sardella, Hadley Wilson

Cath Lab Room Setup and Basic Equipment (Guiding Catheters, Wires, and Balloons) Bonnie H. Weiner


Interventional Pharmacology Overview for PCI and ACS Piera Capranzano


Atherotomy, Atherectomy, and Embolic Protection Robert T. Pyo


DES Systems and Outcomes Gennaro Sardella


SCAI Cath Lab Leadership Bootcamp @ TCT 2016

Cardiovascular Research Foundation Room 103A, Level 1Accreditation: CME/ASRT/CNE

Bootcamp I: Leadership and AdministrationModerators: Robert J. Applegate, Charles E. Chambers Discussants: Megan Berlinger, Kirk N. Garratt, Ehtisham Mahmud, Bernadette S. Speiser

Welcome and Introduction Charles E. Chambers

Effective Strategies for Success of the Medical Director Ehtisham Mahmud

The Role and Responsibilities of the Cath Lab Manager Bernadette S. Speiser

Physician and Management Partnerships: Benefits and Challenges Megan Berlinger

How to Defuse Interpersonal Conflicts in the Cath Lab Kirk N. Garratt

Roundtable Discussion With Audience Q&A

Bootcamp II: Economics and PaymentsModerators: Megan Berlinger, Peter L Duffy Discussants: Robert J. Applegate, Kirk N. Garratt, Duane S. Pinto

A Primer of Cath Lab Economics 2016 Robert J. Applegate

Cath Lab as a Value Proposition Kirk N. Garratt

MACRA and Payment Changes: Are you Ready? Peter L Duffy

Bundle Payment for PCI: Are You Prepared? Duane S. Pinto


Bootcamp III: QualityModerators: Charles E. Chambers, Michael A. Kutcher Discussants: Ori Ben-Yehuda, Arnold Seto

The 10 Most Important Quality Metrics for Your Cath Lab Michael A. Kutcher

SCAI AUC and PCI Risk Apps: How to Make Them Work in Your Lab Charles E. Chambers

Can Risk-Adjusted Outcomes Differentiate Individual Operator Performance? Arnold Seto

Vendor and Industry Relations: The Good, Bad, and Ugly Ori Ben-Yehuda


Bootcamp IV: New TechnologyModerators: Ehtisham Mahmud, Kenneth Rosenfield Discussants: Emmanouil S. Brilakis, Jason Fontana, Daniel M. Kolansky

High Cost Technologies: How Do You Afford Them? Kenneth Rosenfield

Integration of Novel Technologies in the Cath Lab: An Industry Perspective Jason Fontana

Training Standards for New Technology: Professional Societies, Industry or FDA Daniel M. Kolansky

Occupational Hazards and Technologies to Address Them Emmanouil S. Brilakis


Special Session: Saturday Night Fights at TCT

Walter E. Washington Convention Center Hall BAccreditation: none

Round 1: Bioresorbable Scaffolds – Beauty or the BeastModerator: Mark Reisman

Niche Technology Paul S. Teirstein

Expanded Use Gregg W. Stone

Rebuttal (Niche Technology) Paul S. Teirstein

Rebuttal (Expanded Use) Gregg W. Stone

Discussion

Round 2: TAVR – Opening the FloodgatesModerator: Mark Reisman

Ready for Low-Risk Patients Martin B. Leon

Not so Fast Michael J. Mack

Rebuttal (Ready for Low-Risk Patients ) Martin B. Leon

Rebuttal (Not so Fast) Michael J. Mack

Discussion

Round 3: Revascularization for Stable CAD – Feast or Famine?Moderator: Mark Reisman

CHIP (Complex High-Risk Angioplasty) Is the Future Ajay J. Kirtane

The Mainstay Are Watchful Waiting and Medical Therapy David J. Maron

Rebuttal (CHIP) Ajay J. Kirtane

Rebuttal (Medical Therapy) David J. Maron

Discussion

Round 4: DAPT Duration – On Again, Off AgainModerator: Mark Reisman

The Longer the Better Laura Mauri

The Shorter the Better George D. Dangas

Rebuttal (Longer the Better) Laura Mauri

Rebuttal (Shorter the Better) George D. Dangas

Discussion

Satellite Special Session: The Translational Pathways for Cardiovascular Devices; Current and Future Direction (Sponsored by ISCTR)

Walter E. Washington Convention Center Room 146A, Level 1Accreditation: none

Session I - Basic Process for Device DevelopmentModerators: Jack C. Lewin, Bram D. Zuckerman

Welcome Statement ISCTR Lecturers: Nabil Dib, Spencer B. King III

ISCTR Mission And Statement of Meeting Purpose ISCTR Lecturer: Nabil Dib

Requirement for New Technology to be Included in the Guidelines, “The Ultimate Goal” ISCTR Lecturer: Alice K. Jacobs

CMS Criteria For Reimbursement of Cardiovascular Innovation ISCTR Lecturer: Joseph Chin

Regulatory Requirement for Marketing Approval ISCTR Lecturer: Deborah Castillo, PhD

Pre-Clinical and Clinical Trial Design and Endpoints of Fast Track to Device Approval ISCTR Lecturer: Roseann White

A Unified Approach for Clinical Trial Design That Meets The Requirement of Regulatory Approval, Reimbursement And The ClinicalPractice Guideline ISCTR Lecturer: Mitchell W. Krucoff

Panel Discussion Discussants: Deborah Castillo, PhD, Anthony N. DeMaria, Nabil Dib, Alice K. Jacobs, Spencer B. King III, Mitchell W. Krucoff, Jack C.Lewin, Robert Roberts, Stanton J. Rowe, Chuck Simonton, Roseann White, Bram D. Zuckerman

Break

Break

Session II – Pre-Clinical, Early Feasibility, and Safety Study for Device DevelopmentModerators: Andrew Farb, David Reuter, MD

Current Challenges and Future Direction for Feasibility and Early Human Study for Device Evaluation; FDA Point of View ISCTR Lecturer: Andrew Farb

Current Challenges and Future Direction for Feasibility and Early Human Study for Device Evaluation; Industry Point of View ISCTR Lecturer: David Reuter, MD

Requirements for Medical Device Manufacturing And Iteration; Industry Point of View ISCTR Lecturer: Richard J. Rapoza

Requirements for Medical Device Manufacturing And Iteration; FDA Point of View ISCTR Lecturer: Brad Quinn

Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation; Investigator Point Of View ISCTR Lecturer: Renu Virmani

Optimal Pre-Clinical Study Design and Endpoints for Device Evaluation; FDA Point Of View ISCTR Lecturer: Judith Davis, DVM

Panel Discussion Discussants: Judith Davis, DVM, Andrew Farb, Robert Kohler, Michael Minogue, James E. Muller, Laura Perkins, DVM, Brad Quinn, RichardJ. Rapoza, Patricia Todd, Renu Virmani, Roseann White

Lunch

Presentation of the Glen and Marilyn Nelson Award

Presentation of the Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Medicine to Robert Califf Award Presenters: Anthony N. DeMaria, Marilyn Nelson ISCTR Lecturer: Nabil Dib

Keynote Speaker Dr. Robert Califf: The Translational Pathway to Expedite Scientific Discovery to Patients ISCTR Lecturer: Robert M. Califf

Session III – Aortic Valve DevelopmentModerators: Spencer B. King III, Stanton J. Rowe

The Clinical Need for Innovative Treatment for Aortic Valve Disease ISCTR Lecturer: Martin B. Leon

Current Challenges and Future Direction for Aortic Valve Development and Iteration; Industry Point of View ISCTR Lecturer: Stanton J. Rowe

Current Challenges and Future Direction for Aortic Valve Development and Iteration; FDA Point Of View ISCTR Lecturer: Nicole Ibrahim

Panel Discussion Discussants: Nicole Ibrahim, Spencer B. King III, Michael J. Mack, Stanton J. Rowe, Patricia Todd, Renu Virmani, Bram D. Zuckerman

Session IV – Mitral/Tricuspid Valve DevelopmentModerators: Dorothy Abel, MD, Gregg W. Stone

The Clinical Need for Innovative Treatment for Mitral/Tricuspid Valve Disease ISCTR Lecturer: Michael J. Mack

Current Challenges and Future Direction for Mitral/Tricuspid Valve Development And Iteration; Industry Point of View ISCTR Lecturer: Patricia Todd

Current Challenges and Future Direction for Mitral/Tricuspid Valve Development and Iteration; FDA Point of View ISCTR Lecturer: John C Laschinger

Panel Discussion Discussants: Dorothy Abel, John C Laschinger, Michael J. Mack, Gregg W. Stone, Patricia Todd, Renu Virmani

Session V - Coronary Stent DevelopmentModerators: Neal Fearnot, Spencer B. King III

The Clinical Need for Innovative Coronary Stent ISCTR Lecturer: Gregg W. Stone

Current Challenges and Future Direction for Coronary Stent Development and Iteration; FDA Point of View ISCTR Lecturer: Michael C. John

Current Challenges and Future Direction for Coronary Stent Development and Iteration; Industry Point of View ISCTR Lecturer: Chuck Simonton

Panel Discussion Discussants: Neal Fearnot, Michael C. John, Spencer B. King III, Chuck Simonton, Gregg W. Stone, Craig A. Thompson, Mark Toland

Break

Session VI – Catheter Ablation DevelopmentModerators: Mark Fellman, MD, Douglas Packer, MD

The Clinical Need for the Treatment of Arrhythmia, Innovative Catheter Ablation ISCTR Lecturer: Douglas Packer, MD

Current Challenges and Future Direction for Catheter Ablation Development and Iteration; Industry Point of View ISCTR Lecturer: Uri Yaron, PhD

Current Challenges and Future Direction for Catheter Ablation Development and Iteration; FDA Point of View ISCTR Lecturer: Mark Fellman, MD

Panel Discussion Discussants: Mark Carlson, Anthony N. DeMaria, Jun Dong, MD, PhD, Mark Fellman, MD, Timothy Laske, PhD, Douglas Packer, MD, Win-Kuang Shen, MD, Uri Yaron, PhD

Session VII – Consensus Document

Writing Consensus Document ISCTR Lecturer: Anthony N. DeMaria

Panel Discussion Discussants: Anthony N. DeMaria, Nabil Dib, Andrew Farb, Spencer B. King III, Jack C. Lewin, Rick McGuire, James E. Muller, RobertRoberts, Stanton J. Rowe, Chuck Simonton, Roseann White, Bram D. Zuckerman

Satellite Special Session: Durable Polymers: Re-evaluating Their Role in Cardiovascular Devices (Sponsored by CVPath Institute, Inc. andUC Berkeley, Supported by Abbott)

Walter E. Washington Convention Center Room 145A, Level 1Accreditation: CME

Durable Polymers: Re-evaluating Their Role in Cardiovascular DevicesChairs: Aloke V. Finn, Kevin Healy, MD, Renu Virmani Facultys: Sripal Bangalore, David Grainger, PhD, Hyo-Soo Kim, Gaku Nakazawa, MD, Tullio Palmerini, Buddy Ratner, PhD, Kazuyuki Yahagi,MD

Inauguration Kevin Healy, PhD, Renu Virmani

History of Polymers in Cardiology Renu Virmani

Fundamentals of Blood-Material Interaction and DES Polymers in Review David Grainger, PhD

Specifics of Blood-Material Interaction for Fluoropolymer vs Metal Buddy Ratner, PhD

Latest Preclinical Findings From Second Generation DES Aloke V. Finn

Break

Relevant Clinical Data Summary - BMS vs Polymeric DES Tullio Palmerini

Relevant Clinical Data Summary - Different Polymeric DES Head-to-Head Data Gaku Nakazawa, MD

Moderated Panel and Audience Q&A Moderator: Aloke V. Finn

Poster Abstracts and Challenging Cases

Walter E. Washington Convention Center Hall B, Lower LevelAccreditation: none

Breakfast Meeting: A New Era in Fusion Imaging for Structural Heart Procedures (Sponsored by Siemens)


Check In and Breakfast

A New Era in Fusion Imaging for Structural Heart ProceduresFacultys: Brian Bethea, MD, Brij Maini

A New Era in Image Guidance for Structural Heart Procedures: Leveraging a Team-based Approach for Improved Outcomes Brian Bethea, MD, Brij Maini

Mitraclip case and discussion on how to troubleshoot when encountering difficulty in gaining access Brian Bethea, MD, Brij Maini

Two TAVR cases including a valve-in-valve patient and a case performed using ICE Brian Bethea, MD, Brij Maini

Watchman procedure that will showcase the use of CT, Angio with contrast, 3D TEE, and ICE Brian Bethea, MD, Brij Maini

Q&A Discussion Moderators: Brian Bethea, MD, Brij Maini

Breakfast Meeting: Cathworks “Wire-less” Angiography FFR: Clinical and Cath Lab Integration Pathways (Sponsored by CathWorks Ltd)



Cathworks “Wire-less” Angiography FFR: Clinical and Cath Lab Integration PathwaysChairs: Bernard De Bruyne, Ran Kornowski Facultys: John D. Carroll, Pablo Codner, MD, William F. Fearon, Peter J. Fitzgerald, Martin B. Leon

Introduction Martin B. Leon

Clinical Value and Limitations of Current FFR Systems William F. Fearon

3D Coronary Reconstruction From 2D Coronary 3D From 2D Coronary Angiograms John D. Carroll

Cathworks Technology and Updates from the Clinical Validation Studies Bernard De Bruyne

Interesting Cathworks Clinical Cases from Investigator Sites Pablo Codner, MD

“Live” Case-in-a-Box: Newest Cathworks On-site System Ran Kornowski

Roundtable Discussion Moderators: John D. Carroll, Ran Kornowski

Breakfast Meeting: Chocolate: Second Generation Balloon DCB Platform (Sponsored by TriReme Medical, LLC)

Walter E. Washington Convention Center Room 144B, Level 1Accreditation: none


Chocolate: Second Generation Balloon DCB PlatformChairs: Martin B. Leon, Jasvindar Singh Facultys: Tim A. Fischell, Manish A. Parikh, Mehdi H. Shishehbor

Chocolate's Unique Mechanism of Action - Clear and Visible Difference Tim A. Fischell

Clinical Perspective Martin B. Leon

Coronary Chocolate and OVP - The Importance and Need for Optimal Vessel Prep Jasvindar Singh

Coronary Chocolate Acute, Image-Guided Mechanistic Registry, Chocolate Heart FIM and DCB Future Manish A. Parikh

First Head-to-Head Peripheral DCB Study - Chocolate Touch Mehdi H. Shishehbor

Breakfast Meeting: Contrast-Induced Acute Kidney Injury: Focus on Hydration and Dye Saving (Sponsored by CRF, Supported by OspreyMedical and Renal Guard Solutions Inc.)

Walter E. Washington Convention Center Room 143C, Level 1Accreditation: none


Contrast-Induced Acute Kidney Injury: Focus on Hydration and Dye SavingFacultys: Prakash Balan, Somjot S. Brar, Carlo Briguori, Alaide Chieffo, Steffen Desch, Giora Weisz

Welcome and Introductions Somjot S. Brar

Importance of Hydration: How to Do it Best? RenalGuard Therapy Somjot S. Brar

Dye Saving Tips: The DyeVert Plus System Steffen Desch

Case Presentation: A Difficult Patient at High Risk for AKI - How to Choose Optimal Dye Savings and Hydration Methods Case Presenter: Alaide Chieffo

Practical Application: Incorporating a Hydration and Dye Savings Protocol for Patients at High Risk of AKI Prakash Balan

Discussion: The Future of AKI Regarding Contrast and Hydration Status

Breakfast Meeting: Endovascular Carotid Barostimulation: A Novel Interventional Approach to Hypertension Treatment (Sponsored byVascular Dynamics, Inc.)

Walter E. Washington Convention Center Room 149, Level 1Accreditation: none


Endovascular Carotid Barostimulation: A Novel Interventional Approach to Hypertension TreatmentChair: Gregg W. Stone Facultys: Mark C. Bates, Farrell O. Mendelsohn, Wilko Spiering, Bryan Williams

Introduction Gregg W. Stone

Endovascular Carotid Barostimulation via Transcatheter-Delivered Implant: Device Technology and Mechanism of Action Moderator: Gregg W. Stone Discussant: Mark C. Bates

Procedure Description and Case Report Farrell O. Mendelsohn

Evidence of Safety and Preliminary Efficacy: European Results From First-in-Man Study Wilko Spiering

Introduction to a Randomized, Blinded, Sham Controlled Pivotal Trial Moderator: Gregg W. Stone Discussant: Bryan Williams

Discusssion Moderator: Gregg W. Stone

Breakfast Meeting: Intra-aortic Balloon Counterpulsation for Percutaneous Aortic Valve or Complex PCI Procedures: Award-Winning CasePresentations (Sponsored by CRF, Supported by Getinge Group)



Intra-aortic Balloon Counterpulsation for Percutaneous Aortic Valve or Complex PCI ProceduresChairs: Tayo A. Addo, George D. Dangas, Vijay Kunadian Facultys: Etelberto Hernández, Kevin O'Gallagher, Vimalkumar Veerappan Kandasamy

Electrical Storm in the Setting of Right Coronary Artery ST Elevation Myocardial Infarction and the Role of Intra-aortic Balloon PumpCase Presenter: Vimalkumar Veerappan Kandasamy

Q&A

Complicated Acute Coronary Syndrome in an Elderly Patient: Usefulness of Intra-aortic Balloon Pump in Urgent High-riskPercutaneous Coronary Intervention Case Presenter: Etelberto Hernández

Q&A

IABP Support for Emergency Transfer Following Iatrogenic Coronary Dissection Case Presenter: Kevin O'Gallagher

Q&A

Breakfast Meeting: Moving Forward in Anticoagulation Care With the Availability of a Reversal Agent (Sponsored by Boehringer-Ingelheim)



Moving Forward in Anticoagulation Care With the Availability of a Reversal Agent

Moving Forward in Anticoagulation Care With the Availability of a Reversal Agent James A. Reiffel

Breakfast Meeting: The Transcatheter Revolution – Are You and the Heart Team Ready? (Sponsored by CRF, Supported by Medtronic, Inc.)

Walter E. Washington Convention Center Room 144C, Level 1Accreditation: CME


The Transcatheter Revolution – Are You and the Heart Team Ready?Co-Chairs: A. Pieter Kappetein, Paul Sorajja Facultys: Ted Feldman, Christopher U. Meduri, Michael J. Reardon, Mathew Williams

Going Beyond the High-risk Patient: The New Boundaries for Transcatheter Therapy Michael J. Reardon

The Halo Effect and Bottom-Line Results From Therapy Expansion Christopher U. Meduri

How to Meet the Logistical Challenges of a Rapidly Growing Program Mathew Williams

Leveraging the TAVR Experience Into TMVR: Similarities and Differences for the Heart Team Ted Feldman

Panel Q&A

Main Arena I, Sunday, Oct. 30

Walter E. Washington Convention Center Ballroom, Level 3Accreditation: CME/ASRT/CNE

Plenary Session I. Live CasesLive Case Moderator: Martin B. Leon Live Case Co-Moderator: Antonio Colombo Live Case Discussants: Alexandre Abizaid, Jorge A. Belardi, Paul Hsien-Li Kao, Dimitrios Karmpaliotis, Akiko Maehara, Seung-Jung Park,Ashok Seth, Craig R. Smith, Hendrik Treede, Stephan Windecker, Alan C. YeungDigital Moderator: Nirat Beohar Digital Panelists: Adriano Caixeta, Simon R. Dixon, Michael S. Lee Factoid Facultys: Jaya Chandrasekhar, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong Hwa Yamamoto

Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China Live Case Operators: Jie Qian, MD, Shubin Qiao, MD, Yongjian Wu, MD, Yuejin Yang, MD

Zhongshan Hospital, Shanghai, China Live Case Operators: Junbo Ge, Lei Ge, MD

Plenary Session II. Late-Breaking Clinical Trials 1: Cosponsored by The LancetModerator: Gregg W. Stone Digital Moderator: Wayne B. Batchelor Digital Panelists: Andrea Abizaid, Vinay K. Bahl, Francesco Prati Discussants: Giuseppe Biondi-Zoccai, Stephane Cook, Marco A. Costa, Stephen G. Ellis, John McB. Hodgson, Angela Hoye, Ik-Kyung Jang,Peter Juni, Sigmund Silber Co-Moderator: Stuart Spencer

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation inPatients With Coronary Artery Disease Ziad A. Ali

Moderated Roundtable Discussion Discussant: Ziad A. Ali

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-BasedDrug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary ArteryDisease Clemens von Birgelen

Moderated Roundtable Discussion Discussant: Clemens von Birgelen

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease David E. Kandzari

Moderated Roundtable Discussion Discussant: David E. Kandzari

Plenary Session III. Live CasesLive Case Moderator: Gregg W. Stone Live Case Co-Moderator: Patrick W. Serruys Live Case Discussants: Anita Asgar, Christian W. Hamm, Spencer B. King III, Ran Kornowski, Raj Makkar, Gary S. Mintz, Barry D.Rutherford, Manel Sabate, Joachim Schofer, Joanna J. Wykrzykowska, Ralph Stephan von Bardeleben Digital Moderator: Fernando Alfonso Digital Panelists: Ian C. Gilchrist, Detlef G. Mathey, Richard Smalling Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong Hwa Yamamoto

McGill University Health Center, Montreal, Canada Live Case Operators: Fahd Mahkdom, MD, Giuseppe Martucci, MD, Nicolo Piazza

Antwerp Cardiovascular Centre, ZNA Middelheim, Antwerp, Belgium Live Case Operators: Benjamin Scott, MD, Stefan Verheye, Paul Vermeersch, MD

Plenary Session IV. Career Achievement AwardAward Presenters: Martin B. Leon, Gregg W. Stone Award Recipient: Runlin Gao

Plenary Session V. TCT Focus Session#1: The Innovators RoundtableModerator: Juan F. Granada Digital Moderator: Louis A. Cannon Digital Panelists: Neal L. Eigler, Tim A. Fischell, Robert J. Lederman Discussants: Shmuel Banai, Todd J. Brinton, Daniel Burkhoff, Elazer R. Edelman, Andrew Farb, Peter J. Fitzgerald, Barry T. Katzen, FrankLitvack, John B. Simpson, Paul G. Yock Co-Moderator: Martin B. Leon

Featured Lecture: Interventional Innovation is Alive and Well – Reflections and Predictions Elazer R. Edelman

Featured Lecture: The Digital Health Revolution Will Transform Cardiovascular Disease Management in the Future Peter J. Fitzgerald

Animated Discussion

Plenary Session VI. First Report Investigations 1Moderator: David W.M. Muller Digital Moderator: Jonathan M. Hill Digital Panelists: Stephen P. Hoole, Hyo-Soo Kim, Jacek Legutko Discussants: Dariusz Dudek, Michael Joner, Henning Kelbæk, Takeshi Kimura, Masato Nakamura, Yoshinobu Onuma, Serban Puricel, DavidG. Rizik, Giulio G. Stefanini

ABSORB China: Two-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable VascularScaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Runlin Gao

Moderated Roundtable Discussion Discussant: Runlin Gao

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable VascularScaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease Patrick W. Serruys

Moderated Roundtable Discussion Discussant: Patrick W. Serruys

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-CoatedStent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk Philip M. Urban

Moderated Roundtable Discussion Discussant: Philip M. Urban

Coronary Theater I, Sunday, Oct. 30

Walter E. Washington Convention Center Coronary Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: LM/BifurcationLive Case Moderator: George D. Dangas Live Case Co-Moderator: Issam D. Moussa Live Case Discussants: Yasushi Asakura, Donald Cutlip, Jorge Gaspar, Dietmar H. Glogar, Michalis Hamilos, Niels R. Holm, Irene M. Lang,Manish A. Parikh, Jamil Abdalla Saad Digital Moderator: Kevin J. Beatt Digital Panelists: Somjot S. Brar, Jose de Ribamar Costa Jr, R. Stefan Kiesz Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

Antwerp Cardiovascular Centre, ZNA Middelheim Antwerp, Belgium Live Case Operators: Alessia Azzano, MD, Benjamin Scott, MD, Stefan Verheye, Paul Vermeersch, MD, PhD

Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China Live Case Operators: Jie Qian, MD, Shubin Qiao, MD, Yongjian Wu, MD, Yuejin Yang, MD

Session II. Live Cases: CTOs/CHIPLive Case Moderator: J. Aaron Grantham Live Case Co-Moderator: Christoph K. Naber Live Case Discussants: Carlo Briguori, Pawel E. Buszman, Andrejs Erglis, Gary Gershony, Robert J. Gil, Hyeon-Cheol Gwon, Thomas A.Ischinger, Henning Kelbæk, Bernhard Witzenbichler Digital Moderator: Alan C. Yeung Digital Panelists: Michael A. Kutcher, Gennaro Sardella, Hadley Wilson Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

Zhongshan Hospital, Fudan University, Shanghai, China Live Case Operators: Junbo Ge, Lei Ge, MD

McGill University Health Center, Montreal, Canada Live Case Operators: Sonny Dandona, MD, Rustem Dautov, MD, Stéphane Rinfret, Luiz Fernando Ybarra, MD

Didactic Session: Clinical Trial Design, Statistics, and Interpretation


Session I. Hot Topics in Clinical Trial DesignModerators: Roxana Mehran, Pascal Vranckx Discussants: Scott Berry, Sanjay Kaul, Thomas McAndrew, Stuart J. Pocock, John A. Spertus, Tracy Y. Wang

Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials Robert A. Harrington

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in aFrequentist Framework! Stuart J. Pocock

Debate: What Is the Optimal Study Design for Maximizing Trial Efficiency, Success, and Interpretability? Adaptive Design in ABayesian Framework! Scott Berry


Issues With Non-inferiority Trials: Choosing the Margin and Comparator; Creep, Noise, and More Sanjay Kaul

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance? John A. Spertus

The Extraordinary Frustration of Converting Meaningful Clinical Trial Results (and Guidelines) Into Changes in Clinical Practice Pascal Vranckx


Session II. Clinical Trial Interpretation – Common PitfallsModerators: Peter Juni, E. Magnus Ohman Discussants: Ori Ben-Yehuda, John A. Bittl, Ioanna Kosmidou, Stuart J. Pocock, Gregg W. Stone, Jan Tijssen

Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint? Gregg W. Stone

Levels of Evidence: Single-center vs Multicenter Trials Roxana Mehran

Clinical Trial Interpretation: Relative vs Absolute Differences John A. Bittl

Value and Hazards of Subgroup Analysis: the SYNTAX to EXCEL Case Study Ori Ben-Yehuda


Session III. Limitations of Observational Studies and Randomized TrialsModerators: Eugene H. Blackstone, Robert W. Yeh Discussants: Scott Berry, Donald Cutlip, Kirk N. Garratt, Robert A. Harrington, Stuart J. Pocock, Tracy Y. Wang

Importance of Unmeasured Confounders in Observational Registries: ASCERT and Other Examples Kirk N. Garratt

Comparison of Propensity Score Methods and Covariate Adjustment in Observational Studies: Similarities and Differences Stuart J. Pocock

Can Propensity and Instrumental Variable Methods Overcome the Limitations of Observational Databases: Lessons FromTRANSLATE-ACS Tracy Y. Wang

When Are Randomized Trials Not Enough, and Can Observational Data Reliably Inform Comparative Effectiveness Decisions? Robert A. Harrington


Session IV. If You Want to Publish, Do a Meta-analysis! BUT…Moderators: Ori Ben-Yehuda, Tullio Palmerini

Strengths and Limitations of Meta-analysis: Standard, Network and Bayesian Techniques, and the Value of Individual Patient-levelData Pooling Giuseppe Biondi-Zoccai

What Journal Editors Think of Meta-analysis: A Roundtable Discussion Discussants: Anthony N. DeMaria, Joseph A. Hill, Spencer B. King III, Stuart Spencer, David O. Williams

What Clinicians and Trialists Think of Meta-analysis: A Roundtable Discussion Discussants: David A. Cox, Donald Cutlip, Bernard J. Gersh, Laura Mauri, E. Magnus Ohman, Harvey D. White

What Statisticians Think of Meta-analysis: A Roundtable Discussion Discussants: Scott Berry, Eugene H. Blackstone, Peter Juni, Stuart J. Pocock, Jan Tijssen, Roseann White

Take-home Messages: Strengths, Limitations, and the Future of Meta-analysis Moderators: Ori Ben-Yehuda, Tullio Palmerini

Session V. Advanced Concepts You Should UnderstandModerators: Scott Berry, Stuart J. Pocock Discussants: Eugene H. Blackstone, Peter Juni, Bjorn Redfors, Jan Tijssen, William S. Weintraub

Limitations of Composite Endpoints and Strategies for Hierarchical Testing Jan Tijssen

Analyzing Repeat Events Eugene H. Blackstone

Accounting for the Risk of Competing Events Peter Juni

Surrogate Endpoints: Construction, Validation, and “Trustiness” William S. Weintraub

Mediation Analysis: A Method to Assign Attributable Risk Bjorn Redfors

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED,DAPT, and Others) Ajay J. Kirtane


Didactic Session: Interventional Therapies for Hypertension (Renal Denervation and Beyond)


Session I. Hypertension Treatment 2016: Updated Review of the EssentialsModerators: Felix Mahfoud, Michael A. WeberDiscussants: Chaim S. Lotan, Marie-Claude Morice, Vasilios Papademetriou, Wilko Spiering, Terje K. Steigen, Renu Virmani

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others) Michael A. Weber

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management? Ehtisham Mahmud


The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology) Michael Joner

Hypertension Treatment Targets Beyond the Kidneys Atul Pathak


Session II. Critical Appraisal of Ongoing and Planned Studies in Renal DenervationModerators: Farrell O. Mendelsohn, Stephen G. Worthley Discussants: Bagrat Alekyan, Steven L. Almany, Darrel P. Francis, Melvin D. Lobo, James R. Margolis, Kintur Sanghvi, Michael A. Weber

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year Felix Mahfoud

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices Horst Sievert

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials Bryan Williams

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE Ajay J. Kirtane

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program David E. Kandzari

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program William B. White

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study Laura Mauri

Device Overview and Ongoing Study Design: Kona WAVE IV Trial Roland E Schmieder

Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial David E. Kandzari

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Justin E. Davies

Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Martin B. Leon


Session III. Novel Hypertension Approaches Beyond Renal DenervationModerators: Ajay J. Kirtane, Bryan Williams Discussants: Mark C. Bates, Sameer Gafoor, Vasilios Papademetriou, C. Venkata S. Ram, Robert S. Schwartz, Horst Sievert, WojtekWojakowski

Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results Atul Pathak

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies Wilko Spiering

Shunt-based Technologies for Hypertension Control: The Rox Medical Program Paul A. Sobotka

Pacing-based Treatments of Hypertension: BackBeat Medical Karl-Heinz Kuck

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies William B. White


Session IV. Autonomic Modulation: New Targets, New OpportunitiesModerators: Elazer R. Edelman, Krishna J. Rocha-Singh Discussants: Justin E. Davies, Richard R. Heuser, Michael Joner, William B. White, Adam Witkowski

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure Farrell O. Mendelsohn

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias Vivek Y. Reddy

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions Adam Witkowski


Didactic Session: Left Atrial Appendage Closure, Part 1: Indications and Outcomes


Session I. Atrial Fibrillation Background and Management: Core ConceptsModerators: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt Discussants: Michael D. Ezekowitz, Christopher B. Granger, Michelle O'Donoghue, Vivek Y. Reddy

Atrial Fibrillation: Scope of the Problem Michael D. Ezekowitz

Role of LAA in Atrial Arrhythmias: Origin and Maintenance Karl-Heinz Kuck

Impact of LAA Exclusion on Neurohormonal Modulation DJ Lakkireddy

Warfarin and NOACS for Atrial Fibrillation: Efficacy, Complications, and Compliance Michelle O'Donoghue

What are Valid Absolute and Relative Contraindications to Warfarin and NOACs? Freek W.A. Verheugt

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation Vivek Y. Reddy

Risk Scores for Stroke Risk and Bleeding in Atrial Fibrillation: Accuracy and Utility in Trials and the Real World Christopher B. Granger


Session II. Clinical Outcomes After LAA ClosureModerators: Vivek Y. Reddy, Steven J. Yakubov Discussants: Krzysztof Bartus, Peter C. Block, Eulogio J. Garcia, Philippe Garot, Clifford J. Kavinsky, Giuseppe Tarantini

Surgical Approaches to LAA Closure: Techniques, Devices, and Results Marc Gillinov

Epicardial Closure of the LAA With the Lariat: What Do we Know About It’s Safety and Efficacy? Matthew J. Price

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant IndicatedPatients (Including Cost-effectiveness) Vivek Y. Reddy

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? David R. Holmes Jr.

Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry Martin W Bergmann


Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and FutureStudies Apostolos Tzikas

Early and Late Results With the Occlutech LAA Occluder (and Future studies) Horst Sievert

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies) Gregg W. Stone

Early and Late Results With the LAmbre LAA Occluder (and Future Studies) Yat-Yin Lam

Early Clinical Results With the Cardia LAA Occluder (and Future Studies) Josep Rodés-Cabau

Rationale for and Outcomes of LAA Closure Plus Pulmonary Vein Isolation Jamil Abdalla Saad


Session III. Two Great LAA Closure DebatesModerators: David R. Holmes Jr., Josep Rodés-Cabau Discussants: Steven R. Bailey, Patrick A. Calvert, Reda Ibrahim, Ioanna Kosmidou, Jan Kovac, Randall J. Lee

Pre-debate #1 Vote: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No – Chronic Anticoagulation Shouldbe Offered First Stefan C. Bertog

Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes – As Long As Full Consent IsProvided, Let the Patient Decide! David Hildick-Smith


Post-debate #1 Vote (Who Won?): Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

Pre-debate #2 Vote: How Should Patients With Atrial Fibrillation and Recent Stents or ACS Be Managed? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No – A Combination of AntiplateletAgents and Warfarin/NOACs Shoud Be Tried First! Freek W.A. Verheugt

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes – Minimize Bleeding Risk andImprove Long-term Outcomes! Brian K. Whisenant


Post-debate #2 Vote (Who Won?): How Should Patients With Atrial Fibrillation and Recent Stents or ACS Be Managed? Poll Moderators: David R. Holmes Jr., Josep Rodés-Cabau

Didactic Session: Metallic Drug-Eluting Stents: New Data, New Directions


Session I. Worldwide Clinical Trial Summaries and Updates With the Major DESModerators: Dean J. Kereiakes, Pieter C. Smits Discussants: Sripal Bangalore, Giuseppe De Luca, David G. Rizik, Erick Schampaert, Dinesh Shah, Christian M. Spaulding

Stent Design and Comprehensive Data Review: Xience Cobalt Chromium Fluoropolymer-Based Everolimus-Eluting Stents Tullio Palmerini

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy Dean J. Kereiakes

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents Roxana Mehran

Stent Design and Comprehensive Data Review: BioMatrix Biolimus-Eluting Stents Stephan Windecker

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents Shigeru Saito

Stent Design and Comprehensive Data Review: Orsiro Cobalt Chromium Sirolimus-Eluting Stents Thomas Pilgrim

Comparative DES Outcomes: What Have We Learned From 7 SORT-OUT Trials? Lisette Okkels Jensen

Comparative DES Outcomes: What Have We Learned From the SCAAR Registry? Update on Recent New Generation DES Stefan K. James

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond Patrick W. Serruys

The Last Word on DES in Diabetics: Two-Year TUXEDO Outcomes Upendra Kaul


Session II. Debate and Audience SurveyModerators: Manel Sabate, Robert-Jan van Geuns Discussants: Ehrin J. Armstrong, Dariusz Dudek, Giampaolo Niccoli, Ron Waksman, Simon J. Walsh, Hadley Wilson

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely UsedContemporary Metallic DES? No – for All Practical Purposes the Outcomes Are Similar! Julinda Mehilli

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely UsedContemporary Metallic DES? Yes – There Are Important Distinctions Relevant to Our Patients! Manel Sabate

Rebuttal Questions to the Debaters

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role! Eric R. Bates

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History! Sunil V. Rao

Rebuttal Questions to the Debaters

What Proportion of PCI Patients Will You Treat With BMS Today? Poll Moderators: Manel Sabate, Robert-Jan van Geuns


Session III: Metal Stent Failures: Deep Dive Into Stent Thrombosis and RestenosisModerators: Fernando Alfonso, Stephan Windecker Discussants: Fausto Feres, Ioannis Iakovou, Takeshi Kimura, Masato Nakamura, Pieter R. Stella, Thomas D. Stuckey

Very Late Failures After Metallic DES: Frequency and Clinical Predictors Mahesh V Madhavan

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as StentsEvolve? Aloke V. Finn

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer? Juan F. Granada

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES? Elazer R. Edelman

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies Yasunori Ueda

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With CaseExamples) Akiko Maehara

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis? Gary S. Mintz

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications Stephen WL Lee

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety? Giulio Guagliumi

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and ThrombosisTiming Robert-Jan van Geuns

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond Giulio G. Stefanini

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Case Presenter: Ehrin J. Armstrong

Prognosis and Treatment Options for DES Restenosis and Re-restenosis Fernando Alfonso

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Ron Waksman

Case Presentation: Evaluation and Management of Recurrent DES Restenosis Case Presenter: Adnan K. Chhatriwalla


Didactic Session: PCI Pharmacotherapy: Procedural Antithrombins and Acute/Chronic DAPT


Session I: Bivalirudin vs Heparin ± GP IIb/IIIa Inhibitors 2016: Dissecting the MeritsModerators: A. Michael Lincoff, Franz-Josef Neumann Discussants: Somjot S. Brar, Piera Capranzano, Mark B. Effron, Bill J. French, Yaling Han, Carey D. Kimmelstiel, Arnold Seto

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients UndergoingPrimary PCI! A. Michael Lincoff

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMIPatients Undergoing Primary PCI! Jorge F. Saucedo

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Harvey D. White

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Gregg W. Stone

Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials John A. Bittl


Session Question #1: In STEMI Patients Undergoing Primary PCI With Heparin Anticoagulation, How Frequently Should GP IIb/IIIaInhibitors Be Used? Poll Moderators: A. Michael Lincoff, Franz-Josef Neumann

Session Question #2: In STEMI Patients Undergoing Primary PCI With Femoral Access, What Proportion Should Be Treated WithBivalirudin ? Poll Moderators: A. Michael Lincoff, Franz-Josef Neumann

Session Question #3: In STEMI Patients Undergoing Primary PCI With Radial Access, What Proportion Should Be Treated WithBivalirudin? Poll Moderators: A. Michael Lincoff, Franz-Josef Neumann

Closing Comments From the Moderators: What Have We Learned? Moderators: A. Michael Lincoff, Franz-Josef Neumann

Session II: The Role of Cangrelor Across the Spectrum of PCIModerators: Deepak L. Bhatt, Christian W. Hamm Discussants: Dimitrios Alexopoulos, Dominick J. Angiolillo, David Erlinge, Eli I. Lev, Duane S. Pinto, Gary L. Schaer

Cangrelor Deep Dive: What Have We Learned From the CHAMPION Trials? Deepak L. Bhatt

Transitioning Between Cangrelor and Oral P2Y12 Inhibitors: All the Permutations Paul A. Gurbel

Debate: Making the Case for Cangrelor Use in All PCI Patients! Franz-Josef Neumann

Debate: Making the Case for Very Limited Use of Cangrelor! Sorin J. Brener


Session Question #1: What Percentage of Patients With STEMI Undergoing Primary PCI Should Be Treated With Cangrelor ? Poll Moderators: Deepak L. Bhatt, Christian W. Hamm

Session Question #2: In Patients With NSTE-ACS, What Is the Optimal P2Y12 Inhibitor Approach? Poll Moderators: Deepak L. Bhatt, Christian W. Hamm

Session Question #3: In Patients With Stable CAD Undergoing PCI Who Were Not Preloaded With An Oral P2Y12 Inhibitor, WhatPercentage Should Be Treated With Cangrelor ? Poll Moderators: Deepak L. Bhatt, Christian W. Hamm

Closing Comments From the Moderators: What Have We Learned? Moderators: Deepak L. Bhatt, Christian W. Hamm

Session III: DAPT DurationModerators: John A. Bittl, Daniel I. Simon Discussants: Sorin J. Brener, Hyeon-Cheol Gwon, Sanjay Kaul, Glenn N. Levine, Jean-François Tanguay, Philip M. Urban

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most! Laura Mauri

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most! Salvatore Cassese

Summary and Rationale For the ESC Guidelines on DAPT Duration After PCI Freek W.A. Verheugt

Summary and Rationale For the ACC-AHA Guidelines on DAPT Duration After PCI Glenn N. Levine

Strengths and Limitations of Risk Scores to Identify Patients for Long vs Short DAPT Roxana Mehran

Individualizing Care: Which Patients Might Benefit From Prolonged DAPT? Who Might Be Harmed? Robert W. Yeh

Optimal DAPT Duration After Complex or Complicated PCI: A Pooled Analysis Gennaro Giustino

If Prolonged (>1 year) DAPT Is Chosen: Choosing Between Clopidogrel, Prasugrel and Ticagrelor C. Michael Gibson

Rationale and Studies of P2Y12 Inhibitor Monotherapy After DES In Patients In Normal Sinus Rhythm Patrick W. Serruys

Do All Patients With ACS Need 1 Year (Or Longer) DAPT After PCI? Tullio Palmerini

From ARCTIC to ANTARCTICA: Is the Concept of Tailored Antiplatelet Therapy Finished Eric Van Belle


Session Question #1: What Is the Optimal DAPT Duration For Most Patients With Stable CAD Treated With Contemporary DES WhoAre at Low Bleeding Risk ? Poll Moderators: John A. Bittl, Daniel I. Simon

Session Question #2: What Is the Optimal DAPT Duration For Most Patients With Stable CAD Treated With Contemporary DES WhoAre at Moderate/High Bleeding Risk? Poll Moderators: John A. Bittl, Daniel I. Simon

Session Question #3: What Is the Optimal DAPT Duration For Most Patients With Troponin+ ACS Treated With Contemporary DESWho Are at Low Bleeding Risk? Poll Moderators: John A. Bittl, Daniel I. Simon

Session Question #4: What Is the Optimal DAPT Duration For Most Patients With Contemporary DES Who Are at Moderate/HighBleeding Risk ? Poll Moderators: John A. Bittl, Daniel I. Simon

Closing Comments From the Moderators: What Have We Learned? Moderators: John A. Bittl, Daniel I. Simon

Didactic Session: Peripheral Vascular Intervention, Part 1: Aortoiliac, Renal, Mesenteric, and Venous


Session I. Aortoiliac InterventionModerators: D. Christopher Metzger, Constantino S. Pena Discussants: Ehrin J. Armstrong, Lawrence A. Garcia, Zvonimir Krajcer, Kenneth Ouriel, Mehdi H. Shishehbor, David P. Slovut

Introduction to the TCT 2016 Peripheral Vascular Intervention Sessions Michael R. Jaff

Management of Iliac Artery Occlusions: Essential Literature Review Mehdi H. Shishehbor

Technical Components of Iliac Artery Occlusion Endovascular Treatment: The Tips and Tricks David P. Slovut

Optimal Stent Selection for Aortoiliac Intervention: Understanding the Differences Ehrin J. Armstrong

Management of Complications From Aortoiliac Intervention Constantino S. Pena


LIVE-IN-A-BOX CASE DEMONSTRATION: Aortoiliac Intervention Case Presenter: D. Christopher Metzger

Session II. Renal and Mesenteric IschemiaModerators: Gary M. Ansel, Michael R. Jaff Discussants: Herbert D. Aronow, Sahil A. Parikh, John H. Rundback, Ido Weinberg

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications? Sahil A. Parikh

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment Michael R. Jaff

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes Mehdi H. Shishehbor


LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia) Case Presenter: D. Christopher Metzger

Pre-debate Vote: Is Chronic Mesenteric Ischemia Best Managed by Surgery or Catheter-based Intervention? Poll Moderators: Gary M. Ansel, Michael R. Jaff

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention! Herbert D. Aronow

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Surgery

Rebuttal Questions From the Moderators and Audience

Post-debate Vote (Who Won?): Is Chronic Mesenteric Ischemia Best Managed by Surgery or Catheter-based Intervention? Poll Moderators: Gary M. Ansel, Michael R. Jaff

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It Constantino S. Pena

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia) Case Presenter: D. Christopher Metzger

Session III. Complex Venous InterventionModerators: Mahmood K. Razavi, Robert M. Schainfeld Discussants: Gary M. Ansel, Frank F. Ing, Lindsay S. Machan, Jose M. Wiley

Recannalizing Occluded Systemic Veins Case Presentation (With Discussion) Case Presenter: Frank F. Ing

Didactic Session: Radial Access and Intervention


Session I: Radial Access and Intervention – The EvidenceModerators: Francesco Burzotta, Sunil V. Rao Discussants: Olivier F. Bertrand, Davide Capodanno, Sanjit S. Jolly, Michael A. Kutcher, Samir B. Pancholy, Mladen I. Vidovich

Introduction Poll Moderators: Francesco Burzotta, Sunil V. Rao

Audience Survey: Question 1: How Often Do you Use Radial Access in ACS Patients? Poll Moderators: Francesco Burzotta, Sunil V. Rao

Audience Survey: Question 2: If I Am Unable to Complete the Procedure From the Radial Site, My Standard Approach Is to Switchto? Poll Moderators: Francesco Burzotta, Sunil V. Rao

Radial Access in ACS: Case Closed? Davide Capodanno

Update on Radial Artery Occlusion: Incidence, Presentation, Prevention, and Treatment Samir B. Pancholy

Radial to Femoral Crossovers: Frequency, Predictors and Techniques to Minimize Olivier F. Bertrand

Anatomical Variants and Their Impact on Radial Success Francesco Burzotta


Session II: Radial Approach Controversies – Rapid Fire DebatesModerators: Ian C. Gilchrist, James Nolan Discussants: Morton J. Kern, Mamas Mamas, Ramon Quesada, Jennifer A. Tremmel

Predebate Poll: Are Femoral Outcomes Worse at High Volume Radial Centers? Poll Moderators: Ian C. Gilchrist, James Nolan

Debate - Are Femoral Outcomes Worse at High Volume Radial Centers? The Evidence Is Clear, Femoral Outcomes Are Worse atHigh Volume Radial Centers! Michel R. Le May

Debate - Are Femoral Outcomes Worse at High Volume Radial Centers? Nonsense, Radial Operators Are Great at Femoral Access,Too! James Nolan


Postdebate Poll: Are Femoral Outcomes Worse at High Volume Radial Centers? Poll Moderators: Ian C. Gilchrist, James Nolan

Predebate Poll: Is Complex PCI With Radial Access as Good as With Femoral Access? Poll Moderators: Ian C. Gilchrist, James Nolan

Debate - Is Complex PCI Just As Good With Radial Access? Even Complex PCI Can Be Done via Radial Access! Ramon Quesada

Debate - Is Complex PCI Just As Good With Radial Access? Femoral Access Is Still the Way to Go for Complex Cases! John C. Messenger


Postdebate Poll: Is Complex PCI With Radial Access as Good as With Femoral Access? Poll Moderators: Ian C. Gilchrist, James Nolan

Predebate Poll: Is the Radial Approach Preferred for Patients With Prior CABG? Poll Moderators: Ian C. Gilchrist, James Nolan

Debate - Is the Radial Approach Preferred for Patients With Prior CABG? Femoral Access Is Preferred in Patients With Prior CABG!Daniel H. Steinberg

Debate - Is the Radial Approach Preferred for Patients With Prior CABG? It’s Just a Matter of Proficiency! Stefano Rigattieri


Postdebate Poll: Is the Radial Approach Preferred for Patients With Prior CABG? Poll Moderators: Ian C. Gilchrist, James Nolan

Predebate Poll: Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Poll Moderators: Ian C. Gilchrist, James Nolan

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? No Way, Preserve Future Dialysis Access atAll Costs! Michael S. Lee

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Of Course! Renal Patients Are at theHighest Risk! Binita Shah


Post Debate Poll: Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Poll Moderators: Ian C. Gilchrist, James Nolan

Session III: Perfecting the Transradial TechniqueModerators: Ian C. Gilchrist, Rajiv Gulati Discussants: Khaldoon Alaswad, Ivo Bernat, Ronald Caputo, Sasko Kedev, Tejas Patel, Adhir Shroff

Dealing With Arterial Tortuosity In the Arm, Chest, and Heart Tejas Patel

Increasing Guide Support: Large Bore Guides and Guide Extensions Rajiv Gulati

Transulnar PCI: How and When To Do It Sasko Kedev

Transradial CTOs: Strategies for Success Khaldoon Alaswad

PRACTICAL: A Randomized Trial of Radial Artery Clamp Time Shahar Lavi


Session IV: Radical Radial Cases and Teachable MomentsModerators: Francesco Burzotta, Shigeru Saito Discussants: Robert J. Applegate, Warren J. Cantor, Tak W. Kwan, Jose L. Leiva-Pons, Christopher Pyne

Unprotected Left Main and Multivessel Transradial PCI Case Presenter: Vladimir Dzavik

Addressing a CTO With Slender Technique Case Presenter: Shigeru Saito

My Best Radial Case of Last Year Case Presenter: Yujie Zhou

A Predictable Complication (In retrospect) and A Great Save: When Transradial Goes Wrong Case Presenter: Mauricio G. Cohen

A Complex Transradial Peripheral Case Case Presenter: Zoltan Ruzsa

Didactic Session: The Left Main and Bifurcation Summit, Part 1: Technique and Cases


Session I. Anatomical and Physiologic Considerations in Bifurcation LesionsModerators: Antonio Colombo, Thierry Lefevre Discussants: Nicolas Foin, Ioannis Iakovou, Allen Jeremias, Jens Flensted Lassen, Marco V. Wainstein, Joanna J. Wykrzykowska

Bifurcation Lesion Anatomy: The Basics Jens Flensted Lassen

How Intravascular Ultrasound Imaging Can Guide and Improve Left Main and Non-Left Main Bifurcation Lesion PCI: Studies andPractical Case examples Akiko Maehara

How Should I Use FFR in Left Main and Non-Left Main Bifurcation Lesions? Studies and Practical Case Examples Bon-Kwon Koo

Technical Uncertainties 1: When to Predilate the Side Branch? Studies and Practical Case Examples Hyeon-Cheol Gwon

Technical Uncertainties 2: Kiss, POT, and RePOT - When and How? Ioannis Iakovou


Session II. Left Main and Non-Left Main Bifurcation Lesion PCI: How to Do ItModerators: Philippe Généreux, David Hildick-Smith Discussants: Theodore A. Bass, Francesco Burzotta, Bernard R. Chevalier, Robert J. Gil, Azeem Latib, Thierry Lefevre

Lessons Learned From Bench Testing: What Should Be the Ideal Stenting Technique for Bifurcations? Nicolas Foin

Provisional Side Branch Stenting: Lesion Selection, Technique, and Decision-making Thierry Lefevre

Double Stenting With Culotte: Step-by-step Bernard R. Chevalier

Double Stenting With DK-Crush: Step-by-step Shao-Liang Chen

Double Stenting With TAP: Step-by-step Francesco Burzotta

Technical Aspects Specific for the Left Main Distal Bifurcation I: Lessons From Experience Nicholas J. Lembo

Technical Aspects Specific for the Left Main Distal Bifurcation II: Insights From the MITO Registry Sunao Nakamura


Session III. Novel Bifurcation Technologies and ApproachesModerators: Francesco Burzotta, Dean J. Kereiakes Discussants: Nirat Beohar, Antonio Colombo, Carlo Di Mario, Vladimir Dzavik, Manuel Pan, Goran Stankovic

Dedicated Bifurcation Stents (Tryton, Axxess, and Others): When, Why, and How? Antonio L. Bartorelli

BVS in Bifurcation Lesions: What to Do and What Not to Do Manuel Pan

Bail-out Side Branch Stenting After BVS Azeem Latib

Drug-eluting Balloons for Bifurcations in Daily Practice Goran Stankovic


Session IV. Left Main PCI in Daily Practice: Cases SeriesModerators: David E. Kandzari, Jens Flensted Lassen Discussants: Yaron Almagor, Dietmar H. Glogar, Thierry Lefevre, Alexander Grigorievich Osiev, Manuel Pan, Seung-Jung Park

Distal LM Cases With Difficult Side Branches Access Case Presenter: Thierry Lefevre

Complex Left Main Cases With Planned One-stent Approach Case Presenter: Yves R. Louvard

Complex Left Main Cases With Planned Two-stent Approach Case Presenter: David G. Rizik

Management of the Left Circumflex: Case Presentations Case Presenter: Carlo Di Mario

Strategies for Calcified Left Main Bifurcation Lesions Case Presenter: Mathew K. Samuel

A Case Series of Left Main Trifurcations Afzalur Rahman

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab Philippe Généreux


Didactic Session: Transcatheter Aortic Valve Therapies Part 1: Evolving Clinical Indications for TAVR - Now and in the Future

Walter E. Washington Convention Center Room 146B/C, Level 1Accreditation: CME/CNE/ASRT

Session I. TAVR 2016: Clinical Indications IModerators: Patrick T. O'Gara, Alec S. Vahanian Discussants: Samir R. Kapadia, A. Pieter Kappetein, Martin B. Leon, Michael J. Mack, Josep Rodés-Cabau, Wilson Y. Szeto, E. Murat Tuzcu

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR Samir R. Kapadia

An Interesting Alternative: The New WikiRecs for TAVR Use in Lower Risk Patients Catherine M. Otto

Flash Debate: Point – Guidelines Should Remain the Standard for Clinical Practice! Patrick T. O'Gara

Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving Transcatheter Valve Therapies! John G. Webb


Real-world Requirements and Expectations for TAVR in Lower Risk Patients Martin B. Leon

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Susheel Kodali

Intermediate-Risk Studies II: Updates From SURTAVI Jeffrey J. Popma


Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study Neil E. Moat

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial Michael J. Mack

Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Jeffrey J. Popma


Flash Debate: Point – Surgical Risk Stratification for TAVR Should Be Replaced by Anatomic and Clinical Profiling! Stephan Windecker

Flash Debate: Counterpoint – Stay the Course: We Need the Next Round of Low-Risk Randomized TAVR Studies AND Long-TermFollow-up to Justify Changes! Lars G. Svensson

Flash Debate: Counterpoint – The Emergence of TAVR Risk Scores Are a Better Solution to Patient Selection! David J. Cohen


Session II. TAVR 2016: Clinical Indications IIModerators: A. Pieter Kappetein, Allan Schwartz Discussants: Anita Asgar, Vinayak Bapat, Linda D. Gillam, Ran Kornowski, Jonathon A. Leipsic, Catherine M. Otto, Philippe Pibarot, Vinod H.Thourani

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR Lars Sondergaard

TAVR Outcomes and Technical Pearls in Bicuspid Aortic Stenosis (With Case Examples) Mathew Williams


Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies Danny Dvir

Transcatheter Valve-in-Valve Therapy: Clinical and Technical Pearls Vinayak Bapat


Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis Philippe Pibarot

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR Howard C. Herrmann


Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial Martin B. Leon

Severe Asymptomatic Aortic Stenosis: Introduction to EARLY-TAVR Philippe Généreux

Symptomatic High-Risk Aortic Regurgitation: Is TAVR A Viable Alternative? Hendrik Treede


Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies(Including MitraClip) Marco Barbanti

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much toTreat James B. Hermiller Jr

Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, andAccessory Therapies (Including LAA Closure) Samir R. Kapadia


Didactic Session: Transcatheter Mitral Valve Therapies Part 1: Current Standard of Care


Session I. Mitral Regurgitation: The Big PictureModerators: Ted Feldman, Allan Schwartz Discussants: Wayne B. Batchelor, Blase A. Carabello, JoAnn Lindenfeld, Francesco Maisano, Randolph P. Martin, Mark Reisman

A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists Mark Reisman

Epidemiology and Treatment of Primary and Secondary Mitral Regurgitation: Global Perspectives Ralph Stephan von Bardeleben

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the BenefitsSubstantial? JoAnn Lindenfeld

What’s New and What's Controversial in the US and EU Guidelines? Catherine M. Otto


Session II. Mitral Regurgitation Core Concepts: ImagingModerators: Paul A. Grayburn, Patrizio Lancellotti Discussants: Jeroen J. Bax, Linda D. Gillam, Jonathon A. Leipsic, Stamatios Lerakis, Maurice E. Sarano, Neil J. Weissman

Echo Quantification of MR Severity: Classification and Common Pitfalls Paul A. Grayburn

Prognostic and Treatment Decision Implications of Exercise Induced Mitral Regurgitation Patrizio Lancellotti

Strengths and Weaknesses of CMR for Quantification of MR Stamatios Lerakis

Emerging Role of CT for Assessment of Mitral Valve Anatomy and Dysfunction Hasan Jilaihawi

Procedural Guidance: Beyond TEE - ICE, Navigator, and More Brij Maini


Session III. Mitral Regurgitation: Evolution of Surgical TherapyModerators: Michael J. Mack, Francesco Maisano Discussants: Michael Argenziano, James S. Gammie, Marc Gillinov, Patrick M. McCarthy, Neil E. Moat, Robert L Smith

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs “Real Life” Surgeons Patrick M. McCarthy

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes? Robert L Smith

Applying Lessons From the CTSN to Clinical Practice Michael J. Mack

How Good Can Surgical Outcomes Be in Secondary MR? Michael Argenziano

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation Marco Moscarelli


Session IV. Mitral Regurgitation: New MitraClip Evidence and KnowledgeModerators: Alec S. Vahanian, Ralph Stephan von Bardeleben Discussants: Gorav Ailawadi, Stephan Baldus, Olaf Franzen, David W.M. Muller, Michael J. Rinaldi

MitraClip: 40,000 Cases Worldwide: What We Know and What We Don’t Ted Feldman

Updated MitraClip Outcomes From the STS TVT Registry Gorav Ailawadi

Updated MitraClip Outcomes From European Registries Ralph Stephan von Bardeleben

Predictors of MitraClip Outcomes: TRAMI and GRASP-IT Davide Capodanno

How and When to Use Multiple MitraClips Stephan Baldus

Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits? Hüseyin Ince

Techniques to Achieve >1+ MR After MitraClip: How Often Is This Obtainable? Saibal Kar

Complications After MitraClip: Frequency, Avoidance, and Treatment Scott Lim

Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients Gregg W. Stone

Pre-debate Vote: What Is the best treatment for End-stage Heart Failure Patient With Severe FMR? MitraClip or LVAD/Transplant?Poll Moderators: Alec S. Vahanian, Ralph Stephan von Bardeleben

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!Saibal Kar

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time – Go Straight toLVAD/Transplant! Nir Uriel

Post-debate Vote (Who Won?): What Is the Best Treatment for End-stage Heart Failure Patient With Severe FMR? MitraClip orLVAD/Transplant? Poll Moderators: Alec S. Vahanian, Ralph Stephan von Bardeleben


Learn the Technique (Case Reviews): Below the Knee Access and Intervention


Below the Knee Access and InterventionModerators: Koen Deloose, Jihad A. Mustapha Discussants: Lawrence A. Garcia, Ethan C. Korngold, Jose M. Wiley

How Do I Perform the "Ideal BTK Angioplasty?" Case-Based Experiences Case Presenter: Koen Deloose

Long CTO: How Do I Get Across Antegrade? Case Presenter: Ethan C. Korngold

When Do I Switch to Pedal Retrograde Access and How Do I Do it? Case Presenter: Jihad A. Mustapha

This Vessel Is a Rock! How and When to Debulk? Case Presenter: William A. Gray

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More Case Presenter: Jihad A. Mustapha

A Case Series of Ischemic and Nonischemic Leg Ulcers Case Presenter: Ethan C. Korngold

Learn the Technique (Case Reviews): Complex Bifurcations (Organized by the European Bifurcation Club)


Complex BifurcationsModerator: Goran Stankovic Discussants: Jens Flensted Lassen, Thierry Lefevre, Yves R. Louvard

How and When to Perform Provisional T Stenting According to EBC Standards (With Case Examples) Case Presenter: Thierry Lefevre


How and When to Perform Inverted Provisional T Stenting (Step-by-step With Case Examples) Case Presenter: Yves R. Louvard


How and When to Perform Culotte Stenting (Step-by-step With Case Examples) Case Presenter: Jens Flensted Lassen


How and When to Perform DK Crush Stenting (Step-by-step With Case Examples) Case Presenter: Goran Stankovic


Learn the Technique (Case Reviews): CTO Antegrade Reentry Techniques

Walter E. Washington Convention Center Room 144B, Level 1Accreditation: CME/ASRT/CNE

CTO Antegrade Reentry TechniquesModerators: Colm Hanratty, Simon J. Walsh Discussants: J. Aaron Grantham, James C. Spratt, R. Michael Wyman

Case #1: Antegrade Dissection and Reentry: Stingray Is Not STAR Case Presenter: James C. Spratt


Cases #2 and #3: Antegrade Dissection and Reentry: Bridgepoint Step-by-step (2 Cases) Case Presenter: Colm Hanratty


Cases #4 and #5: Antegrade Dissection and Reentry: Salvaging Success From Imminent Failure Case Presenter: R. Michael Wyman


Case #6: A Case That Could Only Be Done With Antegrade Dissection and Reentry Case Presenter: Simon J. Walsh


Learn the Technique (Case Reviews): Interventional “Rich Emotional Experiences” (aka Complications)


Interventional “Rich Emotional Experiences” (aka Complications)Moderator: Dimitrios Karmpaliotis Discussants: Khaldoon Alaswad, Emmanouil S. Brilakis, Francesco Pelliccia, Ashish Pershad, Minh Vo

Guide Catheter Complications Case Presenter: Francesco Pelliccia


My Worst Perforation of the Year Case Presenter: Khaldoon Alaswad


My Most Unforgettable Atherectomy Complication of the Year Case Presenter: Minh Vo


Stent Embolizations Case Presenter: Emmanouil S. Brilakis


A Guide Extension Misadventure Case Presenter: Ashish Pershad


Learn the Technique (Case Reviews): Management of Calcified Coronary Lesions

Walter E. Washington Convention Center Room 145A, Level 1Accreditation: CME/ASRT/CNE

Management of Calcified Coronary LesionsModerators: Mohamed Abdel-Wahab, Philippe Généreux Discussants: Maurice Buchbinder, Jeffrey Chambers, Ajay J. Kirtane, Jeffrey W. Moses, Mark Reisman

Case Presentations: Choosing Between Rotational and Orbital Atherectomy Case Presenter: Jeffrey W. Moses


Case Presentations: Knowing When Balloon-Only Lesion Preparation of Calcified Lesions Is Sufficient Case Presenter: Mohamed Abdel-Wahab


Case Presentations: Intravascular Imaging and Physiologic Assessment Should Be Mandatory When Treating Calcified Lesions Case Presenter: Ziad A. Ali


Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds Case Presenter: Manuel Pan


Learn the Technique (Case Reviews): Nuts and Bolts of FFR, iFR, and CFR


Nuts and Bolts of FFR, iFR, and CFRModerators: Javier Escaned, Habib Samady Discussants: Justin E. Davies, Allen Jeremias, David F. Kong, Giampaolo Niccoli

In This Case: FFR in Complex Multivessel PCI Was Key for Decision-making Case Presenter: Keith G. Oldroyd


In This Case: iFR Vessel Mapping Was Key to Identify the PCI Target Segment Case Presenter: Hitoshi Matsuo


In This Case: Contrast Was an Alternative to Adenosine for Stenosis Interrogation Case Presenter: William F. Fearon


In This Case: Microcirculation Assessment With CFR and IMR Was Key for Decision-making Case Presenter: Bon-Kwon Koo


Learn the Technique (Case Reviews): Nuts and Bolts of OCT Imaging


Nuts and Bolts of OCT ImagingModerators: Akiko Maehara, Francesco Prati Discussants: Hiram G Bezerra, Giulio Guagliumi, Yukio Ozaki, Enrico Romagnoli

Case Presentations: OCT-Guided Stent Implantation: How to Do It Case Presenter: Takashi Akasaka


Case Presentations: How to Deploy a Bioresorbable Scaffold With OCT. Preintervention and Postintervention Information Case Presenter: Corrado Tamburino


Case Presentations: Just Don’t Do it! Lessons From Baseline and Postintervention OCT Case Presenter: Francesco Prati


Case Presentations: When OCT Changes Your Strategy in ACS Case Presenter: Fernando Alfonso


Learn the Technique (Case Reviews): Paravalvular Leak Closure

Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME/ASRT/CNE

Paravalvular Leak ClosureModerators: Eulogio J. Garcia, E. Murat Tuzcu Discussants: Reda Ibrahim, Amar Krishnaswamy, Carlos E. Ruiz

Introduction to Paravalvular Leak Closure E. Murat Tuzcu

Case #1. Post-SAVR Paravalvulular Leak Case Presenter: Eulogio J. Garcia

Case #2. Post-TAVR Paravalvulular Leak Case Presenter: Reda Ibrahim


Case #3. Mitral Leak, Transfemoral Closure Case Presenter: Amar Krishnaswamy

Case #4 Mitral Leak, Transapical Closure Case Presenter: Carlos E. Ruiz


Take-home Message E. Murat Tuzcu

Learn the Technique (Case Reviews): Procedural Optimization of Bioresorbable Vascular Scaffolds


Procedural Optimization of Bioresorbable Vascular ScaffoldsModerators: Antonio Colombo, Gary S. Mintz Discussants: Azeem Latib, Maurizio Menichelli, Ashok Seth

Case Presentations: Bioresorbable Scaffolds in Diffuse Disease – How to Do It Case Presenter: Ashok Seth


Case Presentations: Bioresorbable Scaffolds in STEMI – How to Do It Case Presenter: Maurizio Menichelli


Case Presentations: How to Use IVUS to Optimize Bioresorbable Scaffold Implantation Case Presenter: Antonio Colombo


Case Presentations: Bioresorbable Scaffolds in Bifurcation Lesions – How to Do It Case Presenter: Azeem Latib


Learn the Technique (Case Reviews): TAVR Tips and Tricks


Learn the Technique (Case Reviews): TAVR Tips and TricksModerators: Stanley J. Chetcuti, Susheel Kodali Discussants: Vasilis Babaliaros, Vinayak Bapat, Isaac George, Christian Spies

Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned Case Presenter: Hasan Jilaihawi

Case #2: Transcatheter Valve-in-Valve in a Patient With a Small Aortic Bioprosthesis: Optimizing Hemodynamics Case Presenter: Vasilis Babaliaros

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented? Case Presenter: Isaac George

Case #4: Transseptal Transcatheter Treatment of Failed Mitral Bioprosthesis (With Tips and Tricks) Case Presenter: Christian Spies

Case #5: Suboptimal Transcatheter Treatment of Failed Prior Surgical Mitral Repair Case Presenter: Vinayak Bapat

Learn the Technique (Case Reviews): Transseptal Puncture


Transseptal PunctureModerators: Samir R. Kapadia, Horst Sievert Discussants: Saibal Kar, Paul Sorajja

Step-by-step Basic Transseptal Puncture Paul Sorajja

Complications of Transseptal Puncture: Recognition and Management Horst Sievert

Case #1: Transseptal Puncture for MitraClip Case Presenter: Saibal Kar


Case #2: Transseptal Puncture for Paravalvular Leak Closure Case Presenter: Samir R. Kapadia


Case #3: Transseptal Puncture for Left Atrial Appendage Closure Case Presenter: Brian K. Whisenant


Transseptal Puncture for Transcatheter Mitral Valve Repair Procedures: Technical and Imaging Considerations Samir R. Kapadia

Learn the Technique (Case Reviews): Acute Infarct Angioplasty and Cardiogenic Shock


Acute Infarct Angioplasty and Cardiogenic ShockModerators: Stefan K. James, Holger Thiele Discussants: Anthony H. Gershlick, Jose P.S. Henriques, Morton J. Kern, Michael J. Lim, Michael Mooney, Goran K. Olivecrona

Treatment of Cardiogenic Shock With IABP: I Believe There Is Still a Role! Case Presenter: Morton J. Kern

Treatment of Cardiogenic Shock With Impella or Tandem Heart Case Presenter: Jose P.S. Henriques

Treatment of Refractory Cardiogenic Shock With ECMO Case Presenter: Michael Mooney

Multivessel PCI in Cardiogenic Shock Case Presenter: Anthony H. Gershlick

Recognition and Treatment of Right Ventricular Cardiogenic Shock Case Presenter: Michael J. Lim

Learn the Technique (Case Reviews): Bailout Techniques for Transradial Complications


Bailout Techniques for Transradial ComplicationsModerators: Samir B. Pancholy, Tejas Patel Discussants: Rajiv Gulati, Sunil V. Rao

Case Presentation(s): How to Treat a Radial Artery Perforation Case Presenter: Sunil V. Rao


Case Presentation(s): How to Undo Catheter Kinks and Knots Case Presenter: Tejas Patel


Case Presentation(s): How to Remove Entrapped Hardware Case Presenter: Rajiv Gulati


Case Presentation(s): How to Treat a Radial Artery Pseudoaneurysm Case Presenter: Samir B. Pancholy


Learn the Technique (Case Reviews): Carotid and Stroke Intervention


Carotid and Stroke InterventionModerators: Zvonimir Krajcer, D. Christopher Metzger Discussants: Leo Nelson Hopkins, Rahul Sakhuja, Mark H. Wholey

Radial Access to Carotid Stenting Case Presenter: Sasko Kedev

Direct Carotid Access During Acute Stroke Intervention Case Presenter: Mark H. Wholey

Tips and Tricks for Use of Proximal Embolic Protection During Carotid Stenting: A Case Series Case Presenter: D. Christopher Metzger

Optimal Device Selection for Carotid Stenting Case Presenter: Rahul Sakhuja

Acute Stroke Intervention: Case #1 Case Presenter: Leo Nelson Hopkins

Acute Stroke Intervention: Case #2 Case Presenter: Bernhard Reimers

Learn the Technique (Case Reviews): Complex Congenital Interventions

Cardiovascular Research Foundation Room 143B, Level 1Accreditation: CME/ASRT/CNE

Complex Congenital InterventionsModerators: Ziyad M. Hijazi, Damien P. Kenny Discussants: Elchanan Bruckheimer, Matthew A Crystal, Clifford J. Kavinsky, Eustaquio Maria Onorato, Nathan W Taggart

Case #1: Creation of a Fenestration in a Failed Fontan With PLE Case Presenter: Nathan W Taggart


Case #2: Acquired Aortic Atresia (Coarctation of the Aorta) in the Adult Patient Case Presenter: Elchanan Bruckheimer


Case #3: Coronary Artery Fistula Closure Case Presenter: Damien P. Kenny


Case #4: ASD Closure in an Elderly Patient Case Presenter: Matthew A Crystal


Learn the Technique (Case Reviews): CTO Retrograde Reentry Techniques


CTO Retrograde Reentry TechniquesModerators: Masahiko Ochiai, James C. Spratt Discussants: Kambis Mashayekhi, Hisayuki Okada, Ashish Pershad, Eugene B. Wu

Case #1: IVUS-Guided Stent Reverse CART Case Presenter: Hisayuki Okada


Case #2: Laser-Assisted Reverse CART Case Presenter: Ashish Pershad


Case #3: Stent Reverse CART-Troubles and Solutions Case Presenter: Eugene B. Wu


Case #4: Rendezvous After Successful Reverse CART Case Presenter: Kambis Mashayekhi


Learn the Technique (Case Reviews): LAA Occlusion Tips and Tricks


LAA Occlusion Tips and TricksModerators: Matthew J. Price, Jason H. Rogers Discussants: Petr Neuzil, Ramon Quesada, Jacqueline Saw

Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away Case Presenter: Jacqueline Saw


Cases #3 and #4: Transseptal Puncture for LAA Closure - When Location Makes a Difference Case Presenter: Jason H. Rogers


Cases #5 and #6: Sheath Selection, Orientation, and Lobe Position to Optimize Occluder Deployment Case Presenter: Ramon Quesada


Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned Case Presenter: Petr Neuzil


Learn the Technique (Case Reviews): Left Main Intervention


Left Main InterventionModerators: David Hildick-Smith, Marie-Claude Morice Discussants: Alaide Chieffo, Philippe Garot, Talib Majwal, Seung-Jung Park

Case #1: One Stent Is Enough (for This and Most Patients)! Case Presenter: Philippe Garot


Case #2: Imaging Is Crucial! Case Presenter: Seung-Jung Park


Case #3: When Two Stents Are Needed: Nothing Is Better Than DK-Crush! Case Presenter: Shao-Liang Chen


Case #4: When Two Stents Are Needed: I Prefer Culotte! Case Presenter: David Hildick-Smith


Learn the Technique (Case Reviews): MitraClip Tips and Tricks

Walter E. Washington Convention Center Room 144C, Level 1Accreditation: CME/CNE/ASRT

MitraClip Tips and TricksModerators: James B. Hermiller Jr, Paul Sorajja Discussants: Hüseyin Ince, Samir R. Kapadia, Scott Lim, Moody M Makar

Case #1: Advanced MitraClip Steering: When Guide Torque and M-Knob Aren’t Enough Case Presenter: Scott Lim


Case #2: I Can’t Grasp the Leaflets - Tips and Tricks for the Difficult Grasp Case Presenter: Samir R. Kapadia


Case #3: Commissural MitraClip: Maximizing Success in the Corners Case Presenter: Hüseyin Ince


Case #4: The ABCs of Efficient TEE During MitraClip Case Presenter: Moody M Makar


Learn the Technique (Case Reviews): Nuts and Bolts of IVUS and NIRS Imaging


Nuts and Bolts of IVUS and NIRS ImagingModerators: Subhash Banerjee, Akiko Maehara Discussants: Ryan D. Madder, Gary S. Mintz, Keith G. Oldroyd

Case #1: Five Essentials From IVUS and NIRS Imaging Case Presenter: Akiko Maehara

Case #2: Pre-PCI Assessment of the Distal Left Main Bifurcation With Imaging Both Branches Case Presenter: Jose M. de la Torre Hernandez

Case #3: Severe Calcification Leading to Stent Underexpansion Case Presenter: Keith G. Oldroyd

Case #4: Progressive Intramural Hematoma Case Presenter: Subhash Banerjee

Case #5: Large Lipid Rich Plaque With Distal Embolization Case Presenter: Ryan D. Madder

Learn the Technique (Case Reviews): Venous Disease Intervention

Walter E. Washington Convention Center Room 143C, Level 1Accreditation: CME/CNE/ASRT

Venous Disease InterventionModerator: Brian G DeRubertis Discussants: Gary M. Ansel, Matthew D. Bacchetta, Mahmood K. Razavi, Kenneth Rosenfield, Akhilesh K. Sista

Lysis of Deep Venous Thrombosis Case Presenter: Akhilesh K. Sista

Catheter-Directed Thrombolysis for Pulmonary Emboli Case Presenter: Gary M. Ansel

Role of Pulmonary Embolism Response Team Case Presenter: Kenneth Rosenfield

Surgical Pulmonary Embolectomy for Pulmonary Emboli Case Presenter: Matthew D. Bacchetta

Stenting Chronic Venous Obstruction Case Presenter: Mahmood K. Razavi

Learn the Technique (Case Reviews): When Bypass Grafts Fail


When Bypass Grafts FailModerators: Barry D. Rutherford, Gerard T. Wilkins Discussants: David E. Kandzari, James M. McCabe, Masahisa Yamane, Robert J. de Winter

Case #1: LIMA-LAD Anastomotic Lesion With Heavily Calcified Native LAD Lesion Case Presenter: David E. Kandzari

Discussion and Roundtable Q&A

Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF Case Presenter: James M. McCabe


Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium Case Presenter: Masahisa Yamane


Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation Case Presenter: Colm Hanratty


CardioVascular Professionals (CVP) Course: 25th Annual Cardiovascular Nurse and Technologist Symposium Part II: Main Sessions


Session I. Welcome and Introductory Keynote

Welcome and Introduction Marian C. Hawkey

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime A. Pieter Kappetein

Session II. Transcatheter Aortic Valve TherapiesModerator: Marian C. Hawkey Discussants: Patricia Keegan, Amanda M Kirby, Sandra Lauck, Tamim Nazif

TAVR 2016: Where We Are and Where We Are Going Tamim Nazif

TAVR 2016: Making the Case For New Patient Subsets (Low Risk, Bicuspid, etc.) Patricia Keegan

Processes for Individualized TAVR Patient Selection and Clinical Pathways Sandra Lauck

Integration of the Extended Heart Team for Clinical Decision-Making in Patients With Aortic Stenosis Amanda M Kirby

Case Presentations and Moderated Discussion Moderator: Thomas H. Maloney Discussants: Marian C. Hawkey, Patricia Keegan, Amanda M Kirby, Sandra Lauck, Tamim Nazif

Discussion/ Q&A

Session III. Transcatheter Mitral/Tricuspid Therapies – Current and Emerging TherapiesModerator: Russell A. Brandwein Discussants: Rebecca T. Hahn, Elizabeth M. Perpetua

Transcatheter Mitral Valve Repair and Replacement: Today and Tomorrow Elizabeth M. Perpetua

From Surgical to Transcatheter Treatment of Tricuspid Regurgitation Russell A. Brandwein

Discussion

Session IV. Structural Heart Disease: It’s Not Only Valves!Moderator: Sarah Clarke Discussants: John D. Carroll, Jessica Forman, Samir R. Kapadia, Saibal Kar, Megan M Kennison

LAA Closure Review: Brief Review of Anatomy, Rationale, and Trial Results Jessica Forman

LAA Closure: What Have We Learned 18 Months After Approval? Saibal Kar

PFO Closure: Rationale, Patient Selection and Outcomes Megan M Kennison

Paravalvular Leak Repair: An Emerging Structural Procedure Samir R. Kapadia

Discussion/Q&A

Session V. TCT 360 – Peripheral Vascular InterventionModerator: Julie Logan Discussants: George L Adams, Amanda Bailey, Jessica Forman, Michael Guiry, D. Christopher Metzger, Laurie Z. Ventura

Lower Extremity Vascular Disease Intervention: Live Case Review (Wellmont Holston Valley Hospital) Case Presenter: Julie Logan

Session VI. Visit Nurse Tech Exhibits/ Lunch

Nurse Tech Exhibits/ Lunch

Session VII. Keynote

25th Anniversary Keynote Lecture Alexandre Abizaid

Session VIII. 25th Anniversary Special SessionModerators: Regina Deible, Mary K. Egan Discussants: Marian C. Hawkey, Alexandra J. Lansky, Thomas H. Maloney, Christopher M. Nelson

Introduction Regina Deible, Mary K. Egan

25th Anniversary Video Regina Deible, Mary K. Egan

Looking Back Over 25 Years of the Nurse/Tech Symposium Alexandra J. Lansky

Evolution of the Nurse/Tech Team Christopher M. Nelson

Evolution of the Nurse/Tech Role in the Cath Lab Mary K. Egan

What’s Next for the Nurse/Tech Team? Regina Deible

Moderated Discussion/Audience Q&A

Session IX. Complex Higher-Risk (and Indicated) Patients (CHIP)Moderator: Martina Kelly Speight Discussants: Sarah Clarke, Regina Deible, Philippe Généreux, William L. Lombardi, Paul D. Mahoney, Thomas H. Maloney, Mathew Williams

Deep Dive into CHIP (TED Talk): What Is It, and Why Is It Important? Ajay J. Kirtane

Edited Taped Cases 1: TBD Lauren Morris

Edited Taped Cases 2: TBD Colin M. Barker

Resources Needed for CHIP Michael Guiry

Session X. Debates/ ControversiesModerator: Russell A. Brandwein Discussants: Robert A. Guyton, Susheel Kodali, Marie-Claude Morice

Debate: TAVR for Low Risk Patients – Is It time? YES, the Data Is Sufficient and Our Patients Want It! Susheel Kodali

Debate: TAVR for Low Risk Patients – Is It time? NO, We Don’t Yet Know if It’s as Durable as Surgical AVR! Isaac George

Rebuttal and Q&A

Debate: PCI vs CABG for Left Main Disease - CABG Is and Remains the Gold Standard! Robert A. Guyton

Debate: Move Aside - PCI is Taking Over! Marie-Claude Morice

Rebuttal and Q&A

Session XI. Cath Lab Challenge

Introduction of Session Sarah Clarke

Round 1: Twenty Questions Christopher M. Nelson

Round 2 (the Top 3 Players): Five Questions Julie Logan

Crown the Winner! Russell A. Brandwein

iASSESS, Day 1 - Sunday, Oct. 30


iASSESS, Day 1: Morning SessionModerators: Tayo A. Addo, George D. Dangas

Femoral Access Technique, Complications, and Vascular Closure Devices Moderator: Jose M. Wiley Arnold Seto

Radial Access for Angiography and PCI: Technique, Complications, and Comparison to the Femoral Approach Moderator: Sunil V. Rao Jordan Safirstein

Stable Angina Decision-making: PCI vs CABG vs OMT Moderator: Tayo A. Addo Robert T. Pyo

Break

NSTEACS: Risk Stratification and Treatment Moderator: Emmanouil S. Brilakis Dimitriy N. Feldman

STEMI Treatment Strategies: Drugs and Devices Moderator: Tayo A. Addo Dharam J. Kumbhani

Cardiogenic Shock and High-risk PCI: Patient Approach and Hemodynamic Support Devices Moderator: Manish A. Parikh Sahil A. Parikh

Break

iASSESS, Day 1: Afternoon SessionModerators: Emmanouil S. Brilakis, Manish A. Parikh

Current Generation DES and Bioabsorbable Scaffolds Moderator: Dimitriy N. Feldman Rajesh V Swaminathan

Restenosis and Stent Thrombosis: Frequency, Predictors, and Treatments Moderator: George D. Dangas Rajesh V Swaminathan

Complex Coronary Lesions I: Left Mains, Bifurcations Moderator: Goran Stankovic Tayo A. Addo

Complex Coronary Lesions II: CTO, SVGs Moderator: Emmanouil S. Brilakis Kevin J. Croce

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients With ACS and PCI Moderator: Frederick Feit Sripal Bangalore

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation Moderator: Duane S. Pinto Dimitriy N. Feldman

International Session: Controversies in Left Main PCI Presented by: Bulgarian Society of Interventional Cardiology; Hungarian WorkingGroup of Interventional Cardiology; Hong-Kong Stent Group; Romanian Working Group of Interventional Cardiology


Controversies in Left Main PCIModerator: Michael Kang-Yin Lee Discussants: Istvan F. Edes, Valeri L Gelev, Bela Merkely, Stefan Mot, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Li-Wah Tam, Vasil Velchev,Lucian Zarma

Romania Presents: Left Main PCI in the Patient With New Onset ACS Lucian Zarma

Bulgaria Presents: A Case of Left Main PCI in a Patient With ACS Case Presenter: Ivo Petrov

Romania Presents: How Would I Treat This Patient? Stefan Mot

Bulgaria Presents: How Did I Treat This Patient? Case Presenter: Ivo Petrov


Bulgaria Presents: Distal Left Main Stenting Techniques Valeri L Gelev

Romania Presents: A Case of Distal Left Main PCI With Self-aposable Stents Using the “Cullotte Technique” Case Presenter: Marin Postu

Bulgaria Presents: How Would I Treat This Patient? Case Presenter: Kiril Karamfiloff

Romania Presents: How Did I Treat This Patient? Case Presenter: Marin Postu


Hungary Presents: Use of Imaging for Left Main PCI Optimization Istvan F. Edes

Hong Kong Presents: A Case of Imaging Guidance During Left Main PCI Case Presenter: Li-Wah Tam

Hungary Presents: How Would I Treat This Patient? Zoltan Ruzsa

Hong Kong Presents: How Did I Treat This Patient? Case Presenter: Li-Wah Tam


Hong Kong Presents: Complications of Left Main PCI Michael Kang-Yin Lee

Hungary Presents: A Case of a Complication of Left Main PCI Case Presenter: Zoltan Ruzsa

Hong Kong Presents: How Would I Manage This Complication? Li-Wah Tam

Hungary Presents: How Did I Manage This Complication? Case Presenter: Zoltan Ruzsa


International Session: TAVR in Patients With Severe Mitral Regurgitation and Coronary Artery Disease, Presented by the Coronary Atheromaand Interventional Cardiology Group (GACI); German Society of Cardiology, Working Group on Interventional Cardiology, Czech Associationof Interventional Cardiology and the Polish Association of Cardiovascular Interventions


Session I. Transfemoral TAVR in Patients With Severe Coronary Artery DiseaseModerators: Eric Van Belle, Jochen Wöhrle Discussants: Marian Branny, Dariusz Dudek, Michael Haude, Petr Kala, Jacek Legutko, Flavien Vincent

Introduction and Session Objectives Eric Van Belle

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in aSingle or Staged Procedure)? Dariusz Dudek

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure? Case Presenter: Flavien Vincent

Germany Responds: How Would I Treat This Case? Michael Haude

France Presents: How Did I Treat This Case? Flavien Vincent

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure? Case Presenter: Marian Branny

Poland Responds: How Would I Treat This Case? Marek Grygier

Czech Republic Presents: How Did I Treat This Case? Case Presenter: Marian Branny

Conclusions and Take-home Messages Jochen Wöhrle

Session II. Transfemoral TAVR in Patients With Severe Mitral RegurgitationModerators: Dariusz Dudek, Petr Kala Discussants: Michael Haude, Martin Mates, Eric Van Belle, Jochen Wöhrle

Introduction and Session Objectives Petr Kala

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single orStaged Procedures)? Holger Thiele

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Andrzej J. Ochala

France Responds: How Would I Treat This Case? Patrick Ohlmann

Poland Presents: How Did I Treat This Case? Case Presenter: Andrzej J. Ochala

Germany Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure? Case Presenter: Michael Haude

Czech Republic Responds: How Would I Treat This Case? Martin Mates

Germany Presents: How Did I Treat This Case Michael Haude

Conclusions and Take-home Messages Dariusz Dudek

International Session: Management of Complex Cardiovascular and Structural Interventions Presented by the Working Group onInterventional Cardiology, Cardiology Society of Serbia; FYR Macedonian Society of Cardiology; Hellenic Society Working Group onInterventional Cardiology; Cyprus Society of Cardiology; and Slovenian Working Group for Interventional Cardiology


Management of Complex Cardiovascular and Structural InterventionsModerator: Georgios Sianos Discussants: Matjaz Bunc, Christos Christou, Milan A. Nedeljkovic, Sinisa Stojkovic Co-Moderator: Sasko Kedev

Introduction and Session Objectives Sinisa Stojkovic

The Big Picture: CTO and TAVR in Everyday Practice? Georgios Sianos

Case Reviews: TAVR Valve-in-Valve Case Presenter: Matjaz Bunc

My Thoughts on TAVR Valve-in-Valve Procedures Milan A. Nedeljkovic


Case Reviews: Selecting the Optimal Strategy for Complex CTO Intervention Case Presenter: Georgios Sianos

My Thoughts on Strategy Selection for Complex CTOs Sinisa Stojkovic


Case Reviews: Transradial Approach in Complex Coronary Lesions Case Presenter: Sasko Kedev

My Thoughts on the Radial Approach in Complex PCI Christos Christou


Take-home Messages? Sasko Kedev

International Session: Challenging Complex Cases From Tunisia, Iran, and UAE Presented by Tunisian Working Group on InterventionalCardiology (GTCI), Iranian Society of Interventional Cardiology (ISOIC), and Emirates Cardiac Society


Challenging Complex Cases From Tunisia, Iran, and UAEModerators: Habib Gamra, Mahmoud Hashemian, Abdullah Shehab

Introduction and Session Objectives Abdullah Shehab

BVS in Primary PCI Using A Robotic Cath Lab System Case Presenter: Arif Al Nooryani


Complicated CTO PCI Case Presenter: Negar Salehi

Complicated CTO PCI: Lessons From an Expert Case Presenter: Mahmoud Hashemian


Simultaneous TAVR and Endovascular Aortic Aneurysm Repair Case Presenter: Walid Ouertani

Management and Long-term Outcome of a Dislodged Stent in the Left Main Case Presenter: Zied Ben ElHadj


Conclusions and Take-home Messages Habib Gamra

International Session: Complex Cases and Complications in Coronary and Structural Intervention Presented by the Portuguese Associationof Interventional Cardiology (APIC); Sociedade Brasileira de Hemodinâmica e Cardiología Intervencionista (SBHCI); Philippine HeartAssociation and the Singapore Cardiac Society


Complex Cases and Complications in Coronary and Structural InterventionModerators: Rui Campante Teles, Marcelo Jose de Carvalho Cantarelli Discussants: Huay Cheem Tan, Richard Nicandro Torres

Portugal Presents a Case: MitraClip and LAA Closure - Both in the Same Procedure


Brazil Presents a Case: Complex Access in TAVI – the Transcaval Approach Case Presenter: Dimytri Alexandre Siqueira


Singapore Presents a Case: Complex PCI Case Presenter: Jack Wei Chieh Tan


Philippines Presents a Case: Cardiogenic Shock in Non-STEMI Case Presenter: Richard Nicandro Torres


Portugal Presents a Case: CHIP - Complete Revascularization in MVD With CTO Case Presenter: João AB Brum Silveira


Brazil Presents a Case: An Unusual Thrombus During Primary PCI Case Presenter: Alexandre Schaan Quadros


Closing Remarks Marcelo Jose de Carvalho Cantarelli

International Session: Our Most Educational Interventional Cases Presented by Colegio Argentino de Cardioangiólogos Intervencionistas(CACI) and Groupe Atheroma et Cardiologie Interventionnelle (GACI)


Our Most Educational Interventional CasesModerator: Alejandro Cherro Discussants: Matthieu Godin, Jose O. Gomez Moreno, Raul Solerno, Ernesto M. Torresani

Introduction and Session Objectives Alejandro Cherro

Argentina Presents a Case of a LIMA-Coronary Vein Fistula Post-CABG Case Presenter: Ernesto M. Torresani

Review of Postsurgical Iatrogenic Coronary Fistulae? Jose O. Gomez Moreno


Argentina Presents a Case of a Percutaneous Closure of Paravalvular Aortic Regurgitation Case Presenter: Raul Solerno

Management Options for Postsurgical Paravalvular Aortic Regurgitation Fernando Cura


France Presents a Case of an Aortic Valve in Valve Procedure

Treatment Options After Unsuccessful Aortic Valve Replacement Oscar A. Mendiz


France Presents a Case of Post-Myomectomy Subaortic Interventricular Communication: Endovascular Management Case Presenter: Matthieu Godin


International Session: Current PCI Controversies in Left Main Intervention Presented by the Canadian Association of InterventionalCardiology; Danish Cardiological Society; Vietnamese Cardiovascular Society; Korean Society of Interventional Cardiology.


Current PCI Controversies in Left Main InterventionModerators: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen Discussants: Evald H. Christiansen, Payam Dehghani, Kyung Woo Park, Hung Manh Pham, Erick Schampaert

Introduction Thomas Engstroem

Canada Presents: CABG vs PCI in Left Main Disease Samer Mansour

Denmark Presents: A Case of Restenosis in the Left Main Bifurcation Case Presenter: Jens Flensted Lassen

Canada Comments: How Would I Treat This Case? Case Presenter: Payam Dehghani

Denmark Presents: How Did I Treat This Case? Case Presenter: Jens Flensted Lassen

Canada Presents: A Case of "Ad Hoc" Left Main PCI Case Presenter: Erick Schampaert

Vietnam Comments: How Would I Treat This Case? Hung Manh Pham

Canada Presents: How Did I Treat This Case? Case Presenter: Erick Schampaert

Vietnam Presents: A Case of Recurrent, Subacute Left Main Stent Thrombosis Case Presenter: Quang Ngoc Nguyen

Denmark Comments: How Would I Treat This Case? Evald H. Christiansen

Vietnam Presents: How Did I Treat This Case? Case Presenter: Quang Ngoc Nguyen

South Korea Presents: A Case of Left Main Bifurcation Disease With LAD CTO in a Young Patient Case Presenter: Kyung Woo Park

Denmark Comments: How Would I Treat This Case? Lisette Okkels Jensen

South Korea Presents: How Did I Treat This Case? Case Presenter: Kyung Woo Park

Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCI Guidance Jean-Michel Paradis

Conclusion and Take-home Messages Thomas Engstroem

International Session: Current PCI Hot Topics: Management of Complications and BRS for Complex Lesions presented by AICT (AsianInterventional Cardiovascular Therapeutics), APSIC (Asian Pacific Society of Interventional Cardiology), TSCI (Taiwan Society of

Cardiovascular Interventions), ISIC (Indonesian Society of Interventional Cardiology), CIAT (Cardiovascular Intervention Association ofThailand), and CVIT (Japanese Association of Cardiovascular Intervention and Therapeutics)


Session I. Optimization of Outcomes After PCI With Bioresorbable ScaffoldsModerators: Teguh Santoso, Wasan Udayachalerm Discussants: Jun-Jack Cheng, Muhammad Munawar, Mathew K. Samuel, Huay Cheem Tan, Damras Tresukosol, Chiung Jen Wu, YoshitoYamamoto, Robaayah Zambahari

Introduction Wasan Udayachalerm

Treatment of Chronic Total Occlusions Naoki Masuda

Treatment of Bifurcation Stenosis Teguh Santoso

Treatment of In-Stent Restenosis Wasan Udayachalerm

Late Bioresorbable Scaffold Malapposition and Aneurysm Jun-Jack Cheng

Roundtable Discussion With Audience Q&A Moderators: Teguh Santoso, Wasan Udayachalerm

Conclusion and Take-home Message Teguh Santoso

Session II. PCI for Complex LesionsModerators: Jun-Jack Cheng, Yoshito Yamamoto Discussants: Muhammad Munawar, Mathew K. Samuel, Teguh Santoso, Huay Cheem Tan, Damras Tresukosol, Wasan Udayachalerm,Chiung Jen Wu, Robaayah Zambahari

Introduction Yoshito Yamamoto

Case #1 (From Japan): Perforation During CTO Intervention: Case Introduction Case Presenter: Satoru Sumitsuji

Comments on Case #1 (From Taiwan): How Would I Treat? Commentator: Paul Hsien-Li Kao

Case #1 (From Japan): Perforation During CTO Intervention: How Did I Treat? Case Presenter: Satoru Sumitsuji


Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction Case Presenter: Linda Lison

Comments on Case #2 (From Thailand): How Would I Treat? Commentator: Anuruck Jeamanukoolkit

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat? Case Presenter: Linda Lison


Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: Case Introduction Case Presenter: Wen-Lieng Lee

Comments on Case #3 (From Indonesia): How Would I Treat? Commentator: Muhammad Munawar

Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: How Did I Treat? Case Presenter: Wen-Lieng Lee

Roundtable Discussion With Audience Q&A Moderators: Jun-Jack Cheng, Yoshito Yamamoto

Conclusions and Take-home Message Jun-Jack Cheng

Partnership Session: SOLACI in Partnership With TCT: Complex Cinical Cases Resolved With Current Evidence


SOLACI in Partnership With TCT: Complex Cinical Cases Resolved With Current EvidenceModerators: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad

Introduction and Session Objectives Moderator: Ricardo Lluberas

Case 1: Primary PTCA With High Thrombotic Burden: How Did I Treat it? Case Presenter: Gustavo S. Vignolo

Comments and What I Might Have Done Differently Fausto Feres

Case 2: A Complex Left Main Bifurcation: How Did I Treat it? Case Presenter: Mario Araya

Comments and What I Might Have Done Differently Oscar A. Mendiz

A Proximal LAD Chronic Total Occlusion. How Did I Treat It? Fernando Cura

Comments and What I Might Have Done Differently Jose L. Leiva-Pons

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It? Antonio Enrique Dager

Comments and What I Might Have Done Differently Jose Armando Mangione

Session Evaluation and Take-home Messages Jeffrey W. Moses

Partnership Session: TCT Highlights at BIT


Percutaneous Intervention for Complex Lesions: "Keep It Simple!"Moderator: Afzalur Rahman Discussants: Abdullah Al Shafi Majumder, Rabin dra Nath Chakraborty, Alaide Chieffo, Alok Mazumdar, Christoph K. Naber, Sanjeeb Roy

Welcome and Introductory Remarks Afzalur Rahman

Case #1: Left Main PCI: Keep It Simple Case Presenter: Afzalur Rahman


Case #2: Bifurcation PCI: Keep It Simple Case Presenter: Alaide Chieffo


Case #3: CTO PCI: Keep It Simple Case Presenter: Kaisar Nasrullah Khan


Case #4: Complex PCI From the Radial Artery: Keep It Simple Case Presenter: Rabin dra Nath Chakraborty


Take Home Messages: Keep it Simple, But Not Too Simple! Christoph K. Naber

Closing Remarks Rabin dra Nath Chakraborty

Interventional Innovation I: Interventional Innovation and Best Technological Concepts I


Session I. Peripheral Vascular InnovationsModerators: Lawrence A. Garcia, Jihad A. Mustapha Discussants: Robert M. Bersin, Salvatore Cassese, Eric J. Dippel, Alan B. Lumsden, D. Christopher Metzger, Stephen R. Ramee

Novel Sirolimus Eluting Coated Balloon (Med Alliance) John E. Shulze

A Novel System to Save Contrast During Coronary Angiography: The DyeVert Randomized Controlled Study Steffen Desch


Low Frequency Therapeutic Ultrasound (LOTUS) to Improve Outcomes of Acute and Chronic Kidney Disease (Sonogenix) Michael Dae


Catheter-Based Venous Clot Retractor and Encapsulation Technology (XCoil) Paul Abrams


Novel Catheter for the Treatment of Acute Pulmonary Embolism and Large Vessel DVT (Thrombolex) Riyaz Bashir


Session II. Interventional Heart FailureModerators: Daniel Burkhoff, Ileana L. Pina Discussants: Jozef Bartunek, JoAnn Lindenfeld, William W. O'Neill, Atul Pathak, John S. Sapirstein, Hiroo Takayama

Caval Flow Regulator Catheter Balloon for Heart Failure Treatment Jose E. Herrera


Novel Device Based Therapy for Heart Failure Preserved Ejection Fraction Samuel J. Asirvatham


Percutaneous Platform Technology for Intra-cardiac Sensing in Heart Failure Patients (CorVivo) James Coleman


Non-blood Contacting Cardiac Assist Device for Heart Failure Patients (CorInnova) William C Altman


Moderated Discussion: Interventional Heart Failure

Session III. Emerging Mitral Repair TechnologiesModerators: Ted Feldman, Juan F. Granada Discussants: Jeffrey S. Borer, Maurice Buchbinder, Marco Moscarelli, Jason H. Rogers, Carlos E. Ruiz, Frederick G. St. Goar

Transcatheter Leaflet Extender for Mitral Valve Repair (MitraPlug) Muralidhar Padala


Transcatheter Mitral Chordal Replacement (ChordArt) Alberto Weber


Percutaneous Plication of Mitral Valve Prolapse (MitraClamp) Rachid Zegdi


Transvascular Repair of Mitral Valve Prolapse: The Mitral Butterfly Werner Mohl


Moderated Discussion: Emerging Mitral Repair Technologies

Session IV. TAVR Innovations and Ancillary DevicesModerators: Mark Reisman, Josep Rodés-Cabau Discussants: Jorge A. Belardi, Goran K. Olivecrona, Michael J. Reardon, Gerhard C. Schuler, Giuseppe Tarantini, Torsten P. Vahl

Anatomical Device Imaging Reconstruction for Procedural Planning in SHD Interventions (FEOPS) Matthieu De Beule


First-In-Human Experience With a Novel Active Fixation Temporary Pacing Lead: Safety and Efficacy of the Tempo Lead Mark W.I. Webster

The Role of Non-invasive Central Aortic Pressures In Cardiovascular Disease Eyal Ben -Assa


Total Embolic Protection in TAVR Procedures (Emboline) Scott Russell


A Novel Bioprosthesis Designed for Optimization of Valve-in-Valve Procedures Danny Dvir


Foldax: Preclinical Results With a Novel Thin-leaflet Synthetic Valve Steven J. Yakubov

Roundtable Discussion with Audience Q&A

Moderated Discussion: TAVR Innovations and Ancillary Devices

Special Session: Japan-USA Synergies 12th Year at TCT - HBD 2016 Think Tank West


Session I. Introduction of HBD, Japan-USA SynergiesModerators: Neal Fearnot, Hiroyoshi Yokoi Discussants: Mitchell W. Krucoff, Steve Rowland

“HBD” History and Significance Mitchell W. Krucoff

Lessons Learned Through HBD: The Regulator’s View Madoka Murakami

Lessons Learned Through HBD: The Industry’s View Steve Rowland


Session II. Harmonization by DataModerator: Mitchell W. Krucoff Discussants: Neal Fearnot, John C Laschinger, Danica Marinac-Dabic, Shigeru Saito Co-Moderator: Kazuhiro Sase, MD, PhD

Latest Discussion in MDEpiNet and IMDRF Registry WG Danica Marinac-Dabic

Efforts in Japan: JMACS, JTVAR Registry, CIN Akihide Konishi

Aims and Goals of the International TAVR Registry John C Laschinger

Utilization of Registry Data in Medical Care Taku Inohara

Significance of Post-Marketing Data for Industry Neal Fearnot


Session III. How Can Digital Technology Change Medical Care?Moderators: Fumiaki Ikeno, Linda Ricci Discussants: Akihide Konishi, Michael McConnell, Joseph Robertson, John Stevens, Bradley Merrill Thompson

Digital Health Technology Peter J. Fitzgerald

Digital Health Products Handling in Japan Akihide Konishi

Current Status of US Medical Software Related Regulations Linda Ricci

Industry’s Challenges in the US and Japan John Stevens

Wearable Device Changes Medical Care Joseph Robertson

Digital Health Regulation Bradley Merrill Thompson


Lunch

Session IV. Atherectomy Device and Drug-Coated BalloonModerators: Schuyler Jones, Misti Malone Discussants: Shin Iwamoto, George Papandreou, Steve Rowland, Scott Ward, Eleni Whatley, Hiroyoshi Yokoi

US Academia View Michael R. Jaff

Japan Academia View Hiroyoshi Yokoi

Overview of the Clinical Trials for Drug-Coated Balloons George Papandreou

Overview of the Clinical Trials for Atherectomy Brad Martinsen, PhD

Points To Consider in the Review of Endovascular Treatment Devices: Japanese Regulatory View Shin Iwamoto

Points to Consider in the Review of Endovascular Treatment Devices: US Regulatory View Eleni Whatley


Session V. Who Are the Most Appropriate Subjects for Left Atrial Appendage Closure Devices?Moderators: Mitchell W. Krucoff, Shigeru Saito Discussants: Hidehiko Hara, Rachel Neubrander, Kenneth Stein, MD, Sara Takahashi

Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure DeviceCandidates in Both Countries Christopher B. Granger

Appropriate Use Criteria of LAA Closure Devices: US Industry View Kenneth Stein, MD

Appropriate Use Criteria of LAA Closure Devices: FDA’s View Rachel Neubrander

Appropriate Use Criteria of LAA Closure Devices: PMDA’s View Sara Takahashi


Session VI. Novel HBD Approaches to Introduction in US and JapanModerator: Mitchell W. Krucoff Discussants: Neal Fearnot, Fumiaki Ikeno, Madoka Murakami

TVA Medical Approach Katherine Kumar

Summary Mitchell W. Krucoff

Special Session: Advances in Endovascular Treatment of Aortic Disease: Learning Through Cases and Debates


Advances in Endovascular Treatment of Aortic Disease: Learning Through Cases and DebatesModerators: Robert M. Bersin, Brian G DeRubertis Discussants: Ehrin J. Armstrong, Michael D. Dake, Christoph A. Nienaber, Ivo Petrov

State of the Art Lecture: Limitations With Current EVAR Technology and What Lies Ahead Barry T. Katzen

Complex Endograft Cases: Sealing Techniques, Chimneys, and Snorkels Case Presenter: Venkatesh G Ramaiah

Case Presentation: Ruptured AAA Case Presenter: Brian G DeRubertis

Management of Ruptured Abdominal Aortic Aneurysms - Open vs Endovascular Repair Zvonimir Krajcer


Postdebate Vote: Should Most Ruptured Abdominal Aortic Aneurysms Be Treated With Open Surgical Repair vs EndovascularTechniques ? Poll Moderators: Robert M. Bersin, Brian G DeRubertis

Management Strategies for Complicated Acute Type B Dissection: Case-Based Illustrations Case Presenter: Christoph A. Nienaber

Treatment Strategies to Rescue Failing Endografts Constantino S. Pena

State-of-the-Art Lecture: Latest Advances in a Large Bore Vascular Closure Devices - What Does the Future Hold? Zvonimir Krajcer


Special Session: TCT 2016 Transcatheter Heart Valve Innovation Session


Session I. Bench to Bedside: The Conundrum of Pre-Clinical Testing for Transcatheter Valve Therapies – When Is My Device Ready forHuman Testing?Moderators: Elazer R. Edelman, Juan F. Granada, Changfu Wu Discussants: Aaron Chalekian, Robert Chang, Andrew Cleeland, Andrew Farb, Rick Geoffrion, Claire Hambright, Natalie Miller, Yoram Richter,Victoria Rodriguez, Jonas Runquist

FDA Perspectives Changfu Wu

Animal Testing: FDA Expectations Natalie Miller

Animal Testing: “Real-World” Experiences and Translational Challenges Juan F. Granada

Transcatheter Mitral Replacement Devices: An Update from the International Organization for Standardization (ISO) Cardiac ValvesCommittee Aaron Chalekian

Panel Discussion and Audience Q&A

Session II. First-In-Human Use: Device Failure Modes and Lessons Learned from Early Human StudiesModerators: John G. Webb, Ajit Yoganathan Discussants: John P. Cheatham, James B. Hermiller Jr, Albert Markus Kasel, Timothy Kelley, Scott Lim, Ulrich Steinseifer, Hendrik Treede

The TAVR Development Journey: Lessons Learned and Drivers of Success John G. Webb

Lessons Learned from Early FIH/EFS Trials: Mitral Valve Replacement and Repair Technologies Vinayak Bapat

Lessons Learned from Early FIH/EFS Trials: Tricuspid Valve Repair Technologies Scott Lim

Lessons Learned from Early FIH/EFS Trials: Transcatheter Pulmonary Valve Replacement John P. Cheatham


Session III. The Transition to Pivotal Clinical Trials: How to Launch the Clinical Pathway…Moderators: Charles J. Davidson, Nicole Ibrahim Discussants: Marco Barbanti, Andreas Baumbach, Stephen J.D. Brecker, Mayra Guerrero, John C Laschinger, Dan Mans, James M. McCabe

FDA Perspectives John C Laschinger

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials Paul Sorajja

TMVR Clinical Trial Design: Early Insights from Industry Dan Mans


Session IV. Ongoing Controversies (Clinical and Otherwise) in Transcatheter Valve TherapiesModerators: Carlos E. Ruiz, Ulrich Steinseifer Discussants: Danny Dvir, Wayne Falk, Rebecca T. Hahn, Hasan Jilaihawi, Russ Joseph, Raj Makkar, David Mester, Neelakantan Saikrishnan

Leaflet Thickening, Dysfunction, and Thrombosis: Latest Recommendations by the ISO Cardiac Valves Committee Ulrich Steinseifer

Leaflet Thickening, Dysfunction, and Thrombosis: Clinical Perspectives- Are Problems Under-Reported? Are the Changes a ClassEffect? Raj Makkar


Paravalvular Regurgitation - The Achilles Heel or Problem Solved: Latest Updates on the Assessment of Paravalvular Regurgitation(Aortic and Mitral) Rebecca T. Hahn

Paravalvular Regurgitation - The Achilles Hell or Problem Solved: Better Assessment of PVL on the Bench - Recommendations bythe ISO Cardiac Valves Committee Neelakantan Saikrishnan


Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Engineering Perspectives Ajit Yoganathan

Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Clinical Updates Danny Dvir


Presentation Theater Program: LDL and the Interventional Cardiologist (Sponsored by AMGEN)

Walter E. Washington Convention Center Presentation Theater 4, Exhibit Hall, Level 2Accreditation: none

LDL and the Interventional CardiologistFaculty: C. Michael Gibson

LDL and the Interventional Cardiologist C. Michael Gibson

Presentation Theater Program: New FDA Indications for the Use of Percutaneous Hemodynamic Support: Improving Outcomes in ProtectedPCI and Cardiogenic Shock (Sponsored by CRF, Supported by ABIOMED,Inc.)


New FDA Indications for the Use of Percutaneous Hemodynamic Support: Improving Outcomes in Protected PCI and CardiogenicShockChair: William W. O'Neill Facultys: Navin K. Kapur, William L. Lombardi, James M. McCabe

Welcome William W. O'Neill

The Role of Hemodynamic Support Devices in Complex Patients and Complete Revascularization William L. Lombardi

Implications of Public Reporting on the Treatment of Complex Patients James M. McCabe

Developing Algorithms, Protocols, and Heart Team Approach to Treating AMICGS: Detroit CSI Experience William W. O'Neill

Door to Unloading: Paradigm Shift for Heart Recovery Navin K. Kapur

Presentation Theater Program: The DAPT Decision: Do Polymers Matter? (Sponsored by Abbott)


The DAPT Decision: Do Polymers Matter?Chair: George D. Dangas Facultys: Sripal Bangalore, Yoshihiro Morino, MD, Renu Virmani

Pre-Clinical Data on the Fluoropolymer Renu Virmani

Fluoropolymer’s Role in Healing – The MECHANISM Trial Yoshihiro Morino, MD

Clinical Data in Support of Fluoropolymer and Implications for DAPT Sripal Bangalore

Evolution of DAPT Perspectives in the United States Roxana Mehran

Presentation Theater Program: Trialign: The New Era of Tricuspid Repair (Sponsored by Mitralign)

Walter E. Washington Convention Center Presentation Theater 2, Hall A, Lower LevelAccreditation: none

Trialign: The New Era of Tricuspid RepairChairs: Martin B. Leon, Scott Lim Facultys: Gorav Ailawadi, Charles J. Davidson, Rebecca T. Hahn, Azeem Latib, Christopher Meduri, MD, Joachim Schofer

Session Overview Scott Lim

Surgical Options for the Tricuspid Valve Gorav Ailawadi

Trialign Tricuspid Repair Approach Azeem Latib

SCOUT I Early Feasibility Results Rebecca T. Hahn

Trialign in Practice: System Versatility Charles J. Davidson

The Tricuspid Patient: From Forgotten to Found Christopher Meduri, MD

Trialign System Experience Curve Joachim Schofer

Session Summary Martin B. Leon

Presentation Theater Program: What Every Interventionalist Needs to Know About Atrial Fibrillation, Anticoagulation, and the Role ofAntidotes (Sponsored by CRF, Supported by Boehringer Ingelheim Pharmaceuticals, Inc., Boston Scientific Corporation, and Bristol-MyersSquibb /Pfizer Pharmaceuticals Partnership)

Walter E. Washington Convention Center Presentation Theater 1, Hall A, Lower LevelAccreditation: CME

What Every Interventionalist Needs to Know About Atrial Fibrillation, Anticoagulation, and the Role of AntidotesChair: Michael D. Ezekowitz Facultys: William A. Gray, Freek W.A. Verheugt

Pharmacology of Novel Anticoagulants and Their Antidotes Michael D. Ezekowitz

Anticoagulation, Atrial Fibrillation in the Setting of ACS Freek W.A. Verheugt

Anticoagulation and Atrial Fibrillation in the Setting of TAVR George D. Dangas

Anticoagulation and Atrial Fibrillation in the Setting of LAA Closure William A. Gray

Illustrative Cases Case Presenter: Michael D. Ezekowitz

Presentation Theater Program: ADVANCING Control With the Lotus Edge TAVR System (Sponsored by Boston Scientific Corporation)


ADVANCING Control With the Lotus Edge TAVR SystemChair: Michael J. Reardon Facultys: Ted Feldman, Matthias Gotberg, MD, Ian T. Meredith

The Lotus Valve and Lotus Edge: Technology Overview and Clinical Data Update Ted Feldman

Next Generation Lotus Edge in Everyday Practice Matthias Gotberg, MD

Lotus Edge: Features and Benefits of the Latest Technology and Beyond Ian T. Meredith

Q&A Moderator: Michael J. Reardon Discussants: Ted Feldman, Matthias Gotberg, MD, Ian T. Meredith

Presentation Theater Program: Beyond Bare Metal: Precise and Durable Outcomes With the GORE® TIGRIS® Vascular Stent (Sponsored byGore & Associates)


Beyond Bare Metal: Precise and Durable Outcomes With the GORE® TIGRIS® Vascular StentFaculty: Casey Becker, MD

Precise and Durable Outcomes With the GORE® TIGRIS® Vascular Stent Casey Becker, MD

Presentation Theater Program: Building Absorb Experience in the Lab (Sponsored by Abbott)


Building Absorb Experience in the LabChair: David G. Rizik Facultys: Thomas Schmitz, MD, John Wang, MD, Nick E. J. West, Robert-Jan van Geuns

Welcome David G. Rizik

What Are the Potential Benefits With Absorb for Your Patients? Nick E. J. West

Launching BRS Therapy and Growing With Absorb John Wang, MD

The Dynamics of Patient Selection With Increased Absorb Experience Thomas Schmitz, MD

Discussion Moderator: David G. Rizik Discussants: Thomas Schmitz, MD, John Wang, MD, Nick E. J. West, Robert-Jan van Geuns

Presentation Theater Program: Left Atrial Appendage Closure: Outstanding Data, Outstanding Questions (Sponsored by CRF, Supported bySentreHEART, Inc.)


Left Atrial Appendage Closure: Outstanding Data, Outstanding QuestionsChair: William A. Gray Facultys: Ori Ben-Yehuda, DJ Lakkireddy, Robert J. Sommer, Steven J. Yakubov

Welcome and Introductions William A. Gray

Left Atrial Appendage Occlusion (LAAO) in OAC-Ineligible Patients: Who Should Be Considered and How Common Are They? Ori Ben-Yehuda

Does the Availability of Novel/Alternative Oral Anticoagulants Change the Conclusions From the Watchman Trial Data? Robert J. Sommer

Are there Opportunities to Improve on the Watchman Outcomes? Current and Future Device Approaches Steven J. Yakubov

Ligation Meets Ablation: Early Data on the Synergistic Effects of PV Ablation With LAA Ligation, and the AMAZE Trial DJ Lakkireddy

Discussion

Presentation Theater Program: TAVR in 2016: Realities and Controversies! (Sponsored by CRF, Supported by Edwards Lifesciences)


TAVR in 2016: Realities and Controversies!Co-Chairs: Martin B. Leon, Michael J. Mack Facultys: Vasilis Babaliaros, Philippe Généreux

Reality #1 Which Intermediate-Risk Patients are Candidates for TAVR vs. SAVR? Michael J. Mack

Controversy #1 How Should Potential Durability Differences Influence TAVR vs. SAVR Choices in Younger and Lower Risk Patients? Martin B. Leon

Reality #2 How to Optimize the Clinical Care Pathway: From Referral to Treatment to Safe (Early) Discharge Home Vasilis Babaliaros

Controversy #2 The Evidence Pathway from Inoperable to Asymptomatic AS Philippe Généreux

Roundtable Discussion


Walter E. Washington Convention Center Hall A, Lower LevelAccreditation: none

Hands on HeartsModerators: Robert Kutys, Maria E. Romero, Nicole Singer

ITC Theater: LAA & Mitral


Faculty ModerationModerator: Torsten P. Vahl

Evening Program: A New Era of P2Y12 Inhibitors: Transitioning From Intravenous to Oral Platelet Inhibition After PCI (Sponsored by CRF,Supported by CHIESI USA,Inc.)

Marriott Marquis Washington DC Marquis Ballroom, Salon 1-4, Level M2Accreditation: CME

Check In and Reception

A New Era of P2Y12 Inhibitors: Transitioning From Intravenous to Oral Platelet Inhibition After PCICo-Chairs: Gregg W. Stone, Harvey D. White Facultys: Dominick J. Angiolillo, Deepak L. Bhatt, C. Michael Gibson, Philippe Généreux, Christian W. Hamm, Robert A. Harrington

Is Oral Agent Preloading Before PCI Safe or Effective? Theory and Evidence C. Michael Gibson


Outcomes of Establishing Potent P2Y12 Receptor Inhibition With Intravenous Cangrelor: Lessons From the PHOENIX and theCHAMPION Trials Robert A. Harrington


Intraprocedural Stent Thrombosis: What Is It, Why Should We Care, and How Can We Prevent It? Philippe Généreux


Transitioning From Oral to Intravenous P2Y12 Receptor Blockade, and From Intravenous to Oral P2Y12 Receptor Blockade: Whatthe Practitioner Needs to Know Dominick J. Angiolillo

Patient Selection and Adjunct Pharmacology for Potent Intravenous Platelet Inhibition: Practical Considerations Deepak L. Bhatt


Case Reviews: Anti-platelet Agent Decision Making Case Presenter: Christian W. Hamm

Evening Program: Breaking Barriers Through Disruptive Technologies (Sponsored by Boston Scientific Corporation)

Marriott Marquis Washington DC Liberty Ballroom, Level M4Accreditation: none


Breaking Barriers Through Disruptive TechnologiesChair: Charles Gibson Vivek Wadhwa Facultys: Samir R. Kapadia, Ian T. Meredith, Matthew J. Price, Michael J. Reardon

Welcome and Introduction of Program Host Moderator: Charles Gibson Ian T. Meredith

Disruptive Technology Panel Discussion (PCI, TAVR, LAAC) Discussants: Samir R. Kapadia, Ian T. Meredith, Matthew J. Price, Michael J. Reardon

Keynote Presentation Vivek Wadhwa

Evening Program: DESolve® NXT…The NEXT Breakthrough in BRS Innovation (Sponsored by Elixir Medical Corp.)

Marriott Marquis Washington DC Marquis Ballroom, Salon 6, Level M2Accreditation: none


DESolve® NXT…The NEXT Breakthrough in BRS InnovationChairs: Alexandre Abizaid, Martin B. Leon, Roxana Mehran Facultys: Niels R. Holm, Holger M. Nef, Jack Wei Chieh Tan

Session Objectives Martin B. Leon

DESolve NX Four-Year Clinical Update and Future Clinical Programs Martin B. Leon

DESolve NX Four-Year Clinical Update and Future Clinical Programs Andrea Abizaid

DESolve Real-world: Europe Experience Holger M. Nef

DESolve Real-world: Asia Experience Jack Wei Chieh Tan

BIFSORB Pilot I Niels R. Holm

AMITY Program Update Roxana Mehran

Session Key Learning Roxana Mehran

Evening Program: Interventional Management of Complex Patients: Cutting-edge Technologies for the Advanced Interventionalist(Sponsored by St. Jude Medical)

Marriott Marquis Washington DC Marquis Ballroom, Salon 5, Level M2Accreditation: none


Interventional Management of Complex Patients: Cutting-edge Technologies for the Advanced InterventionalistFacultys: Alexandre Abizaid, Ziad A. Ali, Navin K. Kapur, Ajay J. Kirtane, Martin B. Leon

Welcome/Objectives Ziad A. Ali

Management Strategies for the Complex Patient Ajay J. Kirtane

High-risk PCI Support Devices Navin K. Kapur

OCT Guided Precision PCI Ziad A. Ali

The Importance of Imaging With BRS Alexandre Abizaid

Closing Moderator: Martin B. Leon Discussants: Alexandre Abizaid, Ziad A. Ali, Navin K. Kapur, Ajay J. Kirtane

Moderated Challenging Cases: Coronary I


Moderated Challenging Cases: Coronary IModerators: Tayo A. Addo, Jose de Ribamar Costa Jr

TCT 1023: Treating an Extremely Rare Complication After Permanent Pacemaker Implantation Case Presenter: Sankha Das

TCT 1088: Percutaneous Treatment of Giant Left Main Aneurysm Case Presenter: Thyago Furquim

TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left VentricularDysfunction and Ischemia Case Presenter: Francesco Giannini

TCT 1239: Rotablation of the Tortuous Artery - Victory Declared Too Early Case Presenter: Muntaser Musameh

Moderated Challenging Cases: Coronary II


Moderated Challenging Cases: Coronary IIModerators: Maurice Buchbinder, Marco A. Costa

TCT 1042: "Piggy-Back" PCI in a Heterotopic Donor Heart Case Presenter: Heath Adams

TCT 1112: Transradial Left Main PCI Nightmare: Two Embolized Stents Requiring Retrieval Case Presenter: Srikanth Adusumalli

TCT 1129: Safety and Efficacy of Percutaneous Implantable Right Ventricular Assist Device for Management of Right VentricularFailure Secondary to Acute Inferior Myocardial Infarction Case Presenter: Abhishek Sawant

Moderated Challenging Cases: Endovascular


Moderated Challenging Cases: EndovascularModerators: William A. Gray, Issam D. Moussa

TCT 1456: Novel Treatment of Luminal Dissection With Focal Using the Tack Endovascular System Case Presenter: Edward Koifman

TCT 1423: Antegrade Access and Retrograde SFA Recanalization: the Potential Impact of Profunda Femoris Artery and Its CollateralVessels Case Presenter: Franz Hafner

TCT 1418: Right Coronary Artery Chronic Total Occlusion Percutaneous Coronary Intervention with a Rare Complication Case Presenter: Judit Karacsonyi

TCT 1162: Impella 5.0 Fracture And Transcatheter Retrieval Case Presenter: Moses Mathur

Moderated Challenging Cases: Structural I


Moderated Challenging Cases : Structural IModerators: Henrique B. Ribeiro, Dimytri Alexandre Siqueira

TCT 1600: Minimally Invasive Mitral Valve Replacement With Sapien S3 Valve in a Patient With Severe MAC Case Presenter: Deborah Tabachnick

TCT 1611: Trialign: Transcatheter Repair of the Tricuspid Valve Case Presenter: Nadira Hamid

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease,and Severe Aortic Stenosis: Importance of Preprocedural Planning Case Presenter: Chris Meduri

TCT 1651: TAVI-in-Mitral Valve Ring for Annuloplasty Ring Stenosis, Using New Lotus Valve With Depth-Guard Modification: EarlyAnchoring Facilitating Controlled and Accurate Deployment Within a High-risk Patient Case Presenter: Saib Khogali

Moderated Poster Session: Circulatory Support


Moderated Poster Session: Circulatory SupportModerators: Simon R. Dixon, Kirk N. Garratt

TCT 114: Comparing Hemodynamic Profiles and Outcomes in Cardiogenic Shock Requiring VA-ECMO or Impella for CirculatorySupport Michele Esposito

TCT 115: Clinical features and Outcomes in Patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock Supportedwith Extracorporeal Membrane Oxygenation, Single Center Experience Sungsoo Cho

TCT 116: Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous Coronary Intervention For ACS: Meta-Analysis ofRCT’s Mohammad Ansari

TCT 117: Impact of Intra-Aortic Balloon Pump Use on Mortality in Patients with Cardiogenic Shock Treated with PrimaryPercutaneous Coronary Intervention: An Observational Study of 21,210 Patients with ST-Elevation Myocardial Infarction from theLondon Hea Krishnaraj Rathod

Moderated Poster Session: PCI and Patients With Renal Insufficiency


Moderated Poster Session: PCI and Patients With Renal InsufficiencyModerators: Joseph P. Carrozza Jr, Charles J. Davidson

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney DiseaseZiad A. Ali

TCT 314: The Impact of Chronic Kidney Disease on Outcomes Following Percutaneous Coronary Interventions Versus CoronaryArtery Bypass Grafting in Patients with Complex Coronary Artery Disease: 5-Year Follow-Up of the SYNTAX Trial Milan Milojevic

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radialversus Trans-Femoral Approach Arie Steinvil

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity – Nationwide Study of Acute Kidney InjuryFollowing Coronary Angiography and Intervention Ingibjorg Gudmundsdottir

Moderated Poster Session: Primary PCI and Patient Subsets


Mod Posters/Cases 3, Exhibit Hall, Level 2Accreditation: none

Moderated Poster Session: Primary PCI and Patient SubsetsModerators: Laurent Bonello, David Erlinge

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early InvasiveProcedures Celina Yong

TCT 141: Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in Patients with Systemic lupus Erythematosus:Analysis from Nationwide Inpatient Sample (NIS) Konstantinos Voudris

TCT 142: Temporal Trends in Incidence of Acute Myocardial Infarction in Patients with Malignancy Undergoing PercutaneousCoronary Intervention (PCI) Konstantinos Voudris

TCT 143: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients with History of MalignancyKonstantinos Voudris

Moderated Poster Session: Thrombectomy and Primary PCI


Moderated Poster Session: Thrombectomy and Primary PCIModerators: Francesco Burzotta, Vasim Farooq

TCT 144: Impact of Thrombus Aspiration in Primary Percutaneous Coronary Intervention On Long-Term Outcome Edward Koifman

TCT 145: Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock Ruben Vergara

TCT 146: Routine Aspiration Thrombectomy is Associated with Increased Stroke Rates During Primary Percutaneous CoronaryIntervention for Myocardial Infarction Oliver Guttmann

TCT 147: Local Intracoronary Delivery of Eptifibatide Plus Verapamil via Thrombus Aspiration Catheter to Prevent No-Reflow inAcute ST Elevation Myocardial Infarction Patients with large Thrombus Burden. Mohamed Hamza

Moderated Poster Session: Culprit vs Complete Revascularization in Primary PCI


Moderated Poster Session: Culprit vs Complete Revascularization in Primary PCIModerators: Warren J. Cantor, Thomas D. Stuckey

TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated MyocardialInfarction. Results From the ESTROFA MI+75 Nationwide Registry Jose M. de la Torre Hernandez

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction:Analysis of a 8 Year-All-Comers Registry Ana Belen Cid Alvarez

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous CoronaryIntervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease Mohamed Hamza

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are LessonsLearned? Ivo van Dongen

Moderated Poster Session: Physiologic Lesion Assessment


Moderated Poster Session: Physiologic Lesion AssessmentModerators: Michalis Hamilos, Pim A.L. Tonino

TCT 512: Fractional Flow Reserve-Guided Deferred vs Complete Revascularisation in Patients With Diabetes Mellitus Elvin Kedhi

TCT 513: Discordance In Stenosis Classification by Pressure-Only Indices of Stenosis Severity is Related to Differences in CoronaryFlow Reserve – the RESOLVING DISCORD Study Christoper Cook

TCT 514: Comparison of Angiographic Scores and Fractional Myocardial Mass: Use of Fractional Myocardial Mass forComprehensive Evaluation of Coronary Artery Disease IL Park

TCT 515: Prognostic Implications of Instantaneous Wave-Free Ratio (iFR) and Resting Distal-to-Aortic Pressure Ratio (Pd/Pa)Compared with Fractional Flow Reserve (FFR). A 10-Year Follow-Up Study After Deferral of Revascularization G.W. Wijntjens

Moderated Poster Session: Pulmonary Thromboembolism and Pulmonary Hypertension


Moderated Poster Session: Pulmonary Thromboembolism and Pulmonary HypertensionModerators: Irene M. Lang, Ehtisham Mahmud

TCT 825: Simplicity Denervation System for Pulmonary Artery Denervation in Patients with Chronic Thrombembolic PulmonaryHypertension (first-in-man study) Boris Rudenko

TCT 769: Ultrasound-Assisted Catheter-Directed Thrombolysis in the Treatment of High Risk Pulmonary Embolism: A Meta-AnalysisWissam Jaber

TCT 770: Catheter-Directed Thrombolysis Versus Systemic Thrombolysis in Pulmonary Embolism: Predictors of in Hospital Mortalityand Major Bleeding. Shilpkumar Arora

TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervationfor Patients with Pulmonary Arterial Hypertension Shao-Liang Chen

Moderated Poster Session: TAVR Outcomes

Walter E. Washington Convention Center Mod Posters/Cases 4, Exhibit Hall, Level 2

Accreditation: none

Moderated Poster Session: TAVR OutcomesModerators: Jean-Claude Laborde, Azfar G. Zaman

TCT 647: The Failing Right Heart: Implication and Evolution in High-Risk Patients Undergoing Transcatheter Aortic ValveImplantation. Luca Testa

TCT 648: Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement Anna Sannino

TCT 649: Prognostic Value of Right Ventricular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Replacement Islam Abdelkarim

TCT 650: Predictors of Mortality in Patients with Persistent Pulmonary Hypertension Following Transcatheter Aortic ValveReplacement Ahmad Masri

Edited Taped Cases I: Miscellaneous: LV Reduction, Renal Denervation, TAVR, and Virtual Reality Imaging

Walter E. Washington Convention Center Presentation Theater 4, Exhbit Hall, Level 2Accreditation: none

Edited Taped Cases I: Miscellaneous: LV Reduction, Renal Denervation, TAVR, and Virtual Reality ImagingModerators: Oscar A. Mendiz, Giora Weisz Discussants: Richard R. Heuser, Alexandra J. Lansky, David W.M. Muller, Bernhard Reimers

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients Horst Sievert

Discussion

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System Case Presenter: Philipp Lurz

Discussion

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in aPatient With Extremely Calcified Aortic Valve Case Presenter: Caterina Gandolfo

Discussion

Using Virtual Reality in Interventional Cardiology Case Presenter: Silvio J. Bezerra

Discussion

Edited Taped Cases II: Coronary and Peripheral Intervention


Edited Taped Cases II: Coronary and Peripheral InterventionModerators: Mahmood K. Razavi, Gerald S. Werner Discussants: Roger Gammon, Paul Hsien-Li Kao, Tejas Patel, Sudhir Rathore

The Physiological Impact of CTO PCI on Donor Vessel Physiology and the Influence of Collateral Regression Case Presenter: Thomas R. Keeble

Discussion

Transcatheter Repair of a Ruptured Coronary Mycotic Aneurysm Case Presenter: Ho-Ping Yu

Discussion

Hibernating Aneurysm and Ectatic SFA With Large Thrombus Burden Identified Using OCT Guided Atherectomy: ChangingAlgorithms of Care Using Real-Time Imaging During Therapy Case Presenter: Jaafer Golzar

Discussion

Exhibit Hall

Walter E. Washington Convention Center Exhibit Hall, Level 2Accreditation: none

Visit the Exhibit Hall to learn, network, relax, and stay updated on the newest and latest in the industry. More than 120+ booths fill thelarge hall with the latest, cutting-edge products and services, selected just for you. Plan your visit today by sear

Breakfast Meeting: "Glad I had STENTYS on the Shelf”: Where a Self–Apposing Stent Fits Into Everyday Practice. An Interactive CaseReview Session (Sponsored by STENTYS S.A)



"Glad I had STENTYS on the Shelf”: Where a Self–Apposing Stent Fits Into Everyday Practise. An Interactive Case Review SessionChair: Gennaro SardellaFacultys: Christoph A. Kaiser, Corrado Tamburino, Robert-Jan van Geuns

Introduction Gennaro Sardella

Case Presentation 1 Case Presenters: Christoph A. Kaiser, Corrado Tamburino, Robert-Jan van Geuns

Panel and Audience Discussion on Case 1 Moderator: Gennaro Sardella





Review and Conclusions Gennaro Sardella

Breakfast Meeting: Chemical Neuromodulation as a Novel Approach to Renal Denervation (Sponsored by Ablative Solutions, Inc.)



Chemical Neuromodulation as a Novel Approach to Renal DenervationChair: Michael A. Weber Facultys: David E. Kandzari, Felix Mahfoud, Wojtek Wojakowski

Critical Elements for a Successful Study Design in Clinical Trials for Renal Denervation Michael A. Weber

TARGET BP I - Unique Drug/Device Combination Trial Design David E. Kandzari

Looking Ahead: The Potential for Interventional Hypertension Therapy With Targeted Chemical Denervation Felix Mahfoud

Clinical Experience With the Peregrine System™ Infusion Catheter Wojtek Wojakowski

Breakfast Meeting: DCRI Evidence to Practice Series: Interventional Cardiology (Sponsored by Duke Clinical Research Institute)



DCRI Evidence to Practice Series: Interventional CardiologyChair: Sunil V. Rao Facultys: Mauricio G. Cohen, Kirk N. Garratt, James B. Hermiller Jr

Introduction to DCRI Evidence to Practice Series Sunil V. Rao

Latest Interventional Cardiology Research Findings: Journals, Guidelines, Breaking Clinical Research Sunil V. Rao

Complex PCI Management Approaches Moderator: Sunil V. Rao Case Presenter: Mauricio G. Cohen Discussants: Kirk N. Garratt, James B. Hermiller Jr

Management of the Complex Patient Needing Transcather Valve Moderator: Sunil V. Rao Case Presenter: James B. Hermiller Jr Discussants: Mauricio G. Cohen, Kirk N. Garratt

The PCI May Be Simple, but the Patient Is Complex! Moderator: Sunil V. Rao Case Presenter: Kirk N. Garratt Discussants: Mauricio G. Cohen, James B. Hermiller Jr

Conclusion and Podcast Instructions Sunil V. Rao

Breakfast Meeting: Drift-free FFR with a Workhorse Wire: Is it Truly Possible Now? (Sponsored by Opsens)


Check-In & Breakfast

Drift-free FFR with a Workhorse Wire: Is it Truly Possible Now?Chair: Morton J. Kern Facultys: Olivier F. Bertrand, Bernard De Bruyne, Hitoshi Matsuo

Welcome / Review of FFR tools Morton J. Kern

What Makes OptoWire Special? - North American Experience Olivier F. Bertrand

Ooops, Pa ? Pd Bernard De Bruyne

OptoWire - Japanese Experience Hitoshi Matsuo

Q&A and Discussion Morton J. Kern

Wrap-Up/Conclusion

Breakfast Meeting: Establishing the New Standard: Definitive Treatment for Complex Bifurcation Lesions (Sponsored by Tryton Medical, Inc.)



Establishing the New Standard: Definitive Treatment for Complex Bifurcation LesionsChairs: Martin B. Leon, David G. Rizik Facultys: Philippe Généreux, Jens Flensted Lassen, Maciej Lesiak, MD, Joel E. Schneider, MD

Introductory Remarks David G. Rizik

Review Tryton Safety and Efficacy Studies (RCT and Confirmatory Trials)- A Dedicated Approach to Treating Complex BifurcationLesions Philippe Généreux

Importance of Side Branch Ostial Scaffolding Jens Flensted Lassen

One Solution, Many Anatomies David G. Rizik

EU Perspective on Left Main: The Final Frontier Maciej Lesiak

How Tryton Will Change My Daily Practice Joel E. Schneider

Closing Remarks Martin B. Leon

Breakfast Meeting: Management of Complex PCI Patients: Award-Winning Case Presentations (Sponsored by CRF, Supported byABIOMED, Inc.)

Walter E. Washington Convention Center Room 143A, Lower LevelAccreditation: none


Management of Complex PCI PatientsChairs: George D. Dangas, Amir Kaki Panelists: Michael P. Flaherty, Perwaiz M. Meraj, George W. Vetrovec Facultys: Sukhdeep Singh Basra, Nileshkumar Patel, Nishtha Sareen

A Case of Assisted Emergent PCI With Biventricular Impella Case Presenter: Nishtha Sareen

Q&A

Impella for Hemodynamic Support During Percutaneous Intervention of a Distal Left Main Bifurcation Lesion in a Patient With aCoreValve and Aortic Endograft Case Presenter: Nileshkumar Patel

Q&A

A Challenging Case of Extreme Risk Anatomy Undergoing Successful Complex PCI of Ostial LM, Distal LM, Ostial LAD, Ostial LCx,and Proximal LAD - Using Impella Support in a Patient With Severe LV Dysfunction Without Surgical Backup Case Presenter: Sukhdeep Singh Basra

Q&A

Breakfast Meeting: Percutaneous Mitral Interventions Where Are We And Where Do We Go? (Sponsored by CRF, Supported by Abbott)

Walter E. Washington Convention Center Room 149, Level 1Accreditation: CME


Percutaneous Mitral Interventions: Where Are We And Where Do We Go?Chair: Alec S. Vahanian Facultys: Ted Feldman, Saibal Kar, Martin J Swaans

Accepted and Controversial Indications of Mitraclip in Primary MR Saibal Kar

Do the Latest Data in Secondary MR Already Predict COAPT Outcomes? Martin J. Swaans

In Light of More Than 30,000 Patients Treated With Mitraclip, What Will Be the Respective Role of Repair vs Replacement? Ted Feldman


Breakfast Meeting: Precision Coronary Interventions: Tools for Success (Sponsored by ACIST Medical Systems & Medtronic, Inc.)

Walter E. Washington Convention Center Room 145B, Level 1

Accreditation: none


Precision Coronary Interventions: Tools for SuccessChair: Roxana Mehran Co-Chair: Azeem Latib Facultys: Michael C. Kim, Adhir Shroff

Not All PCIs Are the Same. Diagnosis and a Plan Matter. How to Use Your Tools Roxana Mehran

Transradial - Safely Doing PCI Adhir Shroff

Optimize PCI With High-Definition IVUS Azeem Latib

Optimize Physiological Outcomes With Rapid Exchange FFR Microcatheter Michael C. Kim

Wrap Up/Conclusion Azeem Latib

Breakfast Meeting: Robotic Therapy - Current Applications and Future Vision (Sponsored by Corindus Vascular Robotics)



Robotic Therapy - Current Applications and Future VisionChair: Martin B. Leon Facultys: Gregory A. Helmer, MD, Ryan D. Madder, Ehtisham Mahmud, MD, Giora Weisz

Opening Remarks Martin B. Leon

Robotic Therapy: Past, Present, and Future Martin B. Leon

Building a Successful Vascular Robotic Program Gregory A. Helmer, MD

Evidence for Robotic Therapy: From Cath Lab Wellness to Patient Benefits Ryan D. Madder

Complex Robotic Intervention Ehtisham Mahmud, MD

Moderated Discussion and Q&A Moderator: Giora Weisz

Main Arena II, Monday, Oct. 31


Plenary Session I. Live CasesLive Case Moderator: Gregg W. Stone Live Case Co-Moderator: Ian T. Meredith Live Case Discussants: Stephan Baldus, Olaf Franzen, Cindy L. Grines, Michael Haude, James B. Hermiller Jr, Scott Lim, Yves R. Louvard,Reginald I. Low, Jeffrey J. Popma, Pieter C. Smits, Corrado Tamburino Digital Moderator: Adam Witkowski Digital Panelists: Anita Asgar, Francesco Saia, Darren L. Walters Factoid Facultys: Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong Hwa Yamamoto

Heart Center Bonn, University Hospital Bonn, Bonn, Germany Live Case Operators: Eberhard Grube, Georg Nickenig, Wolfgang Schiller, MD, Jan-Malte Sinning, MD, Armin Welz, MD

Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands Live Case Operators: Peter De Jaegere, MD, Roberto Diletti, Nicolas M. Van Mieghem

Plenary Session II. Late-Breaking Clinical Trials 2Moderator: Martin B. Leon Digital Moderator: Keith G. Oldroyd Digital Panelists: Afzalur Rahman, Simon J. Walsh, Bernhard Witzenbichler Discussants: Bagrat Alekyan, Yaron Almagor, Evald H. Christiansen, Ted Feldman, David E. Kandzari, Ruediger Lange, D. ChristopherMetzger, Seung-Jung Park, Marc Ruel, Craig R. Smith, Gregg W. Stone Co-Moderator: Marie-Claude Morice

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients WithLeft Main Coronary Artery Disease Gregg W. Stone

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients WithLeft Main Coronary Artery Disease Evald H. Christiansen

Moderated Roundtable Discussion

Plenary Session III. Live CasesLive Case Moderator: Martin B. Leon Live Case Co-Moderator: Michael J. Reardon Live Case Discussants: Steven F. Bolling, Robert A. Guyton, Jose P.S. Henriques, Omar K. Khalique, John M. Lasala, Alexander Lauten,Patrick M. McCarthy, Stephen R. Ramee, Simon J. Walsh, Gerald S. Werner, Grayson H. Wheatley, R. Michael Wyman Digital Moderator: David J. Cohen Digital Panelists: Gary Gershony, Gary L. Schaer, Jean-François Tanguay Factoid Facultys: Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong Hwa Yamamoto

University of Missouri Kansas City and Saint Luke's Mid America Heart Institute, Kansas City, MO Live Case Operators: J. Aaron Grantham, James Sapontis, MD

NewYork-Presbyterian/Columbia University Medical Center, New York, NY Live Case Operators: Michael A. Borger, Isaac George

Plenary Session IV: Geoffrey O. Hartzler Master Operator AwardAward Presenters: Martin B. Leon, Gregg W. Stone Award Recipient: Patrick L. Whitlow, MD

Plenary Session V. TCT Focus Session #2: New Directions for FDA and the European CommissionModerator: Michael J. Mack Digital Moderator: Aaron V. Kaplan Digital Panelists: Ori Ben-Yehuda, Alexandra J. Lansky, Roxana Mehran Discussants: Angeles Alonso Garcia, Robert M. Califf, Gregory Daniel, Alan G. Fraser, Louis B. Jacques, Mitchell W. Krucoff, Martin B. Leon,Thomas F. Luscher, Patrick W. Serruys, Gregg W. Stone, Stephan Windecker Co-Moderator: Jeffrey Shuren

Featured Lecture: My Vision of the FDA - Dynamic Evolutionary Changes Robert M. Califf

Featured Lecture: The Rationale and Impact of New European Device Regulations Alan G. Fraser

Animated Discussion

Plenary Session VI. First Report Investigations 2Moderator: Patrick W. Serruys Digital Moderator: Joanna J. Wykrzykowska Digital Panelists: Niels R. Holm, Stephen WL Lee, Wojtek Wojakowski Discussants: Salvatore Brugaletta, Jose de Ribamar Costa Jr, Carlo Di Mario, Nicolas Foin, Thomas A. Ischinger, Jens Flensted Lassen,Manel Sabate, Rogerio Sarmento-Leite

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled StentStephen G. Worthley

Moderated Roundtable Discussion Discussant: Stephen G. Worthley

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Alexandre Abizaid

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting BioresorbableVascular Scaffold in Patients With Coronary Artery Disease Ashok Seth

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting BioresorbableVascular Scaffold in Patients With Coronary Artery Disease Antonio Colombo

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting BioresorbableVascular Scaffold in Patients With Coronary Artery Disease Bo Xu

Moderated Roundtable Discussion Discussant: Bo Xu

Coronary Theater II, Monday, Oct. 31


Session I. Live Cases: CHIPLive Case Moderator: Jonathan M. Hill Live Case Co-Moderator: Vladimir Dzavik Live Case Discussants: Herbert D. Aronow, Vinay K. Bahl, Stephen Balter, Laurent Bonello, Marc Etienne Jolicoeur, Christoph A. Kaiser,Tanveer Rab, Gert Richardt, Mohamed Ahmed Sobhy Digital Moderator: Michael J. Cowley Digital Panelists: Nabil Dib, Prakash Krishnan, Expedito E. Ribeiro Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

University of Missouri Kansas City and Saint Luke's Mid America Heart Institute, Kansas City, MO Live Case Operators: J. Aaron Grantham, David Safely, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center NY, NY Live Case Operators: Michael B. Collins, Khady Fall, Ajay J. Kirtane, Manish A. Parikh

Session II. Live Cases: BRSLive Case Moderator: Dean J. Kereiakes Live Case Co-Moderator: Vincent On-Hing Kwok Live Case Discussants: Arif Al Nooryani, Ronald Caputo, John S. Douglas Jr, Antoine Lafont, Talib Majwal, Maurizio Menichelli, SunaoNakamura, Giulio G. Stefanini, Clemens von Birgelen Digital Moderator: David G. Rizik Digital Panelists: Kevin Bainey, Sreenivas Arramraju Kumar, Ian Menown Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands Live Case Operators: Joost Daemen, Peter De Jaegere, MD, Roberto Diletti, Nicolas M. Van Mieghem

Clinique Pasteur Toulouse, Toulouse, France Live Case Operators: Farah Bruno, MD, Jean Fajadet

Structural Theater I, Monday, Oct. 31

Walter E. Washington Convention Center Structural Theater, Lower LevelAccreditation: CME/ASRT/CNE

Session I. Live Cases: TAVRLive Case Moderator: Francesco Maisano Live Case Co-Moderator: Charles J. Davidson Live Case Discussants: Vasilis Babaliaros, Antonio L. Bartorelli, Stefan C. Bertog, Bernard R. Chevalier, Philippe Garot, Biswajit Kar, CliffordJ. Kavinsky, Michael J. Mullen, Duane S. Pinto Digital Moderator: Neal S. Kleiman Digital Panelists: Stanley J. Chetcuti, Dharam J. Kumbhani, Binita Shah Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

NewYork-Presbyterian Hospital/Columbia University Medical Center NY, NY Live Case Operators: Isaac George, Rebecca T. Hahn, Susheel Kodali, Tamim Nazif, Torsten P. Vahl

Clinique Pasteur Toulouse, Toulouse, France Live Case Operators: Nicolas Dumonteil, MD, Didier Tchetche

Session II. Live Cases: Mitral and Tricuspid InterventionsLive Case Co-Moderators: Ian T. Meredith, William W. O'Neill Live Case Discussants: Saif Anwaruddin, Peter C. Block, Justin E. Davies, Hans R. Figulla, A. Pieter Kappetein, Jan Kovac, Roger J. Laham,Oscar A. Mendiz, Maurice E. Sarano Digital Moderator: Jeroen J. Bax Digital Panelists: Marco Barbanti, Verghese Mathew, Jose Luis Navia Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

Heart Center Bonn, University Hospital Bonn, Bonn, Germany Live Case Operators: Eberhard Grube, Fritz Mellert, MD, Georg Nickenig, Wolfgang Schiller, MD, Jan Malte Sinning, MD, Armin Welz, MD,Nikos Werner, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center NY, NY Live Case Operators: Isaac George, Rebecca T. Hahn, Susheel Kodali, Torsten P. Vahl

Didactic Session: Bioresorbable Vascular Scaffolds, Part 1: Devices and Data


Session I. BRS Design and Preclinical LearningsModerators: Elazer R. Edelman, Juan F. Granada Discussants: Aloke V. Finn, Michael Joner, Greg L. Kaluza, Richard J. Rapoza, Habib Samady, Renu Virmani

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on MechanicalProperties, Vascular Compatibility, and Healing I: Pathologic Perspectives Renu Virmani

Implications of Bioresorbable Polymer/Metal Type, Processing, Thickness, Configuration, and Other Variables on MechanicalProperties, Vascular Compatibility, and Healing II: Biomechanical Perspectives Elazer R. Edelman

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More Richard J. Rapoza

Assessment and Implications of Vasomotion: Implications for BRS Habib Samady

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal ScaffoldDismantling) Juan F. Granada


Session II. Absorb BVS UpdateModerators: Stephen G. Ellis, Corrado Tamburino Discussants: Bernard R. Chevalier, Andrejs Erglis, Dean J. Kereiakes, Yoshinobu Onuma, Huay Cheem Tan, Jose M. de la Torre Hernandez

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial Patrick W. Serruys

ABSORB II Clinical Outcomes at 3 Years Bernard R. Chevalier

ABSORB China Clinical Outcomes at 2 Years Runlin Gao

ABSORB Japan Clinical Outcomes at 2 Years Takeshi Kimura

Outcome Registries I: Extended Results From ABSORB EXTEND Alexandre Abizaid

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First Robert-Jan van Geuns

Outcome Registries III: 2-Year Results From ASSURE Detlef G. Mathey

Outcome Registries IV: The UK Absorb Registry Andreas Baumbach

Outcome Registries V: New Insights From GHOST Corrado Tamburino

Outcome Registries VI: France ABSORB Didier Carrié

Outcome Registries VII: IT-DISAPPEARS Anna Sonia Petronio


The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? Yes – With Proper Technique And Planning,Nearly All PCI Patients Can Benefit From BVS! Massimo Napodano

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No – Short-Term Data Is Borderline,Procedures Are More Costly And Complex, And Long-Term Data Is Scant – Best To Wait! Daniel I. Simon

Audience Vote: In What Percentage of Patients Should Absorb Be Used? Poll Moderators: Stephen G. Ellis, Corrado Tamburino

Session III. The Vast BRS World Beyond AbsorbModerators: Ron Waksman, Robert-Jan van Geuns Discussants: Antonio L. Bartorelli, Salvatore Cassese, Kenneth Chin, Hector M. Garcia-Garcia, Vincent On-Hing Kwok, Stephen G. Worthley

Desolve Nx, Cx and Amity: Unique Properties and Results From 150 Um To 120 Um Alexandre Abizaid

FANTOM: Novel Design Attributes and 6-Month FANTOM II Results Jose de Ribamar Costa Jr

MeRes100 – Design Specifications and the 6-months MeRes-1 Results Ashok Seth

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents Michael Haude

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS Patrick W. Serruys

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results Bo Xu

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS Juan F. Granada

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion Guosheng Fu

BRS Snapshots: Renuvia FAST Ian T. Meredith

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device Antoine Lafont

BRS Snapshots: XINSORB Lei Ge

BRS Snapshots: The Biolute BRS Dinesh Shah

BRS Snapshots: ArterioSorb Patrick W. Serruys

BRS Snapshots: Lifetech Iron-Based BRS Runlin Gao

BRS Snapshots: A Novel Biodegradable FE/316L Stent Olivier F. Bertrand

Back to BRS: Falcon, the Next Generation Richard J. Rapoza


Didactic Session: CHIP: Calcified Lesions, Multivessel/Diffuse Disease, Vein Grafts, Shock, and More


Session I. Practical/Logistical Aspects of CHIPModerators: Emmanouil S. Brilakis, Jeffrey W. Moses Discussants: Rajiv Gulati, Jonathan M. Hill, Christoph K. Naber, Robert F. Riley, Adam C Salisbury, Robert W. Yeh Co-Moderator: Ajay J. Kirtane

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go Jeffrey W. Moses

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together? Robert W. Yeh

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: A Mid-CareerPerspective - On-the-job Training With Proctoring Is the Most Reliable Method! Emmanouil S. Brilakis

Flash Perspective: The Best Way to Become a (New) CHIP Operator: When, Where, How, and Why to Train: An Early CareerPerspective - A Dedicated Fellowship Is Necessary for New Trainees to Get Into the CHIP Space! Robert F. Riley


Clinical Risk Assessment and Health Status Goals in the CHIP Population Adam C Salisbury

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program Jonathan M. Hill

Featured Lecture: Mitigating Legal Risk in Higher-Risk Coronary Procedures Elizabeth A. Leedom


Session II. CHIP A-Z: Technique in Complex and High-risk PCIModerators: Jonathan M. Hill, Dimitrios Karmpaliotis

Flash Perspectives on Vascular Access: Nearly All CHIP Cases Can Be Done Transradially! Khaldoon Alaswad

Flash Perspectives on Vascular Access: If You Want to Succeed in CHIP, You Will Use 8 French Femoral Guides Jeffrey W. Moses

CHIP Tricks: Improving Guide Support With Wires, Guide Extensions, and More Dimitrios Karmpaliotis

Roundtable Discussion With Audience Q&A Discussants: Khaldoon Alaswad, Ronald Caputo, Richard R. Heuser, Jeffrey W. Moses, Ramon Quesada, Stéphane Rinfret

Flash Perspective - All Complex PCI Programs Need Dedicated CHIP Operators: Pro! William L. Lombardi

Flash Perspective - All Complex PCI Programs Need Dedicated CHIP Operators: Con! Robert J. Applegate

Using Intravascular Imaging and Physiology to Guide CHIP Cases: The Essentials Gary S. Mintz

Roundtable Discussion With Audience Q&A Discussants: Robert J. Applegate, Morton J. Kern, William L. Lombardi, Gary S. Mintz, Kirti Punamiya, Bernhard Witzenbichler

Flash Perspectives on Calcium Management: The Case for Specialty Balloons Without Atherectomy for Most Cases! Carlo Di Mario

Flash Perspectives on Calcium Management: The Case for Rotational Atherectomy! Jasvindar Singh

Flash Perspectives on Calcium Management: The Case for Orbital Atherectomy! Jeffrey Chambers

Flash Perspectives on Calcium Management: The Case for Laser Atherectomy! Steven P. Marso

Importance of Calcification on PCI Techniques and Outcomes: The Costs of “Atherectomy-Regret” Philippe Généreux

Calcium Disruption With Coronary Lithoplasty. Use of the SHOCKWAVE Balloon in Complex Disease Ian T. Meredith

Roundtable Discussion With Audience Q&A Discussants: Jeffrey Chambers, Philippe Généreux, Steven P. Marso, Ian T. Meredith, Kirti Punamiya, Samin K. Sharma, Jasvindar Singh

2016 Treatment of Saphenous Vein Grafts, Including Management of Acute Occlusions Joseph P. Carrozza Jr

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies Gennaro Sardella

How to Treat Diffuse Disease With Current PCI Devices Corrado Tamburino

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient Gregg W. Stone

Roundtable Discussion With Audience Q&A Discussants: Joseph P. Carrozza Jr, Fazila T. Malik, Gennaro Sardella, Samin K. Sharma, Gregg W. Stone, Corrado Tamburino, Robert J. deWinter

Session III. Ventricular Dysfunction and Hemodynamics in the CHIP PatientModerators: Ulrich P. Jorde, William W. O'Neill Discussants: Adam B. Greenbaum, Sanjog Kalra, Biswajit Kar, Gert Richardt, Hiroo Takayama, Eric Jose Velazquez

The Impact of Ventricular Dysfunction on Prognosis After Coronary Revascularization Eric Jose Velazquez

Flash Perspectives on Percutaneous Circulatory Support: An IABP Is Really All a Good Interventionalist Needs! Gert Richardt

Flash Perspectives on Percutaneous Circulatory Support: The Impella Series of Devices Is the Current Gold Standard for MechanicalSupport! William W. O'Neill

Flash Perspectives on Percutaneous Circulatory Support: ECMO and ECMO Circuit Modifications Are the Best Methods to AchieveTrue Maximal Circulatory Support! Hiroo Takayama

Novel Maximal Circulatory Support Devices on the HORIZON Ulrich P. Jorde

The Role of Right Ventricular and Biventricular Support in CHIP and Shock Cases Sanjog Kalra

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/AxillaryAdvancements Adam B. Greenbaum




Session I. Acute Cardiogenic Shock: What Is the Right Treatment Algorithm?Moderators: Simon R. Dixon, Holger ThieleDiscussants: Jerry D Estep, A. Reshad Garan, Ulrich P. Jorde, Susan M Joseph, John C Laschinger

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation Ulrich P. Jorde

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP Susan M Joseph

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella Jerry D Estep

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO A. Reshad Garan


Session II. Chronic Heart Failure: State of the ArtModerators: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld Discussants: Angeles Alonso Garcia, Peter Carson, Anthony N. DeMaria, Robert E. Michler, Ileana L. Pina

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF Ileana L. Pina

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF Peter Carson

Coronary Revascularization in Severe Heart Failure: STICH and Beyond Robert E. Michler


Session III. Therapies for Valve Pathologies in Advanced Heart Failure: When to Treat, When NOT to TreatModerators: Jeroen J. Bax, Ileana L. Pina Discussants: Ori Ben-Yehuda, John C Laschinger, Marco Moscarelli, Joachim Schofer, David P. Slovut, Alec S. Vahanian

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis:Magnitude of Benefit and Prediction of Responders Ori Ben-Yehuda

Surgical and Transcatheter Mitral Valve Repair or Replacement for Patients With Heart Failure and Primary and Secondary MR:Magnitude of Benefit and Prediction of Responders Marco Moscarelli

Role of Surgical and Transcatheter Tricuspid Valve Repair for Patients With Heart Failure Joachim Schofer


Session IV. Ventricular Reverse RemodelingModerator: James E. UdelsonDiscussants: Peter Carson, Arielle Drummond, P.F. Adrian Magee, Petr Neuzil, Teguh Santoso, Anwar Tandar

State-of-the-Art: Surgical and Device-based LV Remodeling as a Treatment for CHF Ileana L. Pina

The Bioventrix SVR Procedure and Outcomes Petr Neuzil

The Parachute Device: Updated Studies and Results Anwar Tandar

Electrical Therapies for CHF Peter Carson


Didactic Session: Late Breaking Interventional Trials 2016 - The Game Changers


Session I. PCI, CABG, and ACSModerators: Sunil V. Rao, Harvey D. White Discussants: Sripal Bangalore, Giuseppe Biondi-Zoccai, Warren J. Cantor, Christian Hengstenberg, Stefan K. James, Marc Etienne Jolicoeur,Expedito E. Ribeiro

Trial #1 - The Essentials of ... ABSORB III – Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting MetallicStents in Coronary Artery Disease Stephen G. Ellis

ABSORB III Critique: Pros and Cons Ron Waksman

Roundtable Discussion With Audience Q&A. Key Question: Which Patients Are Appropriate for ABSORB?

Trial #2 - The Essentials of ... the MATRIX Trial – Access Site and Anticoagulation Type (And Infusion Duration) in ACS Salvatore Brugaletta

MATRIX Critique: Pros and Cons Frederick Feit

Roundtable Discussion With Audience Q&A. Key Questions: Bivalirudin vs Heparin With or Without GP IIb/IIIa Inhibitors in PCI inNSTEACS and STEMI? Does Access Site Affect This Decision? Infusion Duration?

Trial #3 - The Essentials of ... the LEADERS FREE trial Philip M. Urban

LEADERS FREE: Pros and Cons Donald Cutlip

Roundtable Discussion With Audience Q&A. Key Questions: Are BMS Appropriate for Any Patients? Stent Selection for Short andVery Short DAPT Scenarios

Trial #4 - The Essentials of ... STICH and STICHES - Ten-Year Follow-up Robert A. Guyton

STICH and STICHES Critique: Pros and Cons James E. Udelson

Roundtable Discussion With Audience Q&A. Key Question: Which Patients With Ischemic CAD and Depressed LV Function Benefitby Revascularization (And What Type)?

Trial #5 - The Essentials of … TOTAL - One-Year Outcomes of Aspiration in STEMI Warren J. Cantor

TOTAL Critique: Pros and Cons Francesco Burzotta

Roundtable Discussion With Audience Q&A. Key Questions: In Whom Should Aspiration Be Performed? Is Aspiration Harmful?

Session II. Structural Heart Disease and Peripheral Vascular InterventionModerators: William A. Gray, Stephan Windecker Discussants: Tony Das, Michael R. Jaff, Petr Kala, Saibal Kar, Maurice E. Sarano, Bruno Scheller, Paul Sorajja

Trial #6 - The Essentials of…PARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices Vinod H. Thourani

PARTNER 2 and SAPIEN 3 Critique: Pros and Cons Stephan Windecker

Roundtable Discussion With Audience Q&A. Key Question: Are We Ready for TAVR in Low Risk Patients?

Trial #7 - The Essentials of…CTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for SevereIschemic Mitral Regurgitation Michael Argenziano

CTSN Severe MR 2-Year Critique: Pro and Con Patrick M. McCarthy

Roundtable Discussion With Audience Q&A. Key Question: Which Patients With Severe Ischemic MR Should Undergo Mitral ValveSurgery? Repair Or Replacement?

Trial #8 - The Essentials of…The ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients Kenneth Rosenfield

ACT I Critique: Pro and Con Klaus D. Mathias

Roundtable Discussion With Audience Q&A. Key question: Carotid Stenting vs Endarterectomy vs Medical Therapy in AsymptomaticCarotid Disease?

Trial #9 - The Essentials of…IN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions John R. Laird Jr

IN.PACT SFA 3-year Outcomes Critique: Pro and Con Sriram S. Iyer

Roundtable Discussion With Audience Q&A. Key Question: Is There a Single Best Treatment for Most Patients With SFA Disease?

Didactic Session: Peripheral Vascular Intervention, Part 2: SFA, Popliteal, and Below the Knee


Session I. SFA Intervention: Knowns and UnknownsModerators: Tony Das, Koen Deloose Discussants: Brian G DeRubertis, Peter A. Schneider, Ido Weinberg

The Worldwide Epidemic of Peripheral Artery Disease, and Medical Interventions Which Really Work Ido Weinberg

SFA CTO Crossing Techniques: Choosing Between Intraluminal Crossing, Antegrade Subintimal Dissection With Re-entry, andRetrograde SFA Access Brian G DeRubertis

SFA Intervention: Options and When to Switch Krishna J. Rocha-Singh

The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE Ehrin J. Armstrong

No Metallic Implants Anymore: The Case for Routine DCB! Subhash Banerjee

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results Michael R. Jaff


Sessions II. Live Case Demonstrations and Debates: SFA InterventionLive Case Moderators: Michael R. Jaff, Kenneth Rosenfield Live Case Discussants: Tony Das, Brian G DeRubertis, Koen Deloose, Kenneth Ouriel, John H. Rundback

Live Case Demonstration: SFA Intervention- Riverside Methodist Hospital, Columbus OH Live Case Operators: Gary M. Ansel, Charles F. Botti, Jr., MD, FACC, Michael A. Jolly, MD, FACC, John A. Phillips, MD, Mitchell J. Silver,DO, FACC

Pre-debate Vote: Does Atherectomy Improve the Results of DCB? Poll Moderator: Michael R. Jaff

Great Debate 2: Atherectomy Adds Nothing to DCB Success Except Time and Cost! Koen Deloose

Great Debate 2: Atherectomy Is Critical for Success of DCB! Eric J. Dippel


Post-debate Vote (Who Won?): Does Atherectomy Improve the Results of DCB? Poll Moderator: Michael R. Jaff


Session III. Popliteal and BTK Intervention: Case DemonstrationsLive Case Moderators: Michael D. Dake, Zvonimir Krajcer Live Case Discussants: Subhash Banerjee, R. Stefan Kiesz, Ethan C. Korngold, Sahil A. Parikh, Mehdi H. Shishehbor

A Complex Case Presentation (With Discussion): BTK CTO Case Presenter: Peter A. Schneider

Live Case Demonstrations: Complex Popliteal/BTK Intervention- Riverside Methodist Hospital, Columbus OH Live Case Operators: Gary M. Ansel, Charles F. Botti, Jr., MD, FACC, Michael A. Jolly, MD, FACC, John A. Phillips, MD, Mitchell J. Silver,DO, FACC

Session IV. Popliteal and BTK Intervention: Techniques and Unsettled IssuesModerators: George L Adams, John F Angle Discussants: Koen Deloose, Patrick J Geraghty, Raghu Kolluri, Jihad A. Mustapha, Craig M. Walker

My Favorite Infrapopliteal CTO Techniques: Case Examples Craig M. Walker

When and How Do I Perform Retrograde Tibial Access? Jihad A. Mustapha

Best Practices for BTK Angioplasty and When to Debulk Koen Deloose

What Are the Right Endpoints for CLI Clinical Trials? Patrick J Geraghty

Liberty 360: A Prospective, Multicenter Registry Examining the Outcomes of Different Atherectomy Devices and No Atherectomy inPatients With Symptomatic Peripheral Arterial Disease Jihad A. Mustapha

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center Raghu Kolluri


Didactic Session: STEMI, Cardiogenic Shock, and Cardiac Arrest: Unsettled Issues and Emerging Device-Based Approaches


Session I. Primary PCI for STEMI and Multivessel DiseaseModerators: Ran Kornowski, Michel R. Le May Discussants: Giuseppe De Luca, Thomas Engstroem, William D. Knopf, Maurizio Menichelli, Tej Sheth, Marco V. Wainstein

Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions Kevin Bainey

Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them? Jose P.S. Henriques

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only? Henning Kelbæk

Pre-debate Vote: What Is the Most Important Factor in Predicting Future Thrombotic Events in Patients With STEMI and MultivesselDisease? Poll Moderators: Ran Kornowski, Michel R. Le May

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is MostImportant! Anthony H. Gershlick

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single MostImportant Factor! Tej Sheth

Post-debate Vote (Who Won?): What Is the Most Important Factor in Predicting Future Thrombotic Events in Patients With STEMIand Multivessel Disease? Poll Moderators: Ran Kornowski, Michel R. Le May

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-CulpritLesion Case Presenter: Natalia Pinilla-Echeverri

Roundtable Discussion With Q&A

Session II. Cardiac Arrest and Cardiogenic ShockModerators: Cindy L. Grines, Holger Thiele Discussants: Ulrich P. Jorde, Jacques J. Koolen, Sundeep Mishra, Tanveer Rab, Ivan C. Rokos, Nir Uriel

Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy? Christian M. Spaulding

Hypothermia and Cardiac Arrest: New Data on Patient Selection, Timing and Cooling Protocols David Erlinge

Case Presentation: A Patient Presenting With Cardiac Arrest Case Presenter: Michael Mooney


From Severe LV Dysfunction Without Heart Failure to Killip Class III and IV: Who Needs Mechanical Hemodynamic Support DuringPrimary PCI? Vladimir Dzavik

When Mechanical Support During Primary PCI for LV Dysfunction Is Needed: When to Use IABP, Impella, TandemHeart, and/orECMO Holger Thiele

Support for Hemodynamically Severe RV Infarction: When to Use Impella RP, TandemHeart, and/or CentriMag A. Reshad Garan

Outcomes of Impella in 347 Patients With Cardiogenic Shock: The US Impella Registry William W. O'Neill

Establishing ECMO in the Severe Shock and Cardiac Arrest Patient: Practical Issues and Patient Outcomes Hiroo Takayama

Benefit of Supersaturated Oxygen for Large Anterior STEMI: From ICI-HOT to Approval? Gregg W. Stone

PICSO to Improve Myocardial Salvage and Reduce Infarct Size in STEMI: Emerging Data Azfar G. Zaman


Session III. All the Rest: Thrombus Aspiration, Radial Intervention, Intracoronary Therapeutics, and Novel Stent DesignsModerators: Deepak L. Bhatt, Stefan K. James Discussants: Eric R. Bates, Sorin J. Brener, Vasim Farooq, Bill J. French, Christopher Overgaard, Rogerio Sarmento-Leite

Aspiration Thrombectomy in STEMI: Data Synthesis, and How to Identify Patients Who Might Benefit Eric A. Cohen

New Insights Into Thrombus Aspiration for STEMI: Results From the TOTAL Angiographic Core Lab Christopher Overgaard


Pre-debate Vote: Does Radial Access Really Improve Survival for STEMI? Poll Moderators: Deepak L. Bhatt, Stefan K. James

Debate: Does Radial Access Really Improve Survival for STEMI? Yes - Radial Intervention for STEMI Improves Survival and ShouldBe Standard Practice! Michael A. Kutcher

Debate: Does Radial Access Really Improve Survival for STEMI? No - Radial Intervention in STEMI Is Not Clearly Superior to FemoralAccess! Discussant: E. Magnus Ohman

Post-debate Vote (Who Won?): Does Radial Access Really Improve Survival for STEMI? Poll Moderators: Deepak L. Bhatt, Stefan K. James


Ticagrelor vs. Prasgurel in STEMI: What have we learned from PRAGUE-18 Salvatore Cassese

Is There a Current Role for Intracoronary Lytics or GP IIb/IIIa Inhibitors During Primary PCI? C. Michael Gibson

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices? Tullio Palmerini

Biodegradable Scaffolds In STEMI: Rationale, Registry outcomes (Literature search) and TROFI II 2-year Results Manel Sabate




Session I. Develop a CTO Skill Set and Build a CTO Program: Learn From Those Who Have Done ItModerators: James C. Spratt, Simon J. Walsh Discussants: Christopher E. Buller, Tony J. DeMartini, Farouc Jaffer, Steven P. Marso, Satoru Sumitsuji

Why I Became a CTO Operator and What It Means to Me Nicholas J. Lembo


What Is a CTO Skill Set? Why Is It Different and How Do You Build It? Ashish Pershad


How to Establish and Grow a CTO Program: Essentials and Pitfalls Farouc Jaffer


Individual and Programmatic CTO Development: Lessons Learned the Hard Way Steven P. Marso


The Latest Guidewires for CTO PCI: Construction and How to Choose and Use Christopher E. Buller


Microcatheters and Guide Extensions: What Do I Really Need and When/How Should I Use Them? Satoru Sumitsuji


Session II. Fundamental Skills and Algorithms for SuccessModerators: William L. Lombardi, Etsuo Tsuchikane Discussants: Sudhir Rathore, Simon J. Walsh, Gerald S. Werner, R. Michael Wyman

Asia Pacific Algorithm Etsuo Tsuchikane


Hybrid 2.0: Lessons From OPEN CTO R. Michael Wyman


Antegrade Wire Approach Sudhir Rathore


Parallel Wires and Antegrade IVUS Guided Re-entry Gerald S. Werner


Antegrade Dissection and Re-entry Simon J. Walsh


Didactic Session: The Left Main and Bifurcation Summit, Part 2: Left Main Stenting and EXCEL/NOBLE Deep Dive


Session I. Left Main Stenting: Evidence-Based Medicine Pre-EXCEL/NOBLEModerators: Seung-Jung Park, Leif Thuesen Discussants: Mohamed Abdel-Wahab, Carlo Briguori, Francesco Burzotta, Michalis Hamilos, Margaret B. McEntegart, AlexanderGrigorievich Osiev

Left Main PCI vs CABG From the Asan Medical Center: Insights Into Patient Selection and Technique to Optimize Outcomes Seung-Jung Park

What Have We Learned From Contemporary Left Main Observational Studies I? French and LEMAX Registries Philippe Garot

What Have We Learned From Contemporary Left Main Observational Studies II? ESTROFA-LM Jose M. de la Torre Hernandez

What Have We Learned From Contemporary Left Main Observational Studies III? ERACI IV Alfredo E. Rodriguez

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry David Antoniucci

Early Insights From the DELTA-2 Registry Alaide Chieffo

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials? Marie-Claude Morice

Cost-effectiveness of PCI vs CABG in Left Main Disease: Final SYNTAX Results David J. Cohen

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG Davide Capodanno

Impact of Operator Experience on Left Main PCI Outcomes: Fu Wai Experience Bo Xu


Session II: EXCEL Deep-DiveModerators: A. Pieter Kappetein, Marie-Claude Morice Discussants: Adrian P. Banning, Dietmar H. Glogar, Nicholas J. Lembo, Jamil Abdalla Saad, Erick Schampaert, Terje K. Steigen

EXCEL Top Line Results Revisited Gregg W. Stone

Site-reported vs Core Lab Syntax Scores: Discordance and Impact on Outcomes After PCI vs CABG in EXCEL Philippe Généreux

EXCEL Outcomes in Diabetic and Non-diabetic Patients A. Pieter Kappetein

EXCEL Outcomes in Men and Women Patrick W. Serruys

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease Joseph F. Sabik

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory Akiko Maehara


Session III. NOBLE Deep-DiveModerators: Evald H. Christiansen, Per Hostrup Nielsen Discussants: Pawel E. Buszman, Sreenivas Arramraju Kumar, Ramon Quesada, Bernhard Reimers, Marco V. Wainstein

NOBLE Top Line Results Revisited Evald H. Christiansen

Diabetes in the NOBLE Trial Olli A. Kajander

NOBLE Left main Bifurcation Stent Techniques Mitchell Lindsay

SYNTAX Stratified NOBLE Results Ian Menown

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial Niels R. Holm


Session IV. The Closing Debate: Is PCI Now Standard of Care in Left Main Disease?Moderators: Robert A. Guyton, Martin B. Leon Discussants: Adrian P. Banning, Bernard R. Chevalier, Keith G. Oldroyd, Joseph F. Sabik, Mohamed Ahmed Sobhy, Leif Thuesen, Grayson H.Wheatley

Pre-debate Vote: After EXCEL and NOBLE, What Proportion of All Patients With Left Main Disease Needing RevascularizationShould Undergo PCI? Poll Moderators: Robert A. Guyton, Martin B. Leon

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? Yes – the Issue Is No Longer in Doubt! David E. Kandzari

Debate: Is PCI Standard of Care in Left Main Disease After EXCEL and NOBLE? No - So Many Questions Are Still Unanswered! Marc Ruel


Post-debate Vote: After EXCEL and NOBLE, What Proportion of All Patients With Left Main Disease Needing RevascularizationShould Undergo PCI? Poll Moderators: Robert A. Guyton, Martin B. Leon

Didactic Session: Transcatheter Aortic Valve Therapies Part 2: Controversies and Complications

Walter E. Washington Convention Center Room 146B/C, Level 1Accreditation: CME/ASRT/CNE

Session I. TAVR 2016: ControversiesModerators: Raj Makkar, Lars Sondergaard Discussants: Stephan Baldus, Lutz Buellesfeld, Michael Haude, Dominique Himbert, Albert Markus Kasel, Alexandra J. Lansky, Grayson H.Wheatley

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, andthe SENTINEL Clinical Trials Samir R. Kapadia

Flash Debate: Point – Cerebral Protection Is a “Must” for All Patients! Axel Linke

Flash Debate: Counterpoint – Cerebral Protection Is an Unnecessary and Costly Accessory! Haim Danenberg


Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights Raj Makkar

Flash Debate: Point – 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance! Ganesh Manoharan

Flash Debate: Counterpoint – 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy! Raj Makkar


Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability A. Pieter Kappetein

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience Helene Eltchaninoff

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience John G. Webb


Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data Ganesh Manoharan

Flash Debate: Point – In Lower Risk Patients, the Minimalist Strategy Should Be the “Default” Approach! Antonio Colombo

Flash Debate: Counterpoint – In Lower Risk Patients, A Thoughtful “Hybrid” Strategy Is Preferred! Stephen J.D. Brecker


Featured Lecture: The Current Symptom-Based Paradigm for When to Treat Aortic Stenosis Is Flawed - A Hypothesis to IntegrateHemodynamic, Structural, and Functional Parameters Elazer R. Edelman


Controversy 5. Adjunctive Pharmacotherapy for TAVR: “Real World” Usage Patterns of Antiplatelet and Antithrombotic Agents Luis Nombela-Franco

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR Davide Capodanno


Session II. TAVR 2016: ComplicationsModerators: Neil E. Moat, John G. Webb Discussants: Anita Asgar, Marco Barbanti, Nirat Beohar, David J. Cohen, Kendra J. Grubb, Mayra Guerrero, Thierry Lefevre, Mark A. deBelder

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated? Jeffrey J. Popma

A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR Scott Lim

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation Eric Van Belle

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging Pieter R. Stella


Complications 2. How to Prevent and Treat Transfemoral Access Site Complications Stephen R. Ramee

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval) Adam B. Greenbaum


Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC Alexandra J. Lansky

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors – Clinical, Anatomic, Technique-related, and Device-specificSamir R. Kapadia


Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR Marina Urena

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors Ian T. Meredith


Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations Philippe Généreux


Didactic Session: Transcatheter Mitral Valve Therapies Part 2: Emerging Device-Based Solutions


Session I. Emerging Transcatheter Repair Devices for Mitral RegurgitationModerators: Ted Feldman, Scott Lim Discussants: Krzysztof Bartus, Steven L. Goldberg, Omar K. Khalique, Helge Möllmann, Jai Raman, Joerg Seeburger, Frederick G. St. Goar

Next Generation MitraClip: What’s Better and What’s Not Ralph Stephan von Bardeleben

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial andOther Experiences Steven F. Bolling

Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions Francesco Maisano

Direct Annuloplasty II: Mitralign Trial Results and Future Directions Azeem Latib

Direct Annuloplasty III: Guided Delivery Systems – Results, Device Iterations, and Future Directions Horst Sievert

Direct Annuloplasty IV: Millipede Jason H. Rogers

Direct Annuloplasty V: Valcare David Meerkin

Direct Annuloplasty VI: Cardiac Implants Karl-Heinz Kuck


Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans Samir R. Kapadia

Indirect Annuloplasty via the Coronary Sinus II: MVRx David Hildick-Smith

Indirect Annuloplasty via the Coronary Sinus II: Mitral Cerclage Robert J. Lederman

Update on Artificial Chords I: Neochord Joerg Seeburger

Update on Artificial Chords II: Harpoon James S. Gammie

Ventricular Reshaping: From CorCap to VenTouch Ted Feldman


Session II. Transcatheter Mitral Valve Replacement: Devices and Early ExperiencesModerators: Michael J. Mack, Ralph Stephan von Bardeleben Discussants: Anson Cheung, Jose Luis Navia, Wesley R. Pedersen, Michael J. Reardon, Lars Sondergaard, Alfredo Trento

Design Challenges in TMVR: Impossible or Just Near Impossible? Juan F. Granada

Complications That Can Occur After Transcatheter Mitral Valve Replacement Neil E. Moat

CardiAQ: Design and Clinical Trial Updates Gian Paolo Ussia

Tendyne: Design and Clinical Trial Updates David W.M. Muller

Neovasc Tiara: Design and Clinical Trial Updates Anson Cheung

Intrepid: Design and Clinical Trial Updates Vinayak Bapat


HighLife: Design and Clinical Trial Updates Ruediger Lange

Sinomed: Design and Clinical Trial Updates Maurizio Taramasso

Caisson: Design and Clinical Trial Updates Mathew Williams

M-Dock: Design and Clinical Trial Updates Maurice Buchbinder

Valtech TMVR: Design Development Update Karl-Heinz Kuck

Direct Flow TMVR: Design Development Update Azeem Latib

St. Jude TMVR: Design Development Update Anson Cheung

Cephea: Design Development Update Juan F. Granada

Grand Summary: TMVR Outcomes to Date – Successes, Failures, and Implications Michael J. Mack


Featured Clinical Research: Presentations to the Editors of Circulation


Presentations to the Editors of CirculationModerators: Joseph A. Hill, Steven P. Marso Discussants: Emmanouil S. Brilakis, Stefan K. James, Dharam J. Kumbhani, Laura Mauri, David O. Williams

OPINION: OCT Follow-Up Substudy from a Randomized Trial of OFDI-Guided PCI vs. IVUS-Guided PCI Hiromasa Otake


EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI inPatients with STEMI Jose P.S. Henriques


PERFECT: A Prospective Registry Evaluating the Effects of Pan-Pelvic Endovascular Intervention on Erectile Function and LowerUrinary Tract Symptoms Tzung-Dau Wang


A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement Adam B. Greenbaum


DISRUPT CAD: A multicenter, prospective, single-arm study of percutaneous lithoplasty prior to stent implantation in heavilycalcified coronary lesions Todd J. Brinton


Featured Clinical Research: Presentations to the Editors of the Journal of the American College of Cardiology


Presentations to the Editors of the Journal of the American College of CardiologyModerators: Spencer B. King III, Jagat NarulaDiscussants: Stephen G. Ellis, James K. Min, John G. Webb

FAME I and FAME II: Predictive Value of Fractional Flow Reserve After Drug-Eluting Stent Implantation Zsolt Piroth


A Prospective, Single-Center, Randomized Study to Assess Whether Co-Registration of OCT and Angiography can ReduceGeographic Miss Kohei Koyama


YELLOW II: Relationship of Serial Change in Plaque Morphology of Obstructive Non-Culprit Lesions to HDL Efflux, Inflammation andTranscriptome Perturbations in Response to High-Dose Statin Therapy Annapoorna Kini


TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow,Low-Gradient Aortic Stenosis Henrique B. Ribeiro


A Single Center Study Evaluating the Long-Term Durability of Self-Expanding Transcatheter Heart Valves After Treatment of SevereAortic Stenosis Erik W. Holy


Featured Clinical Research: Presentations to the Editors of the European Heart Journal


Presentations to the Editors of the European Heart JournalModerators: Thomas F. Luscher, Patrick W. Serruys Discussants: Carlo Di Mario, Ted Feldman, Felix Mahfoud, Christoph A. Nienaber

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left MainCoronary Artery Disease Alaide Chieffo


GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMIwith and without Preceding Fibrinolytic Therapy Francisco Fdez-Aviles


A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock Jose P.S. Henriques


FORWARD: Multicenter, Prospective Registry Evaluating a Repositionable Self-Expanding Aortic Bioprosthesis in Patients withSevere Aortic Stenosis Stephan Windecker


Multicenter Global Registry Report of the Two-year Outcomes with a Paclitaxel-Coated Balloon in Patients with ComplexFemoropopliteal Lesions D. Christopher Metzger


Oral Abstract Session: ACS/AMI I: Predictors and Prognosis


ACS/AMI I: Predictors and PrognosisModerators: Andreas Baumbach, Kurt Huber Discussants: Andrea Abizaid, Jun-Jack Cheng, Rajiv Gulati, Jamil Abdalla Saad

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A CollaborativePatient-Level Pooled Analysis of 10 Randomized Trials Bjorn Redfors

Discussion

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials ISCTR Lecturer: Suzanne De Waha

Discussion

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI– A Report from SCAAR Elmir Omerovic

Discussion

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients Seiichi Hiramori

Discussion

Oral Abstract Session: Adjunct Pharmacology I: Dual Antiplatelet Agents


Adjunct Pharmacology I: Dual Antiplatelet AgentsModerators: Dimitrios Alexopoulos, Laurent Bonello Discussants: Eric A. Cohen, Germano Di Sciascio, Dimitriy N. Feldman, Francesco Saia

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY TrialRamin Ebrahimi

Discussion

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results Froma Large Single-Center Registry Usman Baber

Discussion

TCT 8: Impact of Aspirin Resistance on Outcomes After Coronary Events Christine Chung

Discussion

TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis FromADAPT-DES Bjorn Redfors

Discussion

Oral Abstract Session: CT or Angiography-Derived FFR


CT or Angiography-Derived FFRModerators: Daniel S. Berman, Pamela S. Douglas Discussants: Lampros K. Michalis, Johan HC Reiber, Jennifer A. Tremmel, Tim P. van de Hoef

TCT 9: A Per-Vessel Level Systematic Review of Computed Tomography-Derived FFR (FFR-CT) Diagnostic Accuracy Studies:Implications for Clinical Decision-making Justin E. Davies

Discussion

TCT 10: Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-FreeFunctional Imaging (WIFI-II) Study Jelmer Westra

Discussion

TCT 11: Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary X-rayAngiography in the International Multicenter FAVOR (Functional Assessment by Various FlOw Reconstructions) Pilot Study Shengxian Tu

Discussion

TCT 12: Real-world Utilization of Computed Tomography Derived Fractional Flow Reserve: Single Center Initial Experience in theUnited States Anas Fares

Discussion

Oral Abstract Session: CTO Techniques and Outcomes I


CTO Techniques and Outcomes IModerators: Christopher E. Buller, Sudhir Rathore Discussants: David Antoniucci, Mauro Carlino, Paul Hsien-Li Kao, Barry D. Rutherford

TCT 13: Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention According to Dissection/Reentry vs WireEscalation Techniques Lorenzo Azzalini

Discussions

TCT 14: Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes After CTO Percutaneous Coronary Interventions: AnObservational Study of 5,496 Patients From the Pan-London CTO Cohort Daniel Jones

Disscussion

TCT 15: Use of Antegrade Dissection Reentry in Coronary Chronic Total Occlusion Percutaneous Coronary Intervention in aContemporary Multicenter Registry Barbara Danek

Discussion

TCT 16: Patient and Procedural Characteristics and In-Hospital Outcomes Associated With the Use of Retrograde RecanalizationTechniques for Chronic Total Occlusion PCI: A Report From the Open CTO Registry Sanjog Kalra

Discussion

Oral Abstract Session: Endovascular Interventions


Endovascular InterventionsModerators: Sriram S. Iyer, Craig M. Walker Discussants: Mark C. Bates, Koen Deloose, Zaza Kavteladze, Klaus D. Mathias

TCT 20: Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes Daniel Ortiz

Discussion

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After EndovascularTreatment for Critical Limb Ischemia (CLI). Takahiro Tokuda

Discussion

TCT 19: Vascular Response to Paclitaxiel-Eluting Nitinol Self-Expanding Stent in Superficial Femoral Artery Lesions: AngioscopicFindings at Two, Six, and Twelve Months After Implantation Toshiro Shinke

Discussion

TCT 17: The Lutonix Global DCB Registry Real World Patients With Complex Femero-Popliteal Lesions – 24 Month Outcomes D. Christopher Metzger

Discussion

Oral Abstract Session: Hemodynamic Support of Cardiogenic Shock: Prognosis, Devices, and ECMO


Hemodynamic Support of Cardiogenic Shock: Prognosis, Devices, and ECMOModerators: Tanveer Rab, Richard Smalling Discussants: Biswajit Kar, William D. Knopf, Michael Mooney, Molly Szerlip

TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMIComplicated by Refractory Cardiogenic Shock Chi-Cheng Huang

Discussion

TCT 22: Dual Mechanical Support Combining Impella Microaxial Pump and Veno-Arterial ECMO Rescues High-risk Patients inRefractory Cardiogenic Shock Joern Tongers

Discussion

TCT 23: Contemporary Trends in Utilization of Mechanical Circulatory Support in Patients Hospitalized After Out-of-Hospital CardiacArrest Nileshkumar Patel

Discussion

TCT 24: Global cVAD Registry: A Global Initiative in Percutaneous Circulatory Support From the cVAD Steering Committee on Behalfof All cVAD Investigators Brij Maini

Discussion

Oral Abstract Session: LAA and PFO Closure: New Devices and Outcomes


LAA and PFO Closure: New Devices and OutcomesModerators: Zahid Amin, Jacqueline Saw Discussants: Steven L. Almany, Hans R. Figulla, Glenn Van Langenhove, Nina C. Wunderlich

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-AnalysisFrom Randomized Trials Luis Nombela-Franco

Discussion

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up Vivek Y. Reddy

Discussion

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy Jens Erik Nielsen-Kudsk

Discussion

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE) David Hildick-Smith

Discussion

Oral Abstract Session: New Bioresorbable Scaffolds


New Bioresorbable ScaffoldsModerators: Jacques J. Koolen, Yoshinobu Onuma Discussants: Ricardo A. Costa, Vasim Farooq, Aloke V. Finn, Nick E. J. West

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-MonthFollow-Up by Optical Coherence Tomography in the FANTOM II Study Jo Simonsen

Discussion

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in theTreatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II Michael Haude

Discussion

TCT 31: Impact of Strut Thickness on Short-term Healing Response After Bioresorbable Scaffold Implantation: Serial OCTEvaluation of Novel Thin Strut Sirolimus-Eluting BRS vs Thick Strut Everolimus-Eluting BRS in Porcine Coronary Arteries Pawel Gasior

Discussion

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: ImagingOutcomes and Four-Year Clinical and Imaging Results Alexandre Abizaid

Discussion

Oral Abstract Session: Outcomes After TAVR and SAVR


Outcomes After TAVR and SAVRModerators: Charles J. Davidson, Michael J. Reardon Discussants: Amit N Patel, Wesley R. Pedersen, E. Murat Tuzcu, Grayson H. Wheatley

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement James Harvey

Discussion

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at IntermediateSurgical Risk: Results from the PARTNER S3i Trial Suzanne Baron

Discussion

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement:Results From the CoreValve US Trial Program James B. Hermiller Jr

Discussion

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points andRelationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized TrialPhilip Green

Discussion

Oral Abstract Session: TAVR Results With Emerging THV Systems


TAVR Results With Emerging THV SystemsModerators: Lutz Buellesfeld, Raj Makkar Discussants: Dominique Himbert, Jean-Claude Laborde, Reginald I. Low, Ganesh Manoharan

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe AorticStenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study Jeffrey J. Popma

Discussion

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve ReplacementWith the SAPIEN 3 Transcatheter Valve Philippe Pibarot

Discussion

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus™ Transcatheter Aortic Replacement Valve in 120High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study Ian T. Meredith

Discussion

TCT 40: One-Year Outcome of a Multicenter Clinical Study Evaluating a Novel Self-Expanding and Resheathable TranscatheterAortic Valve System Ganesh Manoharan

Discussion

Oral Abstract Session: Transcatheter Mitral Valve Repair


Transcatheter Mitral Valve RepairModerators: Stephan Baldus, Allan Schwartz Discussants: Philipp Blanke, Steven L. Goldberg, Helge Möllmann, Joerg Seeburger

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction MulticenterTrial Karl-Heinz Kuck

Discussion

TCT 42: Transcatheter Echo Guided Mitral Valve Repair With Neochord Implantation for Posterior Leaflet Disease: Results FromNeochord Independent International Registry Andrea Colli

Discussion

TCT 43: Outcomes After Paravalvular Leak Closure: Percutaneous Versus Surgical Approaches John Wells

Discussion

TCT 44: Independent Mitral Valve Restenosis Predictors After Percutaneous Mitral Balloon Valvuloplasty in a Large, ConsecutiveCohort Followed for More Than Two Decades Alfredo Nunes Ferreira Neto

Discussion

Oral Abstract Session: Treatment of Specific Coronary Lesion Subsets


Treatment of Specific Coronary Lesion SubsetsModerators: Javier Escaned, Christoph K. Naber Discussants: Kevin Bainey, Graham A. Cassel, Walter Desmet, Pim A.L. Tonino

TCT 45: Five-Year Mortality Predictors After Provisional T-Stenting in Coronary Bifurcation Lesions, With IntracoronaryElectrocardiogram Change Defined Strategy. From Intracoronary Electrocardiogram (ECG) and Myonecrosis After BifurcationStenting (COSIB Kiril Karamfiloff

Discussion

TCT 46: Coronary Artery Aneurysms: Incididence, Etiology, Management, and Outcomes in a Long-term Follow-up Antonio Gomez Menchero

Discussion

TCT 47: Secular Trends in Characteristics, Treatments, and Outcomes in Patients With Unprotected Left Main Coronary ArteryDisease Over Two Decades Duk-Woo Park

Discussion

TCT 48: Medical Therapy and Clinical Outcomes With Spontaneous Coronary Artery Dissection Jaya Chandrasekhar

Discussion

Oral Abstract Session: ACS/AMI II: Anatomy, DES, and BRS Treatment


ACS/AMI II: Anatomy, DES, and BRS treatmentModerators: Michael J. Cowley, Franz-Josef Neumann Discussants: Tayo A. Addo, Bill J. French, Petr Kala, Christopher Pyne

TCT 49: Two-Year Clinical Outcome of Everolimus-Eluting Bioresorbable Scaffold vs Durable Polymer Everolimus-Eluting MetallicStent in Patients With ST-Segment Elevation Myocardial Infarction: Results of the Randomized ABSORB ST-Segment ElevationMyocardi Stephan Windecker

Discussion

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, andFive-Year Follow-up Pablo Salinas

Discussion

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute CoronarySyndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry Joel Sainsous

Discussion

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of TargetLesion Revascularization After Sirolimus-Eluting Stent Implantation Shunsuke Kubo

Discussion

Oral Abstract Session: Adjunct Pharmacology II: Acute and Chronic Antithrombotic Treatments


Adjunct Pharmacology II: Acute and Chronic Antithrombotic TreatmentsModerators: Neal S. Kleiman, David F. Kong Discussants: Kevin J. Beatt, Eli I. Lev, Jorge F. Saucedo, Thomas D. Stuckey

TCT 53: Thromboembolic Event Rate Is Elevated With Lower Adherence to Warfarin and NOACs Jeffrey R Winterfield

Discussion

TCT 54: LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A PrespecifiedSubgroup Analysis of the LEADERS FREE Trial Didier Carrié

Discussion

TCT 55: Risk–Benefit Analysis of Upstream Antithrombotic Therapy in Patients With Non–ST-Segment Elevation Acute CoronarySyndromes Prior to Coronary Angiography Bjorn Redfors

Discussion

TCT 56: Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results From a Large Single-Center Registry Usman Baber

Discussion

Oral Abstract Session: Bioresorbable Scaffold Outcomes: Simple and Complex Lesions


Bioresorbable Scaffold Outcomes: Simple and Complex LesionsModerators: Antonio L. Bartorelli, Kenneth Chin Discussants: Olivier F. Bertrand, Ronald Caputo, Salvatore Cassese, Detlef G. Mathey

TCT 57: Impact of Lesion Length on One-Year Outcomes of Absorb Bioresorbable Vascular Scaffolds Rony Lahoud

Discussion

TCT 58: Long-term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Scaffolds During Daily Practice –Two-Year Results From the ISAR-ABSORB Registry Jens Wiebe

Discussion

TCT 59: Overlapping Bioresorbable Coronary Devices: Immediate Results and Six-Month Follow-up of the REPARA Registry Felipe Hernandez

Discussion

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-LevelPooled Analysis From the ABSORB Randomized Trials Ariel Furer

Discussion

Oral Abstract Session: CTO Techniques and Outcomes II


CTO Techniques and Outcomes IIModerators: Julinda Mehilli, Georgios Sianos Discussants: Omer Goktekin, Colm Hanratty, Annapoorna Kini, Paul Knaapen

TCT 61: Long-term Outcomes of Patients With Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention forChronic Total Occlusion Kambis Mashayekhi

Discussion

TCT 62: Outcomes of Reattempt Percutaneous Coronary Intervention for Chronic Total Occlusion: Two-year Data From RetrogradeSummit Registry Shozo Ishihara

Discussion

TCT 63: Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction Philippe Généreux

Discussion

TCT 64: Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion: Procedural and Long-term Outcomes Lorenzo Azzalini

Discussion

Oral Abstract Session: Diabetes Mellitus and PCI Outcomes


Diabetes Mellitus and PCI OutcomesModerators: Sorin J. Brener, Jean-François Tanguay Discussants: Upendra Kaul, Alfredo E. Rodriguez, Binita Shah, Giuseppe Tarantini

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES Michela Faggioni

Discussion

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A PooledPatient Level Analysis From 17 Randomized Trials Jaya Chandrasekhar

Discussion

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A PooledAnalysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials Rafael Cavalcante

Discussion

TCT 68: One-Year Clinical Outcomes in Patients With Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes MellitusCompared to Non-Diabetics After Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-ComersRegi Deborah Kalkman, MD

Discussion

Oral Abstract Session: New Metallic DES


New Metallic DESModerators: Giuseppe De Luca, Christoph A. Kaiser Discussants: Fausto Feres, Julio C. Palmaz, Thomas Pilgrim, Michael J. Rinaldi

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and theFirst Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT IITrial Li Zhi

Discussion

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-ElutingXience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population Pieter C. Smits

Discussion

TCT 71: The NIREUS Randomized Trial: One-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR)European Angiography Study Pieter C. Smits

Discussion

TCT 72: Short and Medium-term Clinical Outcome of Amphilimus Polymer-Free Drug-Eluting Stent in Diabetic Patients: An All-Comers Multicenter Spanish Registry (Control-8 Registry) Antonio Gomez Menchero

Discussion

Oral Abstract Session: Serial IVUS and OCT Studies


Serial IVUS and OCT StudiesModerators: Hector M. Garcia-Garcia, Ik-Kyung Jang Discussants: Vasileios D. Gkogkas, Vijay Kunadian, Junya Shite, Richard Shlofmitz

TCT 73: Serial Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Analysis of Changing MorphologiesAssociated of Plaque Progression in Patients With Stable Angina Pectoris Myong Hwa Yamamoto

Discussion

TCT 74: A Serial Three-Year and Nine-Year Optical Coherence Tomography Assessment of Vascular Healing Response to Sirolimusand Paclitaxel-Eluting Stents Mariusz Tomaniak

Discussion

TCT 75: Qualitative and Quantitative Evaluation of Dynamic Changes in Non-Culprit Coronary Atherosclerotic Lesion Morphology byOptical Coherence Tomography Bu-Chun Zhang

Discussion

TCT 76: Temporal Change of In-Stent Thrombus Immediately After Percutaneous Coronary Intervention Within Five Minutes UsingOptical Coherence Tomography Hyuck Jun Yoon

Discussion

Oral Abstract Session: TAVR Outcomes


TAVR OutcomesModerators: John M. Lasala, Philippe Pibarot Discussants: Jorge A. Belardi, Jose Armando Mangione, Gerhard C. Schuler, Gian Paolo Ussia

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for AcuteHeart Failure: An Analysis From PARTNER 1 John Petersen

Discussion

TCT 78: Incidence and Outcomes of Vascular Complications and Bleeding Events in Patients Undergoing TAVR in ContemporaryU.S. Practice: Insights From the STS/ACC TVT Registry® Matthew Sherwood

Discussion

TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without OralAnticoagulation Jürgen Rothe

Discussion

TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement(TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter ValvSaif Anwaruddin

Discussion

Oral Abstract Session: TAVR Techniques and Real-World Practice Outcomes


TAVR Techniques and Real-World Practice OutcomesModerators: Mayra Guerrero, Roger J. Laham Discussants: Omar K. Khalique, Ran Kornowski, John C. Messenger

TCT 81: Clinical and Hemodynamic Results After Direct Transcatheter Aortic Valve Replacement Versus Pre-Implantation BalloonAortic Valvuloplasty. A Case-Matched Analysis Luis Nombela-Franco

Discussion

TCT 82: Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (Worldwide TAVRExperience)Survey Luis Nombela-Franco

Discussion

TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape Yoshio Maeno

Discussion

TCT 84: Outcomes of Transcatheter Aortic Valve Replacement Without Predilation of the Aortic Valve: Insights From 1942 PatientsIncluded in the SOURCE 3 Registry Thomas Walther

Discussion

Oral Abstract Session: Transcatheter Tricuspid Valve Repair


Transcatheter Tricuspid Valve RepairModerators: Alexander Lauten, Stephen G. Worthley Discussants: Sameer Gafoor, Jose Luis Navia, Toby Rogers, Robert S. Schwartz

TCT 85: Prevalence of Tricuspid Regurgitation and Its Impact on Mid-Term Outcomes: Insights From a Tertiary Referral Center Claudio Montalto

Discussion

TCT 86: Early Experience With the Trialign System for Transcatheter Tricuspid Valve Repair: A Multicenter Experience Ermela Yzeiraj

Discussion

TCT 87: Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip® System: 30-day Clinical Results in 13Consecutive Patients. Jörg Hausleiter

Discussion

TCT 88: Innovative Transcatheter Tricuspid Valve Repair System. Initial Outcomes From the First in Human Multi-Centre Study Paolo Denti

Discussion

Oral Abstract Session: Treatment of Chronic Thromboembolic Pulmonary Hypertension


Treatment of Chronic Thromboembolic Pulmonary HypertensionModerators: Ori Ben-Yehuda, Ehtisham Mahmud Discussants: Shao-Liang Chen, Stephen P. Hoole, Gagan D Singh

TCT 89: Balloon Pulmonary Angioplasty for Chronic Thromboembolic Hypertension: Report of a Two-Year Experience in a SurgicalCenter Carlos Garcia Alonso

Discussion

TCT 90: Efficacy and Safety of Sequential Hybrid Therapy with Pulmonary Endarterectomy and Additional Balloon PulmonaryAngioplasty for Chronic Thromboembolic Pulmonary Hypertension Kenichi Yanaka

Discussion

TCT 91: Efficacy of Aggressive Balloon Pulmonary Angioplasty on Chronic Thromboembolic Pulmonary Hypertension BeyondNormalized Mean Pulmonary Arterial Pressure Yuto Shinkura

Discussion

TCT 92: Short and Long-term Remodeling of Pulmonary Arteries After Balloon Angioplasty in Patients With Inoperable ChronicThromboembolic Pulmonary Hypertension Nicolay Danilov

Discussion

Oral Abstract Session: Vulnerable Plaque: Imaging and Prognosis


Vulnerable Plaque: Imaging and PrognosisModerators: Farouc Jaffer, Amir Lerman Discussants: Patrick A. Calvert, James A. Goldstein, Jonathan Leor, Guillermo Tearney

TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in PatientsWith Coronary Artery Disease During 4.3 Year Follow-up Eric Boersma

Discussion

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus:Insights From the PROSPECT Study Elvin Kedhi

Discussion

TCT 95: The Interplay Between Features of Plaque Vulnerability and Hemodynamic Relevance of Coronary Artery Stenoses Sabahattin Umman

Discussion

TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-DiabeticOnes. Study With 3D Intravascular Ultrasound and Virtual Histology Tomas Kovarnik

Discussion

iASSESS, Day 2 - Monday, Oct. 31


iASSESS, Day 2: Morning SessionModerators: George D. Dangas, Morton J. Kern

FFR, iFR and Microvascular Assessment Moderator: Verghese Mathew Arnold Seto

Intravascular Imaging: IVUS, OCT, and NIRS Moderator: John McB. Hodgson Stephen P. Hoole

Valvular Heart Disease I: Aortic Stenosis - Valvuloplasty and TAVR Moderator: Dimitriy N. Feldman Rahul Sakhuja

Break

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR Moderator: Michael J. Lim Molly Szerlip

Valvular Heart Disease III: Mitral Stenosis, Pulmonic Stenosis, and Tricuspid Regurgitation Moderator: Michael J. Lim Payam Dehghani

Structural Intervention IV: LAA Closure, HOCM, Paravalvular Leak Moderator: Srihari S. Naidu Adnan K. Chhatriwalla

Break

iASSESS, Day 2: Afternoon SessionModerators: Tayo A. Addo, Dimitriy N. Feldman, Srihari S. Naidu

Endovascular Intervention I: Aorta, Renal, Iliac, Femoropopliteal Moderator: Kenneth Rosenfield Sahil A. Parikh

Endovascular Intervention II: Popliteal, BTK and Carotid Moderator: Prakash Krishnan Karthik R. Gujja

Intervention for Venous Disease Moderator: Raghu Kolluri Vishal Kapur

Congenital Heart Disease: PFO, ASD, PDA and Coarctation Moderator: Harsimran Sachdeva Singh John P. Breinholt

Complications of Coronary and Peripheral Vascular Intervention Moderator: Sahil A. Parikh Ehrin J. Armstrong

Complications of Structural Heart Disease Intervention Moderator: George S. Hanzel Mauricio G. Cohen

FDA Town Hall Meeting at TCT 2016, Part 1: Overarching Concepts


Session I. FDA and European Regulatory Priorities and CourseModerators: Matthew G. Hillebrenner, Gregg W. Stone Discussants: Angeles Alonso Garcia, Alan G. Fraser, Aaron V. Kaplan, Jeffrey Shuren, Bram D. Zuckerman

The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, andPayors Gregg W. Stone

Key Note Lecture I. FDA/CDRH State of the Union Jeffrey Shuren

Key Note Lecture II. Regulatory Reform of Medical Device Approvals by the European Commission – Motivating Factors, AnticipatedChanges, and Timelines Alan G. Fraser


Session II. National Evaluation System for Health TechnologyModerators: Owen Faris, Mitchell W. Krucoff Discussants: Gregory Daniel, David R. Holmes Jr., Louis B. Jacques, Danica Marinac-Dabic, Roxana Mehran, Michael Minogue, GregoryPappas, Jeffrey Shuren, Tamara Syrek Jensen, Craig A. Thompson

Device Performance in Pre-Approval Studies vs Unrestricted “Real-World” Use: Lessons Learned and Future Opportunities Mitchell W. Krucoff

Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and Inform Device Label Expansion David R. Holmes Jr.

Keynote Lecture III. National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future DirectionsGregory Daniel

CMS Perspectives On Post-Approval Device Evaluation (Including NEST) and Reimbursement Tamara Syrek Jensen

MDIC and Industry Perspectives: Potential Effects of NEST on Research, Innovation and Patient Outcomes Michael Minogue


Session III. Moving Towards Simple Trials and Big DataModerators: Deepak L. Bhatt, Roxana Mehran Discussants: Owen Faris, Robert A. Harrington, Harlan Krumholz, Michael S. Lauer, William H. Maisel, E. Magnus Ohman, Stuart J. Pocock,Gregg W. Stone, Pascal Vranckx, Clyde W. Yancy

Pragmatic Simple Trials and Big Data: Advantages and Caveats Robert A. Harrington

Pragmatic Simple Trials and Big Data: Implications for NIH Funding Michael S. Lauer


Session IV. Implications of Data SharingModerators: C. Michael Gibson, A. Michael Lincoff Discussants: Keith D. Dawkins, Rosemarie Hakim, Robert A. Harrington, Harlan Krumholz, Michael S. Lauer, William H. Maisel, GregoryPappas, Manesh R. Patel, Stuart J. Pocock, Stuart Spencer

The Moral Imperative and Potential Benefits of Data Sharing: Journalist Perspective Eric D. Peterson

Opportunities and Risks of Data Sharing I: YODA Proposal Harlan Krumholz

Opportunities and Risks of Data Sharing II: ACCESS CV Proposal Manesh R. Patel

Opportunities and Risks of Data Sharing III: International Consortium Proposal Philip James Devereaux


Session V. Early Feasibility Studies: A Critical AppraisalModerators: Andrew Farb, Aaron V. Kaplan Discussants: Steven R. Bailey, Joseph Chin, Elazer R. Edelman, Juan F. Granada, Martin B. Leon, Stanton J. Rowe, Sean Salmon, RenuVirmani, Carla M Wiese, Changfu Wu

Early Feasibility Studies in USA: Progress Report From the FDA Carla M Wiese

Early Feasibility Studies in the USA: Early Example With Success Steven R. Bailey

EFS in the USA: Challenges and Developments (An Investigator’s Perspective) Martin B. Leon


International Session: PCI Techniques Beyond DES: Multinational Experiences Presented by the Working Group on Invasive andInterventional Cardiology, Croatian Cardiac Society; Working Group on Interventional Cardiology, Belgian Working Group of InterventionalCardiology (BWGIC); Austrian Society of Cardiology; Swiss Working Group Interventional Cardiology and Acute Coronary Syndrome; SlovakSociety of Cardiology, Working Group of the Interventional Cardiology


PCI Techniques beyond DES: Multinational ExperiencesModerators: Guy J. Friedrich, Kurt Huber Discussants: Viliam Fridrich, Petr Kala, Jochen Wöhrle

Introduction and Session Objectives Kurt Huber

Rotablation: What Are the Current Indications? Walter Desmet


BVS in Complex Lesions: Ready or Not? Guy J. Friedrich


DEB: What Are the Potential Indications? Eduard Margetic


New Techniques, New Antithrombotic Therapies Matej Samos


Do We Need New Technologies Beyond/Beside DES? Stephane Cook


Closing Comments and Take-home Messages Guy J. Friedrich, Kurt Huber

International Session: Trends in Treatment of Acute Coronary Syndromes: Insights From Asia, Europe and the Americas, Presented by theSpanish WG on Interventional Cardiology, Dutch Working Group Interventional Cardiology, Turkish Working Group of InterventionalCardiology, Panamanian Society of Cardiology, Peruvian Society of Cardiology


Trends in Treatment of Acute Coronary Syndromes: Insights From Asia, Europe, and the AmericasModerators: Murat Sezer, Niels van Royen Discussants: Javier Escaned, Bertha Gonzales

Panama Presents: Trends in Treatment and Outcomes of ACS in Latin America

Peru Presents: Use of Bioabsorbable Scaffolds in Patients With ACS Bertha Gonzales

Turkey Presents: Strategies to Limit Reperfusion Injury in ACS patients Murat Sezer

Spain Presents: Detection and Treatment of Flow-Limiting Lesions in ACS Patients Javier Escaned

The Netherlands Presents: Detection and Treatment of High-risk Plaques in ACS Patients Niels van Royen


International Session: Interventional Worst Case Scenarios and Best Saves, Presented By the Egyptian Society of Cardiology (EgSC),Kuwait Cardiac Society, National Heart Association of Malaysia NHAM, Colegio Colombiano de Intervencionismo Cardiovascular, and theLatin American Society of Interventional Cardiology (SOLACI)


Interventional Worst Case Scenarios and Best SavesModerators: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari Discussants: Khalid Almerri, Pablo Charry, Ariel Duran, Sameh Shaheen, Muhamad Ali Sheikh Abdul Kader

Introduction and Session Objectives Ahmed Magdy

Egypt Presents: A Case of a High-Risk STEMI Intervention: How Did I Treat? Case Presenter: Ahmed Magdy

Kuwait Responds: How Would I Have Treated This Case in My Cath Lab? Khalid Almerri


Colombia Presents : A Case of Aorto-Cameral Fistula Management: How Did I Treat? Case Presenter: Jorge Villegas

Uruguay Responds: How Would I Have Treated This Case in My Cath Lab? Ricardo Lluberas


Malaysia Presents: A Case of Ischemic Bowel Intervention: How Did I Treat? Case Presenter: Muhamad Ali Sheikh Abdul Kader

Colombia Responds: How Would I Have Treated This Case in My Cath Lab? Pablo Charry


Kuwait Presents: A Case of a Challenging Left Main PCI: How Did I Treat? Case Presenter: Wael Aboushokka

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab? Robaayah Zambahari


Egypt Presents: A Case of a Challenging Bifurcation Intervention: How Did I Treat? Sameh Shaheen

Uruguay Responds: How Would I Have Treated This Case in My Cath Lab? Case Presenter: Ariel Duran


Closing Remarks and Take-home Messages Ahmed Magdy

International Session: Complex PCI and Complication Management, Presented by: Bangladesh Society of Cardiovascular Intervention,Hong Kong College of Cardiology, the Israeli Working Group for Interventional Cardiology, Italian Society of Invasive Cardiology (GISE)

Walter E. Washington Convention Center Presentation Theater 1

Accreditation: none

Session I: Complex PCIModerators: Kam-Tim Chan, Afzalur Rahman Discussants: Syed Ali Ashan, Chris Kwok Yiu Wong

Introduction and Learning Objectives Ariel Finkelstein

Bangladesh Presents: Case 1 Introduction - Complex Left Main Intervention Case Presenter: Afzalur Rahman

Hong Kong Responds: How Would I Treat? Kam-Tim Chan

Bangladesh Responds: How Would I Treat? Syed Ali Ashan

Bangladesh Presents: How I Managed This Case Afzalur Rahman


Hong Kong Presents: Case 2 Introduction - PCI of a Calcified Lesion With a Stuck Balloon Case Presenter: Kam-Tim Chan

Hong Kong Presents: Case 2 Introduction - PCI of a Calcified Lesion With a Stuck Balloon Case Presenter: Afzalur Rahman

Hong Kong Responds: How Would I Treat? Case Presenter: Chris Kwok Yiu Wong

Hong Kong Presents: How I Managed This Case Case Presenter: Kam-Tim Chan


Session II: Management of ComplicationsModerators: Ariel Finkelstein, Ugo Limbruno Discussants: Giovanni Esposito, Alessio G La Manna

Israel Presents: Case 3 Introduction - A Complication of an Antegrade CTO Recanalization Case Presenter: Yaron Almagor

Italy Responds: How Would I Treat? Alessio G La Manna

Israel Responds: How Would I Treat? Haim Danenberg

Israel Presents: How I Managed This Case Case Presenter: Yaron Almagor


Italy Presents: Case 4 Introduction – A Complication of Primary PCI during STEMI Case Presenter: Giovanni Esposito

Israel Responds: How Would I Treat? Haim Danenberg

Italy Responds: How Would I Treat? Ugo Limbruno

Italy Presents: How I Managed This Case Case Presenter: Giovanni Esposito


Closing Comments and Take-home Messages Ariel Finkelstein

International Session: Tough Daily Interventional Cases: A Three-Continent Solution; Presented by British Cardiovascular InterventionSociety (BCIS); South African Society of Cardiovascular Intervention (SASCI); Irish Cardiac Society Working Group; Russian ScientificSociety of Endovascular Therapies; Scottish Cardiac Society Working Group


Session 1. TAVR in Low-Risk PatientsModerator: Niall T. Mulvihill Discussants: Sergey A. Abugov, Peter F Ludman, Michael Mahmoudi

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis Niall T. Mulvihill

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather thanSurgical AVR, Without Further Trial Evidence? Pro Position Antoniette Neylon

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather thanSurgical AVR, Without Further Trial Evidence? Con Position Hellmuth Weich

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature Michael Mahmoudi

Roundtable Discussion With Audience Q&A and Rebuttal to the Debates

Audience Vote: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather thanSurgical AVR, Without Further Trial Evidence? Moderator: Niall T. Mulvihill

Session 2. How Should We Treat TAVR Restenosis?Moderator: Nick Curzen Discussants: Sergey A. Abugov, Bagrat Alekyan, Peter F Ludman, Michael Mahmoudi

Introduction: TAVR Restenosis Nick Curzen

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR Case Presenter: Michael Mahmoudi

Roundtable Discussion With Audience Q&A: How Should We Evaluate and Treat This Patient?

TAVR Restenosis: Review of the Literature Nick Curzen

Case Resolution: How Did We Treat this Patient? Case Presenter: Michael Mahmoudi


Session 3. PCI of Non-Culprit Lesions in STEMIModerator: Graham A. Cassel Discussants: Sergey A. Abugov, Bagrat Alekyan, Peter F Ludman, Margaret B. McEntegart

Introduction: PCI of Non-Culprit Lesions in STEMI Graham A. Cassel

Case #1: STEMI in Patient With Moderate Bystander Disease Case Presenter: Sergey A. Abugov


Case #2: STEMI in Patient With Left Main and Multivessel Disease Case Presenter: Narek Zakaryan


PCI of Non-Culprit Lesion in STEMI: Literature Review Margaret B. McEntegart

PCI of Non-Culprit Lesions in STEMI: Flaws in the Previous Trials Nick Curzen

PCI of Non-Culprit Lesions in STEMI: Take-home Messages Graham A. Cassel

International Session: Featured Session for International Advisory Faculty Opportunities and Challenges: Meeting CHIPs from China - 10/31


Featured Session for International Advisory Faculty Opportunities and Challenges: Meeting CHIPs from ChinaModerators: Shao-Liang Chen, Ajay J. Kirtane, Manish A. Parikh, Bo Xu Discussants: Kefei Dou, Zening Jin, Paul Hsien-Li Kao, Michael Kang-Yin Lee, Jianfang Luo

Welcome and Introduction Shao-Liang Chen, Ajay J. Kirtane

My Most Challenging Case 2016: Severe Calcified Lesion Case Presenter: Juying Qian

Discussion

My Most Challenging Case 2016: Chronic Total Occlusion Case Presenter: Bin Zhang

Discussion

My Most Challenging Case 2016: Severe LV Dysfunction Case Presenter: Qi Zhang

Discussion

My Most Challenging Case 2016: STEMI with Multivessel Disease Case Presenter: Ning Guo

Discussion

Summary Bo Xu

Partnership Session: CACI at TCT: Complex Coronary Angioplasty With Current Generation DAn Update From Registries and RandomizedStudies


CACI at TCT: Complex Coronary Angioplasty With Current Generation DES - An Update From Registries and Randomized StudiesModerators: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez

Welcome! Alejandro Cherro

Rationale and Principal Results of the Excel Trial Tullio Palmerini

Case Presentation: A Complex Distal Left Main Bifurcation Case Presenter: Jose A. Alvarez

Roundtable Discussion With Audience Q&A Discussants: Diego D Grinfeld, Oscar A. Mendiz, Alejandro O. Palacios

Left Main and MVD Stenting With Second Generation DES: The Florence Registry David Antoniucci

Case Presentation: Bifurcation Stenting Strategies in Multivessel Disease Case Presenter: Alejandro D Fernandez

Roundtable Discussion With Audience Q&A Discussants: Ruben A. Piraino, Omar Anibal Santaera, Ernesto M. Torresani

Duration of DAPT Therapy With Contemporary DES (Including BVS) Gustavo A Samaja

Case Presentation: Difficult DAPT Duration Decision After PCI Case Presenter: Marcelo Bettinotti

Roundtable Discussion With Audience Q&A Discussants: Jorge H. Leguizamon, Antonio A Pocovi, Gustavo A Samaja

Take Home Messages: Rationale for a Conservative Strategy During DES Implantation Alfredo E. Rodriguez

Partnership Session: CardioVascular Summit TCTAP in Partnership With TCT: Complex PCI (Left Main, Bifurcation, and CTO): The Simpler,the Better


Complex PCI (Left Main, Bifurcation, and CTO): The Simpler, the BetterModerators: Seung-Jung Park, Alan C. Yeung Discussants: Takashi Akasaka, Alaide Chieffo, Seung-Whan Lee, Nico H.J. Pijls

Welcome and Introductory Remarks Moderator: Seung-Jung Park

Trends in Outcomes of Treatment for LM Artery Disease: IRIS-MAIN Registry Data (N=5,020) Seung-Jung Park

What Really Matters in Bifurcation PCI? Technique or Concept Duk-Woo Park

Should Every CTO Be Opened? From the IRIS-CTO Registry to the Randomized (DECISION-CTO Trial) Seung-Whan Lee

FFR-Guided Decision Making Is Now Standard Nico H.J. Pijls

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013) Jung-Min Ahn

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization Akiko Maehara


Partnership Session: JIM in Partnership With TCT


Session 1. Two Challenging TAVR ComplicationsModerators: Antonio Colombo, Jeffrey W. Moses Discussants: Samir R. Kapadia, Augusto D. Pichard

Case #1: A TAVR Complication to Learn From Case Presenter: Samir R. Kapadia


Case #2: A TAVR Complication to Learn From Case Presenter: Augusto D. Pichard


Session 2. Problems and Solutions With Bioresorbable ScaffoldsModerators: Antonio Colombo, Jeffrey W. Moses Discussants: Carlo Di Mario, Azeem Latib

Case #1: A Novel Issue With a Bioresorbable Scaffold Case Presenter: Patrick W. Serruys


Case #2: A Novel Issue With a Bioresorbable Scaffold Case Presenter: Azeem Latib


Case #3: A Novel Issue With a Bioresorbable Scaffold Case Presenter: Carlo Di Mario


Partnership Session: TCT India Next at TCT2016


Session I. Practice in IndiaModerators: Vinay K. Bahl, Amal Kumar Banerjee, Jamshed J. Dalal, Ajay J. Kirtane, C. Venkata S. Ram, Kamal K. Sethi

Pharmacoinvasive Strategy for Treating Acute MI: Is It The Way Forward in India? Sreenivas Arramraju Kumar

Bifurcation Lesions: Available Devices and How to Choose Balbir Singh

Bioresorbable Vascualr Scaffolds: The Future of PCI? Sundeep Mishra

Internal Pudendal Artery Stenting for Male Erectile Dysfunction: An Emerging (Urological) Realm for the Interventional Cardiologist

Session II. My Worst Cases: How it Happened, and How I Bailed-Out the ProblemModerators: Parag Barwad, Raju Narasa Kavalipati, Fazila T. Malik, Manotosh Panja, Gokul M. Reddy, Kamal K. Sethi

Case 1: Case Presenter: M.S. Hiremath

Case 2: Moderator: Sundeep Mishra

Case 3: Case Presenter: Rabin dra Nath Chakraborty

Case 4: Case Presenter: Jamshed J. Dalal

Case 5: TCT India Next Award Winner Case Presenter: Parag Barwad

Partnership Session: TTT in Partnership With TCT: Tough Cases - How Would I Treat and How Did I Treat?


TTT in Partnership With TCT: Tough Cases - How Would I Treat and How Did I Treat?Moderators: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu Discussants: Paul Hsien-Li Kao, John R. Laird Jr, Wen-Lieng Lee

Case 1: Complex Peripheral Intervention Case Presenter: Chun-Chi Chen

How Would I Treat This Case? Hiroyoshi Yokoi

How Did I Treat This Case? Case Presenter: Chun-Chi Chen


Case 2: Complex PCI Case Presenter: Hsiu-Yu Fang

How Would I Treat This Case? Satoru Sumitsuji

How Did I Treat This Case? Case Presenter: Hsiu-Yu Fang


Case 3: Heavily Calcified Vessel Case Presenter: Wen-Lieng Lee

How Would I Treat This Case? Augusto D. Pichard

How Did I Treat This Case? Case Presenter: Wen-Lieng Lee


Interventional Innovation II: Shark Tank Innovation Competition


Shark Tank Innovation CompetitionChairs: Louis A. Cannon, Juan F. Granada, Chaim S. Lotan Judges: Tony Das, Peter J. Fitzgerald, Frank Litvack, Julio C. Palmaz, Martin T. Rothman, Marvin J. Slepian, Paul G. Yock

Roundtable Discussion: Reflections on Developing a Breakthrough Interventional Technology: A Bioresorbable Vascular Scaffold“Case-Study” Discussants: Stan Fink, Peter J. Fitzgerald, Juan F. Granada, Julio C. Palmaz, Richard J. Rapoza, Chuck Simonton

Introduction: Shark Tank Innovation Competition 2016 Juan F. Granada

Innovative Shock-Wave Wire for CTOs (Soundbite) Christopher E. Buller

Editorial Perspective: CTO Therapies: Market Size and Technical Needs in 2016 Craig A. Thompson

Moderated Discussion: Soundbite and the Unmet Need for CTO Therapies Moderator: Frank Litvack

Noninvasive Assessment of Pedal Reperfusion in CLI Patients (Pedra) Kareen Looi

Editorial Perspective: The World of Diagnostics in BTK Intervention Mahmood K. Razavi

Moderated Discussion: Pedra and BTK Interventions Moderator: Tony Das

Implantable Thermo-reactive Pulmonary Venous Stent for Atrial Fibrillation (Fulgur) Glenn Van Langenhove

Editorial perspective: Interventional Treatment of Atrial Fibrillation: Current Strategy and Unmet Needs Vivek Y. Reddy

Moderated Discussion: Fulger and Atrial Fibrillation Approaches Moderator: Louis A. Cannon

Double-edged Sealing Embolic Protection Device (Transverse) Eric Goslau

Editorial Perspective: Embolic Protection in TAVR Intervention Josep Rodés-Cabau

Moderated Discussion: Transverse and TAVR Embolic Protection Devices Moderator: Chaim S. Lotan

Neuroprotection by Selective Endovascular Brain Cooling (Twinflow) Ronald J. Solar

Editorial Perspective: Interventional Stroke Intervention Leo Nelson Hopkins

Moderated Discussion: Twinflow and Interventional Stroke Therapies Moderator: Paul G. Yock

Pacemaker-Based Treatment for Hypertension (Backbeat) Darren Sherman

Editorial Perspective: Interventional Treatment of Hypertension: A Chance for A Second Wind? Felix Mahfoud

Moderated Discussion: Backbeat and Interventional Hypertension Devices Moderator: Martin T. Rothman

Peer-to-peer Learning In a Global Physician Network (MedShr) Asif Qasim

Editorial Perspective: Digital Health in Interventional Cardiology Giora Weisz

Moderated Discussion: MedShr and the Digital Health Revolution Moderator: Peter J. Fitzgerald

Finalists Selection Announcement: Top 4 Scores Louis A. Cannon

Rebuttal Finalist #1




Final Discussion

Adjourn

Special Session: Fellows Conversations with the Masters


Session IModerator: Roxana Mehran Discussants: Antonio Colombo, Bernard J. Gersh, Robert A. Harrington, Alice K. Jacobs, Spencer B. King III

Session IIModerator: George D. Dangas Discussants: Bernard J. Gersh, Alice K. Jacobs, Jeffrey W. Moses, Kenneth Rosenfield, Ron Waksman

Special Session: Venous Interventions: Pulmonary Emboli, Acute Deep Venous Thrombosis, and Chronic Venous Insufficiency


Venous Interventions: Pulmonary Emboli, Acute Deep Venous Thrombosis, and Chronic Venous InsufficiencyModerators: Michael D. Dake, Michael R. Jaff Discussants: Brian G DeRubertis, Raghu Kolluri, Lindsay S. Machan, Constantino S. Pena

State of the Art Lecture: Latest Medical Therapies for DVT and PE - What the Interventionist Must Know! Michael R. Jaff

Catheter-Directed Thrombolysis and Pharmacomechanical Lysis for Acute DVT: Patient Selection and Outcomes Mahmood K. Razavi

Does This Patient Need an IVC Filter? Rapid Fire Cases Case Presenter: Ido Weinberg

Complex IVC Filter Retrievals: Case Reviews Case Presenter: John H. Rundback

Complex Venous Intervention Case Presentation: Diagnosis and Treatment of May-Thurner Syndrome Case Presenters: Mark J. Goodwin, Constantino S. Pena


Latest Results on Catheter Assisted Thrombolysis and Thrombectomy for Submassive and Massive PE Akhilesh K. Sista

Case Presentation: Chronic Venous Insufficiency with Superficial Venous Reflux Case Presenter: Raghu Kolluri

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease Zvonimir Krajcer

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease Sanjiv Lakhanpal


Special Session: TCT International Fellows Session

Cardiovascular Research Foundation Room 102, Level 1Accreditation: none

Session I. Top Three International Fellows CasesModerator: George D. Dangas Discussants: Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Afzalur Rahman, Balbir Singh, Mohamed Ahmed Sobhy, WojtekWojakowski

Introduction of Top Three Selected Winners Moderator: George D. Dangas

Coronary Venous Angioplasty for CRT-D LV Lead Placement Arindam Pande

Treatment of an Undilatable Stenosis; Coronary Lithoplasty - A New Tool in the Box? Kalpa De Silva

Nightmare in the Cath Lab Khaled Hammad

Discussion

Session II. Fellows Got Talent - Case Competition!Moderator: Wojtek Wojakowski Discussants: Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, George D. Dangas, Afzalur Rahman, Balbir Singh

Fellows Got Talent! (International Case Competition) Moderator: Wojtek Wojakowski

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement Florian Deuschl

Tunnelling Under the Cage, Rather Than Bending the Jail Bars, Enabled Successful Treatment of a Jailed Left Anterior DescendingArtery Jerrett K Lau

Trans-radial (7 French) Rotational Atherectomy in a Patient With Myasthenia Gravis, Chronic (CKD) and IdiopathicThrombocytopenia Purpura (ITP) Akhlaque Uddin

Treatment of a Rare Complication in the 21st Century Balint Kittka

Voting Commences and Winner Announced Moderator: Wojtek Wojakowski

Session III Fellows QuizModerator: Afzalur Rahman Discussants: Carlos Cabrera Arroyo, Rabin dra Nath Chakraborty, Balbir Singh, Mohamed Ahmed Sobhy, Wojtek Wojakowski

TCTMD Global PCI Map Project

TCTMD Global PCI Map Project Ivan C. Rokos



Hands on HeartsModerators: Robert Kutys, Maria E. Romero Nicole Singer

ITC Theater: TAVR, Peripheral Vascular Access


Presentation Theater Program: How Far Can We Go With MitraClip NT (Sponsored by Abbott)


How Far Can We Go With MitraClip NT?Chair: Francesco Maisano Facultys: Saibal Kar, Mathew Williams, Ralph Stephan von Bardeleben

Welcome Francesco Maisano

MitraClip NT – The Foundation and Future for Transcatheter Mitral Valve Repair Francesco Maisano

MitraClip NT: Design Changes Make Big Differences Ralph Stephan von Bardeleben

Clinical Decision Making with MitraClip NT Mathew Williams

Making the Complex Less Complex Saibal Kar

Panel Discussion Discussants: Saibal Kar, Francesco Maisano, Mathew Williams, Ralph Stephan von Bardeleben

Presentation Theater Program: IN.PACT Admiral DCB: Does the Evidence Provide the Power to Change Practice? (Sponsored by Medtronic,Inc.)


IN.PACT Admiral DCB: Does the Evidence Provide the Power to Change Practice?Chair: John R. Laird Jr Facultys: Juan F. Granada, Prakash Krishnan, D. Christopher Metzger

Durability (3Y IP SFA Data) Moderator: John R. Laird Jr D. Christopher Metzger

Consistency and Case Review (IPG Data) Moderator: John R. Laird Jr Prakash Krishnan

Understanding the Strength of the Data Moderator: John R. Laird Jr Juan F. Granada

Presentation Theater Program: Optimizing Outcomes in Complex Coronary Disease (Sponsored by Spectranetics)


Optimizing Outcomes in Complex Coronary DiseaseFacultys: Antonio Colombo, Dimitrios Karmpaliotis, William L. Lombardi, Steven P. Marso, Sahil A. Parikh

Optimizing Outcomes in Complex Coronary Disease Moderator: William L. Lombardi

Cross Reliably - A Contemporary Approach to CTO and Complete Revascularization Steven P. Marso

How You Prep Coronary Vessels Matters - The Evolution of CAD Intervention Antonio Colombo

Improving ISR Outcomes With Laser and AngioSculpt Sahil A. Parikh

Presentation Theater Program: The Future of Physiology: Exploring iFR Co-Registration and Ischemia-Guided PCI (Sponsored by PhilipsVolcano)


The Future of Physiology: Exploring iFR Co-Registration and Ischemia-Guided PCIChair: Habib Samady Facultys: Justin E. Davies, Allen Jeremias, Bruce Samuels, MD, Andrew Sharp, MD

What’s the fascination of a cut point? Ischemia is continuous Moderator: Habib Samady Justin E. Davies

Using physiology to guide PCI Moderator: Habib Samady Bruce Samuels, MD

Can iFR co-registration improve PCI results? (Case-based approach) Moderator: Habib Samady Andrew Sharp, MD

Discussion Moderator: Habib Samady

Presentation Theater Program: Treating Calcified Peripheral Vascular Arteries with the Shockwave Medical Lithoplasty(r) System (Sponsoredby Shockwave Medical, Inc.)


Treating Calcified Peripheral Vascular Arteries with the Shockwave Medical Lithoplasty(r) SystemChair: Todd J. Brinton Facultys: William A. Gray, Michael R. Jaff, Kenneth Rosenfield, Martin Werner, MD

Calcification in Vascular Disease Kenneth Rosenfield

Shockwave Medical Lithoplasty® System Early Experience Todd J. Brinton

Impact of Lithoplasty: DISRUPT PAD Study Results William A. Gray

Case Review and Panel Discussion Moderator: Martin Werner, MD Discussants: Todd J. Brinton, William A. Gray

DISRUPT PAD III Study Design Moderator: William A. Gray

Q&A Discussants: Todd J. Brinton, William A. Gray, Michael R. Jaff, Martin Werner, MD

Presentation Theater Program: Antiplatelet Therapy for Contemporary PCI (Sponsored by Chiesi USA)


Antiplatelet Therapy for Contemporary PCIFacultys: C. Michael Gibson, Duane S. Pinto, Matthew J. Price

Understand the Need for Platelet Inhibition During PCI; Identify the Biologic Targets to Achieve Platelet Inhibition C. Michael Gibson

Review the Clinical Data and Current Clinical Guideline Recommendations for Antiplatelet Therapy Matthew J. Price

Understanding the Role of Cangrelor in Current Practice Duane S. Pinto

Session Q&A Discussants: C. Michael Gibson, Duane S. Pinto, Matthew J. Price

Presentation Theater Program: Approaching Ideal PCI With Absorb (Sponsored by Abbott)


Approaching Ideal PCI With AbsorbChair: Nick E. J. West Facultys: William Bachinsky, MD, Hiram G Bezerra, Salvatore Brugaletta, Christoph K. Naber, Chuck Simonton

Welcome Nick E. J. West

Absorb and Unmet Needs in PCI Chuck Simonton

Impact of Technique on Clinical Outcomes Salvatore Brugaletta

Insights From Real-world Cases Christoph K. Naber

Discussion Discussants: William Bachinsky, Hiram G Bezerra, Salvatore Brugaletta, Christoph K. Naber, Chuck Simonton

Presentation Theater Program: Clinical Kaleidoscope of Novel Interventional Technologies (Sponsored by Meril Life Sciences)

Cardiovascular Research Foundation Presentation Theater 5, Exhibit Hall, Level 2Accreditation: none

Clinical Kaleidoscope of Novel Interventional TechnologiesChair: Teguh Santoso Facultys: Alexandre Abizaid, Ricardo A. Costa, Upendra Kaul, Sasko Kedev, V.K. Ajit Kumar, Martin B. Leon, Yoshinobu Onuma, Ashok Seth,Robaayah Zambahari, Robert-Jan van Geuns

My Experience With BioMime Morph - World's First Tapered Coronary SES Robaayah Zambahari

Optimizing BRS in Your Daily Practice and MeRes-1 Clinical Update Ashok Seth

My Experience With MeRes100 and MeRes-1 Extend Clinical Update Alexandre Abizaid

My Experience From Substance to Sublime - BioMime to MeRes100 Upendra Kaul

MyVal Science and Preclinical and Clinical Update Martin B. Leon

Panel Discussion

Presentation Theater Program: Direct Flow Medical: Evidence, Evolution, and Equipoise (Sponsored by Direct Flow Medical)


Direct Flow Medical: Evidence, Evolution, and EquipoiseChairs: Kendra J. Grubb, Jeffrey J. Popma, Michael J. Reardon Facultys: Daniel Burkhoff, Marc R. Katz, MD, Azeem Latib, Scott Lim, Axel Linke

Introduction and Objectives Jeffrey J. Popma

Clinical Evidence Deep Dive Into the DFM TAVR System Marc R. Katz, MD

Discussion

Physician-Developed Technique Evolution of the DFM TAVR System Scott Lim

Discussion

PVL: Implications for Heart Failure and Hemodynamics Daniel Burkhoff

PVL Equipoise: Balancing Procedure and Patient Outcomes Axel Linke

Discussion

The Direct Flow Medical TMVR System Evolution From Prototype to FIM Azeem Latib

Discussion and Close

Presentation Theater Program: Magmaris, the Resorbable Magnesium Scaffold: Magnesium BRS Features, Benefits, and First Experiencesin Daily Practice (Sponsored by Biotronik)


Magmaris, the Resorbable Magnesium Scaffold: Magnesium BRS Features, Benefits, and First Experiences in Daily PracticeChairs: Ron Waksman, Clemens von Birgelen Facultys: Michael Haude, Michael Joner, Jacques J. Koolen, Jeanette Maier

Objectives and Outline of the Session Ron Waksman

Magnesium: The Underestimated Electrolyte Crucial for Healthy Arteries Jeanette Maier

Magmaris: Understanding the Key Components of Magnesium Degradation Michael Joner

Discussion Moderators: Ron Waksman, Clemens von Birgelen

Expert Magmaris User Shares His Experience: Insights From the BIOSOLVE-II Data and Regular Practice Michael Haude


Magmaris Patient Indications: Consensus and Recommendations by a Panel of Experts Jacques J. Koolen


Key Learnings and Take Away Clemens von Birgelen

Evening Program: Current Perspectives on BTK Intervention: Case-Based Discussion (Sponsored by CRF, Supported by Abbott, BostonScientific Corporation, Cook Medical, and Intact Vascular)

Cardiovascular Research Foundation Marquis Ballroom, Salon 6, Level M2Accreditation: CME


Current Perspectives on BTK Intervention: Case-Based DiscussionCo-Chairs: Juan F. Granada, Michael R. Jaff Facultys: Koen Deloose, William A. Gray, Zaza Kavteladze, Jihad A. Mustapha, Mahmood K. Razavi

Impact of CLI on Mortality, Quality of Life, and Disability Michael R. Jaff

Moderated Discussion

CLI Intervention 101: Mainstream Interventional Strategies and Basic Recanalization Approaches Mahmood K. Razavi

Advanced Interventional Techniques: Available Tools and Outcomes Jihad A. Mustapha


How to Optimize Short and Long-term Durability of BTK Interventions William A. Gray

Emerging Devices: BTK Interventional Pipeline Juan F. Granada


Evening Program: DAPT and Beyond: A Case-Based Guide to Optimal Antiplatelet Therapies (Sponsored by CRF, Supported by Abbott,Boston Scientific, and The Medicines Company)

Marriott Marquis Washington DC Marquis Ballroom, Salon 5, Level M2Accreditation: CME


DAPT and Beyond: A Case-Based Guide to Optimal Antiplatelet TherapiesCo-Chairs: Ajay J. Kirtane, Roxana Mehran Facultys: John A. Bittl, George D. Dangas, James B. Hermiller Jr, John J. Lopez

Welcome, Introductions, and Session Goals Roxana Mehran

Risk Scores Can Help Ajay J. Kirtane

Risk Scores Are Useless- Just Talk to the Patient John J. Lopez

Commentary: How Do You Balance Bleeding Risk vs Ischemic Benefit? John A. Bittl

Roundtable Discussion

Case 1: A Complex LM Bifurcation PCI in an Elderly Woman Case Presenter: James B. Hermiller Jr

Panel and Synthesis

Case 2: An Elderly Patient With Hip Fracture Two Months After PCI Case Presenter: Roxana Mehran

Panel and Synthesis

Case 3: A Patient Who Develops A-Fib After TAVR Case Presenter: George D. Dangas

Panel and Synthesis

Evening Program: The PCI Future Today: Bioresorbable Vascular Scaffolds(Sponsored by CRF, Supported by Abbott)

Marriott Marquis Washington DC Marquis Ballroom, Salon 1-4, Level M2Accreditation: CME


The PCI Future Today: Bioresorbable Vascular ScaffoldsCo-Chairs: Patrick W. Serruys, Gregg W. Stone Facultys: Alexandre Abizaid, David G. Rizik, Manel Sabate, Ashok Seth, Corrado Tamburino

What Have We Learned From Randomized Trials and Registries About the Safety and Efficacy of Bioresorbable Vascular Scaffolds?Gregg W. Stone


So You Want to Implant Absorb? Essential Techniques for Simple and Complex Lesions David G. Rizik


Tips and Tricks for Complex Lesions: Bifurcations, Diffuse Disease, STEMI, ISR, and More Manel Sabate


Beyond Absorb: Novel Attributes and Outcomes of Emerging Scaffolds Alexandre Abizaid


Long-term Imaging Findings With Absorb and Other Scaffolds: Sophisticated Insights Into Potential Long-term Benefits and FailureModes Patrick W. Serruys


A Great BRS Case With Long-term Documented Success Case Presenter: Corrado Tamburino

A Challenging BRS Case With Complications That I Learned A Lot From! Case Presenter: Ashok Seth

Moderated Challenging Cases: Coronary III


Moderated Challenging Cases: Coronary IIIModerators: Emmanouil S. Brilakis, Ricardo A. Costa

TCT 1272: T Modified Bifurcation Technique Guided by IVUS for Left Main Bifurcation Case Presenter: Alexandre Zago

TCT 1483: How to Treat Big Yellow? Is the Use of a Filter Wire Justified? Case Presenter: Jurgen Ligthart

TCT 1033: An Iatrogenic Circumflex Coronary Occlusion Post-Mitral Valve Surgery: Procedural and Management Considerations Case Presenter: Po Fun Chan

TCT 1136: When a Retrograde CTO Unseals Unexpected Pathways Case Presenter: Pierre Deharo

Moderated Challenging Cases: Coronary IV


Moderated Challenging Cases: Coronary IVModerators: Jonathan M. Tobis, Giora Weisz

TCT 1239: Subintimal Balloon Rescue: A Novel Technique for Successful Retrieval of an Entrapped Rotablator Burr Case Presenter: Asif Khan

TCT 1278: Similar Complication Different Ways to Tackle Case Presenter: Jeet Ram Kashyap

TCT 1490: Use of Near Infra-Red Spectroscopy With IVUS to Confirm Coronary Vasospasm as a Cause of ACS Case Presenter: Nilesh Pareek

TCT 1013: PCI of the LAD With ECMO Support in a Young Patient With No Cardiac Activity Case Presenter: Berglind Libungan

Moderated Challenging Cases: Structural II


Moderated Challenging Cases: Structural IIModerators: Jean-Claude Laborde, Thomas Walther

TCT 1494: Combined Rendezvous Approach With the Direct Flow Medical® Aortic Valve Prosthesis to Treat Concomitant Aortic andMitral Stenosis Case Presenter: Ulrich Schafer

TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements Case Presenter: Hellmuth Weich

TCT 1515: The Dance of the Corevalve Case Presenter: Smriti Saraf

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty Case Presenter: Jalal Zamani

Moderated Challenging Cases: Structural III


Moderated Challenging Cases: Structural IIIModerators: David R. Holmes Jr., Clifford J. Kavinsky

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient Case Presenter: Farzin Beygui

TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time Case Presenter: M. Rizwan Sardar

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder Case Presenter: shantanu Deshpande

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aorticand Mitral Valves Case Presenter: Firas Zahr

Moderated Poster Session: Out-of-Hospital Cardiac Arrest and Primary PCI



Moderated Poster Session: Out-of-Hospital Cardiac Arrest and Primary PCIModerators: Michel R. Le May, Ivan C. Rokos

TCT 487: Predictors of All-Cause Mortality in Sudden Cardiac Arrest Patients Referred for Cardiac Catheterization James Xu

TCT 118: Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization AfterOut of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia Nileshkumar Patel

TCT 845: Regional Differences in the Incidence and Outcomes of Hospitalization After Out-of-Hospital Cardiac Arrest in the UnitedStates Nish Patel

TCT 545: Use of Optical Coherence Tomography to Detect Acute Coronary Syndrome in Survivors of Out-of-Hospital Cardiac Arrestwithout ST-Segment Elevation on ECG. Philippe Degrell

Moderated Poster Session: Percutaneous MV Therapies


Moderated Poster Session: Percutaneous MV TherapiesModerators: Brij Maini, James E. Muller

TCT 627: Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients With Functional Mitral Regurgitation(The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort Michael J. Mack

TCT 626: Validating a Prediction Modeling Tool for LVOT obstruction After Transcatheter Mitral Valve Replacement Dee Dee Wang

TCT 628: Very Long-Term (Up To 23 Years) Follow-Up After Successful Mitral Balloon Valvuloplasty In A Large Series Of Patients WithRheumatic Mitral Stenosis Rafael A Meneguz-Moreno

TCT 810: Percutaneous Mitral Valve Repair for Management of Systolic Anterior Motion and Mitral Regurgitation Associated withHypertrophic Cardiomyopathy Saurabh Gupta

Moderated Poster Session: SCAD or Anomalous Coronary Arteries


Moderated Poster Session: SCAD or Anomalous Coronary ArteriesModerators: Theodore A. Bass, Jan J. Piek

TCT 101: Predictors for Recurrent Dissection After Spontaneous Coronary Artery Dissection Jacqueline Saw

TCT 606: Can we justify conservative treatment in adults with Anomalous Coronary Artery Originating from the Opposite Sinus ofValsalva (ACAOS) with Inter-Arterial Course (IAC)? Bart Driesen

TCT 607: Trans-Catheter Closure of Coronary Artery Fistulae in Adult Patients & Long-Term Outcomes: A Single Centre ExperienceAshish Shah

TCT 488: Congenital Coronary Anomalies of Origin and Distribution in Adult Patients Referred for Coronary Angiography Suchit Majumdar

Moderated Poster Session: Stent Fracture


Moderated Poster Session: Stent FractureModerators: Nicolas Foin, Giampaolo Niccoli

TCT 316: Incidence and Clinical Outcomes of Stent Fractures Based on 6555 Patients and 16482 Drug-Eluting Stents From FourCenters Shao-Liang Chen

TCT 315: Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation: 5-Year Clinical Outcome katsuya Miura

TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on TargetLesion Revascularization Kohei Osakada

TCT 442: 3-Year Clinical Outcomes of Complete Versus Partial Stent Fracture After Percutaneous Coronary Intervention withSecond-Generation Drug-Eluting Stent Dong-Kie Kim

Moderated Poster Session: CTO Techniques


Moderated Poster Session: CTO TechniquesModerators: Mauro Carlino, Alfredo R. Galassi

TCT 273: Predictors of Successful Stingray-Assisted Antegrade Dissection Re-entry: Data from the Progress CTO Registry Catalin Toma

TCT 274: Size And Tortuosity of A Collateral Channel Are Important Predictors of Successful Tracking in Retrograde PercutaneousCoronary Intervention (PCI) For Chronic Total Occlusion (CTO) Ching-Chang Huang

TCT 275: Management Strategies for Wire Crossable Undilatable CTO Lesions Antoinette Neylon

TCT 276: Prevalence and 5-Year Outcomes of Full Metal Jacket Drug-Eluting Stenting for Coronary Chronic Total Occlusion Seung-Whan Lee

Moderated Poster Session: Diabetes and PCI Outcomes


Moderated Poster Session: Diabetes and PCI OutcomesModerators: Kevin J. Beatt, Frederick Feit

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents withBiodegradable Polymer. From the SORT OUT VII Trial Julia Ellert

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous CoronaryIntervention with Drug-Eluting Stents Jonathan Murphy

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without DiabetesMellitus Elvin Kedhi

TCT 260: Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes – Insights from the OPEN CTO Registry Adam C Salisbury

Moderated Poster Session: Radiation Protection


Moderated Poster Session: Radiation ProtectionModerators: John A. Ambrose, Norman E. Lepor

TCT 846: Efficient Reduction of Radiation Exposure in the Cathlab Alejandro Gutierrez

TCT 847: Radiation Dose and Radiation Protection for the Head and Neck of Interventional Physicians Kenneth Fetterly

TCT 848: Prevalence of Eye Abnormalities in Cardiac Cath Lab: Results from the Healthy Cath Lab study. Emanuela Piccaluga

TCT 849: Radiation-Associated Lens Changes in the Cardiac Catheterization Laboratory: the IC-CATARACT (CATaracts Attributed toRadiation in the CaTh Lab) Initiative Aris Karatasakis

Moderated Poster Session: Renal Denervation


Moderated Poster Session: Renal DenervationModerators: Melvin D. Lobo, Adam Witkowski

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood PressureOutcomes From the Global SYMPLICITY Registry Felix Mahfoud

TCT 763: Alcohol-Mediated Renal Denervation – Current Status and Future Directions Wojtek Wojakowski

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a RealWorld Patient Population With Uncontrolled Hypertension Felix Mahfoud

TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity and Insulin Resistance in Metabolic SyndromeVasilios Papademetriou

Edited Taped Cases III: Percutaneous Mitral Valve Intervention


Edited Taped Cases III: Percutaneous Mitral Valve InterventionModerators: Danny Dvir, Marco Moscarelli Discussants: Eric Horlick, Jose Luis Navia, Joachim Schofer, Joerg Seeburger

Transcatheter Mitral Valve Repair With MitraClip for Severe Functional Mitral Insufficiency After Heart Transplant Case Presenter: Caterina Gandolfo

Discussion

Changing the Way of Treating Mitral Valve Prolapse: Sutureless Neochordal Replacement Case Presenter: Alberto Weber

Discussion

TransMitral Valve Replacement (VIV) Within a St. Jude Mechanical Mitral Valve Case Presenter: J. Bradley Oldemeyer

Discussion

Transapical Off–Pump Mitral Valve Repair in Patient With Severe Degenerative Mitral Valve Regurgitation After Two RenalTransplants Case Presenter: Krzysztof Wrobel

Discussion

Edited Taped Cases IV: LAA Closure and Congenital Heart Disease Intervention


Edited Taped Cases IV: LAA Closure and Congenital Heart Disease InterventionModerators: Maurice Buchbinder, Horst Sievert Discussants: Steven R. Bailey, Hüseyin Ince, Frank F. Ing, Eustaquio Maria Onorato

Native RVOT Modification and Hybrid Transcatheter Pulmonary Valve Replacement Case Presenter: C. Huie Lin

Discussion

LAA Closure With Amplatzer Amulet: A Step-by-Step Approach Case Presenter: Apostolos Tzikas

Discussion

Real-time 3D Guidance in Recanalization of Interrupted Aorta Case Presenter: C. Huie Lin

Discussion

Combined Single-Session Tavi With Edwards Sapien 3 Aortic Valve and Percutaneous Closure of the Left Atrial Appendage in aElderly Comorbid Patient Case Presenter: Caterina Gandolfo

Discussion

Edited Taped Cases V: Percutaneous Tricuspid Valve Intervention


Edited Taped Cases V: Percutaneous Tricuspid Valve InterventionModerators: Eric Horlick, Josep Rodés-CabauDiscussants: Philipp Blanke, Sameer Gafoor, Alexander Lauten, Toby Rogers

Trialign for Functional TR: Early US Experience Case Presenter: Charles J. Davidson

Discussion

Transcatheter Valve Repair Solution - When, After the Mitral Valve, the Tricuspid Should Be Treated Case Presenter: Maurizio Taramasso

Discussion

Tricuspid Repair with the Trialign System Case Presenter: Charles J. Davidson

Discussion

Exhibit Hall



Breakfast Meeting: Advancements in Diagnosis of Cardiovascular Disease: Integrating FFRct Into Daily Clinical Practice (Sponsored byHeartFlow, Inc.)



Advancements in Diagnosis of Cardiovascular Disease: Integrating FFRct Into Daily Clinical PracticeChair: Manesh R. Patel Facultys: Hiram G Bezerra, Nick Curzen, Simon R. Dixon

Introduction Manesh R. Patel

The PLATFORM trial - Achieving the Triple Aim of Healthcare With FFRCT Manesh R. Patel

Utilization of FFRct - Today and Beyond Faculty: Nick Curzen

Utilization of FFRCT and the Institutional Impact Hiram G Bezerra

Expansion of FFR CT From the Cath Lab to the Emergency Department Simon R. Dixon

Roundtable Discussion Manesh R. Patel

Breakfast Meeting: Best Management for Complex Patients With Complex Disease: The Next Frontier Beyond Revascularization (Sponsoredby CRF, Supported by Sanofi-Aventis)



Best Management for Complex Patients With Complex Disease: The Next Frontier Beyond RevascularizationChair: Roxana Mehran Facultys: C. Michael Gibson, Duane S. Pinto

Introduction and Session Objectives Roxana Mehran

Case Presentation: Patient With ACS and DM and Multi-Vessel Disease- Beyond PCI- Focus on Best Management Case Presenter: Duane S. Pinto

Case Discussion

Beyond Revascularization: Role of PCSK9 Inhibition in Patients Post PCI C. Michael Gibson

Clinical Trials of PCSK9 Inhibitors: Role of Alirocoumab and Evolocumab in Patients With CAD and High LDL Roxana Mehran

Panel Discussion

Breakfast Meeting: Groundbreaking Solutions for Complex PCI and Structural Heart Procedures (Sponsored by GE Healthcare)



Groundbreaking Solutions for Complex PCI and Structural Heart ProceduresFacultys: Tanvir Bajwa, MD, K. Dean Boudoulas, MD

Innovative Imaging in Structural Heart Procedures Tanvir Bajwa, MD

Innovative Imaging for Complex PCI Solutions K. Dean Boudoulas, MD

Breakfast Meeting: Interventional Therapies for Hypertension: Current Evidence and Controversies (Sponsored by CRF, Supported byBoston Scientific Corporation, Medtronic, Inc., ReCor Medical and St. Jude Medical, Inc.)



Interventional Therapies for Hypertension: Current Evidence and ControversiesCo-Chairs: Ajay J. Kirtane, Martin B. Leon Facultys: Justin E. Davies, Juan F. Granada, Felix Mahfoud

Welcome and Introductions Martin B. Leon

Rapid Data Download: Current State of the Evidence for RDN in Hypertension Ajay J. Kirtane

Audience Q&A

Preclinical Insights and Advances in the Understanding of Interventional Hypertension Therapies Juan F. Granada

Audience Q&A

Ongoing and Emerging Studies in the Renal Denervation Space Felix Mahfoud

Audience Q&A

Thinking Outside of the Kidney: Alternative Interventional Therapies for Hypertension Justin E. Davies

Breakfast Meeting: PCI Complications: The Best of the Worst (Sponsored by CRF, Supported by Medtronic, Inc.)



PCI Complications: The Best of the WorstCo-Chairs: James B. Hermiller Jr, Manish A. Parikh Facultys: Nirat Beohar, David A. Cox, Azeem Latib, Steven J. Yakubov

The Coronary Perforation Nightmare Steven J. Yakubov

Discussion

The Coronary That “Spiraled Out of Control” Azeem Latib

Discussion

The "Slam Dunk" STEMI – No Reflow and Beyond David A. Cox

Discussion

My Worst Vascular Complication of the Year Nirat Beohar

Discussion

Breakfast Meeting: Precision Coronary Interventions: The Role of Physiology and Imaging (Sponsored by ACIST Medical & Medtronic)



Precision Coronary Interventions: The Role of Physiology and ImagingChair: Morton J. Kern Facultys: Ziad A. Ali, Clemens von Birgelen

Welcome/Appropriate Use of Physiology and Imaging in PCI - Precision Coronary Interventions Morton J. Kern

The Value of Rapid Exchange Microcatheter-Based FFR in Multi-lesions and Multi-vessels Clemens von Birgelen

The Importance of High Definition IVUS in Complex and Higher Risk Indicated PCI Ziad A. Ali

Wrap-up/Conclusion Morton J. Kern

Breakfast Meeting: TAVR in the US: Navigating the Economic Landscape in 2016 and Beyond (Sponsored by CRF, Supported by EdwardsLifesciences)

Walter E. Washington Convention Center Room 144B, Level 1Accreditation: CME


TAVR in the US: Navigating the Economic Landscape in 2016 and BeyondChair: Hemal Gada Facultys: Thomas Buckingham, David J. Cohen, James Harvey, J.Brad Oldemeyer, Michael J. Rinaldi

Introduction to Perspective-Based Health Economic Analysis Hemal Gada

An Analysis of Societal Cost-effectiveness of TAVR in Current and Lower-Risk Populations David J. Cohen

Provider Perspective of Current TAVR Cost-Effectiveness: Hard Dollars, Hard Sense Michael J. Rinaldi

Nurturing the Minimalist/Optimalist Approach: The Past, The Present, The Future J.Bradley Oldemeyer

Bundled Payments and Accountable Care Organizations: The Restructuring of Operations and Reimbursement Thomas Buckingham

Before and After TAVR: Preparing Patients and Reducing Post-Procedure Resource Consumption James Harvey

Discussion

Breakfast Meeting: What's New or Next in the CHIP Tool Kit? (Sponsored by Boston Scientific Corporation)



What's New or Next in the CHIP Tool Kit?Facultys: Khaldoon Alaswad, William W. O'Neill, Simon J. Walsh

Meet the New CHIP Tools: Sentai, Wolverine, and RotaPro Khaldoon Alaswad

Sentai: Experience with BSC's New Family of Guidewires Simon J. Walsh

When You Need Rota, You Need Rota William W. O'Neill

Main Arena III, Tuesday, Nov. 1


Plenary Session I. Live CasesLive Case Moderator: Martin B. Leon Live Case Co-Moderator: Vinod H. Thourani Live Case Discussants: M Chadi Alraies, G. Michael Deeb, Helene Eltchaninoff, Paul A. Grayburn, Eric Horlick, Samir R. Kapadia, SusheelKodali, Ruediger Lange, Paul Sorajja, E. Murat Tuzcu, John G. Webb, Brian K. Whisenant Digital Moderator: Roger J. Laham Digital Panelists: Pawel E. Buszman, Eric A. Cohen, Jonathan M. Tobis Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong HwaYamamoto

University Hospital Zürich, Zürich, Switzerland Live Case Operators: Bettex Dominique, MD, Thomas Horisberger, MD, Francesco Maisano, Fabian Nietlispach, Michel Zuber, MD

St Thomas’ Hospital, London, United Kingdom Live Case Operators: Jane Hancock, MD, PhD, Bernard Prendergast, MD, FRCP, Simon Redwood, Chris Young, MD, FRCP

Plenary Session II. Late-Breaking Clinical Trials 3: Cosponsored by the Journal of the American Medical AssociationModerator: Gregg W. Stone Digital Moderator: Philippe Pibarot Discussants: Jeroen J. Bax, Philipp Blanke, Stephen J.D. Brecker, Jean-Claude Laborde, Patrizio Lancellotti, Ruediger Lange, Axel Linke, G.Burkhard Mackensen, Raj Makkar, Michael J. Mullen, John A. Spertus Co-Moderators: Robert O. Bonow, Eric D. Peterson

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis UndergoingTranscatheter Aortic Valve Replacement Susheel Kodali

Moderated Roundtable Discussion Discussant: Susheel Kodali

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical AorticValve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis David J. Cohen

Moderated Roundtable Discussion Discussant: David J. Cohen

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement inHigh-Risk and Inoperable Patients With Aortic Stenosis Pamela S. Douglas

Moderated Roundtable Discussion Discussant: Pamela S. Douglas

Plenary Session III. Live CasesLive Case Moderator: Gregg W. Stone Live Case Co-Moderator: Ted Feldman Live Case Discussants: Steven R. Bailey, Koen Deloose, David Hildick-Smith, Reda Ibrahim, Christoph A. Nienaber, Manish A. Parikh, Jan J.Piek, Bernhard Reimers, Kenneth Rosenfield, Jacqueline Saw, Brian K. Whisenant, Steven J. Yakubov Digital Moderator: William A. Gray Digital Panelists: Ehrin J. Armstrong, D. Christopher Metzger, Jean-Michel Paradis Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong HwaYamamoto

CardioVascular Center (CVC) Frankfurt, Frankfurt, Germany Live Case Operators: Markus Reinartz, MD, Horst Sievert, Lauran Vaskelyte, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center, NY, NY Live Case Operators: Philip Green, Akiko Maehara, Anthony L. Pucillo Live Case Guest Operator: Sahil A. Parikh

Plenary Session IV: Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator AwardAward Presenters: Martin B. Leon, Gregg W. Stone Discussants: Nikhil Vilas Joshi, Rishi Puri, Hiroki Shiomi

Plenary Session V. TCT Focus Session #3: Global Cardiovascular Healthcare Initiatives and Data SharingModerator: Robert O. Bonow Digital Moderator: Mitchell W. Krucoff Discussants: Bagrat Alekyan, Rafael Beyar, Valentin Fuster, Runlin Gao, Jack C. Lewin, William H. Maisel, Manesh R. Patel, Eric D. Peterson,Stuart J. Pocock, Stuart Spencer Co-Moderator: Roxana Mehran

Featured Lecture: A Personal Mission to Impact Cardiovascular Health: It Must Start With Children! Valentin Fuster

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise Manesh R. Patel

Animated Discussion

Plenary Session VI. First Report Investigations 3Moderator: Howard C. Herrmann Digital Moderator: Robert J. de Winter Digital Panelists: Mark B. Effron, Asif Qasim, Giulio G. Stefanini Discussants: Eric Boersma, Ricardo A. Costa, Rajesh M. Dave, Nabil Dib, Dariusz Dudek, Francisco Fdez-Aviles, Marc D. Feldman, StephenP. Hoole, Bradley H. Strauss, Bonnie H. Weiner

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic StrokeDavid E. Thaler

Moderated Roundtable Discussion Discussant: David E. Thaler

COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes AfterStent Implantation in Patients With Coronary Artery Disease Giora Weisz

Moderated Roundtable Discussion Discussant: Giora Weisz

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women andMinorities Wayne B. Batchelor

Moderated Roundtable Discussion Discussant: Wayne B. Batchelor

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation Hiroki Shiomi

Moderated Roundtable Discussion Discussant: Hiroki Shiomi

Coronary Theater III, Tuesday, Nov. 1


Session I. Live Cases: CTOsLive Case Moderator: J. Aaron Grantham Live Case Co-Moderator: Masahiko Ochiai Live Case Discussants: Yaron Almagor, Mauro Carlino, Colm Hanratty, Richard R. Heuser, Jacques J. Koolen, Sudhir Rathore, Bradley H.Strauss, Etsuo Tsuchikane, Gerald S. Werner Digital Moderator: Stéphane Rinfret Digital Panelists: Arif Al Nooryani, Kevin J. Beatt, Sanjog Kalra Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY Live Case Operators: Dimitrios Karmpaliotis, Jeffrey W. Moses Live Case Guest Operator: William L. Lombardi

Session II. Live Cases: CTOsLive Case Moderator: James C. Spratt Live Case Co-Moderator: Paul Hsien-Li Kao Live Case Discussants: David Antoniucci, Alfredo R. Galassi, Omer Goktekin, Stephen P. Hoole, Nicholas J. Lembo, Thomas F. Luscher,Sundeep Mishra, Alexander Grigorievich Osiev, Asif Qasim Digital Moderator: Farouc Jaffer Digital Panelists: Kevin J. Croce, Anthony H. Gershlick, Paul Knaapen Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng

York Hospital, York, PA Live Case Operators: Tony J. DeMartini, James Harvey, MD, William J. Nicholson, MD

Structural Theater II, Tuesday, Nov. 1


Session I. Live Cases: Mitral Neochord & LAA ClosureLive Case Moderator: James B. Hermiller Jr Live Case Co-Moderator: Jason H. Rogers Live Case Discussants: Mohamed Abdel-Wahab, Steven F. Bolling, Joseph P. Carrozza Jr, Eulogio J. Garcia, Hüseyin Ince, Chaim S. Lotan,Carlos E. Ruiz, Wilson Y. Szeto, Nina C. Wunderlich Digital Moderator: Martin W Bergmann Digital Panelists: Christian Frerker, Sameer Gafoor, Anuj Gupta Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

CardioVascular Center (CVC) Frankfurt, Frankfurt, Germany Live Case Operators: Markus Reinartz, MD, Horst Sievert, Lauran Vaskelyte, MD

NewYork-Presbyterian Hospital/Columbia University Medical Center Live Case Operators: Angelo B. Biviano, Omar K. Khalique, Robert J. Sommer

Session II. Live Cases: Valve InterventionsLive Case Moderator: Alec S. Vahanian Live Case Co-Moderator: Vinod H. Thourani Live Case Discussants: Robert J. Applegate, Jozef Bartunek, John D. Carroll, Goran K. Olivecrona, Joseph F. Sabik, Gerhard C. Schuler,Jonathan M. Tobis, Alfredo Trento, Wojtek Wojakowski Digital Moderator: Michael J. Rinaldi Digital Panelists: Stephen H. Little, Giuseppe Tarantini, Glenn Van Langenhove Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

University Hospital Zürich, Zürich, Switzerland Live Case Operators: Dominique Bettex, MD, Francesco Maisano, Fabian Nietlispach, Michel Zuber, MD

St. Thomas' Hospital, London, United Kingdom Live Case Operators: Jane Hancock, MD, PhD, Bernard Prendergast, MD, Simon Redwood, Chris Young, MD, FRCP

Didactic Session: Atrial Fibrillation Management in Patients With ACS and PCI: Decisions and Dilemmas


Session I. Management of the Patient With Atrial Fibrillation and Coronary Artery Disease (ACS and PCI)Moderators: David P. Faxon, C. Michael Gibson Discussants: Dominick J. Angiolillo, Deepak L. Bhatt, Davide Capodanno, Christopher B. Granger, Norman E. Lepor, Roxana Mehran, FreekW.A. Verheugt

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT Christopher B. Granger

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPTFreek W.A. Verheugt

European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Davide Capodanno

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation PatientWith ACS or PCI Dominick J. Angiolillo

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding C. Michael Gibson

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy? Roxana Mehran

Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic AF Patient Who Requires PCI Deepak L. Bhatt


Session II: Ongoing Dual vs Triple Antithrombotic Trials in Atrial FibrillationModerators: Freek W.A. Verheugt, Pascal Vranckx Discussants: Deepak L. Bhatt, Mark B. Effron, C. Michael Gibson, Duk-Woo Park, Asif Qasim, Jan Tijssen, Glenn Van Langenhove

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status C. Michael Gibson

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Pascal Vranckx

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status Roxana Mehran

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Deepak L. Bhatt


Session III: Left Atrial Appendage Closure and Ablation as an Alternative to Triple TherapyModerators: Martin W Bergmann, Samir R. Kapadia Discussants: Philippe Garot, Ashish Pershad, Vivek Y. Reddy, Brian K. Whisenant, Harvey D. White

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient Ashish Pershad

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset Brian K. Whisenant

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping Jason H. Rogers

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure? Harvey D. White

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Vivek Y. Reddy


Audience Vote Question #1 (With Discussion): In the Low Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-complex PCI for Stable CAD, What Is the Best Post-PCI Regimen? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

Audience Vote Question #2 (With discussion): In the High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD, What Is the Best Post-PCI Regimen? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

Audience Vote Question #3 (With Discussion): In the Low Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing ComplexMulti-Stent PCI or Any PCI for ACS, What Is the Best Post-PCI Regimen ? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

Audience Vote Question #4 (With Discussion): In the High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing ComplexMulti-Stent PCI or Any PCI for ACS, What Is the Best Post-PCI Regimen? Poll Moderators: Martin W Bergmann, Samir R. Kapadia

Didactic Session: Bioresorbable Vascular Scaffolds, Part 2: Technique and Cases


Session I. BRS Technology, Implantation Technique, and Patient SelectionModerators: Stephen G. Ellis, Patrick W. Serruys Discussants: Bernardo Cortese, Aloke V. Finn, Vasileios D. Gkogkas, Julinda Mehilli, Massimo Napodano, Nick E. J. West

Impact of Different PLLA Polymers and BRS Construction on Implant Technique: From Absorb to DESolve to Fantom to Manli andMore Alexandre Abizaid

BRS Benchtop Findings: Implications for Implantation Techniques Nicolas Foin

Patient and Lesion Selection for BRS: What Is Optimal and What Should Be Avoided? Christoph K. Naber

Impact of Small Vessels on BVS Outcomes and the Role of Target Vessel Mismatch Patrick W. Serruys

PSP: A Synthesis of Technique Imperatives for Absorb Implantation David G. Rizik

A Critical Review of Technique Across the Absorb Trials Stephen G. Ellis

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience Serban Puricel

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry Holger M. Nef

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing Ron Waksman


Session II. Drilling Down: Optimal BRS Technique and Procedural ConsiderationsModerators: Jonathan M. Hill, Christoph K. Naber Discussants: Vincent On-Hing Kwok, Michael Maeng, Evelyn S. Regar, Giuseppe Tarantini, Jose M. de la Torre Hernandez, Clemens vonBirgelen

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS Manel Sabate

Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With Case Examples) Corrado Tamburino

BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA or Intracoronary Imaging (With Case Examples)?Alexandre Abizaid

Can QCA Be Trusted? Insights From OCT and More Yoshinobu Onuma

Pre-Debate Vote: In What Proportion Of BRS Cases Do You Use Intravascular Imaging for Guidance ? Poll Moderators: Jonathan M. Hill, Christoph K. Naber

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective! Joanna J. Wykrzykowska

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine! Ricardo A. Costa

Post-Debate Vote (Who Won?): After the Debate, in What Proportion of BRS Cases Will You Use Intravascular Imaging for Guidance?Poll Moderators: Jonathan M. Hill, Christoph K. Naber

If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT? Carlo Di Mario

Why Is Post-Dilatation Mandatory? Technical And Clinical Considerations (With Case Examples) Azeem Latib


Session III. Lesion-Specific Techniques With Case ExamplesModerators: Dean J. Kereiakes, Robert-Jan van Geuns Discussants: Christophe Dubois, Jacques J. Koolen, Detlef G. Mathey, Sundeep Mishra, Anna Sonia Petronio

Bifurcations and BRS: Techniques, Full Polymer, or Hybrid? Azeem Latib

BRS Bifurcation Rapid-Fire Case Reviews Case Presenter: Manuel Pan


BRS in CTOs: Why and How Jochen Wöhrle

BRS CTO Rapid-Fire Case Reviews Case Presenter: Julinda Mehilli


BRS in Small Vessels and Diffuse Disease: Managing Overlapping Scaffolds; When to Use DES or Balloon Only Jorge A. Belardi

BRS in Small Vessels and Diffuse Disease Rapid-Fire Case Reviews Case Presenter: Kenneth Chin


BRS in STEMI: Rationale and Technique Differences Compared to Stable Lesions Roberto Diletti

BRS STEMI Rapid-Fire Case Reviews Case Presenter: Arif Al Nooryani


BRS in Saphenous Vein Grafts With OCT Guidance (OCTOPUS Registry Results and Case Examples) Case Presenter: Wojtek Wojakowski


Session IV. Mini-Lectures: How to Manage BRS Challenges and FailuresModerators: Ashok Seth, Pieter C. Smits Discussants: Vladimir Dzavik, Andrejs Erglis, David F. Kong, Jens Flensted Lassen, Maurizio Menichelli, Sunao Nakamura

How to Overcome Challenges in Delivering BRS (With Case Examples) Ashok Seth

How to Manage BRS Stent Loss (With Case Examples) Omer Goktekin

Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal Scaffold Dismantling and Fractures (With CaseExamples) Yoshinobu Onuma

How to Manage BRS Thrombosis (With Case Examples) Anuruck Jeamanukoolkit

How to Treat BRS Restenosis (With Case Examples) Pieter C. Smits




Session I. Implanted and Non-invasive Sensors for Outpatient MonitoringModerators: JoAnn Lindenfeld, Ileana L. Pina Discussants: William T. Abraham, Daniel R. Bensimhon, Neal L. Eigler, Brad Quinn, Barbara Riegel

Featured Lecture: Device Overviews and the Promises and Pitfalls of Home Monitoring of CHF William T. Abraham

Cardiomems Results, Practicality, Integration, and Finances Barbara Riegel

Sensible Medical for Preventing Heart Failure Rehospitalizations Daniel R. Bensimhon


Session II. Interatrial ShuntsModerators: Josep Rodés-Cabau, Nir Uriel Discussants: William T. Abraham, Daniel Burkhoff, Irene M. Lang, David W.M. Muller, Sanjiv Shah, Katherine Wallon

Interatrial Shunts: Theoretical Basis and Unanswered Questions Daniel Burkhoff

Interatrial Shunts in HFpEF: Focus on Corvia Sanjiv Shah

Interatrial Shunts in HFrEF: Focus on V-Wave William T. Abraham


Session III. Percutaneous Mechanical Circulatory SupportModerators: David E. Kandzari, Navin K. Kapur Discussants: Fernando Aguel, Matthew D. Bacchetta, Christian Bermudez, Graham A. Cassel, Valluvan Jeevanandam, Biswajit Kar, WilliamW. O'Neill, Robert T. Pyo

State-of-the-Art: Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support Navin K. Kapur

The Impella Family of Devices: Utility of Different Tools for Different Conditions William W. O'Neill

HeartMate PHP: Expanding the Armamentarium for Percutaneous Mechanical Circulatory Support Robert T. Pyo

TandemHeart: Breathing New Life Into an Established Therapy Biswajit Kar

NuPulse: Implantable Counterpulsation for Advanced CHF Valluvan Jeevanandam

Right Ventricular Support Options and Outcomes Christian Bermudez

ECMO: A Primer of Current Devices and Configurations Matthew D. Bacchetta


Session IV. Durable LVADsModerators: Daniel Burkhoff, Yoshifumi Naka Discussants: James W Long, John S. Sapirstein, Keyur Bharat Shah, Palak Shah, Marvin J. Slepian, Nir Uriel, Changfu Wu

State-of-the-Art: Recent LVAD Advances and Ongoing Challenges James W Long

State-of-the Art: Mechanisms and Treatment of Gastrointestinal Bleeding in LVAD Patients Nir Uriel

HVAD & MVAD Palak Shah

Heart Mate III: Has the Problem of Thrombus Been Solved? James W Long

Jarvik: Has the Problem of Driveline Infections Been Solved? Yoshifumi Naka

Heart Assist 5: The Role of Continuous, Remote Flow Monitoring in Patient Care Nir Uriel

Syncardia: The Irreplaceable Role of the Total Artificial Heart Keyur Bharat Shah


Didactic Session: Left Atrial Appendage Closure, Part 2: Devices and Technique


Session I: Imaging the LAA Before and During ClosureModerators: Samir R. Kapadia, Apostolos Tzikas Discussants: Brij Maini, James K. Min, Bushra S Rana, Carlos E. Ruiz, Teguh Santoso, Nina C. Wunderlich

TEE Before and During LAA Closure: A Case Based Overview Case Presenter: Bushra S Rana

CT Evaluation Step by Step: Taped Live Demonstration Apostolos Tzikas

Additional LAA Imaging Techniques (Beyond TEE and CT): ICE, Fusion Imaging, and More Carlos E. Ruiz

The Potential for 3D Printing and Imaging for LAA Closure James K. Min


Session II: Access Technique and ComplicationsModerators: Maurice Buchbinder, Saibal Kar Discussants: Stefan C. Bertog, Patrick A. Calvert, Sameer Gafoor, Eulogio J. Garcia, G. Burkhard Mackensen, Issam D. Moussa

Venous Access Specifics: Puncture, Sheath Introduction, Traversing the IVC, and Puncture Site Closure Sameer Gafoor

How to Perform Transseptal Puncture Safely and Effectively Stefan C. Bertog

Pericardial Access Tips and Tricks Issam D. Moussa


Session III: Device Descriptions and Specific Implant Technique (Case Based)Moderator: Krzysztof Bartus Discussants: Yat-Yin Lam, Randall J. Lee, Jai-Wun Park, Vivek Y. Reddy, Josep Rodés-Cabau, Apostolos Tzikas

General Principles of LAA Closure Case Presenter: Apostolos Tzikas

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder Case Presenter: Saibal Kar

Special Tips and Tricks for LAA Closure Using the ACP/Amulet LAA Occluder Case Presenter: Jai-Wun Park

Special Tips and Tricks for LAA Closure Using the WaveCrest LAA Occluder Case Presenter: Vivek Y. Reddy

Special Tips and Tricks for LAA Closure Using the Occlutech LAA Occluder Case Presenter: Eustaquio Maria Onorato

Special Tips and Tricks for LAA Closure Using the Cardia LAA Occluder Case Presenter: Josep Rodés-Cabau

Special Tips and Tricks for LAA Closure Using the Lifetech LAA Occluder Case Presenter: Yat-Yin Lam

Special Tips and Tricks for LAA Closure Using the Lariat Case Presenter: Randall J. Lee


Session IV: Post-Procedural ManagementModerators: David R. Holmes Jr., Jacqueline Saw Discussants: Steven L. Almany, George S. Hanzel, David Meerkin, Bushra S Rana, Marina Urena

DAPT, Warfarin, NOAC or Nothing After LAA Closure? Maurice Buchbinder

Follow-up Evaluation After LAA Closure Bushra S Rana

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure David R. Holmes Jr.

Management of Residual Leaks After LAA Closure Case Presenter: Jacqueline Saw


Didactic Session: Optimizing Outcomes With Intravascular Imaging and Physiologic Lesion Assessment, Part I


Session I. Coronary Physiology: Core Concepts, Part IModerators: Bernard De Bruyne, Allen Jeremias Discussants: Emanuele Barbato, Angela Hoye, Morton J. Kern, Michael J. Lim

Standard and Novel Pressure Measuring Devices: Differences, Similarities, and Practical Recommendations Morton J. Kern

IMPACT: Randomized Evaluation of a Rapid Exchange FFR Microcatheter in Intermediate Coronary Stenoses Tim P. van de Hoef

Standardization of FFR Acquisition and Storage Bernard De Bruyne

Non-Hyperemic Indices: Glossary and Clinical Outcome Data Allen Jeremias

FFR in the setting of CABG and AS/AVR/TAVR Emanuele Barbato


Session II. Coronary Physiology: Outcomes Data and Focus on ACSModerators: Nick Curzen, Nils Johnson Discussants: Justin E. Davies, Thomas Engstroem, Javier Escaned, Habib Samady, Frederik M. Zimmermann

FFR in ACS: Specifics and Timing of Measurements Habib Samady

FFR in ACS: Current Data Including DOCTORS and Upcoming Studies Thomas Engstroem

iFR in Acute Coronary Syndromes Justin E. Davies

Very Long Term Outcomes after FFR-Based Decision-Making Frederik M. Zimmermann


Session III. Intracoronary Imaging: Focus on Clinical OutcomesModerators: John McB. Hodgson, Neil J. Weissman Discussants: Takashi Akasaka, Ziad A. Ali, Ning Guo, Ryan D. Madder, Francesco Prati

IVUS, NIRS, and OCT Dictionary: Recognizing the Structure of the Coronary Wall and Plaque, and Evaluating Acute Results ofIntervention Ziad A. Ali

Overview of IVUS-based Outcomes Data Ryan D. Madder

Overview of OCT-based Outcomes Data: Ilumien, Opinion and Beyond Francesco Prati

Reproducibility and Standardization of OCT Measurements: Historical Review and a New Approach Annapoorna Kini

My Top Uses for IVUS and/or OCT: A Clinician’s Perspective Takashi Akasaka


Session IV. Coronary Imaging: New Technologies and StrategiesModerators: Adrian P. Banning, Ryan D. Madder Discussants: Ziad A. Ali, Eric Boersma, Marc D. Feldman, Akiko Maehara, Guillermo Tearney

Intravascular Imaging Guidance of BRS Implantation and Follow-up Yoshinobu Onuma

Next Generation IVUS and OCT: HD-IVUS, Heartbeat-OCT, Micro-OCT, Combination Devices, and More Evelyn S. Regar

Angiographic Coregistration of IVUS, OCT, FFR, iFR, and More Giulio Guagliumi

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy Ziad A. Ali

Culprit and Non-Culprit Lesion Assessment in STEMI: A Paradigm Shift Based on Intravascular Imaging (and Physiology)? Ik-Kyung Jang


Didactic Session: Peripheral Vascular Intervention, Part 3: Carotid, Subclavian, Innominate, and Stroke


Session I. Carotid Disease Management – Current Status and New DevelopmentsModerators: Sriram S. Iyer, John R. Laird Jr Discussants: Brian G DeRubertis, William A. Gray, Leo Nelson Hopkins, Klaus D. Mathias, D. Christopher Metzger

Train Interventionalists in Carotid Stenting: Case Volume Requirements and More Klaus D. Mathias

Are Mesh-Covered Stents the Future of CAS? Evaluation With OCT and IVUS William A. Gray


LIVE CASE DEMONSTRATION: Carotid Intervention- Gates Vascular Institute, Buffalo General Medical Center, Buffalo, NY Live Case Operators: Elad Levy, Adnan Siddiqui, Kenneth Snyder

Pre-debate Vote: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Poll Moderators: Sriram S. Iyer, John R. Laird Jr

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Distal Embolic Protection WithContemporary Devices and Techniques Provides Optimal CAS Outcomes William A. Gray

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Proximal Embolic Protection Should BeUtilized for the Majority of CAS Cases D. Christopher Metzger

Debate: What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Proximal Embolic Protection Isn’t Enough –Transcervical Access With Flow Reversal Is the Ideal Strategy for CAS Brian G DeRubertis


Post-debate Vote (Who Won?): What Is the Optimal Technique for Embolic Protection During Carotid Stenting? Poll Moderators: Sriram S. Iyer, John R. Laird Jr

Session II. Acute Stroke InterventionModerators: D. Christopher Metzger, Bernhard Reimers Discussants: Alex Abou-Chebl, Omer Goktekin, Klaus D. Mathias, Aman B Patel, Gary S. Roubin, Rahul Sakhuja

Stenting for Intracranial Atherosclerosis: Who, When, and How Alex Abou-Chebl

Mechanical Thrombectomy in Acute Stroke: Tips, Devices and Acute Results Aman B Patel

VIDEOTAPED CASE DEMONSTRATION: Interventional Management of Acute Stroke Case Presenter: D. Christopher Metzger

Stroke Interventions: Parallels to Primary PCI for Acute MI and the Potential Role of the Cardiologist Bernhard Reimers

Managing Complications of Carotid Interventions Aman B Patel

Building A Multidisciplinary Team for Interventional Acute Stroke Management Bernhard Reimers


Session III: Subclavian and Innominate Intervention: From Occlusive Disease to Aneurysmal InvolvementModerators: William A. Gray, Mehdi H. Shishehbor Discussants: Jacques Busquet, Koen Deloose, Leo Nelson Hopkins, Thomas A. Ischinger, Sriram S. Iyer, Sasko Kedev, Jose M. Wiley

LIVE CASE DEMONSTRATION: Innominate/Subclavian Intervention- Gates Vascular Institute, Buffalo General Medical Center,Buffalo, NY Live Case Operators: Elad Levy, MD, FACS, Adnan Siddiqui, Kenneth Snyder, MD, PhD

Overview of Subclavian and Innominate Artery Interventions Jacques Busquet

Transradial Access for Subclavian, Innominate, and Carotid Artery Disease Sasko Kedev

The Right Choice: Endovascular Therapy vs Surgical Bypass for CLI Koen Deloose


Didactic Session: Right Heart Interventions: Pulmonary Hypertension, Pulmonary Emboli, and Pulmonic/Tricuspid Valve Interventions


Session I: Pulmonary Hypertension and ThromboembolismModerators: Ori Ben-Yehuda, Ehtisham Mahmud Discussants: Christopher F Barnett, Shao-Liang Chen, Mardi Gomberg-Maitland, William W. O'Neill

Acute and Chronic Pulmonary Hypertension: Etiology, Pathophysiology, Diagnosis, and Classification Ori Ben-Yehuda

Acute Pulmonary Thromboembolism: Outcomes of Medical Therapy, Including Lytics Christopher F Barnett

Catheter-directed Interventions For Acute Pulmonary Emboli: Pigtails, Ekos, Angiojet, and Angiovac- Description, Data, and CasesLindsay S. Machan

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation William W. O'Neill


Medical Therapy for Chronic Pulmonary Hypertension: Which Drugs, Which Patients, How Effective? Mardi Gomberg-Maitland

Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work? Matthew D. Bacchetta

Atrial Septostomy for Chronic Pulmonary Hypertension Gagan D Singh

Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights Alex M. K. Rothman

Pulmonary Artery Denervation for Pulmonary Hypertension II: Catheter Development, Procedure, and Acute and Late HemodynamicResults Shao-Liang Chen

Pulmonary Artery Angioplasty for Chronic Pulmonary Thromboembolic Disease: An Option for No Option Patients? Ehtisham Mahmud

Pulmonary Vein Interventions: Indications, Tips and Tricks, Case Presentation Ehtisham Mahmud


Session II: Pulmonic Valve and Vessel InterventionsModerators: Ziyad M. Hijazi, C. Huie Lin Discussants: Zahid Amin, Matthew J. Gillespie, Bryan H. Goldstein, Thomas K. Jones, Carlos E. Ruiz, Nathan W Taggart

Pulmonic Stenosis and Regurgitation: Pathophysiology and Review of Indications for Intervention Bryan H. Goldstein

Native RVOT and RV-PA Conduit Transcatheter Pulmonary Valve Replacement Frank F. Ing

PA Stenting During Transcatheter Pulmonary Valve Replacement Procedures Lee N. Benson

Transcatheter Pulmonary Valve Replacement 1: Melody John P. Cheatham

Transcatheter Pulmonary Valve Replacement 2: Sapien Eric Horlick

The Pulmonary Valve Pipeline: Harmony Valve, Venus P-Valve and More Ziyad M. Hijazi

Preparing for Catastrophe During Right Heart Valve Procedures: Covered Stents and Conduit Rupture, Coronary Compression,ECMO, Interventional Bronchoscopy, Coils, Plugs Thomas K. Jones


Session III: Tricuspid Valve TherapiesModerators: Joachim Schofer, Alec S. Vahanian Discussants: Colin M. Barker, Danny Dvir, Hans R. Figulla, James S. Gammie, Patrizio Lancellotti, Toby Rogers

Anatomy and Pathology of the Tricuspid Valve With a Focus on Feasibility of Percutaneous Interventions Colin M. Barker

Impact and Natural History of Functional Tricuspid Regurgitation Maurice E. Sarano

Surgical Approach to Functional Tricuspid Regurgitation Joerg Seeburger

Interventional Imaging of the Tricuspid Valve Rebecca T. Hahn


Transcatheter Tricuspid Valve Therapies 1: Trialign Description, Results and a Case Rebecca T. Hahn

Transcatheter Tricuspid Valve Therapies 2: 4-Tech Description, Results and a Case Alec S. Vahanian

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case Josep Rodés-Cabau

Transcatheter Tricuspid Valve Therapies 4: Tricuspid MitraClip Procedure, Results and a Case Joachim Schofer

Transcatheter Tricuspid Valve Therapies 5: Millipede Description, Results and a Case Jason H. Rogers

Transcatheter Tricuspid Valve Therapies 6: Cardioband TR Description, Results and a Case Karl-Heinz Kuck

Transcatheter Tricuspid Valve Therapies 7: TRAIPTA Description, Results and a Case Toby Rogers

Transcatheter Tricuspid Valve Therapies 8: IVC/SVC Valved Stents - Results and a Case Alexander Lauten

Tricuspid Valve-in-Valve and Valve-in-Ring Procedures and Outcomes Saif Anwaruddin




Session I. Retrograde TechniquesModerators: Alfredo R. Galassi, Masahiko Ochiai Discussants: Yasushi Asakura, David Hildick-Smith, Paul Knaapen, Jacques J. Koolen, James C. Spratt, Masahisa Yamane

Retrograde Step-by-step James C. Spratt


Contemporary Reverse CART Masahisa Yamane


Hybrid/Guide Extension Reverse CART Paul Knaapen


Session II: Case-Based Education: Learning From OthersModerators: Colm Hanratty, Paul Hsien-Li Kao Discussants: Arun Kalyanasundaram, Paul Knaapen, Jianfang Luo, Sudhir Rathore, James C. Spratt

My Best Antegrade Case(s) of the Last Year Case Presenter: Jianfang Luo


How to Manage the Impenetrable Proximal Cap (Case Presenation) Case Presenter: Arun Kalyanasundaram


My Best Retrograde Case(s) of Last Year Case Presenter: James C. Spratt


Session III. Risks of CTO InterventionModerators: Christopher E. Buller, Masahisa Yamane Discussants: Emmanouil S. Brilakis, Kambis Mashayekhi, Margaret B. McEntegart, Sunao Nakamura, Masahiko Ochiai, Stéphane Rinfret

Risks of Retrograde CTO PCI: Lessons From Registry Data and Personal Experience Emmanouil S. Brilakis


Risks of Antegrade CTO PCI: Lessons From Registry Data and Personal Experience Kambis Mashayekhi


How to Avoid Complications Masahiko Ochiai


Session IV: Learning From ComplicationsModerators: Talib Majwal, Barry D. Rutherford, Gerald S. Werner Discussants: Emmanouil S. Brilakis, J. Aaron Grantham, William L. Lombardi, R. Michael Wyman, Jochen Wöhrle

My Worst Complication(s) of the Last Year Case Presenter: William L. Lombardi


My Worst Complication (s) of the Last Year Case Presenter: J. Aaron Grantham


My Worst Complication(s) of the Last Year Case Presenter: Emmanouil S. Brilakis


Didactic Session: The TCT 2016 Late Breaking Trials: Live Discussion Forum


Session I. Drug-Eluting Stents and Bioresorbable Vascular ScaffoldsModerators: Philip M. Urban, Stephen G. Worthley Discussants: Wayne B. Batchelor, Salvatore Cassese, Bernard R. Chevalier, Runlin Gao, David E. Kandzari, Ashok Seth, Clemens vonBirgelen

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS Sigmund Silber


Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution Christian M. Spaulding


Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results) Robert-Jan van Geuns


Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results) Stephen G. Ellis


Highlights (and my Interpretations) From: PLATINUM DIVERSITY Bonnie H. Weiner


Session II: Left Main PCI vs CABGModerators: Yves R. Louvard, John D. Puskas Discussants: Adrian P. Banning, Evald H. Christiansen, Ajay J. Kirtane, Ian Menown, Joseph F. Sabik, Leif Thuesen

Highlights (and my Interpretations) from: EXCEL and NOBLE Davide Capodanno


Session III: Imaging StudiesModerators: Giulio Guagliumi, Ik-Kyung Jang Discussants: Ziad A. Ali, Takashi Kubo, Akiko Maehara, Gary S. Mintz, James E. Muller, Hiroki Shiomi, Giora Weisz

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR Ron Waksman


Highlights (and my Interpretations) From: ReACT Niels R. Holm


Session IV. Transcatheter Aortic Valve Replacement and Structural Heart InterventionModerators: Jeffrey J. Popma, E. Murat Tuzcu Discussants: David J. Cohen, Susheel Kodali, Axel Linke, Vasilios Papademetriou, Mladen I. Vidovich

Highlights (and my Interpretations) From: SENTINEL Alexandra J. Lansky


Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes Michael J. Mullen


Highlights (and my Interpretations) From: PARTNER I 5-YEAR Echo and PARTNER II Quality of Life Ganesh Manoharan


Didactic Session: Transcatheter Aortic Valve Therapies Part 3: New Technology Forum

Walter E. Washington Convention Center Room 146B/C, Level 1Accreditation: CME/ASRT/CNE

Session I. TAVR 2016: Frequently Used TAVR SystemsModerators: Eberhard Grube, James B. Hermiller Jr Discussants: Mohamed Abdel-Wahab, Stephan Baldus, Anson Cheung, Charles J. Davidson, Ariel Finkelstein, Isaac George, Neal S.Kleiman, Azeem Latib

Sapien 3 and ULTRA: Design Features, Special Attributes, and Clinical Trial Program John G. Webb


Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program Jeffrey J. Popma


Portico: Design Features, Special Attributes, and Clinical Trial Program Raj Makkar


Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program Ted Feldman


Direct Flow: Design Features, Special Attributes, and Clinical Trial Program Azeem Latib


Accurate: Design Features, Special Attributes, and Clinical Trial Program Helge Möllmann


Session II. TAVR 2016: Anatomic Decision-making and TAVR Systems IIModerators: Ganesh Manoharan, Hendrik Treede Discussants: Stephen J.D. Brecker, Chandan Devireddy, Howard C. Herrmann, Hasan Jilaihawi, Jan Kovac, Axel Linke, Michael J. Reardon,Richard Smalling

Which Device and Technique for This Patient? Case Presenters: Tamim Nazif, Torsten P. Vahl

Jena Valve: Design and Clinical Updates Hendrik Treede

Venus A Valve: Design and Clinical Updates Hasan Jilaihawi

Centera: Design and Clinical Updates Stephen G. Worthley

Xeltis: Design and Clinical Updates Christian M. Spaulding

Surveying the Global Landscape of TAVR Newcomers Martin B. Leon


Session III. TAVR 2016: TAVR AccessoriesModerators: Helene Eltchaninoff, Neal S. Kleiman Discussants: Alexandre Abizaid, Peter C. Block, Stephen J.D. Brecker, Haim Danenberg, Hemal Gada, Albert Markus Kasel, Augusto D.Pichard, Molly Szerlip

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy Michael Jonas

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications Wesley R. Pedersen

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical ApplicationsCheng-Han Chen


Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others Alexandre Abizaid


Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others Axel Linke

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical TrialsAndreas Baumbach


Hot Topic Lunch: Fellows Sessions: ACS and Pharmacotherapy Year-in-Review (Sponsored by the American College of Cardiology)


Fellows Sessions: ACS and Pharmacotherapy Year-in-Review (Sponsored by the American College of Cardiology)Moderators: George D. Dangas, Debabrata Mukherjee Discussants: Rajesh M. Dave, Dean J. Kereiakes, Duane S. Pinto, Gary L. Schaer

Achieving Effective and Safe Platelet Inhibition in ACS Paul A. Gurbel


Deciding on the Duration of DAPT Neal S. Kleiman


Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies C. Michael Gibson


ACS and Pharmacotherapy Guidelines Update John A. Bittl




Part 1: Managing Patient, Operator, and Staff RisksModerator: Stephen Balter Discussants: Charles E. Chambers, Sanjog Kalra, Donald L. Miller

Ethics of Irradiating Patients and Staff Charles E. Chambers

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics? Sanjog Kalra

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies Donald L. Miller

Does Newer Equipment Lower Dose? Does Physician Education Help? Stephen Balter


Hot Topic Lunch: Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 1 - Pharmacology and STEMI Care


Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 1 - Pharmacology and STEMI CareModerators: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung Discussants: Eric R. Bates, Deepak L. Bhatt, Hitinder S. Gurm, Timothy D. Henry, Daniel I. Simon

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI! Gennaro Giustino

Return Fire: The Contrarian View: DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI! Discussant: Daniel I. Simon


Opening Salvo: I Don't Believe That Cangrelor Is Needed for Most PCI Procedures in ACS! Eric R. Bates

Return Fire: The Contrarian View: Cangrelor Is Needed for Most PCI Procedures in ACS! Discussant: Deepak L. Bhatt


Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016! Hitinder S. Gurm

Return Fire: The Contrarian View - Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016! Discussant: Timothy D. Henry


Hot Topic Lunch: CT Imaging for the Valve and Structural Heart Disease Interventionalist (Sponsored by the Society of CardiovascularComputed Tomography [SCCT])


CT Imaging for the Valve and Structural Heart Disease Interventionalist (Sponsored By the Society of Cardiovascular ComputedTomography [SCCT])Moderators: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min Discussants: João L Cavalcante, Swaminatha V Gurudevan, Hasan Jilaihawi

Comprehensive CT Algorithm Before TAVR João L Cavalcante

Post-TAVR Valve Thickening: Current Data and Open Questions Hasan Jilaihawi

Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions Jonathon A. Leipsic

Criteria to Select Candidates for Transcatheter Tricuspid Valve Interventions Jeroen J. Bax

Can CT Help to Select LAA Closure Devices? Swaminatha V Gurudevan


Hot Topic Lunch: Early Career Development for the New Interventionalist


Early Career Development for the New InterventionalistModerators: Ehtisham Mahmud, Manish A. Parikh Discussants: Saif Anwaruddin, David A. Cox, Ethan C. Korngold, Molly Szerlip

Balancing Multiple Skills: Coronary, Peripheral and Structural Ehrin J. Armstrong

Roundtable Discussion: When Am I Really Done Training?

Learning the Business of Interventional Cardiology Ethan C. Korngold

Roundtable Discussion: Avoiding "Rookie" Mistakes

Staying Current and Remaining Relevant: Evolving With the Field David A. Cox

Roundtable Discussion: Learning New Skills in an Ever-Changing Field

A Plan for the First Five Years to Grow Your Career Manish A. Parikh

Roundtable Discussion: What If the First Job Isn't Right for Me?

Hot Topic Lunch: Echo Guidance of Interventional Procedures, Part 1: Imaging for Transcatheter Aortic Valve Replacement. An ASE-Sponsored Symposium


Part 1: Imaging for Transcatheter Aortic Valve ReplacementModerators: Patrizio Lancellotti, Sunil V. Mankad Discussants: Thomas Bartel, Rebecca T. Hahn, Stamatios Lerakis, Stephen H. Little, Jeremy J Thaden

Debate: Imaging For TAVR- The Case for TTE and the Minimalist Approach! Stephen H. Little

Debate: Imaging For TAVR- The Case for TEE and MAC/GA! Rebecca T. Hahn


Use of Intracardiac Echocardiography During TAVR Thomas Bartel


Fusion Imaging for TAVR: Is There Added Utility? Jeremy J Thaden


Hot Topic Lunch: Emerging Data and Controversies in the Use of Peripheral Drug-Coated Balloons


Emerging Data and Controversies in the Use of Peripheral Drug-Coated BalloonsModerators: Koen Deloose, William A. Gray Discussants: Lawrence A. Garcia, Juan F. Granada, Prakash Krishnan, John R. Laird Jr, Mahmood K. Razavi, Kenneth Rosenfield

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA John R. Laird Jr

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix Kenneth Rosenfield

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex Prakash Krishnan

"DCB Efficacy In the SFA: Class-Effect or Device Specific" Salvatore Cassese

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world" Koen Deloose

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention? Lawrence A. Garcia

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to “Unlock" the BTK Application Mahmood K. Razavi

Designing a Complication-Free DCB: Is It Possible or Necessary? Juan F. Granada

Roundtable Discussion: With a Question and Answer

Hot Topic Lunch: Fellows Sessions: PCI Year-in-Review (Sponsored by the American College of Cardiology)


Fellows Sessions: PCI Year-in-Review (Sponsored by the American College of Cardiology)Moderators: Sripal Bangalore, George D. Dangas Discussants: Theodore A. Bass, Stephen G. Ellis, Lisette Okkels Jensen, Thomas M Tu

Bioabsorbable Vascular Scaffolds: Landscape in 2016 Alexandre Abizaid


Lesion Optimization Before PCI: Role of Imaging/Atherectomy Philippe Généreux


2016 DAPT Update: Evidence and Guidelines Adnan K. Chhatriwalla


2016 STEMI PCI Update: Evidence and Guidelines Sanjit S. Jolly


2016 CTO Revascularization Update Khaldoon Alaswad


Hot Topic Lunch: Focus on Chronic Kidney Disease and Contrast Nephropathy


Focus on Chronic Kidney Disease and Contrast NephropathyModerators: Somjot S. Brar, Richard Solomon Discussants: Antonio L. Bartorelli, Carlo Briguori, Anuj Gupta, Roxana Mehran, Anand Prasad

CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Anand Prasad


Planning and Performing TAVR in the Patient With CKD Anuj Gupta


Contrast Reduction Strategies in the Patient With CKD Roxana Mehran


Optimizing Fluid Administration for Contrast Nephropathy Prevention Richard Solomon


Hot Topic Lunch: Hybrid Coronary Revascularization: Ready for Prime Time? (Cosponsored by AATS)


Hybrid Coronary Revascularization: Ready for Prime Time? (Cosponsored by AATS)Moderators: John D. Puskas, Gregg W. Stone Discussants: John S. Douglas Jr, Michael E. Halkos, Marc Ruel, Leif Thuesen

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations John S. Douglas Jr

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study) John D. Puskas

Announcing the NIH-sponsored HYBRID Revascularization Trial Gregg W. Stone

Case Introduction: How Would You Revascularize This Patient? Case Presenter: Michael E. Halkos


Case Conclusion: How Did We Revascularize This Patient? Michael E. Halkos


Hot Topic Lunch: Late Career Decisions for the “Experienced” Interventionalist


Late Career Decisions for the “Experienced” InterventionalistModerator: David O. Williams Discussants: Peter C. Block, Michael J. Cowley, Keith D. Dawkins, Spencer B. King III

Overview and Scope of the Problem David O. Williams

“I Used to Be an Interventional Cardiologist”: Psychological Impact George W. Vetrovec

When to Stop Being an Interventionalist: Age Alone? Augusto D. Pichard

Staying in Medicine: Potential Options William W. O'Neill


Adjourn

Hot Topic Lunch: Secondary Prevention After PCI (Today and Tomorrow)- Guideline Therapies, Ranolazine, and PCSK9 Inhibitors


Secondary Prevention After PCI (Today and Tomorrow): Guideline Therapies, Ranolazine, and PCSK9 InhibitorsModerators: Bernard J. Gersh, Felix Mahfoud Discussants: Ori Ben-Yehuda, Evan A. Stein

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control Felix Mahfoud


Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice Evan A. Stein


Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective? Ori Ben-Yehuda


Hot Topic Lunch: The Experts Clash – Debates in Structural Heart Disease (sponsored by BCIS)


The Experts Clash – Debates in Structural Heart Disease (sponsored by BCIS)Moderators: Andreas Baumbach, David Hildick-Smith Discussants: Stephen J.D. Brecker, Eberhard Grube, David R. Holmes Jr., Hüseyin Ince

Pre-debate #1 Poll: Should TAVR Be Offered to Every Patient With Aortic Stenosis? Poll Moderators: Andreas Baumbach, David Hildick-Smith

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy! Michael J. Mullen

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, ValveThrombus, etc. - Wait for the Data in Low-risk Patients! Wilson Y. Szeto

Crossfire and Roundtable Discussion

Post-debate #1 Poll: Should TAVR Be Offered to Every Patient With Aortic Stenosis? Poll Moderators: Andreas Baumbach, David Hildick-Smith

Pre-debate #2 poll: Is Left Atrial Appendage Closure Underutilized? Poll Moderators: Andreas Baumbach, David Hildick-Smith

Debate: Is Left Atrial Appendage Closure Underutilized? Yes, It Should Be Offered to All Patients With Atrial Fibrillation (I Would WantIt!) Ted Feldman

Debate: Is Left Atrial Appendage Closure Underutilized? No, NOACs Have the Best Efficacy and Safety Profile for Most Patients! Jai-Wun Park


Post-debate #2 poll: Is Left Atrial Appendage Closure Underutilized? Poll Moderators: Andreas Baumbach, David Hildick-Smith



Vulnerable Plaque Detection and Treatment, Part 1Moderators: John A. Ambrose, Peter H. Stone Discussants: Vasileios D. Gkogkas, Ik-Kyung Jang, Bon-Kwon Koo, Ryan D. Madder, Yasunori Ueda, Nick E. J. West

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer James E. Muller

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? John A. Ambrose

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying David Erlinge

Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Guillermo Tearney

Detecting and Differentiating Plaque Erosion vs Rupture – and Does It Matter? Giulio Guagliumi

Diagnosis and Treatment of Erosion in ACS: The EROSION Study Ik-Kyung Jang




Part 2: Managing Patient, Operator, and Staff RisksModerators: Stephen Balter, Donald L. Miller Discussants: James A. Goldstein, Cari M. Kitahara, Edwin M. Leidholdt, Jr., Madan M Rehani

Are You Wearing Your Radiation Monitor? Edwin M. Leidholdt, Jr.

Why Does My Back Hurt? Nonradiation Risks In The Lab James A. Goldstein

Why Can't I See You Anymore? Radiation Effects On The Eye Madan M Rehani

Where Did My Cancer Come From? Radiation Epidemiology, Including Brain Cancer David Borrego, Cari M. Kitahara


Hot Topic Lunch: Challenging PFO Cases: Closure Versus Medical Management


Challenging PFO Cases: Closure Versus Medical ManagementModerators: John D. Carroll, David E. Thaler Discussants: Ted Feldman, Clifford J. Kavinsky, Michael J. Mullen, Mark Reisman, Christian Spies

Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke Case Presenter: Mark Reisman

Roundtable Discussion With Audience Q&A and Vote: Should the PFO be Closed?

Case #1 – Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Mark Reisman

Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved? Case Presenter: Ted Feldman


Case #2 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Ted Feldman

Case #3 - Introduction: Professional Diver With Decompression Illness Case Presenter: Michael J. Mullen


Case #3 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Michael J. Mullen

Case #4 - Introduction: Retinal Artery Occlusion and PFO Case Presenter: Clifford J. Kavinsky


Case #4 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Clifford J. Kavinsky

Case #5 - Introduction: History of VTE and New Cortical Stroke Case Presenter: Christian Spies


Case #5 - Resolution: Did We Close It (?), and Long-term Patient Outcomes Case Presenter: Christian Spies

Hot Topic Lunch: Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 2 – Devices


Controversies in Interventional Cardiology: The Skeptic’s Corner, Part 2 – DevicesModerators: Sanjay Kaul, Jeffrey J. Popma Discussants: Salvatore Cassese, Michael Haude, Raj Makkar, John D. Puskas

Opening Salvo: I Don't Believe TAVR Should Be the Predominant Form of Valve Replacement for Low and Intermediate Risk PatientsWith Severe AS!

Return Fire: The Contrarian View: TAVR Should Be The Predominant Form of Valve Replacement For Low and Intermediate RiskPatients With Severe AS! Discussant: Jeffrey J. Popma


Opening Salvo: I Don't Believe Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI! Salvatore Cassese

Return Fire: The Contrarian View - Bioresorbable Scaffolds Provide Meaningful Value for Most Patients Undergoing PCI! Discussant: Michael Haude


Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for MostPatients With Left Main CAD! John D. Puskas

Return Fire: The Contrarian View - PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!Discussant: Raj Makkar


Hot Topic Lunch: Coronary Drug-Coated Balloons: Devices, Applications, and Emerging Data


Coronary Drug-Coated Balloons: Devices, Applications, and Emerging DataModerators: Fernando Alfonso, Juan F. Granada Discussants: Bernardo Cortese, Germano Di Sciascio, Bruno Scheller

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should bethe Treatment of Choice! Bruno Scheller

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? No! Current Data Indicates DCB Is a SecondLine Therapy! Fernando Alfonso


DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls Bernardo Cortese


Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use? Azeem Latib


Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road? Juan F. Granada


Hot Topic Lunch: CT Imaging for the Coronary Interventionalist (Sponsored by the Society of Cardiovascular Computed Tomography[SCCT])


CT Imaging for the Coronary Interventionalist (Sponsored by the Society of Cardiovascular Computed Tomography [SCCT])Moderators: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min Discussants: Farouc Jaffer, Paul Knaapen, Manesh R. Patel

CT for Automated Quantification of Coronary Artery Stenosis Paul Knaapen

Understanding FFRct Jonathon A. Leipsic

Integrated Anatomical and Functional Assessment of Coronary Artery Stenosis Manesh R. Patel

CT For Procedural Planning in CTO and Complex Coronary Interventions Farouc Jaffer

Can CT Identify Vulnerable Plaque and Eventually Predict Myocardial Infarction? James K. Min


Hot Topic Lunch: Echo Guidance of Interventional Procedures, Part 2: The Integral Role of Imaging in Structural Heart Disease Innovation.An ASE-Sponsored Symposium


Part 2: The Integral Role of Imaging in Structural Heart Disease InnovationModerators: Stephen H. Little, G. Burkhard Mackensen Discussants: Paul A. Grayburn, Rebecca T. Hahn, Patrizio Lancellotti, Neil J. Weissman

From Pre-Clinical to Post-Approval: The Essential Role of Imaging Neil J. Weissman


Imaging for Tanscatheter Mitral Valve Interventions Paul A. Grayburn


Imaging for Tricuspid Valve Interventions Rebecca T. Hahn


Imaging and New Approaches to Valve Research Patrizio Lancellotti


Hot Topic Lunch: Fellows Sessions: Valvular Heart Disease Year-in-Review (Sponsored by the American College of Cardiology)


Fellows Sessions: Valvular Heart Disease Year-in-Review (Sponsored by the American College of Cardiology)Moderators: Blase A. Carabello, George D. Dangas Discussants: Verghese Mathew, Tamim Nazif, Azfar G. Zaman

TAVR: Current Status of Devices and Indications Vinod H. Thourani

Future TAVR Devices and Adjunctive Therapies George D. Dangas

Transcatheter Mitral Valve Repair: Results With Approved Devices (US and OUS) Alec S. Vahanian

Transcatheter Mitral Valve Replacement Howard C. Herrmann

Devices for the Right Heart (Tricuspid and Pulmonic Valves) Colin M. Barker


Hot Topic Lunch: Interventional and Surgical Valve Procedures: Case Studies in Conflict and Consensus (Cosponsored by AATS)


Session I: Intermediate Risk Patients With Severe Aortic StenosisModerators: Michael A. Borger, Vinod H. Thourani Discussants: Martin Misfeld, Josep Rodés-Cabau, Brian K. Whisenant

The Case for TAVR Brian K. Whisenant

The Case for Sutureless/ Rapid Deployment Valves Michael A. Borger


Session II: Management of Isolated Severe TR Postcardiac SurgeryModerators: Michael A. Borger, Vinod H. Thourani Discussants: Martin Misfeld, Josep Rodés-Cabau, Brian K. Whisenant

The Case for Transcatheter Therapy Josep Rodés-Cabau

The Case for Surgery Martin Misfeld


Hot Topic Lunch: Revascularization Decisions and Therapies for the Diabetic Patient


Revascularization Decisions and Therapies for the Diabetic PatientModerators: John A. Bittl, David J. Maron Discussants: Michael E. Farkouh, John A. Spertus, Jennifer A. Tremmel, Stephen D. Wiviott

Introduction David J. Maron

Case Presentation: Diabetes, Comorbidities, and Multivessel Disease Case Presenter: Kishore J. Harjai

The Case for a Trial of Medical Therapy Case Presenter: Michael E. Farkouh

The Case for CABG Case Presenter: A. Pieter Kappetein

The Case for Multivessel PCI Case Presenter: Sripal Bangalore

When Equipoise Exists: Is Unbiased, Informed Consent Possible? Case Presenter: John A. Spertus

Case Resolution: What Was Done Case Presenter: Kishore J. Harjai


Hot Topic Lunch: The Experts Clash – Debates in Coronary Heart Disease (sponsored by BCIS)


The Experts Clash – Debates in Coronary Heart Disease (sponsored by BCIS)Moderators: Adrian P. Banning, Nick Curzen Discussants: Anthony H. Gershlick, Stefan K. James, Jens Flensted Lassen, Mark A. de Belder

Pre-debate #3 Poll: Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Poll Moderators: Adrian P. Banning, Nick Curzen

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start PayingAttention to This Phenomenon! Robert-Jan van Geuns

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? No, Much Ado About Nothing! Samir B. Pancholy


Post-debate #3 Poll: Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Poll Moderators: Adrian P. Banning, Nick Curzen

Pre-debate #4 Poll: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the IndexProcedure? Poll Moderators: Adrian P. Banning, Nick Curzen

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? No, in theMiddle of the Night and With Complex Anatomy ... Are You Kidding?! Herbert D. Aronow

Debate: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the Index Procedure? Yes, inMost Patients, to Improve Prognosis and Reduce Costs! Keith G. Oldroyd


Post-debate #4 poll: Should Complete Revascularization in STEMI and Multivessel Disease Be Performed During the IndexProcedure? Poll Moderators: Adrian P. Banning, Nick Curzen



Vulnerable Plaque Detection and Treatment, Part 2Moderators: Gregg W. Stone, Ron Waksman Discussants: Patrick A. Calvert, Vasim Farooq, Hector M. Garcia-Garcia, Takashi Kubo, Amir Lerman, Ryan D. Madder

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will itSucceed?! Vasim Farooq

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT Seung-Jung Park

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner? Sanjit S. Jolly

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque Jonathan Leor

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer John A. Ambrose


Maintenance of Certification (MOC) Course I


Interventional Cardiology 2016 Module ReviewModerator: Emmanouil S. Brilakis Discussants: Tayo A. Addo, Nicola Corvaja, Dimitriy N. Feldman, Robert T. Pyo

Welcome and Introduction Tayo A. Addo

Maintenance of Certification (MOC) Course II


Interventional Cardiology 2015 Module ReviewModerator: Tayo A. Addo Discussants: Nicola Corvaja, Dimitriy N. Feldman, Robert T. Pyo, Elias Sanidas

Welcome and Introduction George D. Dangas

Maintenance of Certification (MOC) Course III


Interventional Cardiology 2014 Module ReviewModerator: Tayo A. Addo Discussants: Nicola Corvaja, Dimitriy N. Feldman, Robert T. Pyo, Elias Sanidas

Welcome and Introduction Tayo A. Addo

FDA Town Hall Meeting at TCT 2016, Part 2: Device Specifics


Session I. Bioresorbable Scaffolds and New Metallic DES: Pathways to Regulatory ApprovalModerators: Michael C. John, Gregg W. Stone Discussants: Jeffrey A. Anderson, Elazer R. Edelman, Andrew Farb, Gerardine Finn, David E. Kandzari, Martin B. Leon, Semih Oktay, ChuckSimonton, George W. Vetrovec, Jason R. Weidman

FDA Regulatory Considerations for Novel and Not-So-Novel New Metallic DES and Bioresorbable Scaffolds P.F. Adrian Magee

FDA Perspectives on Short DAPT IDE Trials Andrew Farb

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives Chuck Simonton

Industry Perspectives: Balancing Innovation and Robust Clinical Evidence Generation With Declining DES Use and ReimbursementJason R. Weidman


Session II. TAVR Revolution: Lessons Learned, Future ExpectationsModerators: Nicole Ibrahim, Martin B. Leon Discussants: Samir R. Kapadia, A. Pieter Kappetein, Alexandra J. Lansky, John C Laschinger, Michael J. Mack, Raj Makkar, Azin Parhizgar,Jaime Raben, Rhonda J Robb, Larry L. Wood

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and Newand Iterative Device Approval Pathways Jaime Raben

Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance Raj Makkar

Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More) Martin B. Leon


Session III. Mitral and Tricuspid Repair/Replacement DevicesModerators: Matthew G. Hillebrenner, Michael J. Mack Discussants: Ori Ben-Yehuda, Juan F. Granada, John C Laschinger, Martin B. Leon, Scott Lim, JoAnn Lindenfeld, Stanton J. Rowe, John A.Spertus, Gregg W. Stone, Changfu Wu

Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies John C Laschinger

Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened? Gregg W. Stone

The Tricuspid Valve: Challenges for Clinical Investigation Rebecca T. Hahn


Session IV. LAA Closure: Approval Pathways and Reimbursement ChallengesModerators: Aaron V. Kaplan, Rachel Neubrander Discussants: Steven R. Bailey, Keith D. Dawkins, Andrew Farb, David Hildick-Smith, Saibal Kar, Russell Seiber, Tamara Syrek Jensen,Katherine Wallon, Brian K. Whisenant, Steven J. Yakubov

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions – What FDA Would Like to See Katherine Wallon

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOACConsiderations and More – Industry and Clinician Perspectives Brian K. Whisenant

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations Tamara Syrek Jensen


International Session: Case-Based Complications: Interventional Flavors From Latin America, Mexico, and the Middle East Presented by:Sociedad de Cardiología Intervencionista de México (SOCIME), Venezuelan Society of Cardiology, Saudi Arabian Cardiac InterventionalSociety (SACIS), Colegio Argentino CardioAngiólogos Intervencionistas (CACI)


Case-Based Complications: Interventional Flavors From Latin America, Mexico, and the Middle EastModerators: Juan F. Granada, Oscar A. Mendiz Discussants: Waqar H. Ahmed, Mirvat Alasnag, Ricardo Lluberas

Introduction and Session Goals Moderators: Juan F. Granada, Oscar A. Mendiz

Saudi Arabia Presents: A Case When TAVR Crashes Case Presenter: Khaled F Al-Shaibi


Mexico Presents: A PCI Case With a Major Complication Case Presenter: Carlos Cabrera Arroyo


Saudi Arabia Presents: A Case of Coronary Compression After TAVR Case Presenter: Fawaz AlMotairi


Argentina Presents: A Case of a TAVR Complication Case Presenter: Oscar A. Mendiz


Venezuela Presents: A Case of a TAVR Complication Case Presenter: Carlos D Calderas


Conclusions and Take-home Messages Moderator: Waqar H. Ahmed

International Session: Interventional Cardiology in India: Coordinated by NIC


Introduction – Dr. Amal K. Banerjee, Dr. Narenda N. Khanna

Session I: Indian Panorama 1 – Unique Knowledge from IndiaModerators: Vinay K. Bahl, Amal Kumar Banerjee

Imaging-Guided Left Main Intervention Brian V Pinto

The Science and Technique of Bifurcation Stenting Vinay K. Bahl

Takayasu’s Arteritis: Lessons From a Large Interventional

Rationale and Experience With the Pharmacoinvasive Strategy in STEMI Upendra Kaul

Roundtable Discussion and Audience Q&A

Session II. Indian Panorama 2: The Great CasesModerators: M.S. Hiremath, Kamal K. Sethi

My Most Rewarding Case: Case #1 Case Presenter: Sreenivas Arramraju Kumar

My Most Rewarding Case: Case #2 Case Presenter: Jamshed J. Dalal

My Most Rewarding Case: Case #3 Case Presenter: Rabin dra Nath Chakraborty

My Worst Nightmare Case I Learned From: Case #1 Case Presenter: Amal Kumar Banerjee

My Worst Nightmare Case I Learned From: Case #2 Case Presenter: M.S. Hiremath

My Worst Nightmare Case I Learned From: Case #3

My Worst Nightmare Case I Learned From: Case #4 Case Presenter: Sundeep Mishra

International Session: Optical Coherence Tomography in Bifurcation Lesions Present by the Nordic-Baltic-British Study Group forInterventional Cardiology


Optical Coherence Tomography in Bifurcation LesionsModerators: Evald H. Christiansen, Simon J. Walsh Discussants: Adrian P. Banning, Andrejs Erglis, Niels R. Holm, Olli A. Kajander

Session I. ”Simple” Bifurcation Treatment Guided by OCT

Case #1: OCT in a Bifurcation: Is Seeing the Same As Believing? Case Presenter: Giovanni Luigi De Maria

Case #2: Optimized Treatment of a Not So Simple LMCA Case Bifurcation Case Presenter: Rikard B.A. Linder

Case #3: Simple Stenting With a Kiss and OCT Case Presenter: Julian Strange


Session II. OCT Guided Two-Stent Treatment of Bifurcation Lesions

Case #4: Where are the Guide Wires? Two-stent Treatment by OCT Case Presenter: Hannu Romppanen

Case #5: This is Why OCT is Encouraged by EBC for Complex Bifurcations Case Presenter: Jens Flensted Lassen

Case #6: No Guessing Needed Using OCT for This Bifurcation Case Presenter: Henning Kelbæk


Session III. BRS in Bifurcations I

Case #7: All the Steps for This Absorb BRS Implanted in a Bifurcation Case Presenter: Andreas Kristensen

Case #8: Absorb and Permanent DES in an LMCA Bifurcation With 3-year Follow-up Case Presenter: Indulis Kumsars

Case #9: Value of Self-Expanding Properties Using Desolve BRS in a Bifurcation Case Presenter: Niels R. Holm


Session VI. BRS in Bifurcations II

Case #10: OCT Was Crucial Implanting BRS in This Bifurcation Case Presenter: Jonathan M. Hill

Case #11: Kissing the Magnesium BRS Case Presenter: Evald H. Christiansen

Case #12: Magnesium BRS in Cross-Over Stenting Case Presenter: Trine Ørhøj Barkholt

Summary Evald H. Christiansen

International Session: Global Hearts Africa Presented by PASCAR and CRF


Global Hearts IntroductionJack C. Lewin

Session I: Ischemic Heart Disease and ACS in AfricaModerators: Graham A. Cassel, Awad AA Mohamed Discussants: Habib Gamra, Bernard J. Gersh, Mpiko Ntsekhe, Mohamed Ahmed Sobhy

Summary & Update of the 2016 Presentations Awad AA Mohamed

Delivery System and Therapeutic Challenges and Opportunities in Africa Harun A Otieno

Roundtable Discussion & Audience Q&A

Session II: Rheumatic Heart Disease in AfricaModerators: Habib Gamra, Ahmed Suliman Discussants: Graham A. Cassel, Hugh J. Linnehan, Awad AA Mohamed, Mpiko Ntsekhe, Mohamed Ahmed Sobhy

Update on Epidemiology, Prevention, Screening, and Control Bernard J. Gersh

Delivery System and Therapeutic Challenges with RHD in Africa Mohamed Ahmed Sobhy

Impact of Percutaneous Mitral Valve Repair and Replacement on RHD Patient Outcomes Hugh J. Linnehan

Roundtable Discussion & Audience Q&A Moderators: Habib Gamra, Ahmed Suliman

Session III: Improving CV Outcomes in Africa Through the Global Hearts InitiativeModerators: Jack C. Lewin, Hugh J. Linnehan Discussants: Awad AA Mohamed, Harun A Otieno, Mohamed Ahmed Sobhy

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results Habib Gamra

Needs Assessment for Cath Lab Improvement and Support Graham A. Cassel

Global Hearts Action Plan for 2017 Mpiko Ntsekhe


International Session: TAVR in Developing Countries Presented by: Qatar, Algeria, Morocco, Jordan, Australia, and New Zealand


TAVR in Developing CountriesModerators: Ziyad M. Hijazi, David W.M. Muller Discussants: Mohamed Chettibi, Stephen G. Worthley

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR? David W.M. Muller

Preinterventional Selection of Patients: What Tests Must Be Done Prior to TAVR? Clifford J. Kavinsky

Role of Echocardiography in TAVR Muhamed Saric

Valve Selection for TAVR: Similarities and Differences; How to Choose Mohamed Chettibi

Experience With the Balloon Expandable Valves Imad A. Alhaddad

TAVR Case Study With a Balloon Expandable Valve Case Presenter: Said Benghezel

TAVR Case Study: Rheumatic AS - Is TAVR Appropriate? Case Presenter: Imad A. Alhaddad

TAVR Case Study With a Self-Expanding Valve Case Presenter: Salem Abujalala

First-in-Human TAVR Studies in New Zealand and Australia: Why There? Darren L. Walters

TAVR Complications: Have We Made Progress Over the Last Five Years? Cherradi rhizlan

Roundtable Discussion With Q&A

International Session: TCT Francophone: New Tip and Tricks From the Francophone Cath Lab

Cardiovascular Research Foundation Room 103B, Level 1Accreditation: none

TCT Francophone: New Tip and Tricks from the Francophone Cath LabModerators: Bernard R. Chevalier, Philippe Généreux Commentators: Walid Jomaa, Christian M. Spaulding Discussants: Khaldoun Ben Hamda, Marc Etienne Jolicoeur, Samer Mansour, Stéphane Rinfret, Jean-François Tanguay, Eric Van Belle

Bifurcations et Trifurcations Avec Angles Extrèmes/Extreme Angulation Bifurcation Yves R. Louvard

Le Ballon Ne Passe Pas/The Ballon Doesn’t Go/CTO Perspectives Stéphane Rinfret

STEMI: Le Gros Caillot Récalcitrant Et Autres Mésaventures Nocturnes/The Big Clot and Other Crazy Night Stories Marc Etienne Jolicoeur

Pousser La Limite Du TAVI Transfemoral En Toute Prudence/How to Push the TF-TAVR Limit Safely! Eric Van Belle

Ma Valve Ne Passes Pas La Valve!/My Valve Doesn’t Cross the Valve! Bernard R. Chevalier

Partnership Session: China Interventional Therapeutics in Partnership With TCT: Left Main Revascularization in the Era of EXCEL


Case 1: Left Main and Multivessel Disease (Syntax Score >32)Moderators: Runlin Gao, Bo Xu Discussants: Guosheng Fu, Philippe Généreux, Shubin Qiao, Ling Tao

Case Introduction: How Should I Treat? Case Presenter: Kefei Dou

How Would I Treat? (Option 1) Philippe Généreux

How Would I Treat? (Option 2) Zening Jin


Case Conclusion: How Did I Treat? Case Presenter: Kefei Dou

Case 2: Distal Left Main Bifurcation (Medina 1,1,1 and Syntax Score < 32)Moderators: Runlin Gao, Bo Xu Discussants: Guosheng Fu, Philippe Généreux, Shubin Qiao, Ling Tao

Case Introduction: How Should I Treat? Case Presenter: Junjie Zhang

How Would I Treat? (Option 1) Jian Liu

How Would I Treat? (Option 2) Qi Zhang


Case Conclusion: How Did I Treat? Case Presenter: Junjie Zhang

Partnership Session: GISE Highlights at TCT: Clinical Crossroads for the Optimal Management of Complex Patients in InterventionalCardiology


Session I. Antiplatelet Therapy Optimization in NSTE-ACSModerators: Roxana Mehran, Ferdinando Varbella Discussants: Dominick J. Angiolillo, Caterina Gandolfo, Ugo Limbruno, Giuseppe Tarantini, Fabio Felice Tarantino

Case Introduction: An Elderly Patient With NSTE-ACS Case Presenter: Alberto Menozzi

To Pretreat or Not to Pretreat? The DUBIUS Trial Giuseppe Tarantini

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment inNSTE-ACS Dominick J. Angiolillo

Case Conclusion: How Did We Treat Our Patient? Case Presenter: Alberto Menozzi


Session II. Stent and Scaffold Selection in Complex PCIModerators: George D. Dangas, Fabio Felice Tarantino Discussants: Dariusz Dudek, Stephen G. Ellis, Giovanni Esposito, Ugo Limbruno, Giampaolo Pasquetto, Stefano Rigattieri

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS? Massimo Fineschi

Choose a Drug-Eluting Stent: Here’s Why Carlo Cernetti

Think Twice: BRS First Francesco Saia

Case Conclusion: How Did We Treat Our Patient? Case Presenter: Massimo Fineschi


Partnership Session: TCT Russia: The Hottest Topics and Cases


TCT Russia: The Hottest Topics and CasesModerators: Bagrat Alekyan, Greg L. Kaluza Discussants: Mitchell W. Krucoff, Mahmood K. Razavi, Thomas D. Stuckey

Case Presentation: ACS Intervention in the Emerging BRS Era Case Presenter: Evgeny V. Merkulov

Editorial Comment: BRS Safety in ACS Intervention, Technical, and Clinical Considerations Mitchell W. Krucoff

Case Presentation: LAA Intervention in the TAVR Patient Case Presenter: Alexey Protopopov

Editorial Comment: Technical, Procedural, and Clinical Considerations William A. Gray

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock Case Presenter: Vladimir Ganyukov

Editorial Comment: Current Guidelines, Device, and Anticoagulation Strategies Thomas D. Stuckey

Case Presentation: BTK Intervention in Critical Limb Ischemia Case Presenter: Zaza Kavteladze

Editorial Comment: Current Techniques, Device Selection, and Outcomes Mahmood K. Razavi

Special Session: Complex Lower Extremity Arterial Interventions


Complex Lower Extremity Arterial InterventionsModerators: Jihad A. Mustapha, Craig M. Walker Discussants: Lawrence A. Garcia, Sriram S. Iyer, R. Stefan Kiesz, Krishna J. Rocha-Singh, Mitchell Weinberg

State of the Art Lecture: Lessons From Coronary CTOs and the Hybrid Algorithm Relevant to Peripheral CTOs Mark J. Goodwin

Case Presentation: Long SFA CTO Case Presenter: Ethan C. Korngold

Atherectomy in SFA CTOs: How to Maximize Outcomes and Prevent Complications Roger Gammon

CTO Crossing and Re-entry Devices: Case-Based Illustrations for How and When to Use Mehdi H. Shishehbor


Tools of the Trade: Devices Selection for Challenging BTK Interventions Jihad A. Mustapha

Case Presentation: Failed Endovascular Intervention Case Presenter: Mehdi H. Shishehbor

Hybrid Surgical Approaches Offer the Best Options for Complex PAD: Case Examples Case Presenter: Koen Deloose

Endovascular Treatment Options in Patients With Chronic Kidney Disease: IVUS, CO2 Assisted, and Hybrid Craig M. Walker

How to Overcome Recoil, Dissection, and Suboptimal Lumen Gain for Treatment of Infrapopliteal Disease Eric J. Dippel


Presentation Theater Program: Cardioband: Clinical Reality for Mitral and Tricuspid Valve Repair (Sponsored by Valtech Cardio)


Cardioband: Clinical Reality for Mitral and Tricuspid Valve RepairChairs: Martin B. Leon, Michael J. Mack Facultys: Paul A. Grayburn, Karl-Heinz Kuck, Azeem Latib

Session Objectives Martin B. Leon

Percutaneous Annuloplasty: Another Step Towards Surgical Standards Michael J. Mack

24 Months Results and Future Clinical Studies Martin B. Leon

Echo Guidance: Anatomy and Physiology Paul A. Grayburn

How Quick Can You Master Cardioband? Azeem Latib

Tricuspid Repair With Cardioband Karl-Heinz Kuck

Session Evaluation and Key Learnings Michael J. Mack

Presentation Theater Program: Challenging Cases in a Real-world Patient Population (Sponsored by Medtronic, Inc.)


Challenging Cases in a Real-world Patient PopulationChair: George D. Dangas Facultys: M.S. Hiremath, MD, PhD, Elvin Kedhi, MD, PhD, Juying Qian, MD, Ramesh S.A. Singh, MD

Welcome and Session Objectives George D. Dangas

Perspectives From China: Heavily Calcified Lesions in Elderly Patient Juying Qian, MD

Perspectives From Belgium: Management of Dual Vessel Disease Elvin Kedhi, MD

Discussion Panel Moderator: George D. Dangas

Perspectives From Malaysia: MVD in Diabetic Patient With Small Vessels Ramesh SA Singh, MD

Perspectives From India: Management of Large Vessels M.S. Hiremath, MD

Discussion Panel Moderator: George D. Dangas

Presentation Theater Program: Rethink DAPT: Optimizing PCI in high-bleeding risk patients With the COBRA PzF NanoCoated Stent (NCS)(Sponsored by CeloNova BioSciences, Inc.)


Rethink DAPT: Optimizing PCI in High-Bleeding Risk Patients With the COBRA PzF NanoCoated Stent (NCS)Chairs: Ajay J. Kirtane, Sigmund Silber, Renu Virmani Facultys: Donald Cutlip, Aloke V. Finn, Rajiv Jauhar, MD, Philip M. Urban

Welcome to Faculty Ajay J. Kirtane

High-Bleeding Risk Patients: Why We Still Need Newer Devices for These Patients Michael Joner

Preclinical Evaluation of the COBRA PzF NanoCoated Stent Faculty: Aloke V. Finn

Clinical Evidence: PzF SHIELD Data and the Introduction to the COBRA REDUCE Trial Donald Cutlip

Moderated Case Presentation: Two-Week DAPT COBRA Case With Follow-up Rajiv Jauhar, MD

Discussion Renu Virmani

Presentation Theater Program: SCAI WIN Complex Coronary Intervention Coast to Coast: A Case-Based Review (Sponsored by Abbott)


SCAI WIN Complex Coronary Intervention Coast to Coast: A Case-Based ReviewChair: Cindy L. GrinesFacultys: Alaide Chieffo, MD, Amir Kaki, MD, Srihari S. Naidu, Ruby Satpathy, MD, Molly Szerlip

Introduction Cindy L. Grines

Fellow Case Review #1

Q&A Moderator: Cindy L. Grines Discussants: Alaide Chieffo, MD, Amir Kaki, MD, Srihari S. Naidu, Ruby Satpathy, MD, Molly Szerlip





Summary and Questions

Presentation Theater Program: The SYNERGY Stent: Clinical Evidence for Optimal Healing and Safety (Sponsored by Boston ScientificCorporation)


The SYNERGY Stent: Clinical Evidence for Optimal Healing and SafetyChair: Adrian P. Banning Facultys: Colm Hanratty, Takafumi Ueno, MD, Renu Virmani

Introductions/Lunch Adrian P. Banning

Vascular Responses of Bioabsorable Polymer DES Renu Virmani

Differential Angioscopic Findings of Neointimal Coverage Among First-, Second-, and Next Generation Drug-eluting Stents Takafumi Ueno, MD

The Belfast Experience: SYNERGY in Real World Practice Colm Hanratty

Discussion/Q&A

The Promise of Reduced DAPT Duration with BP DES Adrian P. Banning

Presentation Theater Program: Advancing Treatment Strategies in Complex Calcified Lesions to Help Optimize Stent Expansion With OrbitalAtherectomy (Sponsored by Cardiovascular Systems, Inc.)


Advancing Treatment Strategies in Complex Calcified Lesions to Help Optimize Stent Expansion With Orbital AtherectomyFacultys: Ehrin J. Armstrong, Philippe Généreux, Michael C. Kim

Welcome Philippe Généreux

Impact of Severe Coronary Calcification on Clinical Outcomes Philippe Généreux

Case Review: Complex PCI With OAS in High-risk Patients Michael C. Kim

OAS Vessel Prep: Considerations for Facilitating BVS Placement in Severe Calcium Ehrin J. Armstrong

ECLIPSE Announcement Philippe Généreux

Q&A Moderator: Philippe Généreux Discussants: Ehrin J. Armstrong, Michael C. Kim

Presentation Theater Program: Built on Results - Stellarex DCB Outcomes From the ILLUMENATE Clinical Program (Sponsored bySpectranetics)


Built on Results: Stellarex DCB Outcomes From the ILLUMENATE Clinical ProgramFacultys: Koen Deloose, Prakash Krishnan, Sean P Lyden, Martin Werner, MD

Built on Results: Stellarex DCB Outcomes From the ILLUMENATE Clinical Program Moderator: Prakash Krishnan

Insights from ILLUMNATE FIH Study 2-year Results Sean P Lyden

Interim 1-year Results from the ILLUMENATE Global Trial Koen Deloose

Latest 1-year results from the ILLUMENATE European Randomized Clinical Trial Martin Werner, MD

Panel Discussion With Q&A

Presentation Theater Program: Redesigning DES – What Matters and Why? (Sponsored by CRF, Supported by Medinol, Inc)


Redesigning DES – What Matters and Why?Co-Chairs: David E. Kandzari, Martin B. Leon Facultys: Ariel Finkelstein, Rajiv Jauhar, Manish A. Parikh, Yoram Richter

Medinol’s Credo – Setting the Bar for Innovation Martin B. Leon

How Are DES Made and Why Do I Care? Yoram Richter

BIONICS and NIREUS - One Year Follow-up David E. Kandzari

Discussion: Are Durable Polymers Really Durable, and Does It Matter? Manish A. Parikh

Discussion: Designing for the Vessel – An Innovative Approach to Stent Design Ariel Finkelstein

Discussion: Deliverability – Does the Journey Make a Difference? Rajiv Jauhar

Closing Remarks – How Do You Pick the Right Stent? David E. Kandzari

Presentation Theater Program: SENTINEL Science: Compelling New Evidence for Cerebral Protection in TAVR (Sponsored by ClaretMedical)


SENTINEL Science: Compelling New Evidence for Cerebral Protection in TAVRChairs: Martin B. Leon, Axel Linke, Raj Makkar Facultys: Jeffrey Browndyke, MD, Michael Dwyer, MD, Samir R. Kapadia, Susheel Kodali, Ronald Lazar, MD, Roxana Mehran, Renu Virmani

Key findings From the Landmark SENTINEL Pivotal Trial Moderator: Samir R. Kapadia Discussant: Raj Makkar

New Neuroimaging Insights Into the Predictors of Cerebral Ischemic Insult During TAVR Michael D. Dwyer, MD Discussant: Axel Linke

Observations From the Neurocognitive Function Substudy of the SENTINEL Trial: Clinical Implications Ronald Lazar, MD Discussant: Jeffrey Browndyke, MD

Concluding Comments Martin B. Leon

Panel Discussion Moderators: Martin B. Leon, Axel Linke, Raj Makkar Discussants: Susheel Kodali, Roxana Mehran, Renu Virmani

Presentation Theater Program: Succeeding with CHIP & Complex PCI (Sponsored by Abbott)


Succeeding with CHIP & Complex PCIChair: Srihari S. Naidu Facultys: Ajay J. Kirtane, Chuck Simonton, James C. Spratt

Introductions and Welcome Srihari S. Naidu

Defining “Complex” PCI & CHIP Ajay J. Kirtane

Modern DES: The EXCEL Trial Chuck Simonton

CHIP Case Reviews James C. Spratt

Interventional Innovation III: Early Feasibility and First in Human Studies


Session I. Structural Heart Disease TechnologiesModerators: Ted Feldman, David Hildick-Smith Discussants: Michael A. Borger, John P. Cheatham, Rebecca T. Hahn, Ziyad M. Hijazi, Saibal Kar

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with BioresorbableFramework in Patients with Clinically Significant ASD or PFO Kolja Sievert

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience Michael J. Mullen


One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve Lee N. Benson

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional TricuspidRegurgitation: 30-Day Results From the SCOUT Trial Rebecca T. Hahn


Session II. Peripheral Vascular Disease Technologies IModerators: Michael D. Dake, Kenneth Rosenfield Discussants: Shao-Liang Chen, Eric J. Dippel, John R. Laird Jr, Alex M. K. Rothman

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial Mehdi H. Shishehbor

Local Ultrasound to Enhance Paclitaxel Delivery after Femoro-Popliteal Treatment in Critical Limb Ischemia: Immediate and MidtermResults of the PACUS Trial Costantino Del Giudice


Safety and Performance of the Shockwave Medical Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: 6-MonthResults from the Two-Phase DISRUPT PAD Study Todd J. Brinton

Long Term Outcomes after Revascularization of Long SFA Occlusions with OCT Guided Atherectomy OCELOT Catheter: Resultsfrom the Pivotal FIH Study Przemek Nowakowski


Session III. Peripheral Vascular Disease Technologies IIModerators: Robert M. Bersin, John R. Laird Jr Discussants: Eric J. Dippel, Sriram S. Iyer, Ethan C. Korngold, Kenneth Rosenfield, Mehdi H. Shishehbor

Simplicity Denervation System for Pulmonary Artery Denervation in Patients with Chronic Thromboembolic PulmonaryHypertension: FIH Results Boris Rudenko

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform CarotidRevascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study Piotr Musialek


Early Results of the PQ Bypass Endovascular Femoro-Popliteal Artery Bypass Study (EFAB) Dainis K Krievins

Arterial Dilatation with Recombinant Human Elastase: A Novel Approach to Treating Peripheral Vascular Disease Ehrin J. Armstrong


Session IV. Emerging Coronary TechnologiesModerators: Fernando Alfonso, Ran Kornowski Discussants: Louis A. Cannon, Christian Hengstenberg, David E. Kandzari, Julio C. Palmaz, Giora Weisz

Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free FunctionalImaging (WIFI-II) Study Jelmer Sybren Westra

FFRangio: Image-Based FFR During Coronary Catheterisation Bernard De Bruyne


Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The“ANCHOR” Study Josep Rodés-Cabau

Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry Bernardo Cortese

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up Pieter R. Stella


The First Clinical Experience with a Novel Directional Coronary Atherectomy Catheter Maoto Habara

Initial Results of First-In-Human Study on the PlasmaWire: A Novel Radiofrequency Wire for Recanalization of Chronic TotalOcclusions Etsuo Tsuchikane


Section V. Interventional Heart Failure and HypertensionModerator: Emerson C. Perin Discussants: Angeles Alonso Garcia, Joost Daemen, William W. O'Neill, Ileana L. Pina, Ramon Quesada, Michael A. Weber

First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF Valluvan Jeevanandam


Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical) William T. Abraham


Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve StimulatorMark W.I. Webster




Hands on HeartsModerators: Robert Kutys, Maria E. Romero, Nicole Singer

ITC Theater: CTO and Complex PCI


Evening Program: Controversies in PCI Optimization: Case-Based Discussion (Sponsored by Philips Volcano)

Marriott Marquis Washington DC Independence Ballroom A-E, Level M4Accreditation: none


Controversies in PCI Optimization: Case-Based DiscussionFacultys: Javier Escaned, Allen Jeremias, Akiko Maehara, Manesh R. Patel, Bruce Samuels, MD

I Have a Mismatch With iFR/FFR, Now What? Allen Jeremias

You Placed a Stent, So Why Is Your FFR Still Ischemic? Manesh R. Patel

Discussion Moderator: Javier Escaned

Could Adding IVUS and SyncVision to Your Routine Make BRS Implantation Easier? Bruce Samuels, MD

Why Would I Not Use IVUS to Guide Left Main PCI? Lessons From EXCEL Akiko Maehara

Discussion

Evening Program: Next Generation DES Technology: Let the Future Begin! (Sponsored by CRF, Supported by Abbott, Amaranth, ElixirMedical, Medtronic, Inc., OrbusNeich, Reva Medical, Inc., and Sino Medical)

Marriott Marquis Washington DC Marquis Ballroom, Salon 1-4, Level M2Accreditation: CMECo-Chairs: Alexandre Abizaid, Martin B. Leon, Gregg W. Stone Facultys: Juan F. Granada, Ajay J. Kirtane, Roxana Mehran, Patrick W. Serruys, Philip M. Urban, Ron Waksman


Session I: MAKING THE CASE FOR BIORESORBABLE POLYMER DES

Update on Bioresorbable Polymer DES: Rationale, Device Landscape, and Data Martin B. Leon

Bioresorbable Polymer-Based Drug Delivery With Endothelial Progenitor Cells to Accelerate Healing: The COMBO Stent Roxana Mehran


Session II: MAKING THE CASE FOR POLYMER-FREE TECHNOLOGIES

1 Year After LEADERS FREE: Have the Results Changed Practice? Philip M. Urban

Development of a Drug-Filled Stent and the RevElution Study Ajay J. Kirtane


Session III: MAKING THE CASE FOR A FULLY BIORESORBABLE FUTURE

Proven Outcomes (Absorb) Patrick W. Serruys

Thin Struts With Self-Correcting Property (DESolve) Alexandre Abizaid

Optimized Polymer (AMARANTH) Juan F. Granada

Radiopacity (FANTOM) Alexandre Abizaid

Metallic-DES-Like Performance (Magmaris) Ron Waksman


Evening Program: The Interventional Toolbox for Complex Higher-Risk (and Indicated) Patients (CHIP)( Sponsored by CRF, Supported byABIOMED, Inc., Abbott, Boston Scientific Corporation, Cardiovascular Systems, Inc., and Vascular Solutions)

Marriott Marquis Washington DC Marquis Ballroom, Salon 5, Level M2Accreditation: CMECo-Chairs: Ajay J. Kirtane, William L. Lombardi, Jeffrey W. Moses Facultys: Emmanouil S. Brilakis, Susheel Kodali, Manish A. Parikh, Gregg W. Stone, Simon J. Walsh


Part I: CTO PCIModerator: Jeffrey W. Moses

The Hybrid Approach to CTO PCI: What It Is, and How It Has Changed CTO PCI William L. Lombardi

Hybrid CTO Case Review - Clinical Presentation/Angiogram Case Presenter: Simon J. Walsh

Discussion of Strategies Moderator: Simon J. Walsh

Discussion of What Was Done Moderator: Simon J. Walsh

Summary With Q&A

Part II: Atherectomy and CalciumModerator: Gregg W. Stone

The Importance of Coronary Calcification in Complex PCI: Data and Devices Gregg W. Stone

Calcified Anatomy Case Review-Clinical Presentation/Angiogram Case Presenter: Susheel Kodali

Discussion of Strategies Moderator: Susheel Kodali

Discussion of What Was Done Moderator: Susheel Kodali

Summary With Q&A

Part III: High-Risk PCIModerator: Ajay J. Kirtane

PCI of High-Risk Patients Under Hemodynamic Support: For Whom and With What? Ajay J. Kirtane

High-Risk PCI Case Review - Clinical Presentation/Angiogram Case Presenter: Emmanouil S. Brilakis

Discussion of Strategies Moderator: Emmanouil S. Brilakis

Discussion of What Was Done Moderator: Emmanouil S. Brilakis

Summary With Q&A

Moderated Challenging Cases: Coronary V


Moderated Challenging Cases: Coronary VModerators: M Chadi Alraies, Jose Armando Mangione

TCT 1055: Retrograde Treatment of a Flush Right Coronary Artery Chronic Total Occlusion Case Presenter: Judit Karacsonyi

TCT 1066: A Successful Case of Left Main Shock Syndrome Due to Thrombosed Coronary Dissection Case Presenter: Weiping Zhang

TCT 1097: Successful Revascularization for Double-Vessel CTO Case Presenter: Dai-Yin Lu

TCT 1103: Retrograde LAD Chronic Total Occlusion via RIMA Case Presenter: Elizabeth Shaw

Moderated Challenging Cases: Coronary VI


Moderated Challenging Cases: Coronary VIModerators: Massoud A. Leesar, Adam Witkowski

TCT 1116: Iatrogenic Left Main Dissection With Flap Extending to Ascending Aorta- A Nightmare Case Presenter: Jabir Abdullakutty

TCT 1128: A Very Complicated Coronary Perforation Case Presenter: Li-Wah Tam

TCT 1176: Calcified Aorto-Ostial Occlusion - A Terrible Combination for Chronic Total Occlusion Case Presenter: Chi Hong Chau

TCT 1035: Entrapment of Intracoronary Optical Frequency Domain Imaging Catheter Case Presenter: Yu Ho Chan

Moderated Challenging Cases: Structural IV


Moderated Challenging Cases: Structural IVModerators: Ruediger Lange, John F. Rhodes

TCT 1620: First-In-Human of Transapical Off-Pump Mitral Valve Repair With Catheter Delivered Annuloplasty Ring for FunctionalMitral Regurgitation Case Presenter: Andrea Colli

TCT 1499: Percutaneous Treatment of Ruptured Chronic False Aneurysm of the Ascending Aorta and Valsalva Sinus in the RightVentricule Case Presenter: Jamel Langar

TCT 1570: Transcatheter Closure of a Sinus Venosus Atrial Septal Defect in a Poor Surgical Candidate Case Presenter: Akanksha Thakkar

TCT 1605: Managing an Acute Aortic Dissection in Transcatheter Aortic Valve Implantation Case Presenter: Oscar Millan-Iturbe

Moderated Challenging Cases: Structural V


Moderated Challenging Cases: Structural VModerators: Massimo Napodano, Alfredo E. Rodriguez

TCT 1567: "Catch Me If You Can" Case Presenter: Rahul Sharma

TCT 1606: Transcatheter Transapical Mitral Valve-in-Valve Implantation for Bioprosthetic Valve Dysfunction Using a Lotus ValveSystem Case Presenter: Oscar Millan-Iturbe

TCT 1614: Clip in SAM Case Presenter: Nadira Hamid

Moderated Poster Session: Bioresorable Scaffold or Drug-Eluting Stent Thrombosis


Moderated Poster Session: Bioresorable Scaffold or Drug-Eluting Stent ThrombosisModerators: Serban Puricel, Clemens von Birgelen

TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials Patrick W. Serruys

TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with BioresorbableScaffolding Platforms in Europe) Registry Niel Ruparelia

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients UndergoingPercutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials. Tannas Jatene

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysisfrom Seventeen Randomized Trials Mahesh V Madhavan

TCT 830: Difference in Hemodynamic Micro-Environment in Vessels Scaffolded with Absorb BVS or Mirage Microfiber SiromilusEluting Scaffold: A Pre-Clinical Study of Endothelial Shear Stress Rafael Cavalcante E. Silva

Moderated Poster Session: Sirolimus-Coated Balloons

Cardiovascular Research Foundation Mod Posters/Cases 2, Exhibit Hall, Level 2Accreditation: none

Moderated Poster Session: Sirolimus-Coated BalloonsModerators: Germano Di Sciascio, Bruno Scheller

TCT 390: Influence of Diabetes on the Safety and Efficacy of Sirolimus-Coated Balloon in A Real-World Multi-Center NanolutèRegistry Dinesh Shah

TCT 388: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Results from the Nanolutè Registry Keyur Parikh

TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the NanolutéRegistry Bernardo Cortese

Moderated Poster Session: Treatment of Bifurcation Lesions


Moderated Poster Session: Treatment of Bifurcation LesionsModerators: Michael A. Kutcher, Issam D. Moussa

TCT 403: Bioresorbable Coronary Devices in Bifurcations: Immediate and 6-month Results of the REPARA Registry Felipe Hernandez

TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in theRandomized Nordic Bifurcation Study Terje K. Steigen

TCT 319: Side Branch Mortality Score for Prediction of Five Year Mortality After Provisional Side Branch Coronary BifurcationStenting – A New Tool Based on Intracoronary Electrocardiogram (iECG) From iECG and Myonecrosis After Bifurcation Stenting Kiril Karamfiloff

TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with Bifurcation Lesions After Recanalization of Chroniccoronary Arteries Occlusions. Comparative Analysis Vitaly Baystrukov

Moderated Poster Session: Vascular Access


Moderated Poster Session: Vascular AccessModerators: Ivo Bernat, Thomas M Tu

TCT 547: Radial Artery Changes After Transradial PCI – A Serial Optical Coherence Tomography Volumetric Study Jan Kanovsky

TCT 358: Bleeding and Vascular Complication Rates Before and After Implementation of a Radial Coronary CatheterizationProgramme – an Observational Study in 12 745 Patients Daniel Kiblboeck

TCT 202: Interaction Between Choice of Anticoagulation, Antiplatelet Therapy and Access Site on Mortality and Bleeding AfterPercutaneous Coronary Intervention: Insights from the California NCDR Registry. Femi Philip

TCT 359: Ulnar Artery Transient Compression Facilitating Radial Artery patent hemostasis (ULTRA). A Novel Technique to ReduceRadial Artery Occlusion Michail Koutouzis

Moderated Poster Session: Bioresorable Scaffold Implantation Techniques


Moderated Poster Session: Bioresorable Scaffold Implantation TechniquesModerators: Ronald Caputo, Maurizio Menichelli

TCT 397: Effect of Post-Dilatation on Device Expansion and Arterial Healing Following Everolimus-Eluting Bioresorbable Stent(Absorb BVS) Versus Durable Polymer Everolimus-Eluting Metallic Stent (EES) Implantation in STEMI Patients: Substudy of ABSORBSTE Kyohei Yamaji

TCT 398: Impact of Scaffold Oversizing, Underexpansion and Post-Dilatation on Acute Angiographic and One Year clinical Outcomesin Patients with ACS Treated with Bioresorbable Vascular Scaffolds. A Pooled Analysis from BVS STEMI First and BVS EXPAND StudiMariusz Tomaniak

TCT 399: Impact of Post-Dilatation on Angiographic and Clinical Outcomes of Patients Undergoing Bioresorbable ScaffoldImplantation in Clinical Practice Jen Wiebe

TCT 400: The Importance of Implantation Technique in Ensuring Optimal Outcomes After Bioresorbable Scaffold Implantation:Implications From a Real-World Cohort Akihito Tanaka

Moderated Poster Session: PCI Complications



Moderated Poster Session: PCI ComplicationsModerators: Mauricio G. Cohen, Bernhard Witzenbichler

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI):Insights from a Multi-center Australian Registry Stavroula Papapostolou

TCT 251: Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention Gaurav Patel

TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in theUnited Kingdom Between 2006–2013: an analysis of 527,121 Cases from the British Cardiovascular Intervention Society DatabaseTim Kinnaird

TCT 259: Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence and Outcomes Oliver Guttmann

Moderated Poster Session: Physiologic Lesion Assessment and Aortic Stenosis


Moderated Poster Session: Physiologic Lesion Assessment and Aortic StenosisModerators: Alan C. Yeung, Tim P. van de Hoef

TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic ValveStenosis. Gabriele Pesarini

TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI. Gabriele Pesarini

TCT 518: The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an IntermediateCoronary Artery Stenosis Yuhei Kobayashi

TCT 519: Correlation Between Invasive CFR AND Echocardiographic Parameters in Severe Aortic Stenosis Alejandro Gutierrez

Moderated Poster Session: Vulnerable Plaque


Moderated Poster Session: Vulnerable PlaqueModerators: Eric Boersma, James E. Muller

TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are EvenlyDistributed Throughout the Entire Right Coronary Artery? –Results from Computational Fluid Dynamics Simulation by CT-FFR Takayoshi Toba

TCT 598: Plaque Rupture in Coronary Atherosclerosis is Associated with Increased Plaque Structural Stress Charis Costopoulos

TCT 599: Not All Plaque Ruptures Are Born Equal: An Optical Coherence Tomography Study Hesham R.M. Sherif

TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study Tadayuki Kadohira

Exhibit Hall



Breakfast Meeting: Guidewire Design and Selection: A User’s Guide (Sponsored by CRF, Supported by Abbott, Boston ScientificCorporation, and Medtronic, Inc.)



Guidewire Design and Selection: A User’s GuideCo-Chairs: Martin B. Leon, Jeffrey W. Moses Facultys: Christopher E. Buller, Dimitrios Karmpaliotis, Ajay J. Kirtane, James C. Spratt

Welcome and Introductions Jeffrey W. Moses

Anatomy and Design of Coronary Guidewires 101: Engineering for the Interventionalist Christopher E. Buller

Hydrophilic and Support Wires Ajay J. Kirtane

Applied Use of Coronary Guidewires: Basic Principles for Wire Manipulation James C. Spratt

CTO Wires: Antegrade and Retrograde Approaches Case Presenter: Dimitrios Karmpaliotis

Discussion

Breakfast Meeting: Integrating Physiology and Imaging Into the Cath Lab: What Technology Should I Use and How and When Should I UseIt? (Sponsored by CRF, Supported by Boston Scientific Corporation, GE Healthcare and St. Jude Medical, Inc.)

Cardiovascular Research Foundation Room 145B, Level 1Accreditation: CME


Integrating Physiology and Imaging Into the Cath Lab: What Technology Should I Use and How and When Should I Use It?Co-Chairs: John McB. Hodgson, Gary S. Mintz Facultys: Allen Jeremias, Bon-Kwon Koo, Yoshinobu Onuma

How Do I Assess an Intermediate Lesion? FFR? iFR? Angio-FFR? Allen Jeremias

How Do I Optimize Metallic Stent Implantation? John McB. Hodgson

How Do I Optimize Bioresorbable Vascular Scaffold Implantation? Yoshinobu Onuma

How and When Do I Assess a Jailed Side Branch After Provisional Stenting? Bon-Kwon Koo

How Do I Assess Causes of Stent Thrombosis and In-Stent Restenosis? Gary S. Mintz

Discussion

Main Arena IV, Wednesday, Nov 2


Plenary Session I. Live CasesLive Case Moderator: Gregg W. Stone Live Case Co-Moderator: Michael J. Mack Live Case Discussants: Shmuel Banai, Maurice Buchbinder, Vladimir Dzavik, Steven L. Goldberg, Howard C. Herrmann, Samir R. Kapadia,Massoud A. Leesar, Sigmund Silber, Jean-François Tanguay, Leif Thuesen, Nicolas M. Van Mieghem Digital Moderator: Alexandre Abizaid Digital Panelists: Kenneth Chin, Stamatios Lerakis, Ashish Pershad, Harsimran Sachdeva Singh Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong HwaYamamoto

San Raffaele Scientific Institute, Milan Italy Live Case Operators: Alaide Chieffo, Antonio Colombo, Azeem Latib, Matteo Montorfano, MD

The Mount Sinai Hospital, New York, NY Live Case Operator: David H. Adams

Plenary Session II. Late-Breaking Clinical Trials 4Moderator: Martin B. Leon Digital Moderator: Louis A. Cannon Digital Panelists: Gary Gershony, Aaron V. Kaplan Discussants: Peter C. Block, Maurice Buchbinder, William A. Gray, David R. Holmes Jr., Sriram S. Iyer, David Meerkin, Sahil A. Parikh, JosepRodés-Cabau, Pieter R. Stella, Craig M. Walker Co-Moderator: Robert J. Sommer

ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment ofDiseased Superficial Femoral and Popliteal Arteries Sean P Lyden

Moderated Roundtable Discussion Discussant: Sean P Lyden

WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Devicefor Stroke Prevention in Patients With Atrial Fibrillation David R. Holmes Jr.

Moderated Roundtable Discussion Discussant: David R. Holmes Jr.

AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device forStroke Prevention in Patients With Atrial Fibrillation David Hildick-Smith

Moderated Roundtable Discussion Discussant: David Hildick-Smith

Plenary Session III. Live CasesLive Case Moderator: Martin B. Leon Live Case Co-Moderator: Josep Rodés-Cabau Live Case Discussants: Anson Cheung, Tony J. DeMartini, Chandan Devireddy, Anthony H. Gershlick, Linda D. Gillam, Mayra Guerrero,Nicholas J. Lembo, Brij Maini, Jeffrey W. Moses, David W.M. Muller, Harsimran Sachdeva Singh, Hadley Wilson Digital Moderator: Tamim Nazif Digital Panelists: Antonio L. Bartorelli, Pieter R. Stella, Torsten P. Vahl Factoid Facultys: Adriano Caixeta, Jaya Chandrasekhar, Christine J. Chung, Darshan Doshi, Serdar Farhan, Jonathan Soverow, Myong HwaYamamoto

Henry Ford Hospital, Detroit, MI Live Case Operators: Marvin Eng, MD, FACC, Adam B. Greenbaum, William W. O'Neill, Gaetano Paone, MD

Scripps Clinic and Research Foundation, La Jolla, CA Live Case Operators: Matthew J. Price, Curtiss Stinis, MD, Paul S. Teirstein

Plenary Session IV. Best Abstract Award (Cosponsored by EuroIntervention and Cardiac Catheterization and Interventions)Moderators: Steven R. Bailey, Patrick W. Serruys

Announcement of the Winning Submission and Presenter Moderators: Steven R. Bailey, Patrick W. Serruys

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder WithBioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO) Horst Sievert

Presentation of the Award Horst Sievert

Plenary Session V. Innovation Highlights at TCT 2016Moderators: Juan F. Granada, Greg L. Kaluza

The TCT 2016 Innovation Award Competition: Session Highlights and Winners Announcement Juan F. Granada

Shark Tank Innovation Award Competition Winner (Presentation)

Plenary Session VI. TCT Focus Session #4: Rediscovering Cardiovascular HemodynamicsModerator: William T. Abraham Digital Moderator: Srihari S. Naidu Digital Panelists: Mark Goldberger, Susan M Joseph, Jens Kastrup Discussants: M Chadi Alraies, Daniel Burkhoff, Francisco Fdez-Aviles, Hans R. Figulla, Navin K. Kapur, David W.M. Muller, Marvin J. Slepian,Hiroo Takayama, James E. Udelson, Nicolas M. Van Mieghem Co-Moderator: Ajay J. Kirtane

Featured Lecture: New Tools to Understand and Teach Cardiovascular Hemodynamics Daniel Burkhoff

Featured Lecture: Hemodynamic and Device-Directed Approaches to Patients With Shock and Heart Failure Navin K. Kapur

Animated Discussion

Plenary Session VII. First Report Investigations 4Moderator: Gary S. Mintz Digital Moderator: Robert-Jan van Geuns Digital Panelists: Tony J. DeMartini, Roberto Diletti, Michael Haude Discussants: M Chadi Alraies, Mauro Carlino, Evald H. Christiansen, Kevin J. Croce, Lei Ge, Dimitrios Karmpaliotis, Manuel Pan, GeorgiosSianos, Giulio G. Stefanini, Bradley H. Strauss, Mladen I. Vidovich, Wojtek Wojakowski

PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients With Coronary Artery Chronic Total Occlusions Koen Teeuwen

Moderated Roundtable Discussion Discussant: Koen Teeuwen

TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients With Coronary Artery Chronic TotalOcclusions Christopher E. Buller

Moderated Roundtable Discussion Discussant: Christopher E. Buller

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months andNeoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Giulio Guagliumi

Moderated Roundtable Discussion Discussant: Giulio Guagliumi

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal orDrug-Eluting In-Stent Restenosis – Six Month-Nine Month Clinical and Angiographic Follow-up Results Fernando Alfonso

Moderated Roundtable Discussion Discussant: Fernando Alfonso

Coronary Theater IV, Wednesday, Nov. 2


Session I. Live Cases: Imaging, Physiology and AtherectomyLive Case Moderator: Ajay J. Kirtane Live Case Co-Moderator: Ziad A. Ali Live Case Discussants: Kevin J. Croce, Marc D. Feldman, Angela Hoye, David F. Kong, Jorge H. Leguizamon, Mathew K. Samuel, Mladen I.Vidovich, Marco V. Wainstein Digital Moderator: Nick E. J. West Digital Panelists: Dimitriy N. Feldman, Roger Gammon, Pim A.L. Tonino Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom Live Case Operators: Rasha Al-Lamee, MD, Christopher Baker, MD, PhD, Justin E. Davies, Iqbal Malik, MD, PhD, Sayan Sen, MD, PhD

The Mount Sinai Hospital, NY, NY Live Case Operators: George D. Dangas, Annapoorna S. Kini, MD, Samin K. Sharma

Session II: Live Cases: Imaging, Physiology and AtherectomyLive Case Moderator: John McB. Hodgson Live Case Co-Moderator: Alexey Protopopov Live Case Discussants: Joost Daemen, Giulio Guagliumi, Michael C. Kim, Jacek Legutko, James R. Margolis, Evelyn S. Regar, Thomas MTu, Pascal Vranckx, Tim P. van de Hoef Digital Moderator: Allen Jeremias Digital Panelists: Ioannis Iakovou, Jasvindar Singh, Christian M. Spaulding Factoid Facultys: Bimmer E. Claessen, Rajesh Gupta, Vivian Ng, Elias Sanidas

Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom Live Case Operators: Rasha Al-Lamee, MD, Christopher Baker, MD, PhD, Justin E. Davies, Iqbal Malik, MD, PhD, Sayan Sen, MD, PhD

Scripps Clinic and Research Foundation, La Jolla, CA Live Case Operators: Curtiss Stinis, MD, Paul S. Teirstein

Structural Theater III, Wednesday, Nov. 2


Session I: Live Cases: Lampoon & TAVRLive Case Moderator: Ted Feldman Live Case Co-Moderator: Brian K. Whisenant Live Case Discussants: Colin M. Barker, Philipp Blanke, Mauricio G. Cohen, Amit N Patel, Ramon Quesada, Toby Rogers, Glenn VanLangenhove, Adam Witkowski, Jochen Wöhrle Digital Moderator: Kishore J. Harjai Digital Panelists: Nicola Corvaja, Tamim Nazif, Bushra S Rana Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

Henry Ford Health System, Detroit, MI Live Case Operators: Marvin Eng, MD, FACC, Adam B. Greenbaum, William W. O'Neill, Gaetano Paone, MD Live Case Guest Operators: Vasilis Babaliaros, Robert J. Lederman

San Raffaele Scientific Institute, Milan, Italy Live Case Operators: Alaide Chieffo, Antonio Colombo, Azeem Latib, Matteo Montorfano, MD

Session II: Live Cases: LAA ClosureLive Case Moderator: Philippe Généreux Live Case Co-Moderator: Krzysztof Bartus Live Case Discussants: Haim Danenberg, Isaac George, George S. Hanzel, Michael J. Lim, Paul D. Mahoney, Massimo Napodano, AugustoD. Pichard, Eric Van Belle, Grayson H. Wheatley Digital Moderator: Jeffrey J. Popma Digital Panelists: David A. Cox, Petr Kala, Kambis Mashayekhi Factoid Facultys: Seyi Bolorunduro, Michela Faggioni, Ramin S. Hastings, Birgit Vogel

The Mount Sinai Hospital, NY, NY Live Case Operators: Srinivas Dukkipati, MD, Vivek Y. Reddy

Henry Ford Health System, Detroit, MI Live Case Operators: Marvin Eng, MD, FACC, Adam B. Greenbaum, William W. O'Neill, Gaetano Paone, MD

Walter E. Washington Convention Center WASHINGTON, DC ... · Discussants: Robert J. Applegate, Kirk...

Documents

Transcript of Walter E. Washington Convention Center WASHINGTON, DC ... · Discussants: Robert J. Applegate, Kirk...